FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Souza, MA
   Cecatti, JG
   Guida, JP
   Souza, JP
   Gulmezoglu, AM
   Betran, AP
   Torloni, MR
   Vogel, JP
   Costa, ML
AF Souza, Marcio A.
   Cecatti, Jose G.
   Guida, Jose P.
   Souza, Joao P.
   Gulmezoglu, Ahmet M.
   Betran, Ana P.
   R.Torloni, Maria
   Vogel, Joshua P.
   Costa, Maria L.
CA WHO-MCS Study Grp
TI Analgesia for vaginal birth: Secondary analysis from the WHO
   Multicountry Survey on Maternal and Newborn Health
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article; Early Access
DE Analgesia; Birth; Epidural; Labor; Maternal health; Vaginal birth
ID EPIDURAL ANALGESIA; LABOR; INTERVENTIONS; ANESTHESIA; DELIVERY;
   CRITERIA; MISS; CARE; PAIN
AB Objective To evaluate the use of analgesia during labor in women who had a vaginal birth and to determine the factors associated with its use.
   Methods A secondary analysis was performed of the WHO Multicountry Survey on Maternal and Newborn Health, a cross-sectional, facility-based survey including 359 healthcare facilities in 29 countries. The prevalence of analgesia use for vaginal birth in different countries was reported according to the Human Development Index (HDI). Sociodemographic and obstetric characteristics of the participants with and without analgesia were compared. The prevalence ratios were compared across countries, HDI groups, and regions using a design-based chi(2) test.
   Results Among the 221 345 women who had a vaginal birth, only 4% received labor analgesia, mainly epidural. The prevalence of women receiving analgesia was significantly higher in countries with a higher HDI than in countries with a lower HDI. Education was significantly associated with increased use of analgesia; nulliparous women and women undergoing previous cesarean delivery had a significantly increased likelihood of receiving analgesia.
   Conclusion Use of analgesia for women undergoing labor and vaginal delivery was low, specifically in low-HDI countries. Whether low use of analgesia reflects women's desire or an unmet need for pain relief requires further studies.
C1 [Souza, Marcio A.; Cecatti, Jose G.; Guida, Jose P.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, Brazil.
   [Souza, Joao P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Ribeirao Preto, SP, Brazil.
   [Gulmezoglu, Ahmet M.; Betran, Ana P.; Vogel, Joshua P.] WHO, UNDP UNFPA UNICEF WHO World Bank Special Program, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [R.Torloni, Maria] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Vogel, Joshua P.] Burnet Inst, Maternal & Child Hlth Program, Melbourne, Vic, Australia.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM mlaura@unicamp.br
FU UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction; WHOWorld Health
   Organization; United States Agency for International DevelopmentUnited
   States Agency for International Development (USAID); Ministry of Health,
   Labour and Welfare of JapanMinistry of Health, Labour and Welfare,
   Japan; Gynuity Health Projects
FX UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction; WHO; United
   States Agency for International Development; Ministry of Health, Labour
   and Welfare of Japan; Gynuity Health Projects
CR Anim-Somuah M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub4
   [Anonymous], 2004, Obstet Gynecol, V104, P213
   Betran AP, 2018, LANCET, V392, P1358, DOI 10.1016/S0140-6736(18)31927-5
   BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343
   Butwick AJ, 2018, ANESTHESIOLOGY, V129, P448, DOI 10.1097/ALN.0000000000002322
   Committee on Practice BulletinsObstetrics, 2017, Obstet Gynecol, V129, pe73, DOI 10.1097/AOG.0000000000002018
   Debiec J, 2009, ANESTHESIOLOGY, V111, P1093, DOI 10.1097/ALN.0b013e3181ba3f28
   Freeman L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205220
   Grisaru-Granovsky S, 2018, J PERINAT MED, V46, P261, DOI 10.1515/jpm-2016-0382
   Hawkins JL, 2010, NEW ENGL J MED, V362, P1503, DOI 10.1056/NEJMct0909254
   Hu LQ, 2015, INT J GYNECOL OBSTET, V129, P17, DOI 10.1016/j.ijgo.2014.10.030
   Kamakshi Garg, 2018, Anesth Essays Res, V12, P501, DOI 10.4103/aer.AER_48_18
   Kingdon C, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0570-z
   Kpea L, 2015, ANESTH ANALG, V121, P759, DOI 10.1213/ANE.0000000000000832
   Lally JE, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-7
   Lange EMS, 2017, SEMIN PERINATOL, V41, P293, DOI 10.1053/j.semperi.2017.04.006
   Lowe NK, 2002, AM J OBSTET GYNECOL, V186, pS16, DOI 10.1067/mob.2002.121427
   MELZACK R, 1984, PAIN, V19, P321, DOI 10.1016/0304-3959(84)90079-4
   Oladapo OT, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002492
   Olufolabi AJ, 2015, ANESTH ANALG, V120, P1317, DOI 10.1213/ANE.0000000000000464
   Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1
   Pileggi-Castro C, 2014, BJOG-INT J OBSTET GY, V121, P110, DOI 10.1111/1471-0528.12637
   Santos JP, 2015, CLINICS, V70, P820, DOI 10.6061/clinics/2015(12)10
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Schnittger T, 2007, ANAESTHESIA, V62, P44, DOI 10.1111/j.1365-2044.2007.05297.x
   Scott JR, 2014, BJOG-INT J OBSTET GY, V121, P157, DOI 10.1111/1471-0528.12449
   Sia ATH, 2010, BEST PRACT RES CL OB, V24, P303, DOI 10.1016/j.bpobgyn.2009.12.001
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286
   Souza MA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7596165
   United Nations Development Programme, 2013, HUM DEV REP 2013
   Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X
   Vogt SE, 2011, CAD SAUDE PUBLICA, V27, P1789, DOI 10.1590/S0102-311X2011000900012
   Wang Q, 2018, ARCH GYNECOL OBSTET, V298, P89, DOI 10.1007/s00404-018-4777-6
   Whitburn LY, 2019, WOMEN BIRTH, V32, P28, DOI 10.1016/j.wombi.2018.03.004
   World Health Organization, 2018, WHO REC INTR CAR POS
NR 37
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
DI 10.1002/ijgo.13424
EA NOV 2020
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA OP8FA
UT WOS:000588324100001
PM 33064850
DA 2020-12-08
ER

PT J
AU Sanchez, MP
   Guida, JP
   Simoes, M
   Marangoni, M
   Cralcev, C
   Santos, JC
   Dias, TZ
   Luz, AG
   Costa, ML
AF Sanchez, Mariana P.
   Guida, Jose P.
   Simoes, Marcela
   Marangoni-Junior, Marcos
   Cralcev, Christopher
   Santos, Juliana C.
   Dias, Tabata Z.
   Luz, Adriana G.
   Costa, Maria L.
TI Can pre-eclampsia explain higher cesarean rates in the different groups
   of Robson's classification?
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article; Early Access
DE Audit; Birth; Cesarean rates; Delivery; Pre-eclampsia; Robson
   classification
ID PREGNANCY; DELIVERY
AB Objective To evaluate the impact of pre-eclampsia on cesarean delivery by using the Robson classification. Methods A retrospective cross-sectional study including all women who delivered in a referral maternity hospital in southeast Brazil from January 2017 to February 2018. Women were classified into 1 of 10 Robson groups and then further subdivided into pre-eclampsia (PE) and non-PE (NPE) groups. Frequency of cesarean was determined for each group and compared by using chi(2)and prevalence ratio. Results Overall, 3102 women were included, of whom 1578 (50.9%) delivered by cesarean. Classification in Robson group 5 was the most frequent among all women (n=727, 23.4%). In the PE group (n=258, 8.3%), group 10 was the most frequent classification (n=120, 46.5%); in NPE, Robson group 5 was the most frequency (n=682, 24.0%). Pre-eclampsia was associated with a higher occurrence of cesarean (77.5% vs 48.4%; prevalence ratio, 2.29; 95% confidence interval, 1.82-2.82), owing to higher rates in Robson groups 1, 5, and 10. Conclusion Pre-eclampsia was associated with a higher occurrence of cesarean delivery in some Robson groups. Robson classification may be used to evaluate the impact of specific conditions at a facility level to help plan future interventions to optimize the use of cesarean.
C1 [Sanchez, Mariana P.; Guida, Jose P.; Simoes, Marcela; Marangoni-Junior, Marcos; Cralcev, Christopher; Santos, Juliana C.; Dias, Tabata Z.; Luz, Adriana G.; Costa, Maria L.] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Guida, JP (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM zepauloguida@gmail.com
CR [Anonymous], 1985, LANCET, V2, P436
   [Anonymous], 2017, ROBSON CLASSIFICATIO
   Barros FC, 2015, REV PANAM SALUD PUBL, V38, P217
   Dias MAB, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0231-z
   Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526
   Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6
   Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769
   Bolognani CV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192997
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102
   Chappell LC, 2019, LANCET, V394, P1181, DOI 10.1016/S0140-6736(19)31963-4
   Guida JPD, 2017, REV BRAS GINECOL OBS, V39, P622, DOI 10.1055/s-0037-1604103
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Guida JP, 2018, INT J GYNECOL OBSTET, V143, P101, DOI 10.1002/ijgo.12487
   Guida JPS, 2017, INT J GYNECOL OBSTET, V136, P354, DOI 10.1002/ijgo.12082
   Leal MD, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0230-0
   Nakamura-Pereira M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0228-7
   Peracoli JC, 2019, REV BRAS GINECOL OBS, V41, P318, DOI 10.1055/s-0039-1687859
   Rodrigues OMPR, 2011, REV BRAS GINECOL OBS, V33, P252, DOI [10.1590/S0100-72032011000500008, 10.1590/S0100-72032011000900006]
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004
   Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156
   Fernandes RZS, 2014, CIENC SAUDE COLETIVA, V19, P4457, DOI 10.1590/1413-812320141911.21662013
   Souza JP, 2016, BJOG-INT J OBSTET GY, V123, P427, DOI 10.1111/1471-0528.13509
   Souza MA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7596165
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
NR 27
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
DI 10.1002/ijgo.13370
EA SEP 2020
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA NT6YJ
UT WOS:000573083400001
PM 32920856
DA 2020-12-08
ER

PT J
AU Venceslau, EM
   Guida, JP
   Amaral, E
   Modena, JLP
   Costa, ML
AF Venceslau, Emanuella Meneses
   Guida, Jose Paulo
   Amaral, Eliana
   Proenca Modena, Jose Luis
   Costa, Maria Laura
TI Characterization of Placental Infection by Zika Virus in Humans: A
   Review of the Literature
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Review
DE Zika virus; ZIKV; placenta; Hofbauer cells; TORCH
ID VIRAL-INFECTION; HOFBAUER CELLS; FETAL TISSUE; PATHOLOGY; FETUSES;
   BRAZIL; PROLIFERATION; STATES; BRAIN
AB Objective The aim of the current review is to present a systematic evaluation of reported human placental findings in cases of zika virus (ZIKV) infection.
   Data sources We reviewed the EMBASE, PUBMED, and SCIELO databases until June 2019, without language restrictions.
   Selection of studies The search terms placenta AND zika virus were used. The inclusion criteria of the studies were studies that reported placental findings in humans. Experimental studies, reviews, notes or editorials were excluded. A total of 436 studies were retrieved; after duplicate exclusion, 243 articles had their titles screened, and 128 had their abstract read; of those, 32 were included in the final analysis (18 case reports, 10 case series, and 4 cohorts)
   Data collection We collected data concerning the author, year of publication, study design, number of participants, number of placental samples, onset of symptoms, perinatal outcomes, and main findings on histological analysis.
   Data synthesis The placental pathologic findings were described as mild and nonspecific, similar to those of other placental infections, including chronic placentitis, chronic villitis, increased Hofbauer cells, irregular fibrin deposits, increased mononuclear cells in the villus stroma, villous immaturity, edema, hypervascularization, stromal fibrosis, calcification, and focal necrosis of syncytiotrophoblasts.
   Conclusion Zika infection presents unspecific placental findings, similar to other infections in the toxoplasmosis, other agents, rubella, cytomegalovirus, and herpes (TORCH)group. Characterizing and standardizing placental findings after zika virus infection is key to understanding the mechanisms of congenital diseases.
C1 [Venceslau, Emanuella Meneses; Guida, Jose Paulo; Amaral, Eliana; Costa, Maria Laura] Univ Estadual Campinas, Dept Gynecol & Obstet, Campinas, SP, Brazil.
   [Proenca Modena, Jose Luis] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil.
RP Guida, JP (corresponding author), Univ Estadual Campinas, Campinas, SP, Brazil.
EM zepauloguida@gmail.com
RI ; Proenca-Modena, Jose Luiz/C-8231-2014
OI Guida, Jose Paulo Siqueira/0000-0002-3648-6159; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Amaral, Eliana/0000-0001-9151-3108
FU Fundacao de Amparo a Pesquisa do Estado (FAPESP) [2016/00194-8];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [409605/2016-6]; CAPESCAPES [88882.329828/2019]
FX The present work was financed by Fundacao de Amparo a Pesquisa do Estado
   (FAPESP)-2016/00194-8 and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)-409605/2016-6. Venceslau E. M. has CAPES
   support (88882.329828/2019), and Costa M. L. has CNPq support:
   #409605/2016-6. Amaral E. is a CNPq research fellow. The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the present manuscript.
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burton GJ, 2017, PLACENTA, V60, P134, DOI 10.1016/j.placenta.2017.06.007
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0051
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esquivel M, 2018, AM J OBSTET GYNECO S, V218, P520, DOI [10.1016/j.ajog.2017.11.410, DOI 10.1016/J.AJOG.2017.11.410]
   Felix A, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000009178, 10.1097/md.0000000000009178]
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026
   Guttmacher Institute, 2018, AB LAT AM CAR
   Joerink M, 2011, PLACENTA, V32, P380, DOI 10.1016/j.placenta.2011.02.003
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Maykin M, 2018, AM J OBSTET GYNECOL, V218, pS520
   Merriam AA, 2020, AM J PERINAT, V37, P731, DOI 10.1055/s-0039-1688819
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mletzko J, 2018, REV MED MICROBIOL, V29, P17, DOI 10.1097/MRM.0000000000000121
   MOSTOUFIZADEH M, 1984, ARCH PATHOL LAB MED, V108, P403
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   REDLINE RW, 1993, AM J PATHOL, V143, P473
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rodo C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.008
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Santos GR, 2020, INT J GYNECOL PATHOL, V39, P157, DOI 10.1097/PGP.0000000000000586
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   SCHWARTZ DA, 1992, ARCH PATHOL LAB MED, V116, P21
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Seferovic MD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030712
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Turley M, 2018, AM J OBSTET GYNECOL, V218, pS54
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wongsurawat T, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01020-18, 10.1128/mra.01020-18]
   Yarrington Christina D, 2019, Fertil Res Pract, V5, P1, DOI 10.1186/s40738-018-0053-5
NR 50
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD SEP
PY 2020
VL 42
IS 9
BP 577
EP 585
DI 10.1055/s-0040-1712126
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA OH2YU
UT WOS:000582436300010
PM 32559805
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Baptista, LC
   Costa, ML
   Surita, FG
   Rocha, CD
   Lopes-Cendes, I
   de Souza, BB
   Costa, FF
   de Melo, MB
AF Baptista, Leticia Carvalho
   Costa, Maria Laura
   Surita, Fernanda Garanhani
   Rocha, Cristiane de Souza
   Lopes-Cendes, Iscia
   de Souza, Bruno Batista
   Costa, Fernando Ferreira
   de Melo, Monica Barbosa
TI Placental transcriptome profile of women with sickle cell disease
   reveals differentially expressed genes involved in migration,
   trophoblast differentiation and inflammation
SO BLOOD CELLS MOLECULES AND DISEASES
LA English
DT Article
DE Sickle cell disease; Placenta; Gene expression; Inflammation; RNA-seq
ID CARCINOMA-CELLS; BREAST-CANCER; UP-REGULATION; PREGNANCY; HYPOXIA;
   APOPTOSIS; PREVENTION; SUPPRESSOR; ANEMIA; MODEL
AB Sickle cell disease (SCD) is a group of disorders whose common characteristic is the presence of hemoglobin (Hb) S in erythrocytes. The main consequence of this abnormality is vaso-occlusion, which can affect almost all organs including the placenta. This study aimed to evaluate the gene expression profile in placentas of women with SCD by means of total RNA sequencing. For this, we proposed a case-control study, with three groups of pregnant women: HbSS (n = 10), HbSC (n = 14) and HbAA (n = 21). The results showed differences in expression in a number of genes such as NOS2 (fold change, FC = 4.52), HLAG (FC = 5.56), ASCL2 (FC = 3.61), CXCL10 (FC = -3.66) and IL1R2 (FC = 3.92) for the HbSC group and S100A8 (FC = -3.82), CPXM2 (FC = 4.57), CXCL10 (FC = -4.59), CXCL11 (FC = -3.72) and CAMP (FC = -4.55) for the HbSS group. Differentially expressed genes are mainly associated with migration, trophoblast differentiation and inflammation. The causes leading to altered gene expression in placentas of sickle cell patients are not fully understood, but the presence of intravascular hemolysis and vaso-occlusion, with cycles of ischemia and reperfusion, may contribute to the emergence of an environment which can be very harmful for placental physiology, altering the nutrient supply and metabolic exchange for fetal growth.
C1 [Baptista, Leticia Carvalho; de Souza, Bruno Batista; de Melo, Monica Barbosa] Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, BR-13083875 Campinas, SP, Brazil.
   [Costa, Maria Laura; Surita, Fernanda Garanhani] Univ Campinas UNICAMP, Dept Obstet & Gynecol, BR-13083880 Campinas, SP, Brazil.
   [Rocha, Cristiane de Souza; Lopes-Cendes, Iscia] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet & Genom Med, BR-13083887 Campinas, SP, Brazil.
   [Costa, Fernando Ferreira] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, BR-13083878 Campinas, SP, Brazil.
RP de Melo, MB (corresponding author), Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, BR-13083875 Campinas, SP, Brazil.
EM lecbap@gmail.com; mlaura@unicamp.br; surita@unicamp.br;
   crirocha@gmail.com; icendes@unicamp.br; brunobsouzaa@gmail.com;
   ferreira@unicamp.br; melomb@unicamp.br
FU Sao Paulo Research Foundation (FAPESP) grantFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2015/08330-5, 2014/00984-3];
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [409605/2016-6, 424607/2016-6]
FX This study was supported by Sao Paulo Research Foundation (FAPESP) grant
   2015/08330-5 and grant 2014/00984-3 and the National Council for
   Scientific and Technological Development (CNPq) grant 409605/2016-6 and
   grant 424607/2016-6.
CR Azar C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23379-2
   Baptista LC, 2016, ANN HEMATOL, V95, P1859, DOI 10.1007/s00277-016-2780-1
   Benites BD, 2016, TRANSFUSION, V56, P119, DOI 10.1111/trf.13280
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Chiang EY, 2005, HEMATOL ONCOL CLIN N, V19, P771, DOI 10.1016/j.hoc.2005.08.002
   Cowden Dahl Karen D, 2005, Mol Cell Biol, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005
   Cox SE, 2014, BRIT J HAEMATOL, V165, P699, DOI 10.1111/bjh.12791
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032
   Du L, 2017, J HUM HYPERTENS, V31, P49, DOI 10.1038/jhh.2016.17
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hassell K, 2005, HEMATOL ONCOL CLIN N, V19, P903, DOI 10.1016/j.hoc.2005.07.003
   Hirota Y, 2006, J IMMUNOL, V177, P8813, DOI 10.4049/jimmunol.177.12.8813
   Jain A, 2019, INT J MICROW WIREL T, V11, P1, DOI 10.1017/S175907871800137X
   Jia YY, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116715
   Jiang B, 2003, MOL CELL BIOL, V23, P6117, DOI 10.1128/MCB.23.17.6117-6128.2003
   Jin L, 2012, CELL RES, V22, P1356, DOI 10.1038/cr.2012.90
   Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10
   Kawasaki K, 2015, MOL HUM REPROD, V21, P217, DOI 10.1093/molehr/gau096
   Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938
   Kuypers FA, 2014, HEMATOL ONCOL CLIN N, V28, P155, DOI 10.1016/j.hoc.2013.12.002
   Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107
   Lin Y, 2009, REPRODUCTION, V137, P943, DOI 10.1530/REP-08-0412
   Liu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep36193
   Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mario Nuno-Ayala, 2012, PHYSIOL GENOMICS, V44, P702
   Marshall K, 2018, BLOOD CELL MOL DIS, V73, P1, DOI 10.1016/j.bcmd.2018.08.001
   Martinez VG, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0659-2
   Mendonca R, 2016, INFLAMM RES, V65, P665, DOI 10.1007/s00011-016-0955-9
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Nair RR, 2013, PLACENTA, V34, P824, DOI 10.1016/j.placenta.2013.06.307
   Oh SM, 2019, MOLECULES, V24, DOI 10.3390/molecules24040760
   Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317
   Pantanowitz L, 2000, ARCH PATHOL LAB MED, V124, P1565
   Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116
   Rao X, 2020, NEOPLASMA, V67, P410, DOI 10.4149/neo_2019_190531N475
   Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006
   Sabri A, 2014, FETAL DIAGN THER, V36, P173, DOI 10.1159/000360535
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186
   Shang YY, 2017, EXP CELL RES, V360, P243, DOI 10.1016/j.yexcr.2017.09.014
   Silveira AAA, 2019, J LEUKOCYTE BIOL, V106, P35, DOI 10.1002/JLB.3MIA1118-418RR
   Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003
   Vallelian F, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.392
   Vinchi F, 2016, BLOOD, V127, P473, DOI 10.1182/blood-2015-08-663245
   Wakeland AK, 2017, AM J PATHOL, V187, P767, DOI 10.1016/j.ajpath.2016.11.018
   Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356
   Xu YJ, 2019, J CANCER, V10, P6925, DOI 10.7150/jca.33698
   Ye YS, 2020, CANCER MANAG RES, V12, P2353, DOI 10.2147/CMAR.S228984
NR 50
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1079-9796
EI 1096-0961
J9 BLOOD CELL MOL DIS
JI Blood Cells Mol. Dis.
PD SEP
PY 2020
VL 84
AR 102458
DI 10.1016/j.bcmd.2020.102458
PG 10
WC Hematology
SC Hematology
GA MK4SU
UT WOS:000548779400002
PM 32562953
DA 2020-12-08
ER

PT J
AU Costa, ML
   Pacagnella, RC
   Guida, JP
   Souza, RT
   Charles, CM
   Lajos, GJ
   Haddad, SM
   Fernandes, KG
   Nobrega, GM
   Griggio, TB
   Pabon, SL
   Serruya, S
   Ribeiro-do-Valle, CC
   Cecatti, JG
AF Costa, Maria L.
   Pacagnella, Rodolfo C.
   Guida, Jose P.
   Souza, Renato T.
   Charles, Charles M.
   Lajos, Giuliane J.
   Haddad, Samira M.
   Fernandes, Karayna G.
   Nobrega, Guilherme M.
   Griggio, Thayna B.
   Pabon, Stephanie L.
   Serruya, Suzanne
   Ribeiro-do-Valle, Carolina C.
   Cecatti, Jose G.
CA Brazilian Network Studies Reprod
TI Call to action for a South American network to fight COVID-19 in
   pregnancy
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Coronavirus; COVID-19; Crisis management; Pregnancy; Regional network;
   SARS-CoV-2; Severe maternal morbidity; South America
AB A call to action for joint efforts by South American centers to tackle COVID-19 in pregnancy.
C1 [Costa, Maria L.; Pacagnella, Rodolfo C.; Guida, Jose P.; Souza, Renato T.; Charles, Charles M.; Lajos, Giuliane J.; Nobrega, Guilherme M.; Griggio, Thayna B.; Pabon, Stephanie L.; Ribeiro-do-Valle, Carolina C.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Haddad, Samira M.] UNOESTE, Guaruja Sch Med Sci, Guaruja, SP, Brazil.
   [Fernandes, Karayna G.] Jundiai Sch Med, Jundiai, SP, Brazil.
   [Serruya, Suzanne] Latin Amer Ctr Perinatol CLAP WR FGL PAHO, Montevideo, Uruguay.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM mlaura@unicamp.br
RI FIlho, Edson Cunha/AAX-2927-2020; Souza, Renato Teixeira/G-4205-2017
OI Souza, Renato Teixeira/0000-0002-9075-9269; de Moraes Nobrega,
   Guilherme/0000-0001-9406-4256; Charles, Charles
   M'poca/0000-0001-7133-0574
CR Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Pfitscher LC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1525-z
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   WHO, COR DIS 2019 COVID 1
NR 4
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD AUG
PY 2020
VL 150
IS 2
BP 260
EP 261
DI 10.1002/ijgo.13225
EA JUN 2020
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA MJ7GE
UT WOS:000539781300001
PM 32412120
OA Bronze
DA 2020-12-08
ER

PT J
AU Souza, RT
   Costa, ML
   Mayrink, J
   Feitosa, FE
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Calderon, IM
   Sousa, MH
   Passini, R
   Baker, PN
   Kenny, L
   Cecatti, JG
AF Souza, Renato T.
   Costa, Maria L.
   Mayrink, Jussara
   Feitosa, Francisco E.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Calderon, Iracema M.
   Sousa, Maria H.
   Passini Jr, Renato
   Baker, Philip N.
   Kenny, Louise
   Cecatti, Jose G.
CA Preterm SAMBA Study Grp
TI Perinatal outcomes from preterm and early term births in a multicenter
   cohort of low risk nulliparous women
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CESAREAN-SECTION; MULTICOUNTRY SURVEY; HEALTH; MORTALITY; RATES; CARE
AB Preterm birth is the major contributor for neonatal and under-five years mortality rates and also accounts for a short- and long-term adverse consequences up to adulthood. Perinatal outcomes may vary according to lots of factors as preterm subtype, late prematurity, which account for the vast majority of cases, country and population characteristics. An under-recognition of the perinatal outcomes and its associated factors might have underpowered strategies to provide adequate care and prevent its occurrence. We aim to estimate the frequency of maternal and perinatal outcomes in women with different categories of preterm and term births, factors associated with poorer perinatal outcomes and related management interventions. A multicentre prospective cohort in five maternities in Brazil between 2015 and 2018. Nulliparous low-risk women with singletons were included. Comprehensive data were collected during three antenatal visits (at 19-21weeks, 27-29 weeks and 37-39 weeks). Maternal and perinatal outcomes were also collected according to maternal and neonatal medical records. Women who had spontaneous (sPTB) and provider-initiated (pi-PTB) preterm birth were compared to those who had term birth. Also, late preterm birth (after 34 weeks), and early term (37-38 weeks) were compared to full term birth (39-40 weeks). Bivariate analysis estimated risk ratios for maternal and adverse outcomes. Finally, a multivariate analysis was conducted to address factors independently associated with any adverse perinatal outcome (APO). In total, 1,165 women had outcome data available, from which 6.7% had sPTB, 4.0% had pi-PTB and 89.3% had a term birth. sPTB and pi-PTb were associated with poorer perinatal outcomes, as well as late sPTB, late pi-PTB and early term neonates. pi-PTB (RRadj 8.12, 95% CI [2.54-25.93], p-value 0.007), maternal weight gain between 20 and 27 weeks <p10 (RRadj 2.04, 95% CI [1.23-3.38], p-value 0.018) and participants from the Northeast centres (RRadj 2.35, 95% CI [1.11-4.95], p-value 0.034) were independently associated with APO. According to our findings, Brazil would benefit from strategies to more accurately identify women at higher risk for PTB, to promote evidenced-based decision in preterm and early term provider-initiated deliveries, and to prevent perinatal adverse outcomes.
C1 [Souza, Renato T.; Costa, Maria L.; Mayrink, Jussara; Leite, Debora F.; Passini Jr, Renato; Cecatti, Jose G.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, MEAC Sch Matern, Fortaleza, Ceara, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.] Univ Fed Pernambuco, Matern Clin Hosp, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Vettorazzi, Janete] Fed Univ RS, Matern Clin Hosp, Dept Obstet & Gynaecol, Porto Alegre, RS, Brazil.
   [Calderon, Iracema M.] UNESP, Botucatu Med Sch, Dept Obstet & Gynaecol, Botucatu, SP, Brazil.
   [Sousa, Maria H.] Jundiai Sch Med, Stat Unit, Jundiai, SP, Brazil.
   [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England.
   [Kenny, Louise] Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Calderon, Iracema/W-4336-2019; Leite, Debora F B/D-7299-2018; Souza,
   Renato Teixeira/G-4205-2017
OI Calderon, Iracema/0000-0003-4761-4336; Leite, Debora F
   B/0000-0001-8839-3934; Souza, Renato Teixeira/0000-0002-9075-9269
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [05/2013,
   401636/2013-5]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [05/2013, OPP1107597]
FX This was one of the two big studies selected for sponsoring from the
   research call "Grand Challenges Brazil: Reducing the burden of preterm
   birth" number 05/2013 jointly issued by the Brazilian National Research
   Council (CNPq - Award 401636/2013-5) and the Bill and Melinda Gates
   Foundation (OPP1107597). The funders played no role at all in the study
   design, writing the manuscript nor in the decision to submit the
   manuscript for publication.
CR [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a
   [Anonymous], 2019, OBSTET GYNECOL, V133, pe156, DOI DOI 10.1097/AOG.0000000000003076
   Atalah E, 1997, REV MED CHILE, V125, P1429
   Azevedo Bittencourt Sonia Duarte de, 2014, Cad Saude Publica, V30 Suppl 1, pS1
   Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x
   Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Bodnar LM, 2015, PAEDIATR PERINAT EP, V29, P11, DOI 10.1111/ppe.12168
   Brazil Ministerio da Saude; Centro Brasileiro de Analise e Planejamento, 2009, PESQ NAC DEM SAUD CR
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Chen I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005528.pub3
   Bittencourt SDD, 2015, PAEDIATR INT CHILD H, V35, P206, DOI 10.1179/2046905515Y.0000000028
   Delnord M, 2019, SEMIN FETAL NEONAT M, V24, P3, DOI 10.1016/j.siny.2018.09.001
   Dias TZ, 2017, INT J GYNECOL OBSTET, V139, P222, DOI 10.1002/ijgo.12297
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   FEBRASGO, 2014, ANT CAR GUID
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002255.pub2
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub3
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   GROW, 2014, BULK CENT CALC
   Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783
   Gyamfi-Bannerman C, 2011, SEMIN PERINATOL, V35, P246, DOI 10.1053/j.semperi.2011.05.013
   Helou A, 2017, AUST NZ J OBSTET GYN, V57, P253, DOI 10.1111/ajo.12499
   Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Leal MD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017789
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Melchor JC, 2018, ULTRASOUND OBST GYN, V52, P442, DOI 10.1002/uog.19119
   Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6
   Ministry of Health Brazil, 2012, HIGH RISK PREGN GUID
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Neilson JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004352.pub3
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3
   Sandall J, 2018, LANCET, V392, P1349, DOI 10.1016/S0140-6736(18)31930-5
   Souza JP, 2016, BJOG-INT J OBSTET GY, V123, P427, DOI 10.1111/1471-0528.13509
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza RT, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5476350
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   The National Academies Press. Institute of Medicine (IOM) National Research Council (NRC), 2009, REEXAMINING GUIDELIN
   Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566
   United Nations Development Programme (UNDP), 2010, HUM DEV IND HDI
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   Vogel JP, 2018, BEST PRACT RES CL OB, V52, P3, DOI 10.1016/j.bpobgyn.2018.04.003
   Vogel JP, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000398
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
NR 48
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 22
PY 2020
VL 10
IS 1
DI 10.1038/s41598-020-65022-z
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY4PA
UT WOS:000540510300011
PM 32444773
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Nicolosi, BF
   Souza, RT
   Mayrink, J
   Feitosa, FE
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Sousa, MH
   Costa, ML
   Baker, PN
   Kenny, LC
   Cecatti, JG
   Calderon, IM
AF Nicolosi, Bianca F.
   Souza, Renato T.
   Mayrink, Jussara
   Feitosa, Francisco E.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Sousa, Maria H.
   Costa, Maria L.
   Baker, Philip N.
   Kenny, Louise C.
   Cecatti, Jose G.
   Calderon, Iracema M.
CA Preterm SAMBA Study Grp
TI Incidence and risk factors for hyperglycemia in pregnancy among
   nulliparous women: A Brazilian multicenter cohort study
SO PLOS ONE
LA English
DT Article
ID GESTATIONAL DIABETES-MELLITUS; INTERNATIONAL ASSOCIATION; AGE; CRITERIA;
   OUTCOMES; IMPACT; PREDICTION; GUIDELINES; DIAGNOSIS; BMI
AB Objective
   To assess the incidence and risk factors for hyperglycemia in pregnancy in a cohort of Brazilian nulliparous pregnant women.
   Materials and methods
   This is a secondary analysis of a multicenter cohort study that enrolled 1,008 nulliparous pregnant women at 19-21 weeks. Exclusion criteria included chronic exposure to corticosteroids and previous diabetes. Bivariate and multivariate analyses by Poisson regression were used to identify associated factors.
   Results
   The incidence of hyperglycemia in pregnancy was 14.9% (150/1,008), and 94.7% of these cases were gestational diabetes mellitus (142/150). Significant associated factors included a family history of diabetes mellitus, maternal overweight or obesity at enrollment, and previous maternal conditions (polycystic ovarian syndrome, thyroid dysfunctions and hypertensive disorders). A BMI >= 26.3 Kg/m(2) (RRadj 1.87 [1.66-2.10]) and a family history of diabetes mellitus (RRadj 1.71 [1.37-2.15]) at enrollment were independent risk factors for HIP.
   Conclusions
   A family history of diabetes mellitus and overweight or obesity (until 19-21 weeks of gestation) may be used as selective markers for HIP in Brazilian nulliparous women. Given the scarcity of results in nulliparous women, our findings may contribute to determine the optimal diagnostic approach in populations of similar socioeconomic characteristics.
C1 [Nicolosi, Bianca F.; Calderon, Iracema M.] UNESP, Dept Obstet & Gynecol, Botucatu Med Sch, Botucatu, SP, Brazil.
   [Souza, Renato T.; Mayrink, Jussara; Leite, Debora F.; Costa, Maria L.; Cecatti, Jose G.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, MEAC Matern Sch, Fortaleza, CE, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.] Univ Fed Pernambuco, Matern Clin Hosp, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Vettorazzi, Janete] Fed Univ RS, Matern Clin Hosp, Dept Obstet & Gynecol, Porto Alegre, RS, Brazil.
   [Sousa, Maria H.] Jundiai Sch Med, Stat Unit, Jundiai, SP, Brazil.
   [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England.
   [Kenny, Louise C.] Univ Liverpool, Dept Womens & Childrens Hlth Inst Translat Med, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Calderon, Iracema/W-4336-2019; Leite, Debora F B/D-7299-2018; Souza,
   Renato Teixeira/G-4205-2017
OI Calderon, Iracema/0000-0003-4761-4336; Leite, Debora F
   B/0000-0001-8839-3934; Souza, Renato Teixeira/0000-0002-9075-9269
FU Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
   [OPP1107597]; Brazilian CNPqNational Council for Scientific and
   Technological Development (CNPq) [401636/2013-5]
FX This study was jointly funded by the Bill and Melinda Gates Foundation
   (grant OPP1107597) and the Brazilian CNPq (grant 401636/2013-5). Both
   awarded to JGC. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS137, DOI 10.2337/dc18-S013
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002
   Avalos GE, 2013, DIABETES CARE, V36, P3040, DOI 10.2337/dc12-2669
   Badon SE, 2018, J ENDOCR SOC, V2, P1158, DOI 10.1210/js.2018-00200
   Ben-David A, 2016, MATERN CHILD HLTH J, V20, P833, DOI 10.1007/s10995-015-1914-8
   Bolognani CV, 2014, J MATERN-FETAL NEO M, V27, P943, DOI 10.3109/14767058.2013.847081
   Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011967.pub2
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Collier A, 2017, J DIABETES INVEST, V8, P161, DOI 10.1111/jdi.12552
   Cosson E, 2013, DIABETES CARE, V36, P598, DOI 10.2337/dc12-1428
   Dahanayaka NJ, 2012, CEYLON MED J, V57, P5, DOI 10.4038/cmj.v57i1.4193
   Dennedy MC, 2012, J CLIN ENDOCR METAB, V97, pE608, DOI 10.1210/jc.2011-2674
   Falavigna M, 2013, DIABETES RES CLIN PR, V99, P358, DOI 10.1016/j.diabres.2012.12.009
   Farrar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175288
   Grieger JA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002710
   Hod M, 2015, INT J GYNECOL OBSTET, V131, pS173, DOI [10.1016/S0020-7292(15)30033-3, 10.1016/S0020-7292(15)30007-2]
   Kruse AR, 2015, ACTA OBSTET GYN SCAN, V94, P1367, DOI 10.1111/aogs.12764
   Laine MK, 2018, ACTA OBSTET GYN SCAN, V97, P187, DOI 10.1111/aogs.13271
   Leary J, 2010, BEST PRACT RES CL EN, V24, P673, DOI 10.1016/j.beem.2010.05.009
   Liu LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09055
   McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Morais SS, 2017, CLINICS, V72, P698, DOI 10.6061/clinics/2017(11)09
   Murphy NM, 2016, EUR J OBSTET GYN R B, V199, P60, DOI 10.1016/j.ejogrb.2016.01.044
   Negrato CA, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-3
   North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875
   Organizacao Pan-Americana da Saude. Ministe rio da Sau de. Federacao Brasileira das Associacoes de Ginecologia e Obstetricia, 2016, SOC BRAS DIAB
   Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641
   Schoenaker DAJM, 2018, DIABETES RES CLIN PR, V146, P48, DOI 10.1016/j.diabres.2018.09.021
   Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675
   Sirimarco MP, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-016-0200-2
   Souza RT, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5476350
   Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x
   Trujillo J, 2015, DIABETES RES CLIN PR, V108, P288, DOI 10.1016/j.diabres.2015.02.007
   van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x
   Vernini JM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0206-0
   Visser GHA, 2013, AM J OBSTET GYNECOL, V208, P260, DOI 10.1016/j.ajog.2012.10.881
   von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013
   World Health Organization (WHO), 2013, DIAGN CRIT CLASS HYP
   Zhang CL, 2016, DIABETOLOGIA, V59, P1385, DOI 10.1007/s00125-016-3979-3
NR 40
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2020
VL 15
IS 5
AR e0232664
DI 10.1371/journal.pone.0232664
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LU0VG
UT WOS:000537481000028
PM 32401767
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, EC
   Costa, ML
   Pacagnella, RC
   Silveira, C
   Andreucci, CB
   Zanardi, DM
   Santos, JP
   Angelini, CR
   Souza, RT
   Parpinelli, MA
   Sousa, MH
   Cecatti, JG
AF Ferreira, Elton C.
   Costa, Maria L.
   Pacagnella, Rodolfo C.
   Silveira, Carla
   Andreucci, Carla B.
   Zanardi, Dulce M.
   Santos, Juliana P.
   Angelini, Carina R.
   Souza, Renato T.
   Parpinelli, Mary A.
   Sousa, Maria H.
   Cecatti, Jose G.
TI General and reproductive health among women after an episode of severe
   maternal morbidity: Results from the COMMAG study
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE General health; Maternal death; Maternal near miss; Postpartum period;
   Pregnancy; Reproductive health; Severe maternal morbidity
ID SEVERE OBSTETRIC COMPLICATIONS; NEAR-MISS; CESAREAN-SECTION;
   BURKINA-FASO; MORTALITY; CARE
AB Objective To assess general and reproductive health in women after severe maternal morbidity (SMM).
   Methods A retrospective cohort study was performed at a tertiary maternity hospital. Women with SMM criteria who delivered during 2008-2012 were included in the SMM group. The control group included a random sample of women without SMM delivering in the same year of cases. Both groups were compared regarding sociodemographic/obstetric characteristics, general and reproductive health, using chi(2), Yates chi(2), Fisher exact, and Mann-Whitney tests.
   Results There were 315 women in the SMM group and 323 women in the control group. The SMM group was older and had a history of more medical conditions (hypertension, diabetes, obesity), cesarean deliveries, preterm births, and perinatal deaths. Breastfeeding was negatively affected in these women, as was fertility. The SMM group had a non-significant trend of fewer children after index pregnancy, had new complications in subsequent pregnancies, and required specialized medical care, besides higher risk of death.
   Conclusion Women experiencing SMM are at higher risk of general and reproductive health problems after pregnancy, including risk of death. Therefore, their surveillance and follow-up should continue beyond 42 days postpartum, highlighting the importance of more specialized health care.
C1 [Ferreira, Elton C.; Costa, Maria L.; Pacagnella, Rodolfo C.; Silveira, Carla; Andreucci, Carla B.; Zanardi, Dulce M.; Santos, Juliana P.; Angelini, Carina R.; Souza, Renato T.; Parpinelli, Mary A.; Cecatti, Jose G.] Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, Brazil.
   [Andreucci, Carla B.] Fed Univ Sao Carlos UFSCAR, Dept Med, Sao Carlos, Brazil.
   [Sousa, Maria H.] Jundiai Sch Med, Stat Unit, Jundiai, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; Andreucci, Carla B/J-4845-2015
OI Souza, Renato Teixeira/0000-0002-9075-9269; Andreucci, Carla
   B/0000-0002-5590-108X; ANGELINI, CARINA R/0000-0002-6351-0628
FU CNPq (Brazilian National Research Council)National Council for
   Scientific and Technological Development (CNPq)
FX CNPq (Brazilian National Research Council)
CR Beeson JG, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002665
   Camargo RS, 2011, CLINICS, V66, P1367, DOI 10.1590/S1807-59322011000800010
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2011, CAD SAUDE PUBLICA, V27, P1801, DOI 10.1590/S0102-311X2011000900013
   de la Cruz CZ, 2015, ARCH GYNECOL OBSTET, V292, P1201, DOI 10.1007/s00404-015-3790-2
   Fahmy WM, 2018, MIDWIFERY, V59, P88, DOI 10.1016/j.midw.2018.01.009
   Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8
   Filippi V, 2010, TROP MED INT HEALTH, V15, P733, DOI 10.1111/j.1365-3156.2010.02534.x
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Ganaba R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-22
   Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7
   Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46
   Keag OE, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002494
   Murphy DJ, 2002, EUR J OBSTET GYN R B, V102, P173, DOI 10.1016/S0301-2115(01)00320-7
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Serruya SJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8271042
   Soma-Pillay P, 2018, INT J GYNECOL OBSTET, V141, P133, DOI 10.1002/ijgo.12432
   Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011
   Waterstone M, 2003, BJOG-INT J OBSTET GY, V110, P128, DOI 10.1016/S1470-0328(02)02951-8
   Weathers FW, 1993, 9 ANN C INT SOC TRAU
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   Wright TE, 2016, AM J OBSTET GYNECOL, V215, P539, DOI 10.1016/j.ajog.2016.06.038
   Zwart JJ, 2018, BJOG, V115, P842
NR 25
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUL
PY 2020
VL 150
IS 1
BP 83
EP 91
DI 10.1002/ijgo.13161
EA MAY 2020
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LW6SD
UT WOS:000529797700001
PM 32285452
DA 2020-12-08
ER

PT J
AU Rezende, GP
   Casagrande, L
   Guida, JPS
   Parpinelli, MA
   Surita, FG
   Costa, ML
AF Rezende, Gabriela Pravatta
   Casagrande, Laura
   Siqueira Guida, Jose Paulo
   Parpinelli, Mary Angela
   Surita, Fernanda Garanhani
   Costa, Maria Laura
TI Maternal and Perinatal Outcomes of Pregnancies Complicated by Chronic
   Hypertension Followed at a Referral Hospital
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE preeclampsia; chronic hypertension; obstetrics; maternal morbidity;
   complications of pregnancy
ID WOMEN; RISK; MANAGEMENT; DISEASE
AB Objective To assess maternal and perinatal outcomes of pregnancies in women with chronic hypertension (CH).
   Methods Retrospective cohort of women with CH followed at a referral center for a 5 year period (2012-2017). Data were obtained from medical charts review and described as means and frequencies, and a Poisson regression was performed to identify factors independently associated to the occurrence of superimposed pre-eclampsia (sPE).
   Results A total of 385 women were included in the present study; the majority were > than 30 years old, multiparous, mostly white and obese before pregnancy. One third had pre-eclampsia (PE) in a previous pregnancy and 17% of them had organ damage associated with hypertension, mainly kidney dysfunction. A total of 85% of the patients used aspirin and calcium carbonate for pre-eclampsia prophylaxis and our frequency of sPE was 40%, with an early onset (32.98 +/- 6.14 weeks). Of those, 40% had severe features of PE, including 5 cases of HELLP syndrome; however, no cases of eclampsia or maternal death were reported. C-section incidence was high, gestational age at birth was 36 weeks, and nearly a third (115 cases) of newborns had complications at birth One third of the women remained using antihypertensive drugs after pregnancy.
   Conclusion Chronic hypertension is related with the high occurrence of PE, C-sections, prematurity and neonatal complications. Close surveillance and multidisciplinary care are important for early diagnosis of complications.
C1 [Rezende, Gabriela Pravatta; Casagrande, Laura; Siqueira Guida, Jose Paulo; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM mlaura@unicamp.br
RI ; Surita, Fernanda/H-9575-2012
OI Guida, Jose Paulo Siqueira/0000-0002-3648-6159; Pravatta Rezende,
   Gabriela/0000-0002-7289-0191; Surita, Fernanda/0000-0003-4335-0337
CR Alexander JM, 2013, OBSTET GYN CLIN N AM, V40, P89, DOI 10.1016/j.ogc.2012.11.008
   Aykas F, 2015, J INVEST MED, V63, P641, DOI 10.1097/JIM.0000000000000189
   Boriboonhirunsarn D, 2017, HYPERTENS PREGNANCY, V36, P226, DOI 10.1080/10641955.2017.1311340
   Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803
   Andrade SSD, 2015, EPIDEMIOL SERV SAUDE, V24, P297, DOI 10.5123/S1679-49742015000200012
   FERREIRA SR, 2000, REV BRAS HIPERTENS, V2, P128
   Goulopoulou S, 2017, HYPERTENSION, V70, P1066, DOI 10.1161/HYPERTENSIONAHA.117.08821
   Hadar E, 2015, BEST PRACT RES CL OB, V29, P54, DOI 10.1016/j.bpobgyn.2014.05.011
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Leary PJ, 2012, OBSTET GYNECOL, V120, P1283, DOI [10.1097/AOG.0b013e3182733d56, http://10.1097/AOG.0b013e3182733d56]
   McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036
   Orbach H, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.011
   Podymow T, 2017, SEMIN NEPHROL, V37, P398, DOI 10.1016/j.semnephrol.2017.05.012
   Poon L C, 2017, AM J OBSTET GYNECOL, V217, p585e1
   Siegel AM, 2017, AJP REP, V7, pE145, DOI 10.1055/s-0037-1604076
   van Walraven C, 2003, BRIT MED J, V326, P791, DOI 10.1136/bmj.326.7393.791
   World Health Organization. Global Health Observatory (GHO) [Internet], 2008, RAIS BLOOD PRESS SIT
NR 17
TC 0
Z9 0
U1 2
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAY
PY 2020
VL 42
IS 5
BP 248
EP 254
DI 10.1055/s-0040-1709190
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LU1YF
UT WOS:000537556700004
PM 32483805
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Casagrande, L
   Rezende, GP
   Guida, JP
   Costa, RS
   Parpinelli, MA
   Surita, FG
   Costa, ML
AF Casagrande, Laura
   Rezende, Gabriela P.
   Guida, Jose P.
   Costa, Raquel S.
   Parpinelli, Mary A.
   Surita, Fernanda G.
   Costa, Maria L.
TI Maternal and perinatal outcomes related to superimposed pre-eclampsia in
   a Brazilian cohort of women with chronic hypertension
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Chronic hypertension; Clinical obstetrics; Fetal growth restriction;
   Pre-eclampsia; Prenatal care; Preterm delivery
ID PREGNANCY; CLASSIFICATION; DISORDERS
AB Objective To describe maternal and perinatal outcomes for women with chronic hypertension, comparing those with superimposed pre-eclampsia (SPE) with those without pre-eclampsia (NPE).
   Methods In a retrospective cohort study in a tertiary hospital in Brazil, the records of women with chronic hypertension were reviewed between January 1, 2012, and May 31, 2017, in order to compare maternal and perinatal outcomes among those with and without SPE. Poisson regression was performed to investigate factors independently associated with severe pre-eclampsia.
   Results Of 385 women with chronic hypertension included in the study, 167 were in the SPE group and 218 in the NPE group. The majority were white, overweight (body mass index >= 30 kg/m(2)), with mean age around 31 years. Adverse neonatal outcomes were significantly more prevalent among women with SPE, including small for gestational age (SPE 17.46% vs NPE 9.63%, P=0.01), low birth weight (SPE 2577 g +/- 938 vs NPE 3128 g +/- 723, P=0.003), neonatal intensive care unit admission (SPE 44.91% vs NPE 18.34%, P=0.08), and incidence of cesarean delivery (SPE 79.64% vs NPE 62.38%, P=0.003). Fetal growth restriction (PR [prevalence ratio] 2.62, 95% confidence interval [CI] 1.39-4.94) and previous pre-eclampsia (PR 1.96, 95% CI 1.17-3.28) were associated with severe pre-eclampsia.
   Conclusion SPE is associated with prematurity and higher rates of admission to neonatal intensive care unit. Fetal growth restriction and previous pre-eclampsia are factors associated with severe complications of pre-eclampsia.
C1 [Casagrande, Laura; Rezende, Gabriela P.; Guida, Jose P.; Costa, Raquel S.; Parpinelli, Mary A.; Surita, Fernanda G.; Costa, Maria L.] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Guida, JP (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM zepauloguida@gmail.com
CR Boriboonhirunsarn D, 2017, HYPERTENS PREGNANCY, V36, P226, DOI 10.1080/10641955.2017.1311340
   Chahine KM, 2019, AM J PERINAT, V36, P161, DOI 10.1055/s-0038-1666976
   Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565
   Ferreira EC, 2015, INT J GYNECOL OBSTET, V129, P236, DOI 10.1016/j.ijgo.2014.11.026
   Fonseca A, 2015, MIDWIFERY, V31, P1177, DOI 10.1016/j.midw.2015.09.002
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Guida JP, 2018, INT J GYNECOL OBSTET, V143, P101, DOI 10.1002/ijgo.12487
   Lecarpentier E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062140
   Lugon Jocemir R, 2009, Ethn Dis, V19, pS1
   Lyndon A, 2019, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2019.1628941
   McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x
   Nakanishi S, 2017, PREGNANCY HYPERTENS, V7, P39, DOI 10.1016/j.preghy.2017.01.001
   Prado DS, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000742, 10.11606/s1518-8787.2018052000742]
   REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3
   SIBAI BM, 1983, OBSTET GYNECOL, V61, P571
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Sutton ALM, 2018, OBSTET GYN CLIN N AM, V45, P333, DOI 10.1016/j.ogc.2018.01.012
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   van Oostwaard MF, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.009
NR 19
TC 0
Z9 0
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2020
VL 149
IS 2
BP 148
EP 153
DI 10.1002/ijgo.13114
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LB8XU
UT WOS:000524914600004
PM 32037536
DA 2020-12-08
ER

PT J
AU Costa, ML
   Nobrega, GD
   Antolini-Tavares, A
AF Costa, Maria Laura
   Nobrega, Guilherme de Moraes
   Antolini-Tavares, Arthur
TI Key Infections in the Placenta
SO OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Placenta; Congenital infection; TORCH
ID PARVOVIRUS B19 INFECTION; CONGENITAL-RUBELLA SYNDROME; ZIKA VIRUS;
   CYTOMEGALOVIRUS-INFECTION; TOXOPLASMA-GONDII; PREGNANCY; PROGRESS;
   TRANSMISSION; ELIMINATION; SYPHILIS
AB Congenital infections are an important cause of morbidity and mortality worldwide, especially in low-income settings. This review discusses the main pathways of infections and associated adverse maternal and fetal outcomes, considering the TORCH pathogens, including Zika virus; the acronym stands for Toxoplasma gondii infection, other (Listeria monocytogenes, Treponema pallidum, and parvovirus B19, among others, including Zika virus), rubella virus, cytomegalovirus, and herpes simplex viruses type 1 and type 2.
C1 [Costa, Maria Laura; Nobrega, Guilherme de Moraes] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
   [Antolini-Tavares, Arthur] Univ Estadual Campinas, Sch Med, Dept Pathol Anat, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
EM mlaura@unicamp.br
OI de Moraes Nobrega, Guilherme/0000-0001-9406-4256
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [409605/2016]
FX This work was supported by Grant CNPq #409605/2016 - Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Aguirre AA, 2019, ECOHEALTH, V16, P378, DOI 10.1007/s10393-019-01405-7
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bardaj A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005606
   Barron SD, 1995, SEMIN PERINATOL, V19, P493, DOI 10.1016/S0146-0005(05)80056-4
   Billington WD, 2003, J REPROD IMMUNOL, V60, P1, DOI 10.1016/S0165-0378(03)00083-4
   Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   Crane J, 2014, J OBSTET GYNAECOL CA, V36, P1107, DOI 10.1016/S1701-2163(15)30390-X
   De Beaudrap P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1135-7
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Driggers RW, 2017, NEW ENGL J MED, V37, P51, DOI DOI 10.1097/01.AOA.0000512046.09676.84
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye-Petersen O M, 2006, HDB PLACENTAL PATHOL
   Fried M, 2017, COLD SPRING HARB PER, V7
   Genest DR, 1996, HUM PATHOL, V27, P366, DOI 10.1016/S0046-8177(96)90110-0
   Grant GB, 2017, MMWR-MORBID MORTAL W, V66, P1256, DOI 10.15585/mmwr.mm6645a4
   Heerema-McKenney A, 2018, APMIS, V126, P570, DOI 10.1111/apm.12847
   Imanishi M, 2015, INFECT DIS OBSTET GY, V2015, P1
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009
   Kitt E, 2017, JMM CASE REP, V4, P10
   Klugman D, 2010, PEDIATR CARDIOL, V31, P222, DOI 10.1007/s00246-009-9589-9
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Kontomanolis EN, 2018, CURR PEDIATR REV, V14, P239, DOI 10.2174/1573396314666180820154340
   Lamond NM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020052
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Mace G, 2014, J MATERN-FETAL NEO M, V27, P1375, DOI 10.3109/14767058.2013.853288
   Macnamara FN, 1954, T R SOC TROP MED HYG, V48
   Marin LJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0604-5
   Martinez-Quintana E, 2015, REV PANAM SALUD PUBL, V37, P179
   Matteelli A, 1997, ANN TROP MED PARASIT, V91, P803, DOI 10.1080/00034989760563
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nelson DM, 2015, AM J OBSTET GYNECOL, V213, pS12, DOI 10.1016/j.ajog.2015.08.015
   Nelson R, 2018, LANCET INFECT DIS, V18, P1186, DOI 10.1016/S1473-3099(18)30618-2
   Pandya Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01126
   Paquet C, 2018, J OBSTET GYNAECOL CA, V40, pE687, DOI 10.1016/j.jogc.2018.05.036
   Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6
   Pistorius LR, 2008, FETAL DIAGN THER, V24, P491, DOI 10.1159/000180119
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Rawlinson WD, 2016, CURR OPIN INFECT DIS, V29, P615, DOI 10.1097/QCO.0000000000000317
   Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186
   Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Spiteri G, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000281, 10.1017/s0950268819000281]
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor M, 2018, LANCET GLOB HEALTH, V6, pE26, DOI 10.1016/S2214-109X(17)30422-9
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39
   Vazquez-Boland JA, 2017, MBIO, V8, DOI 10.1128/mBio.00949-17
   Versalovic J, 2011, MANUAL CLIN MICROBIO, DOI [10.1128/9781555816728, DOI 10.1128/9781555816728]
   Vinturache AE, 2016, SEMIN FETAL NEONAT M, V21, P94, DOI 10.1016/j.siny.2016.02.004
   Virginia B, 2015, MMWR-MORBID MORTAL W, V64, P1233
   Weichert A, 2010, FETAL DIAGN THER, V28, P225, DOI 10.1159/000320203
   *WHO, 2000, WHO TECH REP SER, V892, P1
   Xiong YQ, 2019, J CLIN VIROL, V114, P12, DOI 10.1016/j.jcv.2019.03.004
   Yazigi A, 2017, J MATERN-FETAL NEO M, V30, P274, DOI 10.3109/14767058.2016.1169526
   ZHANG LJ, 1995, J INFECT DIS, V171, P1002, DOI 10.1093/infdis/171.4.1002
   Zimmerman LA, 2019, MMWR-MORBID MORTAL W, V68, P396, DOI 10.15585/mmwr.mm6817a4
NR 70
TC 3
Z9 3
U1 3
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8545
EI 1558-0474
J9 OBSTET GYN CLIN N AM
JI Obstet. Gynecol. Clin. N. Am.
PD MAR
PY 2020
VL 47
IS 1
BP 133
EP +
DI 10.1016/j.ogc.2019.10.003
PG 15
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KL2ZL
UT WOS:000513297000011
PM 32008664
DA 2020-12-08
ER

PT J
AU Venceslau, EM
   Guida, JPS
   Nobrega, GD
   Samogim, AP
   Parise, PL
   Japecanga, RR
   de Toledo-Teixeira, DA
   Forato, J
   Antolini-Tavares, A
   Souza, A
   Altemani, A
   Consonni, SR
   Passini, R
   Amaral, E
   Proenca-Modena, JL
   Costa, ML
AF Venceslau, Emanuella Meneses
   Siqueira Guida, Jose Paulo
   Nobrega, Guilherme de Moraes
   Samogim, Ana Paula
   Parise, Pierina Lorencini
   Japecanga, Rodolfo Rosa
   de Toledo-Teixeira, Daniel Augusto
   Forato, Julia
   Antolini-Tavares, Arthur
   Souza, Arethusa
   Altemani, Albina
   Consonni, Silvio Roberto
   Passini, Renato
   Amaral, Eliana
   Proenca-Modena, Jose Luiz
   Costa, Maria Laura
CA Zika-Unicamp Network
TI Adequate Placental Sampling for the Diagnosis and Characterization of
   Placental Infection by Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; placenta; viral persistence; pregnancy; systematic sampling;
   qRT-PCR
ID SEXUAL TRANSMISSION; COLLECTION; LESIONS
AB The detection of Zika virus (ZIKV) in immunoprivileged anatomical sites, potential sites for viral persistence, may guide the confirmation of undefined cases of ZIKV infection and also bring to light unknown pathways of viral transmission. Thus, this study aimed to characterize ZIKV infection in stratified, standardized placental samples in women with exanthematic febrile manifestations during pregnancy and compare findings to the standard investigation protocol of official health agencies. To this end, a case series of placental findings within a prospective cohort study was conducted over a period of 24 months. Serum/urine were obtained at the time of clinical case identification. Placental sampling was performed following standard investigation protocol (samples of 1.0 cm sent to a reference laboratory) and in a systematic way at various regions, such as chorionic plate, chorionic villi, basal plate, amniotic membrane, and umbilical cord, for subsequent ZIKV identification and quantification. Clinical information was obtained and histological preparation with hematoxylin-eosin staining for morphological evaluation was performed. This case series included 17 placentas systematically collected. Of these, 14 were positive by qRT-PCR for ZIKV, 5 in the umbilical cord, 7 in the amniotic membrane, 7 in the chorionic plate, 13 in the chorionic villi, and 7 in the basal plate, whereas none were reported by the reference laboratory. The most common morphological and anatomopathological findings were increased stromal cellularity, villitis, calcification, maternal vascular malperfusion, placental hypoplasia, and maternal-fetal hemorrhage (intervillous thrombi). Seven women presented positive testing for ZIKV in serological and/or molecular tests during gestation in urine. While viral quantification in urine ranged from 10(1) to 10(3) FFU eq/ml, that in different placental regions ranged from 10(3) to 10(8) FFU eq/g. Thus, ZIKV can infect different regions of the placenta and umbilical cord of pregnant women, showing that the systematic collection and adequate storage of the placenta is fundamental for the detection of ZIKV in this organ. The detection of ZIKV in the placenta after several months of initial symptoms suggests that this tissue may be a site for viral persistence during pregnancy.
C1 [Venceslau, Emanuella Meneses; Siqueira Guida, Jose Paulo; Japecanga, Rodolfo Rosa; Passini, Renato; Amaral, Eliana; Costa, Maria Laura] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil.
   [Nobrega, Guilherme de Moraes; Samogim, Ana Paula; Parise, Pierina Lorencini; de Toledo-Teixeira, Daniel Augusto; Forato, Julia; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil.
   [Antolini-Tavares, Arthur; Souza, Arethusa; Altemani, Albina] Univ Estadual Campinas, Sch Med Sci, Dept Pathol Anat, Campinas, Brazil.
   [Consonni, Silvio Roberto] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil.; Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil.
EM jimodena@unicamp.br; mlaura@unicamp.br
RI Freitas, Andre Ricardo Ribas/L-1969-2016; Proenca-Modena, Jose
   Luiz/AAU-7622-2020; Angerami, Rodrigo Nogueira/A-8926-2013;
   Toledo-Teixeira, Daniel A./C-6940-2017
OI Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; de Moraes Nobrega,
   Guilherme/0000-0001-9406-4256; Consonni, Silvio
   Roberto/0000-0003-3149-021X; Toledo-Teixeira, Daniel
   A./0000-0002-4055-058X
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado) [2016/00194-8]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [409605/2016-6]; CAPESCAPES [88882.329828/2019]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [409605/2016-6,
   119172/2018-6]; Student Aid System; FAPESP fellowshipsFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/26908-0, 2017/02402-0]
FX This work was financed by the FAPESP (Fundacao de Amparo a Pesquisa do
   Estado)-2016/00194-8 and CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico)409605/2016-6. EV is supported by CAPES
   (88882.329828/2019). GN is supported by CNPq (119172/2018-6). AS is
   supported by the Student Aid System. PP and DT-T are supported by the
   FAPESP fellowships (2017/26908-0 and 2017/02402-0). MC has CNPq support
   #409605/2016-6. EA is CNPq research fellow. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of this manuscript.
CR Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto de Pesquisa Economica Aplicada [IPEA], 2018, MIN PLAN DES GEST EP
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mi S, 2000, NATURE, V403, P785
   Ministerio da Saude, 2019, B EP
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2017, VIR ZIK BRAS RESP SE
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nelson DM, 2015, AM J OBSTET GYNECOL, V213, pS12, DOI 10.1016/j.ajog.2015.08.015
   Neto A. R. M., 2011, COMMUN CIENCIAS SAUD, V22, P21
   OEHLER E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomar L, 2020, ULTRASOUND OBST GYN, V56, P740, DOI 10.1002/uog.21936
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Romero R, 2018, J PERINAT MED, V46, P613, DOI 10.1515/jpm-2018-0055
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Tamblyn JA, 2013, PLACENTA, V34, P846, DOI 10.1016/j.placenta.2013.07.002
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005
   Xavier Analúcia R., 2017, J. Bras. Patol. Med. Lab., V53, P252, DOI 10.5935/1676-2444.20170039
NR 36
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 21
PY 2020
VL 11
AR 112
DI 10.3389/fmicb.2020.00112
PG 11
WC Microbiology
SC Microbiology
GA LA0IL
UT WOS:000523640800001
PM 32153521
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, RT
   Costa, ML
   Mayrink, J
   Feitosa, FE
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Calderon, IM
   Sousa, MH
   Passini, R
   Baker, PN
   Kenny, L
   Cecatti, JG
   Parpinelli, MA
   Fernandes, KG
   Galvao, RB
   Guida, JP
   Santana, DS
   Franchini, KG
   Cassettari, BF
   Pfitscher, L
   Brust, L
   Melo, EF
   Anacleto, D
   de Lucena, D
   Sousa, B
AF Souza, Renato T.
   Costa, Maria L.
   Mayrink, Jussara
   Feitosa, Francisco E.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Calderon, Iracema M.
   Sousa, Maria H.
   Passini Jr, Renato
   Baker, Philip N.
   Kenny, Louise
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Fernandes, Karayna G.
   Galvao, Rafael B.
   Guida, Jose Paulo
   Santana, Danielly S.
   Franchini, Kleber G.
   Cassettari, Bianca F.
   Pfitscher, Lucia
   Brust, Luiza
   Melo Jr, Elias F.
   Anacleto, Danilo
   de Lucena, Daisy
   Sousa, Benedita
CA Preterm SAMBA Study Grp
TI Clinical and epidemiological factors associated with spontaneous preterm
   birth: a multicentre cohort of low risk nulliparous women
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CERVICAL LENGTH; PREDICTION; PREGNANCY; DELIVERY
AB The objective of this study was to determine incidence and risk factors associated with spontaneous preterm birth (sPTB). It was a prospective multicentre cohort study performed in five Brazilian referral maternity hospitals and enrolling nulliparous women at 19-21 weeks. Comprehensive maternal data collected during three study visits were addressed as potentially associated factors for sPTB. Bivariate and multivariate analysis estimated risk ratios. The main outcomes measures were birth before 37 weeks due to spontaneous preterm labour or premature rupture of membranes (sPTB). The comparison group was comprised of women with term births (>= 37weeks). Outcome data was available for 1,165 women, 6.7% of whom had sPTB, 16% had consumed alcohol and 5% had used other illicit drugs during the first half of pregnancy. Current drinking at 19-21 weeks (RR 3.96 95% CI [1.04-15.05]) and a short cervix from 18-24 weeks (RR 4.52 95% CI [1.08-19.01]) correlated with sPTB on bivariate analysis. Increased incidence of sPTB occurred in underweight women gaining weight below quartile 1 (14.8%), obese women gaining weight above quartile 3 (14.3%), women with a short cervix (<25mm) at 18-24 weeks (31.2%) and those with a short cervix and vaginal bleeding in the first half of pregnancy (40%). Cervical length (RRadj 4.52 95% CI [1.08-19.01]) was independently associated with sPTB. In conclusion, the incidence of sPTB increased in some maternal phenotypes, representing potential groups of interest, the focus of preventive strategies. Similarly, nulliparous women with a short cervix in the second trimester require further exploration.
C1 [Souza, Renato T.; Costa, Maria L.; Mayrink, Jussara; Leite, Debora F.; Passini Jr, Renato; Cecatti, Jose G.; Parpinelli, Mary A.; Fernandes, Karayna G.; Galvao, Rafael B.; Guida, Jose Paulo; Santana, Danielly S.] Univ Estadual Campinas, UNICAMP, Dept Obstet & Gynaecol, Sch Med Sci, Campinas, SP, Brazil.
   [Feitosa, Francisco E.; de Lucena, Daisy; Sousa, Benedita] Univ Fed Ceara, MEAC Sch Matern, Fortaleza, Ceara, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.; Melo Jr, Elias F.; Anacleto, Danilo] Univ Fed Pernambuco, Clin Hosp, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Vettorazzi, Janete; Pfitscher, Lucia; Brust, Luiza] Fed Univ RS, Matern Clin Hosp, Dept Obstet & Gynaecol, Porto Alegre, RS, Brazil.
   [Calderon, Iracema M.; Cassettari, Bianca F.] UNESP, Dept Obstet & Gynaecol, Botucatu Med Sch, Botucatu, SP, Brazil.
   [Sousa, Maria H.] Jundiai Sch Med, Stat Unit, Jundiai, SP, Brazil.
   [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England.
   [Kenny, Louise] Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
   [Franchini, Kleber G.] LNBio, Campinas, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Obstet & Gynaecol, Sch Med Sci, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Calderon, Iracema/W-4336-2019; Leite, Debora F B/D-7299-2018; Souza,
   Renato Teixeira/G-4205-2017
OI Calderon, Iracema/0000-0003-4761-4336; Leite, Debora F
   B/0000-0001-8839-3934; Souza, Renato Teixeira/0000-0002-9075-9269
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [05/2013,
   401636/2013-5]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1107597]
FX The current manuscript was part of them PhD thesis "A comprehensive
   integrative approach to investigate factors associated with preterm
   birth, related perinatal outcomes and its prediction using metabolomic
   markers" by Renato Teixeira Souza under the tutorial of Jose Guilherme
   Cecatti and presented to the Postgraduate Program of Obstetrics and
   Gynecology from the School of Medical Sciences of the University of
   Campinas on 22nd February 201921. This was one of the two big studies
   selected for sponsoring from the research call "Grand Challenges Brazil:
   Reducing the burden of preterm birth" number 05/2013 jointly issued by
   the Brazilian National Research Council (CNPq) (Award 401636/2013-5) and
   the Bill and Melinda Gates Foundation (grant OPP1107597). The funders
   played no role at all in the study design, writing the manuscript nor in
   the decision to submit the manuscript for publication.
CR American College of Obstetricians and Gynecologists, 2014, OBSTET GYNECOL, V123, P372, DOI DOI 10.1097/01.AOG.0000443276.68274.CC
   ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P
   Berghella V, 2007, OBSTET GYNECOL, V110, P311, DOI 10.1097/01.AOG.0000270112.05025.1d
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Carnero AM, 2012, BJOG-INT J OBSTET GY, V119, P924, DOI 10.1111/j.1471-0528.2012.03345.x
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0
   Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904
   Kondracki AJ, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0705-x
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Luke B, 2015, CLIN OBSTET GYNECOL, V58, P585, DOI 10.1097/GRF.0000000000000117
   Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120
   Mayrink J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46011-3
   McIntosh J, 2016, AM J OBSTET GYNECOL, V215, pB2, DOI 10.1016/j.ajog.2016.04.027
   Ministerio da Saude, SINASC SIST INF NASC
   OKITSU O, 1992, ULTRASOUND OBST GYN, V2, P402, DOI 10.1046/j.1469-0705.1992.02060402.x
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Requejo J, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S4
   Sentilhes L, 2017, EUR J OBSTET GYN R B, V210, P217, DOI 10.1016/j.ejogrb.2016.12.035
   SONEK JD, 1990, OBSTET GYNECOL, V76, P172
   Souza RD, 2019, THESIS
   Souza RT, 2019, BIOMED RES INT, V2019, P1
   To MS, 2001, ULTRASOUND OBST GYN, V17, P217, DOI 10.1046/j.1469-0705.2001.00369.x
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   van der Ven J, 2015, ACTA OBSTET GYN SCAN, V94, P1223, DOI 10.1111/aogs.12721
   Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866
NR 28
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 21
PY 2020
VL 10
IS 1
DI 10.1038/s41598-020-57810-4
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KJ6AN
UT WOS:000512142100093
PM 31965004
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Mayrink, J
   Souza, RT
   Feitosa, FE
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Calderon, IM
   Costa, ML
   Kenny, L
   Baker, P
   Cecatti, JG
   Parpinelli, MA
   Fernandes, KG
   Guida, JP
   Santana, D
   Galvao, RBF
   Cassettari, BF
   Pfitscher, L
   de Feitosa, DL
   Ferreira, ED
   Anacleto, D
   Zotareli, V
   Silva, MA
AF Mayrink, Jussara
   Souza, Renato T.
   Feitosa, Francisco E.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Calderon, Iracema M.
   Costa, Maria L.
   Kenny, Louise
   Baker, Philip
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Fernandes, Karayna G.
   Guida, Jose P.
   Santana, Danielly
   Galvao, Rafael B. F.
   Cassettari, Bianca F.
   Pfitscher, Lucia
   de Feitosa, Daisy Lucena
   Ferreira Junior, Elias de Melo
   Anacleto, Danilo
   Zotareli, Vilma
   Silva, Marcia Alice
CA Preterm SAMBA Study Grp
TI Mean arterial blood pressure: potential predictive tool for preeclampsia
   in a cohort of healthy nulliparous pregnant women
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Preeclampsia; Blood pressure; Hypertension; Prenatal screening; Second
   trimester; Third trimester
ID GESTATIONAL HYPERTENSION; MATERNAL FACTORS; RISK; BIOMARKERS
AB Background: Prediction of preeclampsia is a challenge to overcome. The vast majority of prospective studies in large general obstetric populations have failed in the purpose of obtain a useful and effective model of prediction, sometimes based on complex tools unavaible in areas where the incidence of preeclampsia is the highest. The goal of this study was to assess mean arterial blood pressure (MAP) levels at 19-21, 27-29 and 37-39 weeks of gestation and performance of screening by MAP for the prediction of preeclampsia in a Brazilian cohort of healthy nulliparous pregnant women.
   Methods: This was a cohort approach to a secondary analysis of the Preterm SAMBA study. Mean arterial blood pressure was evaluated at three different time periods during pregnancy. Groups with early-onset preeclampsia, late-onset preeclampsia and normotension were compared. Increments in mean arterial blood pressure between 20 and 27 weeks and 20 and 37 weeks of gestation were also calculated for the three groups studied. The accuracy of mean arterial blood pressure in the prediction of preeclampsia was determined by ROC curves.
   Results: Of the 1373 participants enrolled, complete data were available for 1165. The incidence of preeclampsia was 7.5%. Women with early-onset preeclampsia had higher mean arterial blood pressure levels at 20 weeks of gestation, compared to the normotensive group. Women with late-onset preeclampsia had higher mean arterial blood pressure levels at 37 weeks of gestation, than the normotensive groups and higher increases in this marker between 20 and 37 weeks of gestation. Based on ROC curves, the predictive performance of mean arterial blood pressure was higher at 37 weeks of gestation, with an area under the curve of 0.771.
   Conclusion: As an isolated marker for the prediction of preeclampsia, the performance of mean arterial blood pressure was low in a healthy nulliparous pregnant women group. Considering that early-onset preeclampsia cases had higher mean arterial blood pressure levels at 20 weeks of gestation, future studies with larger cohorts that combine multiple markers are needed for the development of a preeclampsia prediction model.
C1 [Mayrink, Jussara; Souza, Renato T.; Leite, Debora F.; Costa, Maria L.; Cecatti, Jose G.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, Matern Hosp, MEAC, Fortaleza, CE, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.] Univ Fed Pernambuco, Matern Hosp, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Vettorazzi, Janete] Fed Univ RS, Matern Hosp, Dept Obstet & Gynecol, Porto Alegre, RS, Brazil.
   [Calderon, Iracema M.] UNESP, Dept Obstet & Gynecol, Botucatu Med Sch, Botucatu, SP, Brazil.
   [Kenny, Louise] Univ Leicester, Coll Life Sci, Leicester, Leics, England.
   [Baker, Philip] Univ Liverpool, Fac Hlth & Life Sci, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England.
   [Parpinelli, Mary A.; Fernandes, Karayna G.; Guida, Jose P.; Santana, Danielly; Galvao, Rafael B. F.] Univ Estadual Campinas, Sch Med Sci, Campinas, Brazil.
   [Cassettari, Bianca F.] Univ Estadual Paulista, Sch Med Botucatu, Sao Paulo, Brazil.
   [Pfitscher, Lucia] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   [de Feitosa, Daisy Lucena] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
   [Ferreira Junior, Elias de Melo; Anacleto, Danilo] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil.
   [Zotareli, Vilma; Silva, Marcia Alice] Cemicamp, Campinas, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
EM cecati@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; feitosa, francisco e/H-8431-2014;
   Calderon, Iracema/W-4336-2019
OI Souza, Renato Teixeira/0000-0002-9075-9269; Calderon,
   Iracema/0000-0003-4761-4336
FU Bill and Melinda Gates Foundation, Seatle, WA [OPP1107597]; CNPq,
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [401636/2013-5]
FX This study was funded by the Bill and Melinda Gates Foundation, Seatle,
   WA (grant OPP1107597) and CNPq, Brazil (grant 401636/2013-5). The
   funders did not influence the study, including development, data
   collection, data analysis or data interpretation.
CR Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102
   Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE
   CONDEAGUDELO A, 1993, AM J OBSTET GYNECOL, V169, P509, DOI 10.1016/0002-9378(93)90609-M
   Gasse C, 2018, PREGNANCY HYPERTENS, V12, P178, DOI 10.1016/j.preghy.2017.11.005
   Ghi T, 2018, FETAL DIAGN THER, V44, P81, DOI 10.1159/000490047
   Hermida RC, 2001, HYPERTENSION, V38, P736, DOI 10.1161/01.HYP.38.3.736
   Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578
   Khodzhaeva ZS, 2016, J MATERN-FETAL NEO M, V29, P2980, DOI 10.3109/14767058.2015.1111332
   Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4
   Nicolaides KH, 2011, FETAL DIAGN THER, V29, P183, DOI 10.1159/000324320
   North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875
   O'Gorman N, 2017, ULTRASOUND OBST GYN, V49, P756, DOI 10.1002/uog.17455
   O'Gorman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011801
   Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397
   Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646
   Poon LCY, 2013, FETAL DIAGN THER, V33, P16, DOI 10.1159/000341712
   Roberts JM, 2007, HYPERTENSION, V49, P15, DOI 10.1161/01.HYP.0000251523.44824.02
   Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003
   Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5
   Strevens H, 2001, ACTA OBSTET GYN SCAN, V80, P824, DOI 10.1034/j.1600-0412.2001.080009824.x
   Tayyar A, 2016, ULTRASOUND OBST GYN, V47, P573, DOI 10.1002/uog.15815
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   (UK). NCCfWsaCsH, 2010, HYP PREGN MAN HYP DI
   van der Tuuk K, 2017, EUR J OBSTET GYN R B, V210, P360, DOI 10.1016/j.ejogrb.2017.01.021
   Wright A, 2015, ULTRASOUND OBST GYN, V45, P698, DOI 10.1002/uog.14783
NR 28
TC 0
Z9 0
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD DEC 3
PY 2019
VL 19
IS 1
AR 460
DI 10.1186/s12884-019-2580-4
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KI6AY
UT WOS:000511432800003
PM 31795971
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Pacagnella, RC
   Mol, B
   Borovac-Pinheiro, A
   Passini, R
   Nomura, ML
   Andrade, KC
   Ellovitch, N
   Fernandes, KG
   Bortoletto, TG
   Pereira, CM
   Miele, MJ
   Franca, MS
   Cecatti, JG
   Moron, AF
   Menezes, CAS
   Paiva, CSM
   Barros, CM
   Paiva, DMC
   Alves, EB
   Moises, ECD
   Barreto, EQS
   Peixoto, FM
   Feitosa, FEL
   Barroso, F
   Carvalho, HC
   Hirakawa, HS
   Pena, J
   Katz, L
   Marques, MCC
   Lima, MMS
   Pereira, MN
   Costa, ML
   Chaves, MTP
   Marilia, GM
   Correia, MD
   Eilovitch, N
   Sass, N
   Ximenes, RLS
   Camargo, RPS
   Guidoni, RGR
   Oliveira, RPC
   Haddad, SEMT
   Costa, SHAM
   Quintana, SM
   Sarmento, SGP
   Silva, TV
AF Pacagnella, Rodolfo C.
   Mol, Ben W.
   Borovac-Pinheiro, Anderson
   Passini Jr, Renato
   Nomura, Marcelo L.
   Andrade, Kleber Cursino
   Ellovitch, Nathalia
   Fernandes, Karayna Gil
   Bortoletto, Thaisa Guedes
   Pereira, Cynara Maria
   Miele, Maria Julia
   Franca, Marcelo Santucci
   Cecatti, Jose G.
   Moron, Antonio F.
   Menezes, Carlos A. S.
   Paiva, Claudio S. M.
   Barros, Cristhiane M.
   Paiva, Djacyr M. C.
   Alves, Eduardo B.
   Moises, Elaine C. D.
   Barreto, Enoch Q. S.
   Peixoto-Filho, Fernando M.
   Feitosa, Francisco E. L.
   Barroso, Frederico
   Carvalho, Herlanio C.
   Hirakawa, Humberto S.
   Pena, Julio
   Katz, Leila
   Marques, Marcelo C. C.
   Lima, Marcelo M. S.
   Pereira, Marcos N.
   Costa, Maria L.
   Chaves, Maria T. P.
   Marilia, G. M.
   Correia-Jr, Mario D.
   Eilovitch, Nathalia
   Sass, Nelson
   Ximenes, Renato L. S.
   Camargo, Rodrigo P. S.
   Guidoni, Rogerio G. R.
   Oliveira, Rone P. C.
   Haddad, Samira E. M. T.
   Costa, Sergio H. A. M.
   Quintana, Silvana M.
   Sarmento, Stephanno G. P.
   Silva, Thais, V
CA P5 Working Grp
TI A randomized controlled trial on the use of pessary plus progesterone to
   prevent preterm birth in women with short cervical length (P5 trial)
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Pessaries; Progesterone; Cervical length measurement; Randomized
   controlled trial
ID SONOGRAPHIC SHORT CERVIX; VAGINAL PROGESTERONE; SINGLETON PREGNANCY;
   ASYMPTOMATIC WOMEN; TWIN PREGNANCIES; RISK; TIME; MULTICENTER; LABOR;
   PECEP
AB Background Preterm birth is the leading cause of mortality and disability in newborn and infants. Having a short cervix increases the risk of preterm birth, which can be accessed by a transvaginal ultrasound scan during the second trimester. In women with a short cervix, vaginal progesterone and pessary can both reduce this risk, which progesterone more established than cervical pessary. The aim of this study is to compare the use of vaginal progesterone alone versus the association of progesterone plus pessary to prevent preterm birth in women with a short cervix. Methods This is a pragmatic open-label randomized controlled trial that will take place in 17 health facilities in Brazil. Pregnant women will be screened for a short cervix with a transvaginal ultrasound between 18 (0/7) until 22 (6/7) weeks of gestational age. Women with a cervical length below or equal to 30 mm will be randomized to the combination of progesterone (200 mg) and pessary or progesterone (200 mg) alone until 36 + 0 weeks. The primary outcome will be a composite of neonatal adverse events, to be collected at 10 weeks after birth. The analysis will be by intention to treat. The sample size is 936 women, and a prespecified subgroup analysis is planned for cervical length (= < or > 25 mm). Categorical variables will be expressed as a percentage and continuous variables as mean with standard deviation. Time to delivery will be assessed with Kaplan-Meier analysis and Cox proportional hazard analysis. Discussion In clinical practice, the combination of progesterone and pessary is common however, few studies have studied this association. The combination of treatment might act in both the biochemical and mechanical routes related to the onset of preterm birth.
   Trial registration: Brazilian Clinical Trial Registry (ReBec) RBR-3t8prz, UTN: U1111-1164-2636, 2014/11/18.
C1 [Pacagnella, Rodolfo C.; Passini Jr, Renato; Ellovitch, Nathalia; Fernandes, Karayna Gil; Bortoletto, Thaisa Guedes; Pereira, Cynara Maria; Miele, Maria Julia; Cecatti, Jose G.] Univ Estadual Campinas, UNICAMP, Dept Obstet & Gynecol, Sch Med Sci, Rua Alexander Fleming 101, BR-13087460 Campinas, SP, Brazil.
   [Mol, Ben W.] Monash Univ, Monash Med Ctr, Obstet & Gynaecol Monash Hlth, 246 Clayton Rd, Clayton, Vic 3168, Australia.
   [Borovac-Pinheiro, Anderson; Nomura, Marcelo L.] Univ Estadual Campinas, UNICAMP, Obstetr Unit, Womans Hosp, Rua Alexander Fleming 101, BR-13087460 Campinas, SP, Brazil.
   [Andrade, Kleber Cursino] Univ Estadual Campinas, UNICAMP, Ultrasound Dept, Womans Hosp, Rua Alexander Fleming 101, BR-13087460 Campinas, SP, Brazil.
   [Franca, Marcelo Santucci] Univ Fed Sao Paulo, UNIFESP, R Napoleao de Barros 715, BR-04024002 Sao Paulo, SP, Brazil.
RP Pacagnella, RC (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Obstet & Gynecol, Sch Med Sci, Rua Alexander Fleming 101, BR-13087460 Campinas, SP, Brazil.
EM rodolfop@unicamp.br
RI Silva, Thais Valeria/AAL-6949-2020; Nakamura-Pereira,
   Marcos/X-1107-2019; Sass, Nelson/AAD-8259-2020; Peixoto-Filho, Fernando
   Maia/AAG-1052-2020; feitosa, francisco e/H-8431-2014; Katz,
   Leila/M-5291-2013; Borovac-Pinheiro, Anderson/G-3913-2018
OI Silva, Thais Valeria/0000-0002-8718-5372; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Sass, Nelson/0000-0001-7187-1004;
   Peixoto-Filho, Fernando Maia/0000-0001-8521-6393; Katz,
   Leila/0000-0001-9854-7917; Borovac-Pinheiro,
   Anderson/0000-0002-2659-6012; Franca, Marcelo
   Santucci/0000-0001-5145-1061
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation;
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX The study was funded by the Bill & Melinda Gates Foundation and
   Brazilian National Research Council (CNPq). No funding agency had any
   influence on the design and decision regarding data collections,
   managements, analysis and writing. The funding body peer-reviewed the
   protocol.
CR Arabin B, 2013, ULTRASOUND OBST GYN, V42, P390, DOI 10.1002/uog.12540
   Bassan H, 2009, CLIN PERINATOL, V36, P737, DOI 10.1016/j.clp.2009.07.014
   Berghella V, 2017, ULTRASOUND OBST GYN, V49, P567, DOI 10.1002/uog.17430
   Berghella V, 2017, ULTRASOUND OBST GYN, V49, P322, DOI 10.1002/uog.17388
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Collins A, 2016, J MATERN-FETAL NEO M, V29, P1125, DOI 10.3109/14767058.2015.1037734
   Conde-Agudelo A, 2016, AM J OBSTET GYNECOL, V214, P235, DOI 10.1016/j.ajog.2015.09.102
   Conde-Agudelo A, 2015, AM J OBSTET GYNECOL, V213, P789, DOI 10.1016/j.ajog.2015.06.015
   Crane JMG, 2008, ULTRASOUND OBST GYN, V31, P579, DOI 10.1002/uog.5323
   Dugoff L, 2017, AM J OBSTET GYNECOL, V216, pS4
   Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
   Fox NS, 2016, OBSTET GYNECOL, V127, P625, DOI 10.1097/AOG.0000000000001300
   Goya M, 2016, AM J OBSTET GYNECOL, V214, P145, DOI 10.1016/j.ajog.2015.11.012
   Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0
   Hamilton BE, 2015, BIRTHS PRELIMINARY D
   Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017
   Hermansen CL, 2007, AM FAM PHYSICIAN, V76, P987
   Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550
   Iams JD, 2014, NEW ENGL J MED, V370, P254, DOI 10.1056/NEJMcp1103640
   Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904
   Jarde A, 2017, J OBSTET GYNAECOL CA, V39, P1192, DOI 10.1016/j.jogc.2017.07.007
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Karbasian N, 2016, J OBSTET GYNAECOL RE, V42, P1673, DOI 10.1111/jog.13138
   Kazemier BM, 2016, J PERINATOL, V36, P516, DOI 10.1038/jp.2016.12
   Liem SMS, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/576723
   Matei A, 2019, EUR J OBSTET GYN R B, V236, P224, DOI 10.1016/j.ejogrb.2018.12.022
   Medley N, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012505.pub2
   NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Nicolaides KH, 2016, NEW ENGL J MED, V374, P1044, DOI 10.1056/NEJMoa1511014
   Nicolaides KH, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.051
   O'Brien JM, 2016, AM J OBSTET GYNECOL, V214, P45, DOI 10.1016/j.ajog.2015.10.934
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Perez-Lopez FR, 2019, ARCH GYNECOL OBSTET, V299, P1215, DOI 10.1007/s00404-019-05096-x
   Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003
   Sinno A, 2009, AM J PERINAT, V26, P761, DOI 10.1055/s-0029-1239495
   Stricker N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.007
   Tajik P, 2016, ULTRASOUND OBST GYN, V48, P48, DOI 10.1002/uog.15855
   Tedesco RP, 2013, MATERN CHILD HLTH J, V17, P1638, DOI 10.1007/s10995-012-1177-6
   The Fetal Medicine Foundation, CERV ASS CERT COMP F
   Vaisbuch E, 2010, ULTRASOUND OBST GYN, V36, P471, DOI 10.1002/uog.7673
   van't Hooft J, 2018, BJOG-INT J OBSTET GY, V125, P8, DOI 10.1111/1471-0528.14987
   van 't Hooft J, 2016, OBSTET GYNECOL, V127, P49, DOI 10.1097/AOG.0000000000001195
   Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1
   World Health Organization, 2012, BORN TOO SOON
   Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157
   Yoshizato T, 2010, J OBSTET GYNAECOL RE, V36, P733, DOI 10.1111/j.1447-0756.2010.01203.x
NR 47
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 27
PY 2019
VL 19
IS 1
AR 442
DI 10.1186/s12884-019-2513-2
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JT9OD
UT WOS:000501309800003
PM 31775669
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Silva, FP
   Souza, RT
   Cecatti, JG
   Passini, R
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Oliveira, PF
   Silva, CM
   Costa, ML
   Pacagnella, RC
   Haddad, SM
   Zotarelli, V
   Gurgel, LT
   Maia, NL
   Mathias, JP
   Marba, ST
   Guinsburg, R
   Martinez, FE
   Quintana, SM
   Melli, PPS
   Feitosa, FE
   Chaves, GN
   Porto, AM
   Coutinho, IC
   Lima, ACB
   Melo, EF
   Leite, DF
   Amorim, MM
   Melo, ASO
   Melo, FO
   Martins, MG
   Nunes, MV
   Paiva, CS
   Lima, MD
   Freire, DM
   Tristao, EG
   Nascimento, DJ
   Menezes, CA
   Aquino, M
   Vettorazzi, J
   Senger, CE
   Assumpcao, AMB
   Guedes, MAF
   Moreira, MEL
   Borges, VT
   Souza, E
   Zamarian, ACP
   Lotufo, FA
   Uzilin, K
   Zanette, EA
   Andreucci, CB
   Oliveira, TA
   Oliveira, LR
   Santos, MAN
   Sass, N
   Silveira, MRF
   Coutinho, PR
   Siqueira, L
AF Silva, Fabia Pigatti
   Souza, Renato T.
   Cecatti, Jose G.
   Passini, Renato, Jr.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Oliveira, Paulo F.
   Silva, Cleide M.
   Costa, Maria L.
   Pacagnella, Rodolfo C.
   Haddad, Samira M.
   Zotarelli, Vilma
   Gurgel, Lucio T.
   Maia Filho, Nelson L.
   Mathias, Jacinta P.
   Marba, Sergio T.
   Guinsburg, Ruth
   Martinez, Francisco E.
   Quintana, Silvana M.
   Melli, Patricia P. S.
   Feitosa, Francisco E.
   Chaves, George N.
   Porto, Ana M.
   Coutinho, Isabela C.
   Barbosa Lima, Antonio C.
   Melo, Elias F.
   Leite, Debora F.
   Amorim, Melania M.
   Melo, Adriana S. O.
   Melo, Fabiana O.
   Martins, Marilia G.
   Nunes, Marinea V.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Tristao, Edson G.
   Nascimento, Denis J.
   Menezes, Carlos A.
   Aquino, Marcelo
   Vettorazzi, Janete
   Senger, Cintia E.
   Assumpcao, Augusta M. B.
   Guedes, Marcela A. F.
   Moreira, Maria E. L.
   Borges, Vera T.
   Souza, Eduardo
   Zamarian, Ana C. P.
   Lotufo, Fatima A.
   Uzilin, Kaliane
   Zanette, Elvira A.
   Andreucci, Carla B.
   Oliveira, Tenilson A.
   Oliveira, Laercio R.
   Santos, Marcos A. N.
   Sass, Nelson
   Silveira, Mirian R. F.
   Coutinho, Pedro R.
   Siqueira, Luciana
CA Brazilian Multictr Study Preterm
TI Role of Body Mass Index and gestational weight gain on preterm birth and
   adverse perinatal outcomes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MATERNAL NUTRITION; OBESITY; RISK; ASSOCIATION; PREGNANCY; EPIDEMIOLOGY;
   COUNTRIES; LABOR
AB The association of body mass index (BMI) and gestational weight gain (GWG) with preterm birth (PTB) remains controversial in the literature. To evaluate different maternal BMI and GWG categories, according to the initial BMI, in relation to different PTB subtypes and perinatal outcomes, we conducted a secondary analysis of a multicentre cross-sectional study, along with a nested case-control study including PTB from 20 centers in Brazil. Pre-pregnancy underweight was associated with a lower risk of provider-initiated PTB, while overweight and obesity were associated with a higher risk of provider-initiated PTB and a lower risk of spontaneous preterm birth. Insufficient gestational weight gain was associated with a higher prevalence of spontaneous PTB and preterm premature rupture of membranes. Excessive GWG correlated with a higher prevalence of provider-initiated PTB or preterm premature rupture of membranes. Irrespective of the initial BMI, the greater the rate of GWG, the higher the predicted probability of all PTB subtypes, except for spontaneous PTB in underweight women and those with normal BMI. On multivariate analysis, the initial BMI was shown to be the only factor associated with pi-PTB. Briefly, further studies evaluating the risk for PTB should consider that GWG may have a different role depending on the initial BMI and PTB subtype.
C1 [Silva, Fabia Pigatti; Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Costa, Maria L.; Pacagnella, Rodolfo C.; Haddad, Samira M.; Zotarelli, Vilma; Gurgel, Lucio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.; Maia Filho, Nelson L.; Mathias, Jacinta P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
   [Oliveira, Paulo F.; Silva, Cleide M.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Unit Stat, Campinas, Brazil.
   [Marba, Sergio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Pediat, Campinas, SP, Brazil.
   [Guinsburg, Ruth] Univ Fed Sao Paulo, UNIFESP, EPM, Div Neonatal Med, Sao Paulo, SP, Brazil.
   [Martinez, Francisco E.; Quintana, Silvana M.; Melli, Patricia P. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Feitosa, Francisco E.; Chaves, George N.] Matern Sch, Fortaleza, Ceara, Brazil.
   [Porto, Ana M.; Coutinho, Isabela C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Barbosa Lima, Antonio C.; Melo, Elias F.; Leite, Debora F.] Univ Fed Pernambuco, Sch Med, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Amorim, Melania M.; Melo, Adriana S. O.; Melo, Fabiana O.] Inst Saude Elpidio Almeida, Campina Grande, Paraiba, Brazil.
   [Martins, Marilia G.; Nunes, Marinea V.] Fed Univ Maranhao UFMA, Dept Gynecol & Obstet, Sao Luis, MA, Brazil.
   [Paiva, Claudio S.; Lima, Moises D.; Freire, Djacyr M.] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Tristao, Edson G.; Nascimento, Denis J.] Univ Fed Parana, Curitiba, Parana, Brazil.
   [Menezes, Carlos A.; Aquino, Marcelo] Univ Fed Bahia, Salvador, BA, Brazil.
   [Vettorazzi, Janete; Senger, Cintia E.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Assumpcao, Augusta M. B.; Guedes, Marcela A. F.; Moreira, Maria E. L.] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Borges, Vera T.] Sao Paulo State Univ, Dept Gynecol & Obstet, Botucatu, SP, Brazil.
   [Souza, Eduardo; Zamarian, Ana C. P.] Univ Fed Sao Paulo, EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Lotufo, Fatima A.; Uzilin, Kaliane] Santa Casa Limeira Hosp, Limeira, SP, Brazil.
   [Zanette, Elvira A.; Andreucci, Carla B.] Santa Casa Sao Carlos Hosp, Sao Carlos, SP, Brazil.
   [Oliveira, Tenilson A.; Oliveira, Laercio R.; Santos, Marcos A. N.] Matern Casa Maternal Leonor Mendes Barros, Sao Paulo, SP, Brazil.
   [Sass, Nelson; Silveira, Mirian R. F.] Matern Escola Vila Nova Cachoeirinha, Sao Paulo, SP, Brazil.
   [Coutinho, Pedro R.; Siqueira, Luciana] Hosp Estadual Sumare, Sumare, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; feitosa, francisco e/H-8431-2014;
   Sass, Nelson/AAD-8259-2020; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Andreucci, Carla B/J-4845-2015; Amorim, Melania
   M/C-5807-2013; BORGES, VERA T/B-7363-2014; Melo, Adriana S O/H-5650-2016
OI Souza, Renato Teixeira/0000-0002-9075-9269; Sass,
   Nelson/0000-0001-7187-1004; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Andreucci, Carla B/0000-0002-5590-108X;
   Amorim, Melania M/0000-0003-1047-2514; BORGES, VERA
   T/0000-0002-9347-9641; Cecatti, Jose Guilherme/0000-0003-1285-8445
FU FAPESP (Foundation for Research Support of the State of Sao Paulo)
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPq (Brazilian National Research Council) BrazilNational Council for
   Scientific and Technological Development (CNPq); Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation [401636/2013-5, 05/2013];
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [401636/2013-5, 05/2013]
FX Other members of the Brazilian Multicenter Study on Preterm Birth study
   group: Maria L. Costa, Rodolfo C. Pacagnella, Samira M. Haddad, Sergio
   T. Marba, Ruth Guinsburg, Francisco E. Martinez, Vilma Zotarelli, Lucio
   T. Gurgel, Francisco E. Feitosa, George N. Chaves, Ana M. Porto, Isabela
   C. Coutinho, Antonio C. Barbosa Lima, Elias F. Melo Jr, Debora F. Leite,
   Melania M. Amorim, Adriana S. O. Melo, Fabiana O. Melo, Marilia G.
   Martins, Marynea V. Nunes, Claudio S. Paiva, Moises D. Lima, Djacyr M.
   Freire, Edson G. Tristao, Denis J. Nascimento, Carlos A. Menezes,
   Marcelo Aquino, Janete Vettorazzi, Cintia E. Senger, Augusta M. B.
   Assumpcao, Marcela A. F. Guedes, Maria E. L. Moreira, Vera T. Borges,
   Nelson L. Maia Filho, Jacinta P. Mathias, Eduardo Souza, Ana C. P.
   Zamarian, Silvana M. Quintana, Patricia P. S. Melli, Fatima A. Lotufo,
   Kaliane Uzilin, Elvira A. Zanette, Carla B. Andreucci, Tenilson A.
   Oliveira, Laercio R. Oliveira, Marcos A. N. Santos, Nelson Sass, Mirian
   R. F. Silveira, Pedro R. Coutinho, Luciana Siqueira. This study was
   supported by a grant from FAPESP (Foundation for Research Support of the
   State of Sao Paulo), and by CNPq (Brazilian National Research Council)
   Brazil. Funders played no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript. The
   current secondary analyses of EMIP data was designed and developed by
   part of the Preterm SAMBA study Group (RTS, RPJ and JGC), a
   collaborative study group on Preterm Birth Research jointly issued by
   the Brazilian National Research Council (CNPq) and the Bill and Melinda
   Gates Foundation (Award 401636/2013-5 -Grand Challenges Brazil: Reducing
   the burden of preterm birth, number 05/2013). Current findings are
   therefore, part of the range of analyses of prematurity from the Preterm
   SAMBA study group.
CR AlSaif S, 2015, LIFE SCI, V125, P2, DOI 10.1016/j.lfs.2015.02.001
   Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Blevins JE, 2013, REV ENDOCR METAB DIS, V14, P311, DOI 10.1007/s11154-013-9260-x
   Bloomfield FH, 2011, ANNU REV NUTR, V31, P235, DOI 10.1146/annurev-nutr-072610-145141
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   Carlson NS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0129-6
   Carnero AM, 2012, BJOG-INT J OBSTET GY, V119, P924, DOI 10.1111/j.1471-0528.2012.03345.x
   Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6
   Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x
   Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a
   El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249
   Faucher MA, 2016, BJOG-INT J OBSTET GY, V123, P199, DOI 10.1111/1471-0528.13797
   Godoy AC, 2015, CLINICS, V70, P758, DOI 10.6061/clinics/2015(11)08
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201
   Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021
   Honest H, 2005, EUR J OBSTET GYN R B, V119, P11, DOI 10.1016/j.ejogrb.2004.07.041
   IOM (Institute of Medicine) NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC
   Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03
   Kominiarek MA, 2018, OBSTET GYNECOL, V132, P875, DOI 10.1097/AOG.0000000000002854
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Luke B, 2005, J PERINAT MED, V33, P500, DOI 10.1515/JPM.2005.088
   Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120
   Neggers Y, 2003, J NUTR, V133, p1737S, DOI 10.1093/jn/133.5.1737S
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x
   Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101
   Parker MG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-153
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293
   Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0
   Salihu HM, 2009, EUR J OBSTET GYN R B, V144, P119, DOI 10.1016/j.ejogrb.2009.02.047
   Salihu HM, 2010, ARCH GYNECOL OBSTET, V282, P127, DOI 10.1007/s00404-009-1213-y
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   Vahratian A, 2004, OBSTET GYNECOL, V104, P943, DOI 10.1097/01.AOG.0000142713.53197.91
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   World Health Organization, 2005, ANN NUMB DEATHS CAUS
NR 43
TC 5
Z9 5
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2019
VL 9
AR 13093
DI 10.1038/s41598-019-49704-x
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW8AR
UT WOS:000485215700003
PM 31511664
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Nobrega, GD
   Samogim, AP
   Venceslau, EM
   Guida, JPD
   Tavares, AA
   Japecanga, RR
   Amaral, E
   Modena, JLP
AF Costa, Maria Laura
   Nobrega, Guilherme de Moraes
   Samogim, Ana Paula
   Venceslau, Emanuella Meneses
   de Siqueira Guida, Jose Paulo
   Tavares, Arthur Antolini
   Japecanga, Rodolfo Rosa
   Amaral, Eliana
   Proenca Modena, Jose Luiz
TI PLACENTAL CHARACTERIZATION OF ZIKA VIRUS INFECTION DURING 2016 OUTBREAK
   IN CAMPINAS/SP - BRAZIL
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Costa, Maria Laura; Venceslau, Emanuella Meneses; de Siqueira Guida, Jose Paulo; Tavares, Arthur Antolini; Japecanga, Rodolfo Rosa; Amaral, Eliana] Univ Estadual Campinas, CAISM, UNICAMP, Womens Hosp Prof Dr Jose Aristodemo Pinotti, Campinas, SP, Brazil.
   [Nobrega, Guilherme de Moraes; Samogim, Ana Paula; Proenca Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, UNICAMP, Dept Genet Evolut Microbiol & Immunol, Campinas, SP, Brazil.
OI de Moraes Nobrega, Guilherme/0000-0001-9406-4256
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.81
BP E42
EP E42
DI 10.1016/j.placenta.2019.06.138
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500137
DA 2020-12-08
ER

PT J
AU Borovac-Pinheiro, A
   Cavichiolli, FS
   Costa, ML
   Surita, FG
AF Borovac-Pinheiro, Anderson
   Cavichiolli, Fernanda Schwartz
   Costa, Maria Laura
   Surita, Fernanda Garanhani
TI Osler-Weber-Rendu syndrome in pregnancy affecting lungs and braina case
   report
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
ID HEREDITARY HEMORRHAGIC TELANGIECTASIA; RISKS; WOMEN
C1 [Borovac-Pinheiro, Anderson; Cavichiolli, Fernanda Schwartz; Costa, Maria Laura; Surita, Fernanda Garanhani] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RP Borovac-Pinheiro, A (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Sao Paulo, Brazil.
EM andersonpinheiro.unicamp@gmail.com
RI Surita, Fernanda Garanhani/H-9575-2012; Borovac-Pinheiro,
   Anderson/G-3913-2018
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Borovac-Pinheiro,
   Anderson/0000-0002-2659-6012
CR Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18
   de Gussem EM, 2014, OBSTET GYNECOL, V123, P514, DOI 10.1097/AOG.0000000000000120
   Garg N, 2014, J BLOOD MED, V5, P191, DOI 10.2147/JBM.S45295
   Gershon AS, 2001, CHEST, V119, P470, DOI 10.1378/chest.119.2.470
   Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35
   Inocencio G, 2013, BMJ CASE REPORTS, V25, P1
   Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x
   McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32
   Shovlin CL, 2008, BJOG-INT J OBSTET GY, V115, P1108, DOI 10.1111/j.1471-0528.2008.01786.x
   Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P
   Stanek J, 2013, ARCH PATHOL LAB MED, V137, P706, DOI 10.5858/arpa.2011-0645-RA
   Wain K, 2012, AM J MED GENET A, V158A, P2009, DOI 10.1002/ajmg.a.35458
NR 12
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0144-3615
EI 1364-6893
J9 J OBSTET GYNAECOL
JI J. Obstet. Gynaecol.
PD JUL 4
PY 2019
VL 39
IS 5
BP 709
EP 711
DI 10.1080/01443615.2019.1581739
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HZ8HJ
UT WOS:000469095100023
PM 31020882
DA 2020-12-08
ER

PT J
AU Mayrink, J
   Souza, RT
   Feitosa, FE
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Calderon, IM
   Sousa, MH
   Costa, ML
   Baker, PN
   Cecatti, JG
   Parpinelli, MA
   Fernandes, KG
   Guida, JP
   Santana, DS
   Barbosa, RM
   Galvao, RBF
   Cassettari, BF
   Pfitscher, L
   de Feitosa, DL
   Ferreira, EM
   Anacleto, D
   Zotareli, V
   Silva, MA
AF Mayrink, Jussara
   Souza, Renato T.
   Feitosa, Francisco E.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Calderon, Iracema M.
   Sousa, Maria H.
   Costa, Maria L.
   Baker, Philip N.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Fernandes, Karayna G.
   Guida, Jose P.
   Santana, Danielly S.
   Barbosa, Ricardo M.
   Galvao, Rafael B. F.
   Cassettari, Bianca F.
   Pfitscher, Lucia
   de Feitosa, Daisy Lucena
   Ferreira Junior, Elias Melo
   Anacleto, Danilo
   Zotareli, Vilma
   Silva, Marcia Alice
CA Preterm SAMBA Study Grp
TI Incidence and risk factors for Preeclampsia in a cohort of healthy
   nulliparous pregnant women: a nested case-control study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MEAN ARTERIAL-PRESSURE; PREDICTING PREECLAMPSIA; PERINATAL OUTCOMES;
   BIOMARKERS; ECLAMPSIA; ASPIRIN; CARE
AB The objective of this study is to determine the incidence, socio-demographic and clinical risk factors for preeclampsia and associated maternal and perinatal adverse outcomes. This is a nested case-control derived from the multicentre cohort study Preterm SAMBA, in five different centres in Brazil, with nulliparous healthy pregnant women. Clinical data were prospectively collected, and risk factors were assessed comparatively between PE cases and controls using risk ratio (RR) (95% CI) plus multivariate analysis. Complete data were available for 1,165 participants. The incidence of preeclampsia was 7.5%. Body mass index determined at the first medical visit and diastolic blood pressure over 75 mmHg at 20 weeks of gestation were independently associated with the occurrence of preeclampsia. Women with preeclampsia sustained a higher incidence of adverse maternal outcomes, including C-section (3.5 fold), preterm birth below 34 weeks of gestation (3.9 fold) and hospital stay longer than 5 days (5.8 fold) than controls. They also had worse perinatal outcomes, including lower birthweight (a mean 379 g lower), small for gestational age babies (RR 2.45 [1.52-3.95]), 5-minute Apgar score less than 7 (RR 2.11 [1.03-4.29]), NICU admission (RR 3.34 [1.61-6.9]) and Neonatal Near Miss (3.65 [1.78-7.49]). Weight gain rate per week, obesity and diastolic blood pressure equal to or higher than 75 mmHg at 20 weeks of gestation were shown to be associated with preeclampsia. Preeclampsia also led to a higher number of C-sections and prolonged hospital admission, in addition to worse neonatal outcomes.
C1 [Mayrink, Jussara; Souza, Renato T.; Leite, Debora F.; Costa, Maria L.; Cecatti, Jose G.] Univ Campinas UNICAMP, Dept Obstet & Gynaecol, Sch Med Sci, Campinas, SP, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, MEAC Matern Sch, Fortaleza, Ceara, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.] Univ Fed Pernambuco, Matern Hosp, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Vettorazzi, Janete] Fed Univ RS, Matern Hosp, Dept Obstet & Gynaecol, Porto Alegre, RS, Brazil.
   [Calderon, Iracema M.] Unesp, Botucatu Sch Med, Dept Obstet & Gynaecol, Botucatu, SP, Brazil.
   [Sousa, Maria H.] Jundiai Sch Med, Stat Unit, Jundiai, SP, Brazil.
   [Baker, Philip N.] Univ Leicester, Coll Life Sci, Maurice Shock Bldg, Leicester, Leics, England.
   [Parpinelli, Mary A.; Fernandes, Karayna G.; Guida, Jose P.; Santana, Danielly S.; Barbosa, Ricardo M.; Galvao, Rafael B. F.] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.
   [Cassettari, Bianca F.] UNESP, Sch Med Botucatu, Botucatu, SP, Brazil.
   [Pfitscher, Lucia] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   [de Feitosa, Daisy Lucena] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
   [Ferreira Junior, Elias Melo; Anacleto, Danilo] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil.
   [Zotareli, Vilma; Silva, Marcia Alice] Univ Estadual Campinas, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Dept Obstet & Gynaecol, Sch Med Sci, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Calderon, Iracema/W-4336-2019; Leite, Debora F B/D-7299-2018; Souza,
   Renato Teixeira/G-4205-2017
OI Calderon, Iracema/0000-0003-4761-4336; Leite, Debora F
   B/0000-0001-8839-3934; Souza, Renato Teixeira/0000-0002-9075-9269
FU Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
   [OPP1107597]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [401636/2013-5]
FX We thanks The Preterm SAMBA study group that also included: Mary A.
   Parpinelli, Karayna G Fernandes, Jose P Guida, Danielly S Santana,
   Ricardo M Barbosa and Rafael B F Galvao, from the School of Medical
   Sciences, University of Campinas, Brazil; Bianca F. Cassettari, School
   of Medicine of Botucatu, UNESP, Brazil; Lucia Pfitscher, School of
   Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil;
   Daisy Lucena de Feitosa, School of Medicine, Federal University of
   Ceara, Fortaleza, Brazil; Elias de Melo Ferreira Junior, Danilo
   Anacleto, School of Medicine, Federal University of Pernambuco, Recife,
   Brazil; Vilma Zotareli and Marcia Alice Silva, from the University of
   Campinas. In addition, we acknowledge the contribution of all
   institutions involved in the entire study, including the funders and
   also the participants, who kindly agreed to take part in the full study.
   This study was jointly funded by the Bill and Melinda Gates Foundation
   (grant OPP1107597) and CNPq (grant 401636/2013-5). The funders played no
   role whatsoever in study development, data collection, data analysis or
   data interpretation.
CR Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629
   Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005
   Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021
   Benton SJ, 2017, PLACENTA, V60, pS32, DOI 10.1016/j.placenta.2016.11.006
   Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198
   Boutin A, 2019, FETAL DIAGN THER, V45, P69, DOI 10.1159/000487301
   Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE
   Conde-Agudelo A, 2004, OBSTET GYNECOL, V104, P1367, DOI 10.1097/01.AOG.0000147599.47713.5d
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Eastabrook G, 2018, PREGNANCY HYPERTENS, V13, P204, DOI 10.1016/j.preghy.2018.06.005
   Gabbay-Benziv R, 2016, PRENATAL DIAG, V36, P34, DOI 10.1002/pd.4707
   Gallo D, 2014, FETAL DIAGN THER, V36, P28, DOI 10.1159/000360287
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Goetzinger KR, 2013, J ULTRAS MED, V32, P1593, DOI 10.7863/ultra.32.9.1593
   Halscott TL, 2014, PRENATAL DIAG, V34, P668, DOI 10.1002/pd.4407
   Hutcheon JA, 2018, HYPERTENSION, V72, P433, DOI 10.1161/HYPERTENSIONAHA.118.10999
   Jauniaux E, 2016, BJOG-INT J OBSTET GY, V123, P1066, DOI 10.1111/1471-0528.13858
   Kale PL, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00179115, 10.1590/0102-311x00179115]
   Kane SC, 2014, AUST NZ J OBSTET GYN, V54, P101, DOI 10.1111/ajo.12151
   Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578
   Kenny LC, 2012, REPROD SCI, V19, p323A
   Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019
   Morais SS, 2018, REV BRAS GINECOL OBS, V40, P11, DOI 10.1055/s-0037-1608885
   Morais SS, 2017, CLINICS, V72, P698, DOI 10.6061/clinics/2017(11)09
   Myatt L, 2012, OBSTET GYNECOL, V119, P1234, DOI 10.1097/AOG.0b013e3182571669
   Nakimuli A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0362-3
   North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875
   O'Gorman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011801
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Phillippi JC, 2013, J MIDWIFERY WOM HEAL, V58, P509, DOI 10.1111/jmwh.12041
   Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45
   Roberts JM, 2017, NAT REV NEPHROL, V13, P603, DOI 10.1038/nrneph.2017.121
   Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559
   Silveira C, 2016, INT J GYNECOL OBSTET, V134, P87, DOI 10.1016/j.ijgo.2015.10.027
   Thornton C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.042
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X
   Visintin C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2207
   Xu TT, 2015, J CLIN HYPERTENS, V17, P567, DOI 10.1111/jch.12541
NR 41
TC 10
Z9 10
U1 0
U2 3
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 2
PY 2019
VL 9
AR 9517
DI 10.1038/s41598-019-46011-3
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IF9MK
UT WOS:000473417000008
PM 31266984
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, RT
   Cecatti, JG
   Passini, R
   Pacagnella, RC
   Oliveira, PF
   Silva, CM
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Costa, ML
   Haddad, SM
   Marba, ST
   Guinsburg, R
   Martinez, FE
   Zotarelli, V
   Gurgel, LT
   Feitosa, FE
   Chaves, GN
   Porto, AM
   Coutinho, IC
   Lima, ACB
   Melo, EF
   Leite, DF
   Amorim, MM
   Melo, ASO
   Melo, FO
   Martins, MG
   Nunes, MV
   Paiva, CS
   Lima, MD
   Freire, DM
   Tristao, EG
   Nascimento, DJ
   Menezes, CA
   Aquino, M
   Vettorazzi, J
   Senger, CE
   Assumpcao, AMB
   Guedes, MAF
   Moreira, MEL
   Borges, VT
   Maia, NL
   Mathias, JP
   Souza, E
   Zamarian, ACP
   Quintana, SM
   Melli, PPS
   Lotufo, FA
   Uzilin, K
   Zanette, EA
   Andreucci, CB
   Oliveira, TA
   Oliveira, LR
   Santos, MAN
   Sass, N
   Silveira, MRF
   Coutinho, PR
   Siqueira, L
AF Souza, Renato T.
   Cecatti, Jose G.
   Passini Jr, Renato
   Pacagnella, Rodolfo C.
   Oliveira, Paulo F.
   Silva, Cleide M.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Costa, Maria L.
   Haddad, Samira M.
   Marba, Sergio T.
   Guinsburg, Ruth
   Martinez, Francisco E.
   Zotarelli, Vilma
   Gurgel, Lucio T.
   Feitosa, Francisco E.
   Chaves, George N.
   Porto, Ana M.
   Coutinho, Isabela C.
   Barbosa Lima, Antonio C.
   Melo Jr, Elias F.
   Leite, Debora F.
   Amorim, Melania M.
   Melo, Adriana S. O.
   Melo, Fabiana O.
   Martins, Marilia G.
   Nunes, Marynea, V
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Tristao, Edson G.
   Nascimento, Denis J.
   Menezes, Carlos A.
   Aquino, Marcelo
   Vettorazzi, Janete
   Senger, Cintia E.
   Assumpcao, Augusta M. B.
   Guedes, Marcela A. F.
   Moreira, Maria E. L.
   Borges, Vera T.
   Maia Filho, Nelson L.
   Mathias, Jacinta P.
   Souza, Eduardo
   Zamarian, Ana C. P.
   Quintana, Silvana M.
   Melli, Patricia P. S.
   Lotufo, Fatima A.
   Uzilin, Kaliane
   Zanette, Elvira A.
   Andreucci, Carla B.
   Oliveira, Tenilson A.
   Oliveira, Laercio R.
   Santos, Marcos A. N.
   Sass, Nelson
   Silveira, Mirian R. F.
   Coutinho, Pedro R.
   Siqueira, Luciana
CA Brazilian Multictr Study Preterm B
TI Cluster analysis identifying clinical phenotypes of preterm birth and
   related maternal and neonatal outcomes from the Brazilian Multicentre
   Study on Preterm Birth
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Cluster; k-means; Maternal outcomes; Neonatal outcomes; Phenotypes;
   Preterm birth
ID ORGANIZATION MULTICOUNTRY SURVEY; ISCHEMIC PLACENTAL DISEASE; SECONDARY
   ANALYSIS; EPIDEMIOLOGY; PREDICTION
AB Objective To explore a conceptual framework of clinical conditions associated with preterm birth (PTB) by cluster analysis, assessing determinants for different PTB subtypes and related maternal and neonatal outcomes. Methods Secondary analysis of the Brazilian Multicentre Study on Preterm Birth of 33 740 births in 20 maternity hospitals between April 2011 and July 2012. In accordance with a prototype concept based on maternal, fetal, and placental conditions, an adapted k-means model and fuzzy algorithm were used to identify clusters using predefined conditions. The mains outcomes were phenotype clusters and maternal and neonatal outcomes. Results Among 4150 PTBs, three clusters of PTB phenotypes were identified: women who had PTB without any predefined conditions; women with mixed conditions; and women who had pre-eclampsia, eclampsia, HELLP syndrome and fetal growth restriction. The prevalence of different preterm subtypes differed significantly in the three clusters, varying from 80.95% of provider-initiated PTBs in cluster 3-6.62% in cluster 1 (P<0.001). Although some maternal characteristics differed among the clusters, maternal and neonatal outcomes did not. Conclusions The analysis identified three clusters with distinct phenotypes. Women from the different clusters had different subtypes of PTB and maternal and pregnancy characteristics.
C1 [Souza, Renato T.; Cecatti, Jose G.; Passini Jr, Renato; Pacagnella, Rodolfo C.] Univ Estadual Campinas, Dept Obstet & Gynaecol, UNICAMP, Sch Med, Campinas, SP, Brazil.
   [Oliveira, Paulo F.; Silva, Cleide M.] Univ Estadual Campinas, Unit Stat, UNICAMP, Sch Med Sci, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Andreucci, Carla B/J-4845-2015; feitosa, francisco e/H-8431-2014; Melo,
   Adriana S O/H-5650-2016; Polido, Carla Betina Andreucci/Y-9743-2019;
   Sass, Nelson/AAD-8259-2020; Amorim, Melania M/C-5807-2013; Souza, Renato
   Teixeira/G-4205-2017; BORGES, VERA T/B-7363-2014
OI Andreucci, Carla B/0000-0002-5590-108X; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Sass, Nelson/0000-0001-7187-1004; Amorim,
   Melania M/0000-0003-1047-2514; Souza, Renato
   Teixeira/0000-0002-9075-9269; BORGES, VERA T/0000-0002-9347-9641
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation
FX CNPq; FAPESP; Bill and Melinda Gates Foundation
CR Ananth CV, 2011, EUR J OBSTET GYN R B, V159, P77, DOI 10.1016/j.ejogrb.2011.07.025
   Barros FC, 2015, JAMA PEDIATR, V169, P220, DOI 10.1001/jamapediatrics.2014.3040
   Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753
   Beckmann JS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0388-7
   Berghella V, 2017, ULTRASOUND OBST GYN, V49, P322, DOI 10.1002/uog.17388
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Esplin MS, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.011
   Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015
   Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865
   Honest H, 2012, CURR OPIN OBSTET GYN, V24, P422, DOI 10.1097/GCO.0b013e328359823a
   IOM (Institute of Medicine) NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC
   Koullali B, 2016, SEMIN FETAL NEONAT M, V21, P80, DOI 10.1016/j.siny.2016.01.005
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P66, DOI 10.1111/1471-0528.12632
   Oyelade J, 2016, BIOINFORM BIOL INSIG, V10, P237, DOI 10.4137/BBI.S38316
   Parker SE, 2014, SEMIN PERINATOL, V38, P133, DOI 10.1053/j.semperi.2014.03.004
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22
   Peek N, 2014, Yearb Med Inform, V9, P42, DOI 10.15265/IY-2014-0018
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866
   Wang LP, 2016, METHODS, V111, P21, DOI 10.1016/j.ymeth.2016.08.014
NR 24
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUL
PY 2019
VL 146
IS 1
BP 110
EP 117
DI 10.1002/ijgo.12839
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IK7IE
UT WOS:000476761900018
PM 31055833
OA Other Gold
DA 2020-12-08
ER

PT J
AU Mariano, S
   Guida, JPD
   de Sousa, MV
   Parpinelli, MA
   Surita, FG
   Mazzali, M
   Costa, ML
AF Mariano, Stephanye
   de Siqueira Guida, Jose Paulo
   de Sousa, Marcos Vinicius
   Parpinelli, Mary Angela
   Surita, Fernanda Garanhani
   Mazzali, Marilda
   Costa, Maria Laura
TI Pregnancy Among Women with Kidney Transplantation: A 20-Years
   Single-Center Registry
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE kidney transplantation; pregnancy; high-risk; hypertension; premature
   birth; dialysis
ID RENAL-DISEASE; OUTCOMES; LIVER
AB Objective To assess maternal and perinatal outcomes in pregnancies after kidney transplantation in a tertiary center in Brazil.
   Methods Retrospective cohort of pregnancies in women with kidney transplantation at the Universidade Estadual de Campinas, from January 1995 until December 2017. Medical charts were reviewed, and maternal and perinatal outcomes were described as means and frequencies. Renal function and blood pressure were evaluated during pregnancy and postpartum.
   Results A total of 22 women had at least 1 pregnancy during the considered time interval, and 3 of them had > 1 pregnancy, totalizing 25 pregnancies. The mean age at transplantation was of 24.6 +/- 4.2 years old, and the mean time interval until pregnancy was of 67.8 +/- 46.3 months. The most frequent complication during pregnancy was hypertension, which affected 11(64.7%) women. The gestational age at delivery was 34.7 +/- 4 weeks, and 47% of these pregnancies were preterm (< 37 weeks). A total of 88.2% of the women delivered by cesarean section. Renal function, measured by serum creatinine, remained stable during pregnancy, and the systolic blood pressure increased significantly, while the diastolic blood pressure did not differ during pregnancy.
   Conclusion Pregnancy after kidney transplantation is a rare event. Pre-eclampsia and prematurity were frequent complications, and cesarean section rates were very high. A specialized antenatal and postpartum care with a multiprofessional approach and continuous monitoring of graft function are essential for the early diagnosis of complications and improved outcomes.
C1 [Mariano, Stephanye; de Siqueira Guida, Jose Paulo; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura] Univ Estadual Campinas, Dept Tocogynecol, Sch Med Sci, Campinas, SP, Brazil.
   [de Sousa, Marcos Vinicius; Mazzali, Marilda] Univ Estadual Campinas, Renal Transplant Res Lab, Renal Transplant Unit, Div Nephrol,Sch Med Sci, Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Rua Tessalia Vieira de Camargo 126, BR-13083887 Campinas, SP, Brazil.
EM lauracosta.unicamp@gmail.com
RI de Sousa, Marcos Vinicius/Q-3018-2019; Surita, Fernanda
   Garanhani/H-9575-2012
OI de Sousa, Marcos Vinicius/0000-0002-0280-1069; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
CR Akar ME, 2015, GYNECOL OBSTET INVES, V79, P13, DOI 10.1159/000365815
   [Anonymous], 2018, REG BRAS TRANSPL, V24
   Basaran O, 2004, TRANSPL P, V36, P122, DOI 10.1016/j.transproceed.2003.11.011
   Blume C, 2014, BEST PRACT RES CL OB, V28, P1123, DOI 10.1016/j.bpobgyn.2014.07.021
   Candido Cristina, 2016, J. Bras. Nefrol., V38, P421, DOI 10.5935/0101-2800.20160067
   Colla L, 2018, J NEPHROL, V31, P361, DOI 10.1007/s40620-018-0477-3
   Filippi V, 2018, INT J GYNECOL OBSTET, V141, P4, DOI 10.1002/ijgo.12463
   Guerra AA, 2010, CAD SAUDE PUBLICA, V26, P163, DOI 10.1590/S0102-311X2010000100017
   Hou S, 2013, ADV CHRONIC KIDNEY D, V20, P253, DOI 10.1053/j.ackd.2013.01.011
   Josephson MA, 2013, ADV CHRONIC KIDNEY D, V20, P433, DOI 10.1053/j.ackd.2013.06.005
   Juliato CRT, 2018, CONTRACEPTION, V98, P252, DOI 10.1016/j.contraception.2018.04.017
   Madej A, 2018, TRANSPL P, V50, P2150, DOI 10.1016/j.transproceed.2018.05.003
   Nadeau-Fredette AC, 2013, ADV CHRONIC KIDNEY D, V20, P246, DOI 10.1053/j.ackd.2013.01.010
   Oliveira LG, 2007, CLIN TRANSPLANT, V21, P301, DOI 10.1111/j.1399-0012.2006.00627.x
   Perales-Puchalt A, 2012, J MATERN-FETAL NEO M, V25, P1363, DOI 10.3109/14767058.2011.634461
   Rocha A, 2013, TRANSPL P, V45, P1088, DOI 10.1016/j.transproceed.2013.02.006
   Sesso Ricardo Cintra, 2017, J. Bras. Nefrol., V39, P261, DOI 10.5935/0101-2800.20170049
   SHAH S, 2016, INT J NEPHROL, pNIL1, DOI DOI 10.1155/2016/4539342
   Sharaf El Din Usama Abdel Azim, 2016, World J Nephrol, V5, P258, DOI 10.5527/wjn.v5.i3.258
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
NR 20
TC 1
Z9 1
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUL
PY 2019
VL 41
IS 7
BP 419
EP 424
DI 10.1055/s-0039-1688834
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IL0SK
UT WOS:000477010000002
PM 31250419
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Angelini, CFR
   Pacagnella, RD
   Silveira, C
   Andreucci, CB
   Ferreira, EC
   Santos, JP
   Zanardi, DMT
   Parpinelli, MA
   Costa, ML
   Cecatti, JG
AF Robles Angelini, Carina Fernanda
   Pacagnella, Rodolfo de Carvalho
   Silveira, Carla
   Andreucci, Carla Betina
   Ferreira, Elton Carlos
   Santos, Juliana Pereira
   Toledo Zanardi, Duke Maria
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Cecatti, Jose Guilherme
TI Lessons from the Field Beyond the Numbers: Narratives of Professionals
   on Women who Experienced Severe Maternal Morbidity
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE personal narratives; childbirth; health personnel; mothers; postpartum
   period
ID SEVERE OBSTETRIC COMPLICATIONS; BURKINA-FASO; PERINATAL LOSS; HEALTH;
   MISS; PREGNANCY; MORTALITY; CONSEQUENCES; VIOLENCE; INTERVENTIONS
AB Objective Several factors might affect the health and the quality of life of women who had a severe maternal morbidity (SMM) or a maternal near-miss (MNM) episode. The objective of the present study was to explore the perspectives of the professionals on the repercussions of SMM or of MNM after interviewing women who survived such episodes. Method Selected cases that captured the attention of professionals were reported. The professionals built individually 10 narratives, which were analyzed with the technique of content analysis. Results According to the perspectives of the professionals, women surviving a severe maternal condition and their families experienced clinical and psychosocial consequences. Some cases portrayed the intense psychological distress in mourning for the loss of the fetus or of their reproductive capacity and changes in family dynamics generating emotional overload, depression, and gender violence. Conclusion The analysis of narratives may offer an idea on the complexity of the perception of care by professionals and on the need for an interdisciplinary follow-up of women surviving an SMM or an MNM episode.
C1 [Robles Angelini, Carina Fernanda; Pacagnella, Rodolfo de Carvalho; Silveira, Carla; Andreucci, Carla Betina; Ferreira, Elton Carlos; Santos, Juliana Pereira; Toledo Zanardi, Duke Maria; Parpinelli, Mary Angela; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Fac Med, Dept Gynecol & Obstet, Rua Tessalia Vieira de Camargo 126, BR-13083887 Campinas, SP, Brazil.
   [Andreucci, Carla Betina] Univ Fed Sao Carlos, Fac Med, Dept Med, Sao Carlos, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Fac Med, Dept Gynecol & Obstet, Rua Tessalia Vieira de Camargo 126, BR-13083887 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Andreucci, Carla B/J-4845-2015; Cecatti, Jose Guilherme/M-5945-2013;
   Polido, Carla Betina Andreucci/Y-9743-2019
OI Andreucci, Carla B/0000-0002-5590-108X; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X
CR Andreucci CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143581
   Angelini CR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9348647
   Angelini CR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e309
   Badenhorst W, 2007, BEST PRACT RES CL OB, V21, P249, DOI 10.1016/j.bpobgyn.2006.11.004
   Bardin L, 2004, ANAL CONTENT, V70
   Berg CJ, 2003, OBSTET GYNECOL, V101, P289, DOI 10.1016/S0029-7844(02)02587-5
   Callister LC, 2006, J PERINAT NEONAT NUR, V20, P227, DOI 10.1097/00005237-200607000-00009
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8
   Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489
   Furuta M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-133
   Furuta M, 2014, MIDWIFERY, V30, P158, DOI 10.1016/j.midw.2013.09.001
   Furuta M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-125
   Gausia K, 2012, J HEALTH POPUL NUTR, V30, P172, DOI 10.3329/jhpn.v30i2.11310
   Gausia K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-451
   Grossman Eloísa, 2006, Rev. bras. educ. med., V30, P6, DOI 10.1590/S0100-55022006000100002
   Kiss LB, 2011, CIENC SAUDE COLETIVA, V16, P1943, DOI 10.1590/S1413-81232011000300028
   Koblinsky M, 2012, J HEALTH POPUL NUTR, V30, P124, DOI 10.3329/jhpn.v30i2.11294
   Mander R, 2009, NURS EDUC TODAY, V29, P117, DOI 10.1016/j.nedt.2008.07.005
   Naved RT, 2012, J HEALTH POPUL NUTR, V30, P181, DOI 10.3329/jhpn.v30i2.11312
   Orazulike NC, 2013, WOMENS HEALTH, V9, P373, DOI [10.2217/WHE.13.35, 10.2217/whe.13.35]
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Robinson GE, 2011, J NERV MENT DIS, V199, P571, DOI 10.1097/NMD.0b013e318225f31e
   Say L, 2018, INT J GYNECOL OBSTET, V141, P1, DOI 10.1002/ijgo.12499
   Silveira C, 2016, INT J GYNECOL OBSTET, V134, P87, DOI 10.1016/j.ijgo.2015.10.027
   Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Storeng KT, 2013, GLOB HEALTH PROMOT, V20, P33, DOI 10.1177/1757975912462420
   Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011
   Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056
   Stratton K, 2008, AUST NZ J OBSTET GYN, V48, P5, DOI 10.1111/j.1479-828X.2007.00806.x
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536
   Turato ER, 2005, REV SAUDE PUBL, V39, P507, DOI 10.1590/S0034-89102005000300025
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1
   WHO, 2000, WOM MENT HLTH EV BAS
NR 37
TC 0
Z9 0
U1 1
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUN
PY 2019
VL 41
IS 6
BP 379
EP 386
DI 10.1055/s-0039-1688833
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IF4ZW
UT WOS:000473091800004
PM 31247666
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Souza, RT
   Cecatti, JG
   Mayrink, J
   Galvao, RB
   Costa, ML
   Feitosa, F
   Rocha, E
   Leite, DF
   Vettorazzi, J
   Tedesco, RP
   Santana, DS
   Souza, JP
   Luiz, CB
   Brust, LC
   Anacleto, D
   Nascimento, LC
   Lucena, D
   Cordeiro, DEF
   Rogerio, MB
AF Souza, Renato T.
   Cecatti, Jose Guilherme
   Mayrink, Jussara
   Galvao, Rafael Bessa
   Costa, Maria Laura
   Feitosa, Francisco
   Rocha Filho, Edilberto
   Leite, Debora F.
   Vettorazzi, Janete
   Tedesco, Ricardo P.
   Santana, Danielly S.
   Souza, Joao Paulo
   Luiz, Carina B.
   Brust, Luiza C.
   Anacleto, Danilo
   Nascimento, Livia C.
   Lucena, Daisy
   Cordeiro, Denise E. F.
   Rogerio, Mariana B.
CA MAES-I Study Grp
TI Identification of earlier predictors of pregnancy complications through
   wearable technologies in a Brazilian multicentre cohort: Maternal
   Actigraphy Exploratory Study I (MAES-I) study protocol
SO BMJ OPEN
LA English
DT Article
ID PHYSICAL-ACTIVITY MONITORS; MULTICOUNTRY SURVEY; SLEEP DISTURBANCES;
   CIRCADIAN-RHYTHM; SEDENTARY TIME; RISK-FACTORS; WRIST; MORTALITY;
   PATTERNS; HIP
AB Introduction Non-invasive tools capable of identifying predictors of maternal complications would be a step forward for improving maternal and perinatal health. There is an association between modification in physical activity (PA) and sleep-wake patterns and the occurrence of inflammatory, metabolic, pathological conditions related to chronic diseases. The actigraphy device is validated to estimate PA and sleep-wake patterns among pregnant women. In order to extend the window of opportunity to prevent, diagnose and treat specific maternal conditions, would it be possible to use actigraphy data to identify risk factors for the development of adverse maternal outcomes during pregnancy?
   Methods and analysis A cohort will be held in five centres from the Brazilian Network for Studies on Reproductive and Perinatal Health. Maternal Actigraphy Exploratory Study I (MAES-I) will enrol 400 low-risk nulliparous women who will wear the actigraphy device on their wrists day and night (24 hours/ day) uninterruptedly from 19 to 21 weeks until childbirth. Changes in PA and sleep-wake patterns will be analysed throughout pregnancy, considering ranges in gestational age in women with and without maternal complications such as pre-eclampsia, preterm birth (spontaneous or provider-initiated), gestational diabetes, maternal haemorrhage during pregnancy, in addition to perinatal outcomes. The plan is to design a predictive model using actigraphy data for screening pregnant women at risk of developing specific adverse maternal and perinatal outcomes.
   Ethics and dissemination MAES-I has been reviewed and approved by each institutional review board and also by the National Council for Ethics in Research. Detailed information about the study is provided in the Brazilian Cohort website (www.medscinet.com/samba) and findings will be published in the scientific literature and institutional webpages.
C1 [Souza, Renato T.; Cecatti, Jose Guilherme; Galvao, Rafael Bessa; Costa, Maria Laura; Santana, Danielly S.] Univ Estadual Campinas, Obstet & Gynecol, Campinas, SP, Brazil.
   [Mayrink, Jussara] Univ Estadual Campinas, Fac Ciencias Med, Campinas, SP, Brazil.
   [Feitosa, Francisco] Univ Fed Ceara, Maternidade Escola, Fortaleza, Ceara, Brazil.
   [Rocha Filho, Edilberto; Leite, Debora F.] Univ Fed Pernambuco, Obstet & Gynecol, Recife, PE, Brazil.
   [Vettorazzi, Janete] Univ Fed Rio Grande do Sul, Obstet & Gynecol, Porto Alegre, RS, Brazil.
   [Tedesco, Ricardo P.] Sch Med Jundiai, Obstet & Gynecol, Campinas, SP, Brazil.
   [Souza, Joao Paulo] Univ Sao Paulo, Social Med, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Luiz, Carina B.; Brust, Luiza C.] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   [Anacleto, Danilo; Nascimento, Livia C.] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil.
   [Lucena, Daisy; Cordeiro, Denise E. F.] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
   [Rogerio, Mariana B.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Joao Paulo/G-1982-2010; Cecatti, Jose Guilherme/M-5945-2013;
   Souza, Renato Teixeira/G-4205-2017; Leite, Debora F B/D-7299-2018
OI Souza, Joao Paulo/0000-0002-2288-4244; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Souza, Renato
   Teixeira/0000-0002-9075-9269; Leite, Debora F B/0000-0001-8839-3934
FU Bill and Melinda Gates Foundation through the Grand Challenge
   Exploration program [OPP1182749]
FX This study was funded by The Bill and Melinda Gates Foundation through
   the Grand Challenge Exploration program, call 19 (research grant
   OPP1182749).
CR Baron KG, 2014, INT REV PSYCHIATR, V26, P139, DOI 10.3109/09540261.2014.911149
   Belton S, 2013, J PHYS ACT HEALTH, V10, P1181, DOI 10.1123/jpah.10.8.1181
   Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   Danilack V, 2015, AM J OBSTET GYNECOL, V212, pS208, DOI 10.1016/j.ajog.2014.10.448
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Diem SJ, 2016, AM J GERIAT PSYCHIAT, V24, P248, DOI 10.1016/j.jagp.2015.12.002
   Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913
   Ellis K, 2016, MED SCI SPORT EXER, V48, P933, DOI 10.1249/MSS.0000000000000840
   Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191
   Falck RS, 2017, J AGING PHYS ACTIV, V25, P51, DOI 10.1123/japa.2015-0256
   Fisher M., 2013, WASHINTON POST
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Haddad SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/989815
   Haney A, 2014, SLEEP MED, V15, P444, DOI 10.1016/j.sleep.2014.01.003
   Hardin P.E., 2000, GENOME BIOL, V1023, P1, DOI 10.1186/gb-2000-1-4-reviews1023
   Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62
   Hayase M, 2014, WOMEN BIRTH, V27, P190, DOI 10.1016/j.wombi.2014.04.002
   Herring SJ, 2014, SLEEP MED, V15, P51, DOI 10.1016/j.sleep.2013.07.018
   Herring SJ, 2013, SLEEP BREATH, V17, P1323, DOI 10.1007/s11325-013-0835-2
   Huberty J, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0212-3
   John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e
   Kamada M, 2016, GAIT POSTURE, V44, P23, DOI 10.1016/j.gaitpost.2015.11.005
   Kizaki T, 2015, CRIT REV IMMUNOL, V35, P261, DOI 10.1615/CritRevImmunol.2015014925
   Koster A, 2016, MED SCI SPORT EXER, V48, P1514, DOI 10.1249/MSS.0000000000000924
   Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546
   Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019
   Loprinzi PD, 2016, PHYSIOL BEHAV, V154, P126, DOI 10.1016/j.physbeh.2015.11.022
   Luft CD, 2007, REV SAUDE PUBL, V41, P606, DOI 10.1590/S0034-89102007000400015
   Lynch BM, 2016, CANCER CAUSE CONTROL, V27, P59, DOI 10.1007/s10552-015-0683-4
   Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872
   McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x
   Mindell JA, 2015, SLEEP MED, V16, P483, DOI 10.1016/j.sleep.2014.12.006
   Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445
   Murphy NM, 2016, EUR J OBSTET GYN R B, V199, P60, DOI 10.1016/j.ejogrb.2016.01.044
   North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875
   Okun ML, 2013, J WOMENS HEALTH, V22, P1028, DOI 10.1089/jwh.2013.4331
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pacagnella RC, 2012, REPROD HEALTH MATTER, V20, P155, DOI 10.1016/S0968-8080(12)39601-8
   Palagini L, 2014, SLEEP MED, V15, P853, DOI 10.1016/j.sleep.2014.02.013
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Pesce Renata P., 2005, Cad. Saúde Pública, V21, P436, DOI 10.1590/S0102-311X2005000200010
   Rowlands AV, 2016, MED SCI SPORT EXER, V48, P2142, DOI 10.1249/MSS.0000000000001015
   Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001
   Sani M, 2015, CHRONOBIOL INT, V32, P650, DOI 10.3109/07420528.2015.1038559
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Staudenmayer J, 2015, J APPL PHYSIOL, V119, P396, DOI 10.1152/japplphysiol.00026.2015
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183
   Tsai SY, 2016, BIRTH-ISS PERINAT C, V43, P176, DOI 10.1111/birt.12215
   Tsai SY, 2016, INT J NURS STUD, V56, P45, DOI 10.1016/j.ijnurstu.2016.01.001
   UNDP, 2015, SUST DEV GOALS
   United Nations Development Programme (UNDP), 2010, HUM DEV IND HDI
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wood AC, 2008, BEHAV RES METHODS, V40, P873, DOI 10.3758/BRM.40.3.873
   World Health Organization, 2015, GLOB STRAT WOM CHILD
   World Health Organization, 2016, WHO REC ANT CAR POS
   Wright SP, 2017, AM J PHYSIOL-REG I, V312, pR358, DOI 10.1152/ajpregu.00349.2016
   Wu J, 2016, HYPERTENSION, V67, P493, DOI 10.1161/HYPERTENSIONAHA.115.06331
NR 62
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD JUN
PY 2019
VL 9
IS 4
AR e023101
DI 10.1136/bmjopen-2018-023101
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA IC7MA
UT WOS:000471157200017
PM 31005906
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Baptista, LC
   Figueira, CO
   Souza, BB
   Fertrin, KY
   Antolini, A
   Costa, FF
   de Melo, MB
   Costa, ML
AF Baptista, Leticia C.
   Figueira, Camilla O.
   Souza, Bruno B.
   Fertrin, Kleber Y.
   Antolini, Arthur
   Costa, Fernando F.
   de Melo, Monica B.
   Costa, Maria Laura
TI Highlight Article: Different morphological and gene expression profile
   in placentas of the same sickle cell anemia patient in pregnancies of
   opposite outcomes
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Placenta; sickle cell disease; gene expression; preeclampsia; and
   pregnancy
ID PERINATAL OUTCOMES; AMNIOTIC-FLUID; DISEASE; WOMEN; MODEL;
   INTERLEUKIN-10; PREECLAMPSIA; AQUAPORIN-1; HEMOGLOBIN; HYPOXIA
AB Environmentally induced changes in placental morphological and molecular phenotypes may provide relevant insight towards pathophysiology of diseases. Sickle cell disease (SCD) is a common inherited hemoglobin disorder characterized by chronic hemolytic anemia and vaso-occlusive crisis. SCD leads to higher morbidity and mortality, especially during pregnancy, with increased risk of preeclampsia (PE). To compare clinical findings, placental morphology, and gene expression in villous placental tissue using next generation sequencing. We included five cases. Two placentas from the same woman with homozygous SCD that had been pregnant twice and had different maternal and fetal outcomes (one early onset PE/eclampsia and a mostly non-complicated pregnancy); an early onset PE, a fetal growth restriction and a term, non-complicated pregnancy. Sixty-four differentially expressed genes were observed in the SCD+PE case, in comparison with the placenta from the SCD without PE, based on fold change. Among these genes, 59 were upregulated and 5 were downregulated. Enrichment analysis indicated two significant biological processes: response to copper ion (CYP1A1, AOC1, AQP1, and ATP5D) and triglyceride-rich lipoprotein particle clearance (GPIHBP1, APOC1, and APOE). The rare opportunity to evaluate the same patient in two different pregnancies, of opposing outcomes, and compare to other conditions of known placental and vascular/inflammatory involvement, may further the understanding of the pathophysiology of PE in SCD. Our results suggest that the clinical association between SCD and PE may be supported by common pathophysiological mechanisms, but that pathways involving response to copper and triglyceride metabolism could be important drivers of PE pathophysiology. Impact statement Environmentally induced changes in placental morphological and molecular phenotypes may provide relevant insight towards pathophysiology of diseases. The rare opportunity to evaluate the same patient, with sickle cell anemia (SCA), in two different pregnancies, of opposite outcomes (one early onset severe preeclampsia (PE) and the other mostly non-complicated) can prove such concept. In addition, the comparison to other conditions of known placental and vascular/inflammatory involvement strengthens such findings. Our results suggest that the clinical association between SCA and PE can be supported by common pathophysiological mechanisms, but that pathways involving response to copper and triglyceride metabolism may be important drivers of the pathophysiology of PE. Future studies using in a larger number of samples should confirm these findings and explore pathways involved in the pathophysiology of PE and its relationship with SCA.
C1 [Baptista, Leticia C.; Souza, Bruno B.; de Melo, Monica B.] Univ Estadual Campinas, UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, BR-13083875 Campinas, SP, Brazil.
   [Figueira, Camilla O.; Costa, Maria Laura] Univ Estadual Campinas, UNICAMP, Dept Obstet & Gynecol, BR-13083880 Campinas, SP, Brazil.
   [Fertrin, Kleber Y.] Univ Washington, Div Hematol, Seattle, WA 98195 USA.
   [Antolini, Arthur] Univ Estadual Campinas, UNICAMP, Dept Pathol, BR-13083887 Campinas, SP, Brazil.
   [Costa, Fernando F.] Univ Estadual Campinas, UNICAMP, Hematol & Hemotherapy Ctr, BR-13083878 Campinas, SP, Brazil.
RP de Melo, MB (corresponding author), Univ Estadual Campinas, UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, BR-13083875 Campinas, SP, Brazil.
EM melomb@uol.com.br
FU Sao Paulo Research Foundation (FAPESP) grant [2015/08330-5,
   2014/00984-3]; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [409605/2016-6]
FX This study was supported by Sao Paulo Research Foundation (FAPESP) grant
   2015/08330-5, grant 2014/00984-3 and the National Council for Scientific
   and Technological Development (CNPq) grant 409605/2016-6.
CR ACOG Committee on Obstetrics, 2007, OBSTET GYNECOL, V78, P229
   Almeida CB, 2016, SICKLE CELL ANEMIA B, P177
   ANGASTINIOTIS M, 1995, B WORLD HEALTH ORGAN, V73, P375
   Arnold LL, 1999, AM J REPROD IMMUNOL, V41, P174
   Asnani MR, 2016, COCHRANE DB SYST REV, V10
   Baptista LC, 2016, ANN HEMATOL, V95, P1859, DOI 10.1007/s00277-016-2780-1
   Belo L, 2002, ATHEROSCLEROSIS, V162, P425, DOI 10.1016/S0021-9150(01)00734-1
   Brook A, 2018, FASEB J, V32, P5436, DOI 10.1096/fj.201800264R
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Claster S, 2009, AM J HEMATOL, V84, P344, DOI 10.1002/ajh.21416
   Copel JA, 2014, OBSTET GYNECOL, V123, P1057, DOI 10.1097/AOG.0000000000000232
   Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x
   Gibbs I, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.003
   Gram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138111
   Guo J, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138636
   Hoppe C, 2009, AM J HEMATOL, V84, P462, DOI 10.1002/ajh.21442
   Howard J, 2012, BEST PRACT RES CL OB, V26, P25, DOI 10.1016/j.bpobgyn.2011.10.001
   Jones K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158050
   Li Liu-xia, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P497
   Liu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep36193
   Malowany JI, 2012, SEMIN DIAGN PATHOL, V29, P49, DOI 10.1053/j.semdp.2011.07.005
   Mann SE, 2005, AM J OBSTET GYNECOL, V192, P2041, DOI 10.1016/j.ajog.2005.02.046
   Martinez Nora, 2017, Adv Exp Med Biol, V969, P199, DOI 10.1007/978-94-024-1057-0_13
   Mendonca R, 2016, INFLAMM RES, V65, P665, DOI 10.1007/s00011-016-0955-9
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927
   Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107
   Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317
   Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270
   Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116
   Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X
   Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408
   Prophet J, 2018, PREGNANCY HYPERTENS, V11, P87, DOI 10.1016/j.preghy.2018.01.006
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Sak S, 2018, J MATERN-FETAL NEO M, P1
   Sanitaria ANdV., 2002, AGEN NACL VIGIL SANI, V1, P7
   Serjeant GR, 2001, BRIT J HAEMATOL, V112, P3, DOI 10.1046/j.1365-2141.2001.02557.x
   SILVER RM, 1993, PLACENTA, V14, P583, DOI 10.1016/S0143-4004(05)80211-5
   Tersigni C, 2018, J REPROD IMMUNOL, V129, P48, DOI 10.1016/j.jri.2018.06.024
   Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x
   Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003
   Uno S, 2018, FOOD CHEM TOXICOL, V113, P73, DOI 10.1016/j.fct.2018.01.029
   Villers MS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.016
   Weatherall DJ, 1997, BRIT MED J, V314, P492, DOI 10.1136/bmj.314.7079.492
   Nomura RMY, 2010, REV BRAS GINECOL OBS, V32, P405, DOI 10.1590/S0100-72032010000800008
   Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9
   Zorca S, 2010, BRIT J HAEMATOL, V149, P436, DOI 10.1111/j.1365-2141.2010.08109.x
NR 48
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD APR
PY 2019
VL 244
IS 5
BP 395
EP 403
DI 10.1177/1535370219834305
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HV4DQ
UT WOS:000465937400008
PM 30818999
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Zanardi, DM
   Parpinelli, MA
   Haddad, SM
   Costa, ML
   Sousa, MH
   Leite, DFB
   Cecatti, JG
   Pacagnella, RC
   Camargo, RS
   Santana, DS
   Zotareli, V
   Gurgel, LT
   Surita, FG
   Silva, JLP
   Amaral, EM
   Say, L
   Pattinson, RC
   Rudge, MV
   Calderon, IM
   Bahamondes, MV
   Goncalves, SP
   Moraes, OB
   Carvalho, SA
   Feitosa, FE
   Chaves, GN
   Brum, IR
   Saint'Ynes, GC
   Menezes, CA
   Santos, PN
   Guanabara, EM
   Almeida, EJ
   Moreira, JL
   Sousa, MR
   Peret, FA
   Paula, LB
   Schmaltz, LE
   Pessoni, C
   Katz, L
   Bione, A
   Lima, ACB
   Filho, EAR
   Amorim, MM
   Radaci, I
   Martins, MG
   Barroso, F
   Oliveira, FC
   Nascimento, DJ
   Paiva, CS
   Lima, MD
   Freire, DM
   Rohloff, RD
   Rodrigues, SM
   Costa, SM
   Pfitscher, LC
   Luz, AG
   Guimaraes, DI
   Lobato, G
   Nakamura-Pereira, M
   Cordioli, E
   Peterossi, A
   Perez, CD
   Peracoli, JC
   Costa, RA
   Maia, NL
   Matias, JP
   Quintana, SM
   Moises, EC
   Lotufo, FA
   Carvalho, LE
   Andreucci, CB
   Zanette, EA
   Aquino, MM
   Ohnuma, MH
   Mattar, R
   Campanharo, FF
AF Zanardi, Dulce M.
   Parpinelli, Mary A.
   Haddad, Samira M.
   Costa, Maria L.
   Sousa, Maria H.
   Leite, Debora F. B.
   Cecatti, Jose G.
   Pacagnella, Rodolfo C.
   Camargo, Rodrigo S.
   Santana, Daniely S.
   Zotareli, Vilma
   Gurgel, Lucio T.
   Surita, Fernanda G.
   Pinto e Silva, Joao L.
   Amaral, Eliana M.
   Say, Lale
   Pattinson, Robert C.
   Rudge, Marilza V.
   Calderon, Iracema M.
   Bahamondes, Maria V.
   Goncalves, Simone P.
   Moraes Filho, Olimpio B.
   Carvalho, Simone A.
   Feitosa, Francisco E.
   Chaves, George N.
   Brum, Ione R.
   Saint'Ynes, Gloria C.
   Menezes, Carlos A.
   Santos, Patricia N.
   Guanabara, Everardo M.
   Almeida, Elson J., Jr.
   Moreira, Joaquim L.
   Sousa, Maria R.
   Peret, Frederico A.
   Paula, Liv B.
   Schmaltz, Luiza E.
   Pessoni, Cleire
   Katz, Leila
   Bione, Adriana
   Barbosa Lima, Antonio C.
   Rocha Filho, Edilberto A.
   Amorim, Melania M.
   Radaci, Ivelyne
   Martins, Marilia G.
   Barroso, Frederico
   Oliveira, Fernando C., Jr.
   Nascimento, Denis J.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Rohloff, Roger D.
   Rodrigues, Simone M.
   Costa, Sergio M.
   Pfitscher, Lucia C.
   Luz, Adriana G.
   Guimaraes, Dan-Iela
   Lobato, Gustavo
   Nakamura-Pereira, Marcos
   Cordioli, Eduardo
   Peterossi, Alessandra
   Perez, Cynthia D.
   Peracoli, Jose C.
   Costa, Roberto A.
   Maia Filho, Nelson L.
   Matias, Jacinta P.
   Quintana, Silvana M.
   Moises, Elaine C.
   Lotufo, Fatima A.
   Carvalho, Luiz E.
   Andreucci, Carla B.
   Zanette, Elvira A.
   Aquino, Marcia M.
   Ohnuma, Maria H.
   Mattar, Rosiane
   Campanharo, Felipe F.
CA Brazilian Network Surveillance Se
TI Adverse perinatal outcomes are associated with severe maternal morbidity
   and mortality: evidence from a national multicentre cross-sectional
   study
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Article
DE Perinatal morbidity; Perinatal mortality; Severe maternal morbidity;
   Maternal near miss; Maternal mortality; Apgar score
ID HEALTH; COMPLICATIONS; SURVEILLANCE; PREGNANCY; NETWORK; BRAZIL
AB PurposeTo assess the association between maternal potentially life-threatening conditions(PLTC), maternal near miss (MNM), and maternal death (MD) with perinatal outcomes.MethodsCross-sectional study in 27 Brazilian referral centers from July, 2009 to June, 2010. All women presenting any criteria for PLTC and MNM, or MD, were included. Sociodemographic and obstetric characteristics were evaluated in each group of maternal outcomes. Childbirth and maternal morbidity data were related to perinatal adverse outcomes (5th min Apgar score<7, fetal death, neonatal death, or any of these). The Chi-squared test evaluated the differences between groups. Multiple regression analysis adjusted for the clustering design effect identified the independently associated maternal factors with the adverse perinatal outcomes (prevalence ratios; 95% confidence interval).ResultsAmong 8271 cases of severe maternal morbidity, there were 714 cases of adverse perinatal outcomes. Advanced maternal age, low level of schooling, multiparity, lack of prenatal care, delays in care, preterm birth, and adverse perinatal outcomes were more common among MNM and MD. Both MNM and MD were associated with Apgar score (2.39; 1.68-3.39); maternal hemorrhage was the most prevalent characteristic associated with fetal death (2.9, 95% CI 1.81-4.66) and anyadverseperinatal outcome (2.16; 1.59-2.94); while clinical/surgical conditions were more related to neonatal death (1.56; 1.08-2.25).ConclusionWe confirmed the association between MNM and MD with adverse perinatal outcomes. Maternal and perinatal issues should not be dissociated. Policies aiming maternal care should include social and economic development, and improvements in accessibility to specialized care. These, in turn, will definitively impact on childhood mortality rates.
C1 [Zanardi, Dulce M.; Parpinelli, Mary A.; Haddad, Samira M.; Costa, Maria L.; Leite, Debora F. B.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
   [Sousa, Maria H.] Jundiai Med Sch, Dept Publ Hlth, Jundiai, SP, Brazil.
   [Leite, Debora F. B.] Univ Fed Pernambuco, Dept Life Sci, Caruaru, PE, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Cordioli, Eduardo/X-1934-2019;
   Moises, Elaine Christine Dantas/N-9522-2019; Surita, Fernanda
   Garanhani/H-9575-2012; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   CORDIOLI, EDUARDO/AAR-6100-2020; Calderon, Iracema/W-4336-2019; Polido,
   Carla Betina Andreucci/Y-9743-2019; Amorim, Melania M/C-5807-2013;
   Andreucci, Carla B/J-4845-2015; Leite, Debora F B/D-7299-2018; feitosa,
   francisco e/H-8431-2014; Katz, Leila/M-5291-2013; Nakamura-Pereira,
   Marcos/X-1107-2019
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; CORDIOLI, EDUARDO/0000-0001-5405-9380;
   Calderon, Iracema/0000-0003-4761-4336; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Amorim, Melania M/0000-0003-1047-2514;
   Andreucci, Carla B/0000-0002-5590-108X; Leite, Debora F
   B/0000-0001-8839-3934; Katz, Leila/0000-0001-9854-7917;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Zanardi,
   Dulce/0000-0002-2993-8460
FU National Research Council (CNPq), through the Department of Science and
   Technology of the Brazilian Ministry of Health (DECIT) [402702/2008-5]
FX We would like to thank our sponsors, the National Research Council
   (CNPq), through the Department of Science and Technology of the
   Brazilian Ministry of Health (DECIT); Grant number 402702/2008-5. We are
   also grateful to all the researchers from the Brazilian Network for the
   Surveillance of Severe Maternal Morbidity Group: Rodolfo C. Pacagnella,
   Rodrigo S. Camargo, Daniely S. Santana, Vilma Zotareli, Lucio T. Gurgel,
   Fernanda G. Surita, Joao L. Pinto e Silva, Eliana M. Amaral, Lale Say,
   Robert C. Pattinson, Marilza V. Rudge, Iracema M. Calderon, Maria V.
   Bahamondes, Simone P. Goncalves, Olimpio B. Moraes Filho, Simone A.
   Carvalho, Francisco E. Feitosa, George N. Chaves, Ione R. Brum, Gloria
   C. Saint'Ynes, Carlos A. Menezes, Patricia N. Santos, Everardo M.
   Guanabara, Elson J. Almeida Jr., Joaquim L. Moreira, Maria R. Sousa,
   Frederico A. Peret, Liv B. Paula, Luiza E. Schmaltz, Cleire Pessoni,
   Leila Katz, Adriana Bione, Antonio C. Barbosa Lima, Edilberto A. Rocha
   Filho, Melania M. Amorim, Ivelyne Radaci, Marilia G. Martins, Frederico
   Barroso, Fernando C. Oliveira Jr., Denis J. Nascimento, Claudio S.
   Paiva, Moises D. Lima, Djacyr M. Freire, Roger D. Rohloff, Simone M.
   Rodrigues, Sergio M. Costa, Lucia C. Pfitscher, Adriana G. Luz, Daniela
   Guimaraes, Gustavo Lobato, Marcos Nakamura-Pereira, Eduardo Cordioli,
   Alessandra Peterossi, Cynthia D. Perez, Jose C. Peracoli, Roberto A.
   Costa, Nelson L. Maia Filho, Jacinta P. Matias, Silvana M. Quintana,
   Elaine C. Moises, Fatima A. Lotufo, Luiz E. Carvalho, Carla B.
   Andreucci, Elvira A. Zanette, Marcia M. Aquino, Maria H. Ohnuma, Rosiane
   Mattar, and Felipe F. Campanharo.
CR Allanson ER, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0472-9
   Anggondowati T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1280-1
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   De Mucio B, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0250-9
   Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630
   Guanais FC, 2015, AM J PUBLIC HEALTH, V105, pS593, DOI 10.2105/AJPH.2013.301452r
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hughes MM, 2017, MATERN CHILD HLTH J, V21, P283, DOI 10.1007/s10995-016-2131-9
   Kale PL, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00179115, 10.1590/0102-311x00179115]
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   Kone S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1858-2
   Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053
   Lazzerini M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019787
   Madeiro AP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0648-3
   Nakimuli A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0362-3
   Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Duarte CMR, 2007, CAD SAUDE PUBLICA, V23, P1511, DOI 10.1590/S0102-311X2007000700002
   Santana DS, 2017, INT J GYNECOL OBSTET, V139, P230, DOI 10.1002/ijgo.12287
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Serruya SJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8271042
   Domingues RMSM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0232-y
   Soma-Pillay P, 2015, SAMJ, S. Afr. med. j., V105, P578, DOI [10.7196/SAMJnew.8038, 10.7196/SAMJNEW.8038]
   Souza JP, 2016, BJOG-INT J OBSTET GY, V123, P427, DOI 10.1111/1471-0528.13509
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Souza JP, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-61
   Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634
   United Nations, 2015, MILL DEV GOALS REP 2
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
   Webbe James, 2017, BMJ Paediatr Open, V1, pe000048, DOI 10.1136/bmjpo-2017-000048
   WHO, 2015, MAT MORT
   WHO UNICEF UNFPA World Bank Group & United Nations Population Division, 2015, TRENDS MAT MORT 1990
   Yoshida S, 2014, LANCET, V384, pE27, DOI 10.1016/S0140-6736(14)60263-4
   2013, WORLD MAL REP 2013, P1
NR 39
TC 5
Z9 5
U1 1
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD MAR
PY 2019
VL 299
IS 3
BP 645
EP 654
DI 10.1007/s00404-018-5004-1
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HM8VJ
UT WOS:000459760600005
PM 30539385
DA 2020-12-08
ER

PT J
AU Oliveira-Neto, AF
   Parpinelli, MA
   Costa, ML
   Souza, RT
   do Valle, CR
   Sousa, MH
   Cecatti, JG
AF Oliveira-Neto, Antonio Francisco
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Souza, Renato Teixeira
   do Valle, Carolina Ribeiro
   Sousa, Maria Helena
   Cecatti, Jose Guilherme
TI Prediction of Severe Maternal Outcome Among Pregnant and Puerperal Women
   in Obstetric ICU
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE maternal near miss, maternal mortality; obstetric intensive care unit;
   severity-of-illness scores
ID INTENSIVE-CARE-UNIT; SYSTEMATIC ANALYSIS; HOSPITAL MORTALITY; ACUTE
   PHYSIOLOGY; NATIONAL LEVELS; APACHE-II; PART 2; SCORE; MORBIDITY;
   DISEASE
AB Objective: World Health Organization recommends the use of maternal near miss as a tool to monitor and improve quality of obstetric care. Severe maternal outcome corresponds to the sum of maternal near miss and maternal death cases. This study was aimed at validating Acute Physiology and Chronic Health Evaluation II and IV, Simplified Acute Physiology Score III, and Sequential Organ Failure Assessment in pregnant and postpartum women in predicting severe maternal outcome. Design: A retrospective cohort study. Setting: Obstetric ICU in a tertiary care hospital in Brazil. Patients: Pregnant and postpartum women admitted to the obstetric ICU during a 3-year period. Interventions: None. Measurements and Main Results: A total of 279 women were admitted to ICU, an admission rate of 34.6/1,000 live births, and the mortality index to severe maternal outcome (maternal death/maternal near miss + maternal death) was 7.7%. Total Sequential Organ Failure Assessment had a better overall performance than remaining scores for total hospitalizations (area under the curve, 0.86; standardized mortality ratio, 0.96; 95% CI, 0.74-1.22), for hypertensive direct causes (area under the curve, 0.81; standardized mortality ratio, 0.73; 95% CI, 0.31-1.43), and indirect causes (area under the curve, 0.89; standardized mortality ratio, 0.85; 95% CI, 0.59-1.19). The Acute Physiology and Chronic Health Evaluation II had a better overall performance than total Sequential Organ Failure Assessment for hemorrhagic causes (area under the curve, 0.75; standardized mortality ratio, 1.0; 95% CI, 0.61-1.54). Conclusions: Total Sequential Organ Failure Assessment may be used to predict severe maternal outcome in obstetric populations admitted to ICU. The Acute Physiology and Chronic Health Evaluation II may be applied to predict severe maternal outcome in hemorrhagic complications. We do not recommend Acute Physiology and Chronic Health Evaluation IV and Simplified Acute Physiology Score III for the prediction of severe maternal outcome.
C1 [Oliveira-Neto, Antonio Francisco; Parpinelli, Mary Angela; Costa, Maria Laura; Souza, Renato Teixeira; do Valle, Carolina Ribeiro; Cecatti, Jose Guilherme] Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Sousa, Maria Helena] Sch Med, Dept Publ Hlth, Jundiai, SP, Brazil.
RP Oliveira-Neto, AF (corresponding author), Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM anttonionetto@gmail.com
RI Souza, Renato Teixeira/G-4205-2017
OI Souza, Renato Teixeira/0000-0002-9075-9269
FU FAPESP (Foundation for Support to Research of the State of Sao Paulo),
   Brazil
FX We gratefully acknowledge the partial financial support of FAPESP
   (Foundation for Support to Research of the State of Sao Paulo), Brazil.
CR Aarvold Alice B R, 2017, Crit Care Med, V45, pe49, DOI 10.1097/CCM.0000000000002018
   Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7
   American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe147, DOI 10.1097/AOG.0000000000001710
   Baskett TF, 2008, BEST PRACT RES CL OB, V22, P763, DOI 10.1016/j.bpobgyn.2008.06.002
   Breslow MJ, 2012, CHEST, V141, P518, DOI 10.1378/chest.11-0331
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Chantry AA, 2015, CRIT CARE MED, V43, P78, DOI 10.1097/CCM.0000000000000601
   Filippi V, 2016, REPROD MATERNAL NEWB, V2, P51, DOI [10. 1596/978-1-4648-0348-2_ch3, DOI 10.1596/978-1-4648-0348-2_CH3]
   Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8
   Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099
   Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146
   Jain S, 2016, INT J GYNECOL OBSTET, V132, P332, DOI 10.1016/j.ijgo.2015.08.005
   Jayaratnam S, 2016, AUST NZ J OBSTET GYN, V56, P381, DOI 10.1111/ajo.12436
   Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Lazzerini M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019787
   LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957
   LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478
   LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284
   MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007
   Martin SR, 2006, AM J OBSTET GYNECOL, V195, P673, DOI 10.1016/j.ajog.2006.05.042
   McGee S, 2002, J GEN INTERN MED, V17, P646
   Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5
   Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856
   Nathan HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168535
   Oliveira-Neto A, 2012, SCI WORLD J, DOI 10.1100/2012/172145
   Pandharipande PP, 2006, CRIT CARE MED, V34, pA1, DOI 10.1097/00003246-200612002-00004
   Paternina-Caicedo A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.103
   Rojas-Suarez J, 2014, CRIT CARE MED, V42, P1047, DOI 10.1097/CCM.0000000000000124
   Ryan HM, 2016, J OBSTET GYNAECOL CA, V38, P909, DOI 10.1016/j.jogc.2016.06.013
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507
   Vasquez DN, 2015, CRIT CARE MED, V43, P1887, DOI 10.1097/CCM.0000000000001139
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156
   Word Health Organization, NEAR MISS APPR MAT H
   World Health Organization, 2012, WHO REC PREV TREATM
   Zeeman GG, 2006, CRIT CARE MED, V34, pS208, DOI 10.1097/01.CCM.0000231884.99763.69
   Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0
NR 39
TC 2
Z9 2
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0090-3493
EI 1530-0293
J9 CRIT CARE MED
JI Crit. Care Med.
PD FEB
PY 2019
VL 47
IS 2
BP E136
EP E143
DI 10.1097/CCM.0000000000003549
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA HN0RD
UT WOS:000459895200009
PM 30422862
DA 2020-12-08
ER

PT J
AU Souza, RT
   Mayrink, U
   Leite, DF
   Costa, ML
   Calderon, IM
   Rocha, EA
   Vettorazzi, J
   Feitosa, FE
   Cecatti, JG
   Baker, PN
   Kenny, L
   Sulek, K
   Parpinelli, MA
   Franchini, KG
   Melo, E
   Anacleto, D
   Cassettari, BF
   Vernini, J
   Pfitscher, L
   Lucena, D
AF Souza, Renato Teixeira
   Mayrink, Ussara
   Leite, Debora Farias
   Costa, Maria Laura
   Calderon, Iracema Mattos
   Rocha Filho, Edilberto Alves
   Vettorazzi, Janete
   Feitosa, Francisco Edson
   Cecatti, Jose Guilherme
   Baker, Philip N.
   Kenny, Louise
   Sulek, Karolina
   Parpinelli, Mary A.
   Franchini, Kleber G.
   Melo, Elias, Jr.
   Anacleto, Danilo
   Cassettari, Bianca F.
   Vernini, Joice
   Pfitscher, Lucia
   Lucena, Daisy
CA Preterm SAMBA Study Grp
TI Metabolomics applied to maternal and perinatal health: a review of new
   frontiers with a translation potential
SO CLINICS
LA English
DT Review
DE Maternal Health (MeSH); Metabolomics (MeSH); Translational Medical
   Research (MeSH); Prediction
ID PRETERM PREMATURE RUPTURE; FOR-GESTATIONAL-AGE; TRIMESTER
   AMNIOTIC-FLUID; HIGH-DIMENSIONAL BIOLOGY; PRENATAL DISORDERS; SYSTEMS
   BIOLOGY; EARLY-PREGNANCY; RISK-FACTORS; AMINO-ACIDS; CHORIOAMNIONITIS
AB The prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and "omics" sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent "boom" in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies.
C1 [Souza, Renato Teixeira; Mayrink, Ussara; Leite, Debora Farias; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Fac Ciencias Med, Dept Ginecol & Obstet, Campinas, SP, Brazil.
   [Leite, Debora Farias; Rocha Filho, Edilberto Alves] Univ Fed Pernambuco, Fac Med, Dept Materno Infantil, Recife, PE, Brazil.
   [Calderon, Iracema Mattos] Univ Estadual Sao Paulo UNESP, Fac Med Botucatu, Dept Ginecol & Obstet, Botucatu, SP, Brazil.
   [Vettorazzi, Janete] Univ Fed Rio Grande do Sul, Fac Med, Dept Ginecol & Obstet, Porto Alegre, RS, Brazil.
   [Feitosa, Francisco Edson] Univ Fed Ceara, Fac Med, Dept Ginecol & Obstet, Fortaleza, Ceara, Brazil.
   [Baker, Philip N.] Univ Leicester, Leicester, Leics, England.
   [Kenny, Louise] Univ Cork, Cork, Ireland.
   [Sulek, Karolina] Univ Auckland, Liggins Inst, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand.
   [Parpinelli, Mary A.] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.
   [Franchini, Kleber G.] LNBio, Campinas, SP, Brazil.
   [Melo, Elias, Jr.; Anacleto, Danilo] Univ Fed Pernambuco, Sch Med, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Cassettari, Bianca F.; Vernini, Joice] UNESP, Sch Med Botucatu, Botucatu, SP, Brazil.
   [Pfitscher, Lucia] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Pfitscher, Lucia] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   [Lucena, Daisy] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Ginecol & Obstet, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Kenny, Louise/X-6329-2019; feitosa,
   francisco e/H-8431-2014; Calderon, Iracema/W-4336-2019; Souza, Renato
   Teixeira/G-4205-2017
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Kenny,
   Louise/0000-0002-9011-759X; Calderon, Iracema/0000-0003-4761-4336;
   Souza, Renato Teixeira/0000-0002-9075-9269
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation [401636/2013-5]; CAPES
   Foundation, an agency under the Ministry of Education of BrazilCAPES
   [88881.134095/2016-01, 8881.134512/2016-01]
FX This review is part of the scope of the Preterm SAMBA Study Group, which
   is an initiative to investigate metabolomic approaches in maternal and
   perinatal health. The Preterm SAMBA Study Group was jointly funded by
   The Brazilian National Research Council (CNPq) and the Bill and Melinda
   Gates Foundation (Award 401636/2013-5, Grand Challenges Brazil: Reducing
   the burden of PTB). RTS and DFL have been awarded Ph.D. scholarships
   from the CAPES Foundation, an agency under the Ministry of Education of
   Brazil, process 88881.134095/2016-01 and 8881.134512/2016-01,
   respectively. The other members of the Preterm SAMBA Study Group that
   supported this review as an initiative for describing new approaches in
   maternal and perinatal health research are as follows: Philip N. Baker,
   University of Leicester, United Kingdom; Louise Kenny, University of
   Cork, Cork, Ireland; Karolina Sulek, Gravida: National Center for Growth
   & Development, Liggins Institute, University of Auckland, Auckland, New
   Zealand; Mary A. Parpinelli, School of Medical Sciences, University of
   Campinas, Campinas, Brazil; Kleber G. Franchini, LNBio, Campinas,
   Brazil; Elias Melo, Jr., and Danilo Anacleto, Department of Mother and
   Child Health, School of Medicine, Federal University of Pernambuco,
   Recife, Brazil; Bianca F. Cassettari and Joice Vernini, School of
   Medicine of Botucatu, UNESP, Brazil; Lucia Pfitscher, Hospital de
   Clinicas de Porto Alegre and School of Medicine, Federal University of
   Rio Grande do Sul, Porto Alegre, Brazil; Daisy Lucena, School of
   Medicine, Federal University of Ceara, Fortaleza, Brazil.
CR AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599
   Albu A R, 2014, J Med Life, V7, P165
   Aletti F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0197-4
   Alonso A, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00023
   American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005
   Antharam VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148824
   Bahado-Singh RO, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.044
   Bahado-Singh RO, 2013, AM J OBSTET GYNECOL, V208, p58e1, DOI DOI 10.1016/J.AJ0G.2012.11.003
   Bamberg Christian, 2004, Semin Fetal Neonatal Med, V9, P387
   Barberini L, 2014, J MATERN-FETAL NEO M, V27, P20, DOI 10.3109/14767058.2014.954786
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Carninci P, 2010, DNA RES, V17, P51, DOI 10.1093/dnares/dsq006
   Centers for Disease Control and Prevention (CDC), 2016, DIAGN TEST
   Chaouachi S, 2011, ARCH PEDIATRIE, V18, P267, DOI 10.1016/j.arcped.2010.12.009
   Chou D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0789-4
   Clark RH, 2014, PEDIATRICS, V134, pE37, DOI 10.1542/peds.2014-0329
   Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430
   Crovetto F, 2014, ULTRASOUND OBST GYN, V43, P34, DOI 10.1002/uog.12537
   de Seymour JV, 2014, ACTA DIABETOL, V51, P887, DOI 10.1007/s00592-014-0626-7
   Denihan NM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/254076
   Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81
   Dessi A, 2015, BEST PRACT RES CL OB, V29, P156, DOI 10.1016/j.bpobgyn.2014.04.023
   Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868
   Dettmer K, 2004, ENVIRON HEALTH PERSP, V112, pA396
   Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108
   Dharuri H, 2014, BBA-MOL BASIS DIS, V1842, P1923, DOI 10.1016/j.bbadis.2014.05.030
   Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m
   Diderholm B, 2009, INDIAN J MED RES, V130, P612
   Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0
   Dudzik D, 2015, J PROTEOME RES, V14, P1432, DOI 10.1021/pr501087x
   Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335
   Engelhardt B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20772
   Fanos V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/720514
   Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
   Garcia-Simon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140993
   Gardosi J, 2012, ARCH DIS CHILD-FETAL, V97, pF314, DOI 10.1136/fetalneonatal-2012-301708
   GARITE TJ, 1982, OBSTET GYNECOL, V59, P539
   Ghartey J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.052
   Ghosh S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1256-z
   Graca G, 2008, ANAL CHEM, V80, P6085, DOI 10.1021/ac800907f
   Graca G, 2012, MOL BIOSYST, V8, P1243, DOI 10.1039/c2mb05424h
   Graca G, 2010, J PROTEOME RES, V9, P6016, DOI 10.1021/pr100815q
   Gracie S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-71
   Haas CT, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0583-9
   Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004
   Harrison A, 2016, MOL CELL PROTEOMICS, V15, P1117, DOI 10.1074/mcp.M115.052498
   Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017
   Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021
   He XL, 2016, ACTA DIABETOL, V53, P119, DOI 10.1007/s00592-015-0737-9
   Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012
   Horgan RP, 2010, PLACENTA, V31, P893, DOI 10.1016/j.placenta.2010.07.002
   Horgan RP, 2009, BJOG-INT J OBSTET GY, V116, P173, DOI 10.1111/j.1471-0528.2008.01997.x
   Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897
   Howman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051836
   Huynh J, 2014, DIABETOLOGIA, V57, P2453, DOI 10.1007/s00125-014-3371-0
   Jain J, 2016, SEMIN FETAL NEONAT M, V21, P129, DOI 10.1016/j.siny.2015.11.002
   Kamath-Rayne BD, 2014, REPROD SCI, V21, P6, DOI 10.1177/1933719113485292
   Karagiannis G, 2011, FETAL DIAGN THER, V29, P148, DOI 10.1159/000321694
   Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012
   Kenny LC, 2008, REPROD SCI, V15, P591, DOI 10.1177/1933719108316908
   Kuc S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098540
   Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494
   Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352
   Li SZ, 2016, BIOL RES NURS, V18, P12, DOI 10.1177/1099800415595463
   Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058
   Lindsay KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145794
   Lowe WL, 2014, DIABETIC MED, V31, P254, DOI 10.1111/dme.12352
   Maddipati KR, 2016, J LIPID RES, V57, P1906, DOI 10.1194/jlr.P069096
   Maddipati KR, 2016, FASEB J, V30, P3296, DOI 10.1096/fj.201600583R
   Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003
   Maitre L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-110
   Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012
   Menon R, 2014, REPROD SCI, V21, P791, DOI 10.1177/1933719113518987
   Mock DM, 2009, J NUTR, V139, P154, DOI 10.3945/jn.108.095273
   Mousavian Z, 2016, SEMIN CELL DEV BIOL, V51, P3, DOI 10.1016/j.semcdb.2015.12.007
   Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195
   Nanda S, 2011, FETAL DIAGN THER, V29, P274, DOI 10.1159/000323327
   Odibo AO, 2011, PRENATAL DIAG, V31, P990, DOI 10.1002/pd.2822
   Oludag T, 2014, J OBSTET GYNAECOL RE, V40, P954, DOI 10.1111/jog.12273
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Palmas F, 2016, EXPERT REV MOL DIAGN, V16, P473, DOI 10.1586/14737159.2016.1139456
   Pappa KI, 2007, AM J OBSTET GYNECOL, V196, P65, DOI 10.1016/j.ajog.2006.06.094
   Patti GJ, 2011, J SEP SCI, V34, P3460, DOI 10.1002/jssc.201100532
   Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982
   Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397
   Poon LCY, 2013, FETAL DIAGN THER, V33, P16, DOI 10.1159/000341712
   Popowski T, 2011, GYNECOL OBSTET FERTI, V39, P302, DOI 10.1016/j.gyobfe.2010.11.006
   Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007
   Rainesalo S, 2004, NEUROCHEM RES, V29, P319, DOI 10.1023/B:NERE.0000010461.34920.0c
   Roberts JM, 2014, SEMIN PERINATOL, V38, P139, DOI 10.1053/j.semperi.2014.03.005
   Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x
   Romero R, 2002, J CLIN ENDOCR METAB, V87, P2431, DOI 10.1210/jc.87.6.2431
   Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618
   Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399
   Saxena A, 2011, WIRES SYST BIOL MED, V3, P527, DOI 10.1002/wsbm.135
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Schatz F, 2016, HUM REPROD UPDATE, V22, P497, DOI 10.1093/humupd/dmw004
   Sulek K, 2014, THERANOSTICS, V4, P953, DOI 10.7150/thno.9265
   Tchirikov M, 2018, J PERINAT MED, V46, P465, DOI 10.1515/jpm-2017-0027
   Thomas MM, 2015, INT J MOL SCI, V16, P27741, DOI 10.3390/ijms161126052
   Thornburg LL, 2016, J MATERN-FETAL NEO M, V29, P2056, DOI 10.3109/14767058.2015.1077224
   Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003
   UNDP, 2015, SUST DEV GOALS
   United Nations Development Programme (UNDP), 2002, MILL DEV GOALS
   Velauthar L, 2014, ULTRASOUND OBST GYN, V43, P500, DOI 10.1002/uog.13275
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Whelan SP, 2014, J SURG RES, V186, P297, DOI 10.1016/j.jss.2013.08.007
   Wilson K, 2014, PEDIATR RES, V75, P367, DOI 10.1038/pr.2013.212
   Wirta V., 2006, MINING TRANSCRIPTOME
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/01.AOG.0000429658.85846.f9, 10.1097/AOG.0b013e31828ec686]
   Yu HY, 2015, BIOSCI TRENDS, V9, P35, DOI 10.5582/bst.2014.01058
   Zhang HP, 2015, GENET EPIDEMIOL, V39, P217, DOI 10.1002/gepi.21887
   Zhang SC, 2009, ANAL CHEM, V81, P6080, DOI 10.1021/ac900424c
   Zhong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032423
   Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g
   Zhou CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139635
NR 122
TC 4
Z9 4
U1 1
U2 8
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2019
VL 74
AR e894
DI 10.6061/clinics/2019/e894
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HQ7YF
UT WOS:000462639300001
PM 30916173
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, MA
   Guida, JPS
   Cecatti, JG
   Souza, JP
   Gulmezoglu, AM
   Betran, AP
   Torloni, MR
   Vogel, JP
   Costa, ML
AF Souza, Marcio A.
   Guida, Jose P. S.
   Cecatti, Jose G.
   Souza, Joao P.
   Gulmezoglu, Ahmet M.
   Betran, Ana P.
   Torloni, Maria R.
   Vogel, Joshua P.
   Costa, Maria L.
TI Analgesia during Labor and Vaginal Birth among Women with Severe
   Maternal Morbidity: Secondary Analysis from the WHO Multicountry Survey
   on Maternal and Newborn Health
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CARE; INTERVENTIONS; CHILDBIRTH; PREGNANCY; FRAMEWORK; MORTALITY;
   DELIVERY
AB Aim. To evaluate the use of analgesia for vaginal birth, in women with and without severe maternal morbidity (SMM) and to describe sociodemographic, clinical, and obstetric characteristics and maternal and perinatal outcomes associated with labor analgesia. Methods. Secondary analysis of the WHO Multicountry Survey on Maternal and Newborn Health (WHO-MCS), a global cross-sectional study performed between May 2010 and December 2011 in 29 countries. Women who delivered vaginally and had an SMM were included in this analysis and were then divided into two groups: those who received and those who did not receive analgesia for labor/delivery. We further compared maternal characteristics and maternal and perinatal outcomes between these two groups. Results. From 314,623 women originally included in WHO-MCS, 9,788 developed SMM and delivered vaginally, 601 (6.1%) with analgesia and 9,187 (93.9%) without analgesia. Women with SMM were more likely to receive analgesia than those who did not experience SMM. Global distribution of SMM was similar; however, the use of analgesia was less prevalent in Africa. Higher maternal education, previous cesarean section, and nulliparity were factors associated with analgesia use. Analgesia was not an independent factor associated with an increase of severe maternal outcome (Maternal Near Miss + Maternal Death). Conclusions. The overall use of analgesia for vaginal delivery is low but women with SMM are more likely to receive analgesia during labor. Social conditions are closely linked with the likelihood of having analgesia during delivery and such a procedure is not associated with increased adverse maternal outcomes. Expanding the availability of analgesia in different levels of care should be a concern worldwide.
C1 [Souza, Marcio A.; Guida, Jose P. S.; Cecatti, Jose G.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Souza, Joao P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Sao Paulo, Brazil.
   [Gulmezoglu, Ahmet M.; Betran, Ana P.; Vogel, Joshua P.] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Torloni, Maria R.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Vogel, Joshua P.] Burnet Inst, Maternal & Child Hlth Program, Melbourne, Vic, Australia.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM marcioasoiza@gmail.com; zepauloguida@gmail.com; cecatti@unicamp.br;
   jpsouza@fmrp.usp.br; gulmezoglum@who.int; betrana@who.int;
   ginecologia@terra.com.br; vogeljo@who.int; mlaura@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Souza, Joao Paulo/G-1982-2010;
   Vogel, Joshua/K-7649-2019
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Souza, Joao
   Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096
FU UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction; USAIDUnited
   States Agency for International Development (USAID); Ministry of Health,
   Labour and Welfare of JapanMinistry of Health, Labour and Welfare,
   Japan; Gynuity Health Projects; WHOWorld Health Organization
FX The WHO Multi-Country Survey on Maternal and Newborn Health was
   financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction; WHO; USAID; the Ministry of Health, Labour and Welfare of
   Japan; and Gynuity Health Projects. The authors thank all members of the
   WHO Global Survey on Maternal and Perinatal Health Research Network and
   the WHO Multi-Country Survey on Maternal and Newborn Health Research
   Network, including regional and country coordinators, data collection
   coordinators, facility coordinators, data collectors, and all staff of
   the participating facilities who made the surveys possible.
CR [Anonymous], 2018, WHO RECOMMENDATIONS
   Benfield R, 2018, MIDWIFERY, V64, P110, DOI 10.1016/j.midw.2018.06.005
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Creanga AA, 2017, OBSTET GYNECOL, V130, P366, DOI 10.1097/AOG.0000000000002114
   de Jonge A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180846
   Dickinson JE, 2003, AUST NZ J OBSTET GYN, V43, P463, DOI 10.1046/j.0004-8666.2003.00152.x
   Fan ZT, 2007, INT J GYNECOL OBSTET, V98, P205, DOI 10.1016/j.ijgo.2007.03.007
   Filippi V, 2018, INT J GYNECOL OBSTET, V141, P4, DOI 10.1002/ijgo.12463
   Firoz T, 2018, INT J GYNECOL OBSTET, V141, P61, DOI 10.1002/ijgo.12469
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Fuglenes D, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.043
   Glance LG, 2007, ANESTHESIOLOGY, V106, P19, DOI 10.1097/00000542-200701000-00008
   Graham W, 2016, LANCET, V388, P2164, DOI 10.1016/S0140-6736(16)31533-1
   Jasen P, 1997, SOC HIST MED, V10, P383, DOI 10.1093/shm/10.3.383
   Kantor E, 2017, ANESTH ANALG, V125, P925, DOI 10.1213/ANE.0000000000002275
   Lally JE, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-7
   Lange EMS, 2017, SEMIN PERINATOL, V41, P293, DOI 10.1053/j.semperi.2017.04.006
   Long Q, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002672
   MELZACK R, 1984, PAIN, V19, P321, DOI 10.1016/0304-3959(84)90079-4
   Mestrovic Ana Havelka, 2015, Coll Antropol, V39, P557
   Osterman MJ, 2008, NATL VITAL STAT REP, V59, P13
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Plante L, 2017, OBSTET GYNECOL, V129, pE73
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sia ATH, 2010, BEST PRACT RES CL OB, V24, P303, DOI 10.1016/j.bpobgyn.2009.12.001
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286
   Torloni MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-78
   Vogt SE, 2011, CAD SAUDE PUBLICA, V27, P1789, DOI 10.1590/S0102-311X2011000900012
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Whitburn LY, 2018, WOMEN BIRTH
NR 31
TC 2
Z9 2
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2019
VL 2019
AR 7596165
DI 10.1155/2019/7596165
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA HM7NQ
UT WOS:000459666100001
PM 30895195
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, RT
   Cecatti, JG
   Costa, ML
   Mayrink, J
   Pacagnella, RC
   Passini, R
   Franchini, KG
   Feitosa, FE
   Calderon, IM
   Rocha, EA
   Leite, DF
   Vettorazzi, J
   Kenny, LC
   Baker, PN
   Parpinelli, MA
   Fernandes, KG
   Guida, JP
   Santana, D
   Barbosa, RM
   Galvao, RBF
   Cassettari, BF
   Pfitscher, L
   de Feitosa, DL
AF Souza, Renato T.
   Cecatti, Jose G.
   Costa, Maria L.
   Mayrink, Jussara
   Pacagnella, Rodolfo C.
   Passini, Renato, Jr.
   Franchini, Kleber G.
   Feitosa, Francisco E.
   Calderon, Iracema M.
   Rocha Filho, Edilberto A.
   Leite, Debora F.
   Vettorazzi, Janete
   Kenny, Louise C.
   Baker, Philip N.
   Parpinelli, Mary A.
   Fernandes, Karayna G.
   Guida, Jose P.
   Santana, Danielly
   Barbosa, Ricardo M.
   Galvao, Rafael B. F.
   Cassettari, Bianca F.
   Pfitscher, Lucia
   de Feitosa, Daisy Lucena
CA Preterm SAMBA Study Grp
TI Planning, Implementing, and Running a Multicentre Preterm Birth Study
   with Biobank Resources in Brazil: The Preterm SAMBA Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PREECLAMPSIA; METABOLOMICS; PREGNANCY; HEALTH
AB Background. Our aim was to describe the steps in planning, implementing, and running a multicentre cohort study of maternal and perinatal health using a high-quality biobank comprised of maternal serum, plasma, and hair samples collected from five sites in Brazil. The Preterm SAMBA study, conducted by the Brazilian Network for Studies on Reproductive and Perinatal Health, was an innovative approach used to identify women at higher risk for preterm birth. It is also of great importance in the study of other maternal and perinatal complications in the context of Brazil, which is a middle-income country. Methods. We described phases of planning, implementing, and running the Preterm SAMBA study, a multicentre Brazilian cohort study of low-risk nulliparous pregnant women, to validate a set of metabolite biomarkers for preterm birth identified in an external cohort. Procedures and strategies used to plan, implement, and maintain this multicentre preterm birth study are described in detail. Barriers and experience cited in the current narrative are not usually discussed in the scientific literature or published study protocols. Results. Several barriers and strategies were identified in different phases of the Preterm SAMBA study at different levels of the study framework (steering committee; coordinating and local centres). Strategies implemented and resources used in the study are a legacy of the Brazilian Network, aimed at training collaborators in such complex settings. Conclusion. The Brazilian Network for Studies on Reproductive and Perinatal Health has gained some experience in conducting a multicentre cohort study using a resourceful biobank which may be helpful to other research groups and maternal/perinatal health networks that plan on employing a similar approach to a similar background.
C1 [Souza, Renato T.; Cecatti, Jose G.; Costa, Maria L.; Mayrink, Jussara; Pacagnella, Rodolfo C.; Passini, Renato, Jr.; Preterm SAMBA Study Grp] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Franchini, Kleber G.] LNBiobrazilian Natl Lab Biosci, Campinas, SP, Brazil.
   [Feitosa, Francisco E.] Univ Campinas UNICAMP, Sch Med Sci, Campinas, SP, Brazil.
   [Calderon, Iracema M.] Univ Fed Ceara, MEAC Matern Sch, Fortaleza, Ceara, Brazil.
   [Rocha Filho, Edilberto A.; Leite, Debora F.] Sao Paulo State Univ Unesp, Botucatu Med Sch, Dept Obstet & Gynecol, Botucatu, SP, Brazil.
   [Vettorazzi, Janete] Univ Fed Pernambuco, Dept Maternal & Child Hlth, Matern Clin Hosp, Recife, PE, Brazil.
   [Kenny, Louise C.] Fed Univ RS, Matern Clin Hosp, Dept Obstet & Gynecol, Porto Alegre, RS, Brazil.
   [Baker, Philip N.] Univ Coll Cork, Dept Obstet & Gynaecol, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland.
   [Baker, Philip N.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.
   Gravida Natl Ctr Growth & Dev, Auckland, New Zealand.
   [Parpinelli, Mary A.; Fernandes, Karayna G.; Guida, Jose P.; Santana, Danielly; Barbosa, Ricardo M.; Galvao, Rafael B. F.] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.
   [Cassettari, Bianca F.] UNESP, Sch Med Botucatu, Campinas, SP, Brazil.
   [Pfitscher, Lucia] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   [de Feitosa, Daisy Lucena] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Kenny, Louise/X-6329-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Souza, Renato Teixeira/G-4205-2017; Cecatti, Jose Guilherme/M-5945-2013;
   Calderon, Iracema/W-4336-2019; Mayrink, Jussara/G-3495-2017
OI Kenny, Louise/0000-0002-9011-759X; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Souza, Renato Teixeira/0000-0002-9075-9269;
   Cecatti, Jose Guilherme/0000-0003-1285-8445; Calderon,
   Iracema/0000-0003-4761-4336; Mayrink, Jussara/0000-0001-5957-4365;
   Feitosa, Francisco/0000-0002-7583-2974
FU School of Medicine, Federal University of Pernambuco, Recife, Brazil;
   Cemicamp; Global Health Strategies; FioCruz (Oswaldo Cruz Foundation,
   Rio de Janeiro) on behalf of BMGF
FX The Preterm SAMBA study group also included Mary A. Parpinelli, Karayna
   G Fernandes, Jose P Guida, Danielly Santana, Ricardo M Barbosa, and
   Rafael B F Galvao, School of Medical Sciences, University of Campinas,
   Brazil; Bianca F. Cassettari, School of Medicine of Botucatu, UNESP,
   Brazil; Lucia Pfitscher, School of Medicine, Federal University of Rio
   Grande do Sul, Porto Alegre, Brazil; Daisy Lucena de Feitosa, School of
   Medicine, Federal University of Ceara, Fortaleza, Brazil. The authors
   also acknowledge the following research assistants, collaborators, and
   staff members of the institution who made a remarkable contribution to
   run the Preterm SAMBA study: Elias de Melo Ferreira Junior, and Danilo
   Anacleto, School of Medicine, Federal University of Pernambuco, Recife,
   Brazil; Vilma Zotareli and Marcia Alice Silva, from Cemicamp, who
   provided administrative and financial support for the study. The authors
   also acknowledge Global Health Strategies and FioCruz (Oswaldo Cruz
   Foundation, Rio de Janeiro), the institutions responsible for financial
   and clinical advisory on behalf of BMGF, which made a remarkable
   contribution to the identification of barriers for study sustainability,
   disruptiveness, and potentiality to scale.
CR Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939
   Betsou F, 2010, CANCER EPIDEM BIOMAR, V19, P1004, DOI 10.1158/1055-9965.EPI-09-1268
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Cecatti J. G., 2009, REPROD HLTH, V6, DOI [10.1186/1742-4755-6-15, DOI 10.1186/1742-4755-6-152-S2.0-70350015004]
   Cecatti JG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1006-9
   Cecatti José G, 2015, Rev. Col. Bras. Cir., V42, P89, DOI 10.1590/0100-69912015S01027
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   He XL, 2016, ACTA DIABETOL, V53, P119, DOI 10.1007/s00592-015-0737-9
   Katz L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-28
   Kenny LC, 2005, METABOLOMICS, V1, P227, DOI 10.1007/s11306-005-0003-1
   Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297
   McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x
   Navaratnam K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-226
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f
   Sulek K, 2014, THERANOSTICS, V4, P953, DOI 10.7150/thno.9265
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 20
TC 4
Z9 4
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2019
VL 2019
AR 5476350
DI 10.1155/2019/5476350
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA HJ2ES
UT WOS:000456979600001
PM 30775382
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Proenca-Modena, JL
   Milanez, GP
   Costa, ML
   Judice, CC
   Costa, FTM
AF Proenca-Modena, Jose Luiz
   Milanez, Guilherme Paier
   Costa, Maria Laura
   Judice, Carla C.
   Maranhao Costa, Fabio Trindade
TI Zika virus: lessons learned in Brazil
SO MICROBES AND INFECTION
LA English
DT Article
DE Zika virus; Epidemics setting; Transmission; Pathogenesis; Arboviruses;
   Brazil
ID NEURAL PROGENITORS; INFECTION; CELLS; AMERICA; BRAIN; TRANSMISSION;
   PATHOGENESIS; ENHANCEMENT; MONOCYTES; GUILLAIN
AB Zika virus (ZIKV) greatly impacted the international scientific and public health communities in the last two years due to its association with microcephaly and other neonatal alterations. This review will discuss lessons learned from viral pathogenesis, epidemiology and clinical findings observed during the ZIKV outbreak occurred between 2014 and 2016 in Brazil. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Proenca-Modena, Jose Luiz; Milanez, Guilherme Paier] Univ Estadual Campinas, Lab Emerging Viruses, Dept Genet Evolut Microbiol & Immunol, Inst Biol,Unicamp, Campinas, SP, Brazil.
   [Costa, Maria Laura] Univ Estadual Campinas, Obstet & Gynecol Dept, Sch Med Sci, UNICAMP, Campinas, SP, Brazil.
   [Judice, Carla C.; Maranhao Costa, Fabio Trindade] Univ Estadual Campinas, Lab Trop Dis, Dept Genet Evolut Microbiol & Immunol, Inst Biol,Unicamp, Campinas, SP, Brazil.
RP Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, Lab Emerging Viruses, Dept Genet Evolut Microbiol & Immunol, Inst Biol, Rua Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil.; Costa, FTM (corresponding author), Univ Estadual Campinas, Lab Trop Dis, Dept Genet Evolut Microbiol & Immunol, Inst Biol, Rua Carl Von Linaeus 2-238, BR-13083864 Campinas, SP, Brazil.
EM jlmodena@unicamp.br; costaftm@unicamp.br
RI Costa, Fabio/E-1181-2012; Milanez, Guilherme/G-6457-2016; Modena, Jose
   Luiz Proenca/C-8231-2014; Proenca-Modena, Jose Luiz/AAU-7622-2020;
   Judice, Carla/P-4738-2014
OI Costa, Fabio/0000-0001-9969-7300; Milanez,
   Guilherme/0000-0002-8599-1098; Modena, Jose Luiz
   Proenca/0000-0002-4996-3153; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Judice, Carla/0000-0003-1839-053X
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/00194-8]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440761/2016-6]
FX We thank Ana Carolina Andrade Vitor Kayano for all figures included in
   this review. All studies with arbovirus in Unicamp (University of
   Campinas) were supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (grant 2016/00194-8 and fellowship to J. A. L.); and the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant
   440761/2016-6, including research fellowships to C. C. J., G. P. M, and
   F. T. M. C.).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Assis AMO, 2007, CAD SAUDE PUBLICA, V23, P2337, DOI 10.1590/S0102-311X2007001000009
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Blom K, 2017, J INTERN MED, V282, P206, DOI 10.1111/joim.12638
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2017, ZIK VIR COLL SUBM SP
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   da Silva Voorham JM, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0029957
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guimarães Reinaldo, 2006, Cad. Saúde Pública, V22, P1775, DOI 10.1590/S0102-311X2006000900002
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hunter FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01248
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pan American Health Organization, 2017, ZIK EP REP BRAZ
   Piersen TC, 2013, FIELDS VIROLOGY, P747
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 70
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 661
EP 669
DI 10.1016/j.micinf.2018.02.008
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500003
PM 29501560
DA 2020-12-08
ER

PT J
AU Santana, DS
   Silveira, C
   Costa, ML
   Souza, RT
   Surita, FG
   Souza, JP
   Mazhar, SB
   Jayaratne, K
   Qureshi, Z
   Sousa, MH
   Vogel, JP
   Cecatti, JG
AF Santana, Danielly S.
   Silveira, Carla
   Costa, Maria L.
   Souza, Renato T.
   Surita, Fernanda G.
   Souza, Joao P.
   Mazhar, Syeda Batool
   Jayaratne, Kapila
   Qureshi, Zahida
   Sousa, Maria H.
   Vogel, Joshua P.
   Cecatti, Jose G.
CA WHO Multi-Country Survey Materna
TI Perinatal outcomes in twin pregnancies complicated by maternal
   morbidity: evidence from the WHO Multicountry Survey on Maternal and
   Newborn Health
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Twin pregnancy; Perinatal outcome; Maternal morbidity
ID FOR-GESTATIONAL-AGE; VAGINAL DELIVERY; OBSTETRIC COMPLICATIONS;
   EPIDEMIOLOGY; COHORT
AB Twin pregnancy was associated with significantly higher rates of adverse neonatal and perinatal outcomes, especially for the second twin. In addition, the maternal complications (potentially life-threatening conditions-PLTC, maternal near miss-MNM, and maternal mortality-MM) are directly related to twin pregnancy and independently associated with adverse perinatal outcome. The objective of the preset study is to evaluate perinatal outcomes associated with twin pregnancies, stratified by severe maternal morbidity and order of birth.
   Secondary analysis of the WHO Multicountry Survey on Maternal and Newborn Health (WHOMCS), a cross-sectional study implemented in 29 countries. Data from 8568 twin deliveries were compared with 308,127 singleton deliveries. The occurrence of adverse perinatal outcomes and maternal complications were assessed. Factors independently associated with adverse perinatal outcomes were reported with adjusted PR (Prevalence Ratio) and 95%CI.
   The occurrence of severe maternal morbidity and maternal death was significantly higher among twin compared to singleton pregnancies in all regions. Twin deliveries were associated with higher rates of preterm delivery (37.1%), Apgar scores less than 7 at 5th minute (7.8 and 10.1% respectively for first and second twins), low birth weight (53.2% for the first and 61.1% for the second twin), stillbirth (3.6% for the first and 5.7% for the second twin), early neonatal death (3.5% for the first and 5.2% for the second twin), admission to NICU (23.6% for the first and 29.3% for the second twin) and any adverse perinatal outcomes (67% for the first twin and 72.3% for the second). Outcomes were consistently worse for the second twin across all outcomes. Poisson multiple regression analysis identified several factors independently associated with an adverse perinatal outcome, including both maternal complications and twin pregnancy.
   Twin pregnancy is significantly associated with severe maternal morbidity and with worse perinatal outcomes, especially for the second twin.
C1 [Santana, Danielly S.; Silveira, Carla; Costa, Maria L.; Souza, Renato T.; Surita, Fernanda G.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Alexander Fleming St 101, BR-13083891 Campinas, SP, Brazil.
   [Souza, Joao P.; Vogel, Joshua P.] WHO, Dept Reprod Hlth & Res, Dev & Res Training Human Reprod HRP, World Bank Special Programme Res,UNDP,UNFPA,UNICE, Geneva, Switzerland.
   [Mazhar, Syeda Batool] Pakistan Inst Med Sci, Islamabad, Pakistan.
   [Jayaratne, Kapila] Minist Hlth, Family Hlth Bur, Maternal & Child Morbid & Mortal Surveillance Uni, Colombo, Sri Lanka.
   [Qureshi, Zahida] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya.
   [Sousa, Maria H.] Jundiai Med Sch, Dept Publ Hlth, Jundiai, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Alexander Fleming St 101, BR-13083891 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Souza, Renato
   Teixeira/G-4205-2017; Souza, Joao Paulo/G-1982-2010; Vogel,
   Joshua/K-7649-2019; Jayaratne, Kapila/ABC-9841-2020
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Souza, Renato
   Teixeira/0000-0002-9075-9269; Souza, Joao Paulo/0000-0002-2288-4244;
   Vogel, Joshua/0000-0002-3214-7096; Jayaratne,
   Kapila/0000-0001-9795-4342; costa, maria laura/0000-0001-8280-3234
FU UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP), World
   Health Organization (WHO), United States Agency for International
   Development (USAID)United States Agency for International Development
   (USAID); Ministry of Health, Labour and Welfare of JapanMinistry of
   Health, Labour and Welfare, Japan; Gynuity Health Projects; University
   of Campinas [11014]
FX Study supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP), World Health Organization (WHO), United States
   Agency for International Development (USAID), the Ministry of Health,
   Labour and Welfare of Japan, and Gynuity Health Projects. Specifically
   for this analysis, a sponsorship from the University of Campinas was
   provided (Faepex, grant 11014). Funding agencies played no other role
   nor influenced data analysis, interpretation of results and writing the
   manuscript.
CR Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001
   Asztalos EV, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.051
   Bangal V. B., 2012, International Journal of Biomedical and Advance Research, V3, P758
   Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939
   Bortolus R, 1999, HUM REPROD UPDATE, V5, P179, DOI 10.1093/humupd/5.2.179
   da Fonseca Catia Regina Branco, 2012, BMC Res Notes, V5, P60, DOI 10.1186/1756-0500-5-60
   de Assuncao RA, 2010, REV ASSOC MED BRAS, V56, P447, DOI 10.1590/S0104-42302010000400018
   Dias T, 2012, ULTRASOUND OBST GYN, V39, P500, DOI 10.1002/uog.11110
   DODD JM, 2015, COCHRANE DB SYST REV, V11
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fernandes-Vale E, 2017, ACTA MEDICA PORT, V30, P148
   Inde Y, 2011, J OBSTET GYNAECOL RE, V37, P843, DOI 10.1111/j.1447-0756.2010.01450.x
   Jacquemyn Y, 2003, TWIN RES, V6, P7, DOI 10.1375/twin.6.1.7
   Lindroos L, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1668-6
   Liu AL, 2012, HONG KONG MED J, V18, P99
   National Institute for Health and Clinical Excellence; The National Collaborating Centre for Primary Care, 2011, NICE CLIN GUID
   Nwankwo TO, 2013, NIGER J CLIN PRACT, V16, P490, DOI 10.4103/1119-3077.116895
   Qazi G, 2011, JCPSP-J COLL PHYSICI, V21, P142, DOI 03.2011/JCPSP.142145
   Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007
   Rizwan Naushaba, 2010, J Ayub Med Coll Abbottabad, V22, P105
   Santana DS, 2016, OBSTET GYNECOL, V127, P631, DOI 10.1097/AOG.0000000000001338
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842
   Smith GCS, 2007, BMJ-BRIT MED J, V334, P576, DOI 10.1136/bmj.39118.483819.55
   Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286
   Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634
   UN, 2015, MILL DEV GOALS REP 2
   United Nations, 2015, SUST DEV GOALS 17 GO
   Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x
   Wen SW, 2005, AUST NZ J OBSTET GYN, V45, P399, DOI 10.1111/j.1479-828X.2005.00444.x
   Werder E, 2013, FERTIL STERIL, V100, P142, DOI 10.1016/j.fertnstert.2013.01.153
   World Health Organization, 2006, NEON PER MORT COUNTR
   Young BC, 2012, SEMIN PERINATOL, V36, P162, DOI 10.1053/j.semperi.2012.02.007
NR 37
TC 12
Z9 14
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 20
PY 2018
VL 18
AR 449
DI 10.1186/s12884-018-2082-9
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HB8DG
UT WOS:000451314700001
PM 30453908
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Guida, JP
   Parpinelli, MA
   Surita, FG
   Costa, ML
AF Guida, Jose P.
   Parpinelli, Mary A.
   Surita, Fernanda G.
   Costa, Maria L.
TI The impact of proteinuria on maternal and perinatal outcomes among women
   with pre-eclampsia
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Eclampsia; HELLP syndrome; Kidney; Pre-eclampsia; Pregnancy; Proteinuria
ID HYPERTENSIVE DISORDERS; MANAGEMENT; PREGNANCY; RISK; DIAGNOSIS
AB Objective: To assess the impact of proteinuria on pregnancy outcomes among women with pre-eclampsia.
   Methods: The present retrospective cohort study included patients with pre-eclampsia who delivered at a referral maternity hospital in Brazil between January 1, 2009, and December 31, 2013. Patients were stratified into three groups based on 24-hour urinary protein excretion during pregnancy: mild (0.3-<2.0 g), severe (2.0-<5.0 g), and massive (>= 5.0 g).
   Results: There were 293 patients included in the study; 88, 129, and 76 had mild, severe, and massive proteinuria, respectively. Chronic hypertension was the most frequent pre-existing condition among all women (86 [29.4%]). The mean pregnancy duration at the onset of maternal pre-eclampsia was longest in the mild group compared and decreased with increasing proteinuria severity (P<0.001). Preterm delivery was recorded among 205 of 293 (70.0%) neonates; there were 66 (22.5%) neonates that were preterm and in the massive proteinuria group. The incidence of severe pre-eclampsia was lowest in the mild proteinuria group (P=0.002) and tended to occur at 34 weeks. Cesarean delivery rates exceeded 80.0% in all groups. Most patients assessed at 40-60 days postpartum remained proteinuric (40/61[66%]).
   Conclusions: Quantifying the severity of proteinuria could identify a subgroup of women with pre-eclampsia at increased risk of adverse outcomes.
C1 [Guida, Jose P.; Parpinelli, Mary A.; Surita, Fernanda G.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM lauracosta.unicamp@gmail.com
RI Guida, Jose Paulo Siqueira/H-2391-2012; Surita, Fernanda
   Garanhani/H-9575-2012
OI Guida, Jose Paulo Siqueira/0000-0002-3648-6159; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; costa, maria laura/0000-0001-8280-3234
CR Ahumada-Barrios ME, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.0775.2750
   Amaral LM, 2015, VASC HEALTH RISK MAN, V11, P403, DOI 10.2147/VHRM.S64798
   Berks D, 2009, OBSTET GYNECOL, V114, P1307, DOI 10.1097/AOG.0b013e3181c14e3e
   Chan P, 2005, BJOG-INT J OBSTET GY, V112, P280, DOI 10.1111/j.1471-0528.2004.00395.x
   Chappell LC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h191
   Cheng SB, 2016, SEMIN IMMUNOPATHOL, V38, P699, DOI 10.1007/s00281-016-0579-8
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Ebbing C, 2017, ACTA OBSTET GYN SCAN, V96, P243, DOI 10.1111/aogs.13066
   Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Kaze FF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-134
   Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4
   LaMarca B, 2016, AM J PHYSIOL-REG I, V311, pR1, DOI 10.1152/ajpregu.00052.2016
   Lotufo FA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1055-0
   Martinez NF, 2014, REV BRAS GINECOL OBS, V36, DOI 10.1590/SO100-720320140005029
   Mateus J, 2017, AJP REP, V7, P49, DOI 10.1055/s-0037-1601866
   Newman MG, 2003, AM J OBSTET GYNECOL, V188, P264, DOI 10.1067/mob.2003.84
   Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Snydal S, 2014, J MIDWIFERY WOM HEAL, V59, P596, DOI 10.1111/jmwh.12260
   Stepan H, 2006, J HUM HYPERTENS, V20, P125, DOI 10.1038/sj.jhh.1001952
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   van der Tuuk K, 2015, EUR J OBSTET GYN R B, V191, P23, DOI 10.1016/j.ejogrb.2015.05.009
   Varner M, 2017, BJOG-INT J OBSTET GY, V124, P1707, DOI 10.1111/1471-0528.14576
   Vigil-De Gracia P, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.016
   von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010
NR 26
TC 7
Z9 9
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD OCT
PY 2018
VL 143
IS 1
BP 101
EP 107
DI 10.1002/ijgo.12487
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GS2OS
UT WOS:000443391100017
PM 29572831
DA 2020-12-08
ER

PT J
AU Costa, ML
   Guida, JPD
   Surita, FG
   Parpinelli, MA
AF Costa, Maria Laura
   de Siqueira Guida, Jose Paulo
   Surita, Fernanda Garanhani
   Parpinelli, Mary Angela
TI Answer - Preterm Preeclampsia and Timing of Delivery: A Systematic
   Literature Review
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
C1 [Costa, Maria Laura; de Siqueira Guida, Jose Paulo; Surita, Fernanda Garanhani; Parpinelli, Mary Angela] Univ Estadual Campinas, Dept Gynecol & Obstet, Rua Alexander Fleming 101, BR-13083880 Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Dept Gynecol & Obstet, Rua Alexander Fleming 101, BR-13083880 Campinas, SP, Brazil.
EM lauracosta.unicamp@gmail.com
RI Surita, Fernanda Garanhani/H-9575-2012
OI Surita, Fernanda Garanhani/0000-0003-4335-0337
CR Churchill D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003106.pub2
   Cluver C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009273.pub2
   Guida JPD, 2017, REV BRAS GINECOL OBS, V39, P622, DOI 10.1055/s-0037-1604103
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
NR 4
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD AUG
PY 2018
VL 40
IS 8
BP 500
EP 500
DI 10.1055/s-0038-1668530
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR5GJ
UT WOS:000442655200014
PM 30142672
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Mayrink, J
   Souza, RT
   Silveira, C
   Guida, JP
   Costa, ML
   Parpinelli, MA
   Pacagnella, RC
   Ferreira, EC
   Sousa, MH
   Say, L
   Chou, D
   Filippi, V
   Barreix, M
   Barbour, K
   von Dadelszen, P
   Cecatti, JG
AF Mayrink, Jussara
   Souza, Renato T.
   Silveira, Carla
   Guida, Jose P.
   Costa, Maria L.
   Parpinelli, Mary A.
   Pacagnella, Rodolfo C.
   Ferreira, Elton C.
   Sousa, Maria H.
   Say, Lale
   Chou, Doris
   Filippi, Veronique
   Barreix, Maria
   Barbour, Kelli
   von Dadelszen, Peter
   Cecatti, Jose G.
CA Brazilian Cohort Severe Maternal
   WHO Maternal Morbidity Workin
TI Reference ranges of the WHO Disability Assessment Schedule (WHODAS 2.0)
   score and diagnostic validity of its 12-item version in identifying
   altered functioning in healthy postpartum women
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Postpartum period; Puerperium; Severe maternal morbidity; WHODAS-12;
   WHODAS-36
ID MATERNAL MORBIDITY; HEMORRHAGE; MISS; TOOL
AB Objectives: To compare scores on the 36-item WHO Disability Assessment Schedule 2.0 tool (WHODAS-36) for postpartum women across a continuum of morbidity and to validate the 12-item version (WHODAS-12).
   Methods: This is a secondary analysis of the Brazilian retrospective cohort study on long-term repercussions of severe maternal morbidity. We determined mean, median, and percentile values for WHODAS-36 total score and for each domain, and percentile values for WHODAS-12 total score in postpartum women divided into three groups: "no," "nonsevere," and "severe" morbidities.
   Results: The WHODAS-36 mean total scores were 11.58, 18.31, and 19.19, respectively for no, nonsevere, and severe morbidity. There was a dose-dependent effect on scores for each domain of WHODAS-36 according to the presence and severity of morbidity. The diagnostic validity of WHODAS-12 was determined by comparing it with WHODAS-36 as a "gold standard." The best cut-off point for diagnosing dysfunctionality was the 95th percentile.
   Conclusion: The upward trend of WHODAS-36 total mean value scores of women with no morbidity compared with those with morbidity along a severity continuum may reflect the impact of morbidity on postpartum functioning.
C1 [Mayrink, Jussara; Souza, Renato T.; Silveira, Carla; Guida, Jose P.; Costa, Maria L.; Parpinelli, Mary A.; Pacagnella, Rodolfo C.; Ferreira, Elton C.; Sousa, Maria H.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Say, Lale; Chou, Doris; Barreix, Maria] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Filippi, Veronique] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Barbour, Kelli] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA.
   [von Dadelszen, Peter] St Georges Univ London, Mol & Clin Sci Res Inst, London, England.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
EM cecatti@unicamp.br
RI de Carvalho Pacagnella, Rodolfo/H-9390-2019; Sullivan,
   Elizabeth/V-6742-2017; Souza, Renato Teixeira/G-4205-2017; Guida, Jose
   Paulo Siqueira/H-2391-2012; Tuncalp, Ozge/Y-2724-2018
OI de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Sullivan,
   Elizabeth/0000-0002-8718-2753; Souza, Renato
   Teixeira/0000-0002-9075-9269; Guida, Jose Paulo
   Siqueira/0000-0002-3648-6159; GADAMA, LUIS/0000-0002-7164-6197; Hindin,
   Michelle J/0000-0001-9941-7639; Tuncalp, Ozge/0000-0002-5370-682X;
   ANGELINI, CARINA R/0000-0002-6351-0628; von Dadelszen,
   Peter/0000-0003-4136-3070
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [471142/2011-5];
   WHOWorld Health Organization [201606719]; Bill & Melinda Gates
   FoundationBill & Melinda Gates Foundation; Human Reproduction Programme
   WHO
FX Brazilian National Research Council (CNPq research grant 471142/2011-5),
   WHO (APW contract 201606719), Bill & Melinda Gates Foundation, Human
   Reproduction Programme WHO.
CR Andreucci CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143581
   Chou D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0789-4
   Dowswell T, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub3
   Fazio A F, 1977, Vital Health Stat 2, P1
   Guida JP, 2018, INT J GYNECOL OBSTET, V141, P55, DOI 10.1002/ijgo.12467
   Handa VL, 2006, SEMIN PERINATOL, V30, P253, DOI 10.1053/j.semperi.2006.07.004
   Haver J, 2016, J MIDWIFERY WOM HEAL, V61, P196, DOI 10.1111/jmwh.12413
   Hua J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012207
   Jabeen M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S6
   Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2
   Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3
   Neiterman E, 2017, SOC SCI MED, V174, P142, DOI 10.1016/j.socscimed.2016.12.029
   Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Peh CX, 2017, J ALZHEIMERS DIS, V55, P823, DOI 10.3233/JAD-160575
   Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X
   Say L, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0164-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Silveira C, 2016, INT J GYNECOL OBSTET, V134, P87, DOI 10.1016/j.ijgo.2015.10.027
   Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005
   Sit D, 2015, J PSYCHIATR RES, V66-67, P95, DOI 10.1016/j.jpsychires.2015.04.021
   Tyrovolas S, 2015, EXP GERONTOL, V64, P70, DOI 10.1016/j.exger.2015.02.010
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   Vivilaki V G, 2016, Psychiatriki, V27, P169
   Zanardi DM, 2016, CLINICS, V71, P593, DOI 10.6061/clinics/2016(10)07
NR 25
TC 5
Z9 5
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2018
VL 141
SU 1
BP 48
EP 54
DI 10.1002/ijgo.12466
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GH6TN
UT WOS:000433577100006
PM 29851111
OA Green Published, Other Gold, Green Accepted
DA 2020-12-08
ER

PT J
AU Silveira, C
   Souza, RT
   Costa, ML
   Parpinelli, MA
   Pacagnella, RC
   Ferreira, EC
   Mayrink, J
   Guida, JP
   Sousa, MH
   Say, L
   Chou, D
   Filippi, V
   Barreix, M
   Barbour, K
   Firoz, T
   von Dadelszen, P
   Cecatti, JG
AF Silveira, Carla
   Souza, Renato T.
   Costa, Maria L.
   Parpinelli, Mary A.
   Pacagnella, Rodolfo C.
   Ferreira, Elton C.
   Mayrink, Jussara
   Guida, Jose P.
   Sousa, Maria H.
   Say, Lale
   Chou, Doris
   Filippi, Veronique
   Barreix, Maria
   Barbour, Kelli
   Firoz, Tabassum
   von Dadelszen, Peter
   Cecatti, Jose G.
CA Brazilian Cohort Severe Maternal
   WHO Maternal Morbidity Working G
TI Validation of the WHO Disability Assessment Schedule (WHODAS 2.0)
   12-item tool against the 36-item version for measuring functioning and
   disability associated with pregnancy and history of severe maternal
   morbidity
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Cohort studies; Disability; Functionality; Pregnancy; Pregnancy
   complications; Severe maternal morbidity; Validation studies
ID HEALTH; AGREEMENT; WOMEN
AB Objective: To validate the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item tool against the 36-item version for measuring functioning and disability associated with pregnancy and the occurrence of maternal morbidity.
   Methods: This is a secondary analysis of the Brazilian retrospective cohort study on long-term repercussions of severe maternal morbidity (SMM) among women who delivered at a tertiary facility (COMMAG study). We compared WHODAS-12 and WHODAS-36 scores of women with and without SMM using measures of central tendency and variability, tests for instruments' agreement (Bland-Altman plot), confirmatory factor analysis (CFA), and Cronbach alpha coefficient for internal consistency.
   Results: The COMMAG study enrolled 638 women up to 5 years postpartum. Although the median WHODAS-36 and -12 scores for all women were statistically different (13.04 and 11.76, respectively; P<0.001), there was a strong linear correlation between them. Furthermore, the mean difference and the differences in variance analyses demonstrated agreement of total scores between the two versions. CFA demonstrated how the WHODAS-12 questions are divided into six previously defined factors and Cronbach alpha showed good internal consistency.
   Conclusion: WHODAS-12 demonstrated agreement with WHODAS-36 for total score and was a good instrument for screening functioning and disability among postpartum women, with and without SMM.
C1 [Silveira, Carla; Souza, Renato T.; Costa, Maria L.; Parpinelli, Mary A.; Pacagnella, Rodolfo C.; Ferreira, Elton C.; Mayrink, Jussara; Guida, Jose P.; Sousa, Maria H.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Say, Lale; Chou, Doris; Barreix, Maria] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Filippi, Veronique] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Barbour, Kelli] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA.
   [Firoz, Tabassum] Brown Univ, Dept Med, Warren Alpert Sch Med, Providence, RI 02912 USA.
   [von Dadelszen, Peter] St Georges Univ London, Mol & Clin Sci Res Inst, London, England.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
EM cecatti@unicamp.br
RI Guida, Jose Paulo Siqueira/H-2391-2012; Sullivan, Elizabeth/V-6742-2017;
   Souza, Renato Teixeira/G-4205-2017; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019; Tuncalp, Ozge/Y-2724-2018
OI Guida, Jose Paulo Siqueira/0000-0002-3648-6159; Sullivan,
   Elizabeth/0000-0002-8718-2753; Souza, Renato
   Teixeira/0000-0002-9075-9269; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Tuncalp, Ozge/0000-0002-5370-682X; Hindin,
   Michelle J/0000-0001-9941-7639; ANGELINI, CARINA R/0000-0002-6351-0628;
   costa, maria laura/0000-0001-8280-3234; GADAMA,
   LUIS/0000-0002-7164-6197; von Dadelszen, Peter/0000-0003-4136-3070
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [471142/2011-5]; Bill &
   Melinda Gates FoundationBill & Melinda Gates Foundation; Human
   Reproduction Programme WHO
FX Brazilian National Research Council (CNPq research grant 471142/2011-5),
   Bill & Melinda Gates Foundation, Human Reproduction Programme WHO.
CR Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Chou D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0789-4
   Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Loosman WL, 2015, NEPHROL DIAL TRANSPL, V30, P1170, DOI 10.1093/ndt/gfv066
   Machiyama K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013903
   Mayrink J, 2018, INT J GYNECOL OBSTET, V141, P48, DOI 10.1002/ijgo.12466
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Say L, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0164-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Silva SM, 2016, DISABIL REHABIL, V38, P2413, DOI 10.3109/09638288.2015.1130178
   Silveira C, 2017, REV BRAS GINECOL OBS, V39, P44, DOI 10.1055/s-0037-1598599
   Silveira C, 2016, INT J GYNECOL OBSTET, V134, P87, DOI 10.1016/j.ijgo.2015.10.027
   Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   World Health Organization, 2010, WHO DIS ASS SCHED 2
   World Health Organization, 2001, INT CLASS FUNCT DIS
   2011, WORLD REP DIS, P1
NR 21
TC 6
Z9 7
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2018
VL 141
SU 1
BP 39
EP 47
DI 10.1002/ijgo.12465
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GH6TN
UT WOS:000433577100005
PM 29851113
OA Other Gold, Green Accepted, Green Published
DA 2020-12-08
ER

PT J
AU Guida, JP
   Costa, ML
   Parpinelli, MA
   Pacagnella, RC
   Ferreira, EC
   Mayrink, J
   Silveira, C
   Souza, RT
   Sousa, MH
   Say, L
   Chou, D
   Filippi, V
   Barreix, M
   Barbour, K
   McCaw-Binns, A
   von Dadelszen, P
   Cecatti, JG
AF Guida, Jose P.
   Costa, Maria L.
   Parpinelli, Mary A.
   Pacagnella, Rodolfo C.
   Ferreira, Elton C.
   Mayrink, Jussara
   Silveira, Carla
   Souza, Renato T.
   Sousa, Maria H.
   Say, Lale
   Chou, Doris
   Filippi, Veronique
   Barreix, Maria
   Barbour, Kelli
   McCaw-Binns, Affette
   von Dadelszen, Peter
   Cecatti, Jose G.
CA Brazilian Cohort Severe Maternal
   WHO Maternal Morbidity Working
TI The impact of hypertension, hemorrhage, and other maternal morbidities
   on functioning in the postpartum period as assessed by the WHODAS 2.0
   36-item tool
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Hemorrhage; Hypertension; Maternal morbidity; Pregnancy; WHODAS 2.0
ID DISABILITY; HEALTH; WOMEN; COHORT; CARE
AB Objective: To assess the scores of postpartum women using the WHO Disability Assessment Schedule 2.0 36-item tool (WHODAS-36), considering different morbidities.
   Methods: Secondary analysis of a retrospective cohort of women who delivered at a referral maternity in Brazil and were classified with and without severe maternal morbidity (SMM). WHODAS-36 was used to assess functioning in postpartum women. Percentile distribution of total WHODAS score was compared across three groups: Percentile (P)<10, 10<P<90, and P>90. Cases of SMM were categorized and WHODAS-36 score was assessed according to hypertension, hemorrhage, or other conditions.
   Results: A total of 638 women were enrolled: 64 had mean scores below P<10 (1.09) and 66 were above P>90 (41.3). Of women scoring above P>90, those with morbidity had a higher mean score than those without (44.6% vs 36.8%, P=0.879). Women with higher WHODAS-36 scores presented more complications during pregnancy, especially hypertension (47.0% vs 37.5%, P=0.09). Mean scores among women with any complication were higher than those with no morbidity (19.0 vs 14.2, P=0.01). WHODAS-36 scores were higher among women with hypertensive complications (19.9 vs 16.0, P=0.004), but lower among those with hemorrhagic complications (13.8 vs 17.7, P=0.09).
   Conclusions: Complications during pregnancy, childbirth, and the puerperium increase long-term WHODAS-36 scores, demonstrating a persistent impact on functioning among women, up to 5 years postpartum.
C1 [Guida, Jose P.; Costa, Maria L.; Parpinelli, Mary A.; Pacagnella, Rodolfo C.; Ferreira, Elton C.; Mayrink, Jussara; Silveira, Carla; Souza, Renato T.; Sousa, Maria H.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Say, Lale; Chou, Doris; Barreix, Maria] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Filippi, Veronique] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Barbour, Kelli] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA.
   [McCaw-Binns, Affette] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Kingston, Jamaica.
   [von Dadelszen, Peter] St Georges Univ London, Mol & Clin Sci Res Inst, London, England.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
EM cecatti@unicamp.br
RI de Carvalho Pacagnella, Rodolfo/H-9390-2019; Guida, Jose Paulo
   Siqueira/H-2391-2012; Souza, Renato Teixeira/G-4205-2017; Sullivan,
   Elizabeth/V-6742-2017; Tuncalp, Ozge/Y-2724-2018
OI de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Guida, Jose Paulo
   Siqueira/0000-0002-3648-6159; Souza, Renato
   Teixeira/0000-0002-9075-9269; Sullivan, Elizabeth/0000-0002-8718-2753;
   von Dadelszen, Peter/0000-0003-4136-3070; Hindin, Michelle
   J/0000-0001-9941-7639; ANGELINI, CARINA R/0000-0002-6351-0628; Tuncalp,
   Ozge/0000-0002-5370-682X; GADAMA, LUIS/0000-0002-7164-6197; costa, maria
   laura/0000-0001-8280-3234
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [471142/2011-5]; Bill &
   Melinda Gates FoundationBill & Melinda Gates Foundation; Human
   Reproduction Programme WHO
FX Brazilian National Research Council (CNPq research grant 471142/2011-5),
   Bill & Melinda Gates Foundation, Human Reproduction Programme WHO.
CR [Anonymous], 2008, INT CLASS FUNCT DIS
   Bhat A, 2017, PSYCHIAT SERV, V68, P17, DOI 10.1176/appi.ps.201600002
   Bokslag A, 2016, EARLY HUM DEV, V102, P47, DOI 10.1016/j.earlhumdev.2016.09.007
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Graham W, 2016, LANCET, V388, P2164, DOI 10.1016/S0140-6736(16)31533-1
   Irwin JL, 2016, ARCH WOMEN MENT HLTH, V19, P1041, DOI 10.1007/s00737-016-0653-1
   Kilpatrick SJ, 2016, AM J OBSTET GYNECOL, V215
   Kumar Narendra, 2016, Indian J Psychol Med, V38, P309, DOI 10.4103/0253-7176.185956
   Norhayati MN, 2016, WOMEN BIRTH, V29, P443, DOI 10.1016/j.wombi.2016.02.002
   Pfitscher LC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1525-z
   Rocha V, 2013, DISABIL REHABIL, V35, P1501, DOI 10.3109/09638288.2012.742677
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Silveira C, 2016, INT J GYNECOL OBSTET, V134, P87, DOI 10.1016/j.ijgo.2015.10.027
   Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005
   Souza JP, 2015, REV BRAS GINECOL OBS, V37, P549, DOI 10.1590/SO100-720320150005526
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   Villanueva G, 2017, DISABIL REHABIL, V39, P677, DOI 10.3109/09638288.2016.1161085
   Wallace M, 2016, PLOS CURR, V8
   World Health Organization, 2015, HLTH 2015 MDGS MILL
   World Health Organization World Bank United Nations Children's Fund United Nations Population Fund, 1990, TRENDS MAT MORT 2010, P2012
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
   2011, WORLD REP DIS, P1
NR 24
TC 6
Z9 6
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2018
VL 141
SU 1
BP 55
EP 60
DI 10.1002/ijgo.12467
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GH6TN
UT WOS:000433577100007
PM 29851117
OA Green Accepted, Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Firoz, T
   McCaw-Binns, A
   Filippi, V
   Magee, LA
   Costa, ML
   Cecatti, JG
   Barreix, M
   Adanu, R
   Chou, D
   Say, L
AF Firoz, Tabassum
   McCaw-Binns, Affette
   Filippi, Veronique
   Magee, Laura A.
   Costa, Maria L.
   Cecatti, Jose G.
   Barreix, Maria
   Adanu, Richard
   Chou, Doris
   Say, Lale
CA WHO Maternal Morbidity Working G
TI A framework for healthcare interventions to address maternal morbidity
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Review
DE Healthcare interventions; Maternal morbidity; Noncommunicable diseases;
   Pregnancy complications
ID NONCOMMUNICABLE DISEASES; SYSTEMATIC ANALYSIS; PREGNANCY; WOMEN;
   PREVALENCE; TRANSITION; COVERAGE; DEATHS; AGENDA; RISK
AB The maternal health agenda is undergoing a paradigm shift from preventing maternal deaths to promoting women's health and wellness. A critical focus of this trajectory includes addressing maternal morbidity and the increasing burden of chronic and non-communicable diseases (NCD) among pregnant women. The WHO convened the Maternal Morbidity Working Group (MMWG) to improve the scientific basis for defining, measuring, and monitoring maternal morbidity. Based on the MMWG's work, we propose paradigms for conceptualizing maternal health and related interventions, and call for greater integration between maternal health and NCD programs. This integration can be synergistic, given the links between chronic conditions, morbidity in pregnancy, and long-term health. Pregnancy should be viewed as a window of opportunity into the current and future health of women, and offers critical entry points for women who may otherwise not seek or have access to care for chronic conditions. Maternal health services should move beyond the focus on emergency obstetric care, to a broader approach that encompasses preventive and early interventions, and integration with existing services. Health systems need to respond by prioritizing funding for developing integrated health programs, and workforce strengthening. The MMWG's efforts have highlighted the changing landscape of maternal health, and the need to expand the narrow focus of maternal health, moving beyond surviving to thriving.
C1 [Firoz, Tabassum] Brown Univ, Dept Med, Providence, RI 02912 USA.
   [McCaw-Binns, Affette] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Kingston, Jamaica.
   [Filippi, Veronique] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Magee, Laura A.] Kings Coll London, Dept Womens Hlth, London, England.
   [Costa, Maria L.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Barreix, Maria; Chou, Doris; Say, Lale] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Adanu, Richard] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana.
RP Firoz, T (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.
EM tfiroz@bcchr.ca
RI Sullivan, Elizabeth/V-6742-2017; Tuncalp, Ozge/Y-2724-2018
OI Sullivan, Elizabeth/0000-0002-8718-2753; costa, maria
   laura/0000-0001-8280-3234; GADAMA, LUIS/0000-0002-7164-6197; von
   Dadelszen, Peter/0000-0003-4136-3070; Tuncalp, Ozge/0000-0002-5370-682X;
   Hindin, Michelle J/0000-0001-9941-7639
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation; Human
   Reproduction Programme WHO
FX Bill & Melinda Gates Foundation, Human Reproduction Programme WHO.
CR Allen LN, 2017, LANCET GLOB HEALTH, V5, pE644, DOI 10.1016/S2214-109X(17)30200-0
   Azenha GS, 2013, B WORLD HEALTH ORGAN, V91, P704, DOI 10.2471/BLT.13.117622
   Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632
   Barreix M, 2018, INT J GYNECOL OBSTET, V141, P10, DOI 10.1002/ijgo.12464
   Bhutta ZA, 2017, ANN NY ACAD SCI, V1393, P61, DOI 10.1111/nyas.13352
   Bryant A, 2016, MATERN CHILD HLTH J, V20, pS81, DOI 10.1007/s10995-016-2168-9
   Chamberlain C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub5
   Community Access Network, 2016, WELC COMM ACC NETW
   Cornell A, 2016, MATERN CHILD HLTH J, V20, pS39, DOI 10.1007/s10995-016-2182-y
   de Jongh TE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010403
   Dean SV, SYSTEMATIC REV PRECO
   Declercq E, 2013, LISTENING TO MOTHERS, VIII
   Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001134.pub3
   Duran G, 2017, ACAD PEDIAT
   Every Woman Every Child, 2015, GLOB STRAT WOM CHILD
   Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012
   Firoz T, 2015, OBSTET MED, V8, P138, DOI 10.1177/1753495X15595308
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8
   Henning PA, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0412-z
   Herath H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179647
   Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176
   Hussein J, 2017, OBSTET MED, V10, P26, DOI 10.1177/1753495X16684709
   Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kanguru L, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23987
   Kapur A, 2015, BEST PRACT RES CL OB, V29, P32, DOI 10.1016/j.bpobgyn.2014.04.016
   Ki-Moon B., 2010, GLOBAL STRATEGY WOME
   Knaul FM, 2016, LANCET GLOB HEALTH, V4, pE227, DOI 10.1016/S2214-109X(16)00044-9
   Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140
   Maternal Health Task Force (MHTF), END PREV MAT MORT
   Ministry of Labour and Social Security, 2006, PATH
   Nair M, 2015, BJOG-INT J OBSTET GY, V122, P653, DOI 10.1111/1471-0528.13279
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9
   Nowik CM, 2016, J OBSTET GYNAECOL CA, V38, P930, DOI 10.1016/j.jogc.2016.05.005
   O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3
   Royal College of Obstetricians and Gynaecologists (RCOG), 2017, ATSM MAT MED
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Schellinger MM, 2017, MATERN CHILD HLTH J, V21, P297, DOI 10.1007/s10995-016-2114-x
   Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022
   SMITH GN, 2009, EXPERT REV OBSTET GY, V4, P355, DOI DOI 10.1586/eog.09.16
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Starrs A, 2015, LANCET, V386, P1111, DOI 10.1016/S0140-6736(15)00250-0
   Steel A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0165-6
   Stephenson J, 2011, WHY SHOULD WE CONSID
   Thatcher A, 2015, ACCENTURE DEV PARTNE
   Tita ATN, 2000, AM J PUBLIC HEALTH, V90, P810
   Tully KP, 2017, AM J OBSTET GYNECOL, V217, P37, DOI 10.1016/j.ajog.2017.03.032
   Vazquez TR, 2017, LANCET, V390, P1473, DOI 10.1016/S0140-6736(17)32470-4
   WHO, 2015, STRAT END PREV MAT M
   WHO, 2015, MED EL CRIT CONTR US
   World Health Organization, 2016, WHO REC ANT CAR POS
   World Health Organization, 2011, GLOBAL STATUS REPORT
   World Health Organization, 2013, WHO REC POSTN CAR MO
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   World Health Organization, 1990, TRENDS MAT MORT 2015, P2015
   Zafar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138026
NR 55
TC 11
Z9 11
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2018
VL 141
SU 1
BP 61
EP 68
DI 10.1002/ijgo.12469
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GH6TN
UT WOS:000433577100008
PM 29851114
OA Other Gold, Green Published
DA 2020-12-08
ER

PT J
AU Dias, TZ
   Fava, ML
   Passini, RP
   Cecatti, JG
   Tedesco, RP
   Lajos, GJ
   Rehder, PM
   Nomura, ML
   Oliveira, PF
   Costa, ML
AF Dias, Tabata Zumpano
   Fava, Mariana Lacerda
   Passini Junior, Renato
   Cecatti, Jose Guilherme
   Tedesco, Ricardo Porto
   Lajos, Giuliane Jesus
   Rehder, Patricia Moretti
   Nomura, Marcelo Luis
   Oliveira, Paulo Fanti
   Costa, Maria Laura
TI Tocolysis among Women with Preterm Birth: Associated Factors and
   Outcomes from a Multicenter Study in Brazil
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE preterm birth; prematurity; preterm labor; tocolysis; neonatal outcomes;
   maternal outcomes
ID HEALTH; LABOR; EPIDEMIOLOGY
AB Objective To evaluate the use of tocolysis in cases of preterm birth due to spontaneous preterm labor in a Brazilian sample.
   Methods A sample of 1,491 women with preterm birth due to spontaneous preterm labor were assessed, considering treatment with tocolysis or expectant management, according to gestational age at birth (< 34 weeks and 34 to 36 + 6 weeks) and drugs prescribed. The study took place in 20 Brazilian hospitals from April 2011 to July 2012. Bivariate analyses were conducted to evaluate associations with sociodemographic and obstetric characteristics and odds ratios with their respective 95% confidence intervals were estimated for maternal and neonatal outcomes.
   Results A total of 1,491 cases of preterm birth were considered. Tocolysis was performed in 342 cases (23%), 233 of which (68.1%) were delivered before 34 weeks. Within the expectant management group, 73% was late preterm and with more advanced labor at the time of admission. The most used drugs were calcium channel blockers (62.3%), followed by betamimetics (33%). Among the subjects in the tocolysis group, there were more neonatal and maternal complications (majority non-severe) and an occurrence of corticosteroid use that was 29 higher than in the expectant management group.
   Conclusion Tocolysis is favored in cases of earlier labor and also among those with less than 34 weeks of gestation, using preferably calcium channel blockers, with success in achieving increased corticosteroid use. Tocolysis, in general, was related to higher maternal and neonatal complication rates, which may be due to the baseline difference between cases at admission. However, these results should raise awareness to tocolysis use.
C1 [Dias, Tabata Zumpano; Fava, Mariana Lacerda; Passini Junior, Renato; Cecatti, Jose Guilherme; Lajos, Giuliane Jesus; Rehder, Patricia Moretti; Nomura, Marcelo Luis; Costa, Maria Laura] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo Porto] Fac Med Jundiai, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
   [Oliveira, Paulo Fanti] Univ Estadual Campinas, Sch Med Sci, Unit Stat, Campinas, SP, Brazil.
RP Dias, TZ (corresponding author), Univ Estadual Campinas, UNICAMP, Cidade Univ, BR-13083970 Campinas, SP, Brazil.
EM tabatazumpano@gmail.com
RI Dias, T\\xc3\\x83\\xc2\\xa1bata/U-4512-2019; Nomura, Marcelo
   Luis/H-9534-2019
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); Foundation for Support
   to Research of the State of Sao Paulo (Fapesp)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2009/53245-5]
FX The authors would like to acknowledge the Brazilian National Research
   Council (CNPq, in the Portuguese acronym) and the Foundation for Support
   to Research of the State of Sao Paulo (Fapesp, in the Portuguese
   acronym) for financial sponsorship of the study (Fapesp Process
   2009/53245-5 [Call AP.PPSUS-1]) and state that these organizations did
   not participate in the study proposal, implementation or interpretation
   of results. The authors also would like to thank the EMIP study group:
   Sergio T Marba, Ruth Guinsburg, Francisco E Martinez, Vilma Zotarelli,
   Lucio T Gurgel, Francisco E Feitosa, George N Chaves, Ana M Porto,
   Isabela C Coutinho, Antonio C Barbosa Lima, Elias F Melo Jr, Debora F
   Leite, Melania M Amorim, Adriana SO Melo, Fabiana O Melo, Marilia G
   Martins, Marynea V Nunes, Claudio S Paiva, Moises D Lima, Djacyr M
   Freire, Edson G Tristao, Denis J Nascimento,Carlos A Menezes, Marcelo
   Aquino, Janete Vettorazzi, Cintia E Senger, Augusta MBAssumpcao, Marcela
   AF Guedes, Maria EL Moreira, Vera T Borges, Nelson L Maia Filho, Jacinta
   P Mathias, Eduardo Souza, Ana CP Zamarian, Silvana M Quintana, Patricia
   PS Melli, Fatima A Lotufo, Kaliane Uzilin, Elvira A Zanette, Carla B
   Andreucci, Tenilson A Oliveira, Laercio R Oliveira, Marcos A N Santos,
   Nelson Sass, Mirian RF Silveira, Pedro R Coutinho, Luciana Siqueira.
CR ACOG Committee on Obstetric Practice, 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00
   Anotayanonth S, 2004, Cochrane Database Syst Rev, pCD004352, DOI 10.1002/14651858.CD004352
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Conde-Agudelo A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.038
   Crowther CA, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001060
   de Oliveira RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141852
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002255.pub2
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub3
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226
   How HY, 2009, AM J PERINAT, V26, P1, DOI 10.1055/s-0028-1090586
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   McCormick MC, 2011, ANNU REV PUBL HEALTH, V32, P367, DOI 10.1146/annurev-publhealth-090810-182459
   Nijman TAJ, 2016, SEMIN FETAL NEONAT M, V21, P121, DOI 10.1016/j.siny.2016.01.004
   Organization WH, 2015, WHO REC INT IMPR PRE
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Preterm labour and birth, 2015, PRET LAB BIRTH
   Reinebrant HE, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub3
   Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3
   Royal College of Obstetricians and Gynaecologists, 2011, TOC WOM PRET LAB
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Tedesco RP, 2013, MATERN CHILD HLTH J, V17, P1638, DOI 10.1007/s10995-012-1177-6
   van Vliet EOG, 2014, EXPERT OPIN PHARMACO, V15, P787, DOI 10.1517/14656566.2014.889684
   Vogel JP, 2014, LANCET, V384, P1869, DOI 10.1016/S0140-6736(14)60580-8
   Vogel JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006169.pub2
NR 26
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD APR
PY 2018
VL 40
IS 4
BP 171
EP 179
DI 10.1055/s-0038-1642025
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GF8LW
UT WOS:000432224600002
PM 29747211
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Pastore, DEA
   Costa, ML
   Parpinelli, MA
   Surita, FG
AF Abib Pastore, Danilo Eduardo
   Costa, Maria Laura
   Parpinelli, Mary Angela
   Surita, Fernanda Garanhani
TI A Critical Review on Obstetric Follow-up of Women Affected by Systemic
   Lupus Erythematosus
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE systemic lupus erythematosus; pregnancy; prenatal care; maternal
   outcomes; fetal outcomes
ID FETAL OUTCOMES; PREGNANCY; MANAGEMENT; DISEASE; CHALLENGES; PREDICTORS;
   NEPHRITIS
AB Objective To review the existing recommendations on the prenatal care of women with systemic lupus erythematosus (SLE), based on currently available scientific evidence.
   Methods An integrative review was performed by two independent researchers, based on the literature available in the MEDLINE (via PubMed), EMBASE and The Cochrane Library databases, using the medical subject headings (MeSH) terms "systemic lupus erythematosus" AND "high-risk pregnancy" OR "prenatal care." Studies published in English between 2007 and 2017 were included; experimental studies and case reports were excluded. In cases of disagreement regarding the inclusion of studies, a third senior researcher was consulted. Forty titles were initially identified; four duplicates were excluded. After reading the abstracts, 7 were further excluded and 29 were selected for a full-text evaluation.
   Results Systemic lupus erythematosus flares, preeclampsia, gestation loss, preterm birth, fetal growth restriction and neonatal lupus syndromes (mainly congenital heartblock) were the major complications described. The multidisciplinary team should adopt a specific monitoring, with particular therapeutic protocols. There are safe and effective drug options that should be prescribed for a good control of SLE activity.
   Conclusion Pregnant women with SLE present an increased risk for maternal complications, pregnancy loss and other adverse outcomes. The disease activity may worsen and, thereby, increase the risk of other maternal-fetal complications. Thus, maintaining an adequate control of disease activity and treating flares quickly should be a central goal during prenatal care.
C1 [Abib Pastore, Danilo Eduardo; Costa, Maria Laura; Parpinelli, Mary Angela; Surita, Fernanda Garanhani] Univ Estadual Campinas Unicamp, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
RP Surita, FG (corresponding author), Univ Estadual Campinas Unicamp, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM surita@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Pastore, Danilo/AAJ-2660-2020
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Pastore,
   Danilo/0000-0001-8081-0035; costa, maria laura/0000-0001-8280-3234
CR Aly EAH, 2016, MIDDLE EAST FERTIL S, V21, P168, DOI 10.1016/j.mefs.2015.12.003
   Andreoli L, 2017, ANN RHEUM DIS, V76, P476, DOI 10.1136/annrheumdis-2016-209770
   Andreoli L, 2017, CURR OPIN RHEUMATOL, V29, P473, DOI 10.1097/BOR.0000000000000415
   Baer AN, 2011, OBSTET GYNECOL SURV, V66, P639, DOI 10.1097/OGX.0b013e318239e1ee
   BORBA EF, 2008, REV BRAS REUMATOL, V48, P196, DOI DOI 10.1590/S0482-50042008000400002
   Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235
   Buyon JP, 2009, BULL HOSP JT DIS, V67, P271
   Chen SY, 2015, INT J ENV RES PUB HE, V12, P9876, DOI 10.3390/ijerph120809876
   Chiu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167946
   Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002
   Cortes-Hernandez J, 2002, RHEUMATOLOGY, V41, P643, DOI 10.1093/rheumatology/41.6.643
   Surita FGD, 2007, SAO PAULO MED J, V125, P91, DOI 10.1590/S1516-31802007000200005
   Doria A, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken151
   Fatemi A, 2013, INT J PREVENTIVE MED, V4, P1004
   Gaballa HA, 2012, EGYPT RHEUMATOL, V34, P159, DOI 10.1016/j.ejr.2012.04.004
   Gladman DD, 1999, ARTHRITIS RHEUM-US, V42, P1785
   Gomez-Puerta J A, 2008, MED LAB, V14, P221
   Jakobsen IM, 2015, SCAND J RHEUMATOL, V44, P377, DOI 10.3109/03009742.2015.1013982
   Keeling SO, 2009, CLIN RHEUMATOL, V28, P1, DOI 10.1007/s10067-008-1031-9
   Knight CL, 2017, OPEN ACCESS RHEUMATO, V9, P37, DOI 10.2147/OARRR.S87828
   Lateef A, 2017, RHEUM DIS CLIN N AM, V43, P215, DOI 10.1016/j.rdc.2016.12.009
   Lateef A, 2013, BEST PRACT RES CL RH, V27, P435, DOI 10.1016/j.berh.2013.07.005
   Lateef A, 2012, NAT REV RHEUMATOL, V8, P710, DOI 10.1038/nrrheum.2012.133
   Madazli R, 2014, ARCH GYNECOL OBSTET, V289, P49, DOI 10.1007/s00404-013-2935-4
   Moroni G, 2016, EUR J INTERN MED, V32, P7, DOI 10.1016/j.ejim.2016.04.005
   Ostensen M, 2017, RHEUM DIS CLIN N AM, V43, P189, DOI 10.1016/j.rdc.2016.12.003
   Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473
   Rahman Farooq Z., 2005, Archives of Gynecology and Obstetrics, V271, P222, DOI 10.1007/s00404-003-0574-x
   de Jesus GR, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/943490
   Ruiz-Irastorza G, 2011, EUR J CLIN INVEST, V41, P672, DOI 10.1111/j.1365-2362.2010.02443.x
   Santamaria Jesus Rodriguez, 2005, An. Bras. Dermatol., V80, P225, DOI 10.1590/S0365-05962005000300002
   Sato E I, 2003, ATUALIZACAO TERAPEUT
   Shaikh MF, 2017, CLIN MED, V17, P78, DOI 10.7861/clinmedicine.17-1-78
   Simard JF, 2017, PAEDIATR PERINAT EP, V31, P29, DOI 10.1111/ppe.12332
   Singh AG, 2015, INT J RHEUM DIS, V18, P172, DOI 10.1111/1756-185X.12524
   Stanhope TJ, 2012, CLIN J AM SOC NEPHRO, V7, P2089, DOI 10.2215/CJN.12441211
   Tedeschi SK, 2015, LUPUS, V24, P1283, DOI 10.1177/0961203315586455
   Tedeschi SK, 2016, CLIN RHEUMATOL, V35, P1725, DOI 10.1007/s10067-016-3270-5
   Warren JB, 2004, OBSTET GYN CLIN N AM, V31, P345, DOI 10.1016/j.ogc.2004.03.007
   Witter FR, 2007, RHEUM DIS CLIN N AM, V33, P253, DOI 10.1016/j.rdc.2007.02.002
   Yamamoto Y, 2016, INT J WOMENS HEALTH, V8, DOI 10.2147/IJWH.S90157
   Zhan ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176457
NR 42
TC 1
Z9 1
U1 1
U2 4
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD APR
PY 2018
VL 40
IS 4
BP 209
EP 224
DI 10.1055/s-0038-1625951
PG 16
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GF8LW
UT WOS:000432224600007
PM 29702718
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Cirelli, JF
   Surita, FG
   Costa, ML
   Parpinelli, MA
   Haddad, SM
   Cecatti, JG
AF Cirelli, Jessica Fernandes
   Surita, Fernanda Garanhani
   Costa, Maria Laura
   Parpinelli, Mary Angela
   Haddad, Samira Maerrawi
   Cecatti, Jose Guilherme
TI The Burden of Indirect Causes of Maternal Morbidity and Mortality in the
   Process of Obstetric Transition: A Cross-Sectional Multicenter Study
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE maternal near-miss; maternal death; indirect causes; reproductive
   health; near-miss; materno; morte materna; causas indiretas; saude
   reprodutiva
ID BRAZILIAN NETWORK; SURVEILLANCE; SEPSIS; DEATH; CARE; INFECTION;
   DISEASES; OUTCOMES; HEALTH
AB Objective The aim of this study is to evaluate the burden of indirect causes of maternal morbidity/mortality in Brazil.
   Methods Secondary analysis of a multicenter cross-sectional study conducted in 27 referral obstetric units within the Brazilian Network for Surveillance of Severe Maternal Morbidity.
   Results A total of 82,388 women were surveilled: 9,555 women with severe maternal morbidity were included, and 942 (9.9%) of them had indirect causes of morbidity/mortality. There was an increased risk of higher severity among the indirect causes group, which presented 7.56 times increased risk of maternal death (prevalence ratio [PR]: 7.56; 95% confidence interval [95%CI]: 4.99-11.45). The main indirect causes of maternal death were H1N1 influenza, sepsis, cancer and cardiovascular disease. Non-public antenatal care (PR: 2.52; 95%CI: 1.70-3.74), diabetes (PR: 1.90; 95%CI: 1.24-2.90), neoplasia (PR: 1.98; 95%CI: 1.25-3.14), kidney diseases (PR: 1.99; 95%CI: 1.14-3.49), sickle cell anemia (PR: 2.50; 95%CI: 1.16-5.41) and drug addiction (PR: 1.98; 95%CI: 1.03-3.80) were independently associated with worse results in the indirect causes group. Some procedures for the management of severity were more common for the indirect causes group.
   Conclusion Indirect causes were present in less than 10% of the overall cases, but they represented over 40% of maternal deaths in the current study. Indirect causes of maternal morbidity/mortality were also responsible for an increased risk of higher severity, and they were associated with worse maternal and perinatal outcomes. In middle-income countries there is a mix of indirect causes of maternal morbidity/mortality that points to some advances in the scale of obstetric transition, but also reveals the fragility of health systems.
   Resumo
   Objetivo O objetivo deste estudo e avaliar a importancia das causas indiretas da morbidade/mortalidade materna no Brasil.
   Metodos Analise secundaria de um estudo transversal multicentrico realizado em 27 unidades obstetricas de referencia da Rede Brasileira de Vigilancia da Morbidade Materna Grave.
   Resultados Um total de 82.388 mulheres foram avaliadas, sendo que 9.555 foram incluidas com morbidade materna grave, 942 (9,9%) delas com causas indiretas de morbidade/mortalidade. Houve risco aumentado de maior gravidade entre o grupo das causas indiretas, que apresentou risco de morte materna 7,56 vezes maior (razAo de prevalencia [RP]: 7.56; intervalo de confianca de 95% [IC95%]: 4.99-11.45). As principais causas indiretas de obitos maternos foram a gripe H1N1, sepses, cancer e doenca cardiovascular. AtencAo pre-natal nAo publica (RP: 2,52; IC95%: 1,70-3,74), diabetes (RP: 1,90; IC95%: 1,24-2,90), neoplasia (RP: 1,98; IC95%: 1,25-3,14), doencas Renais (RP: 1,99; IC95%: 1,14-3,49), anemia falciforme (RP: 2,50; IC95%: 1,16-5,41) e toxicodependencia (PR 1,98; IC95%: 1,03-3,80) foram associados independentemente com piores resultados no grupo de causas indiretas. Alguns procedimentos para o manejo da gravidade foram mais comuns para o grupo de causas indiretas.
   ConclusAo As causas indiretas de morbidade mortalidade materna ocorreram em menos de 10% dos casos, mas foram responsaveis por mais de 40% das mortes maternas no presente estudo. As causas indiretas da morbidade mortalidade materna tambem se relacionaram com maior gravidade, e estiveram associadas a piores resultados maternos e perinatais. Nos paises de renda media, ha uma combinacAo de causas indiretas de morbidade/mortalidade materna que apontam para alguns avancos na escala de transicAo obstetrica, mas tambem mostram a fragilidade dos sistemas de saude.
C1 [Cirelli, Jessica Fernandes; Surita, Fernanda Garanhani; Costa, Maria Laura; Parpinelli, Mary Angela; Haddad, Samira Maerrawi; Cecatti, Jose Guilherme] Univ Estadual Campinas, Sch Med Sci, Dept Obster & Gynecol, Campinas, SP, Brazil.
RP Surita, FG (corresponding author), Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM surita@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012
OI Surita, Fernanda Garanhani/0000-0003-4335-0337
CR Abouchadi S, 2013, TROP MED INT HEALTH, V18, P357, DOI 10.1111/tmi.12053
   Bray F., 2014, WORLD CANC REPORT 20, P54
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Cochet L, 2003, SAMJ S AFR MED J, V93, P700
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lee QY, 2012, ACTA OBSTET GYN SCAN, V91, P87, DOI 10.1111/j.1600-0412.2011.01249.x
   Lumbiganon P, 2014, BJOG-INT J OBSTET GY, V121, P32, DOI 10.1111/1471-0528.12647
   Murthy BK, 2013, INT J PREVENTIVE MED, V4, P105
   Pfitscher LC, 2016, TROP MED INT HEALTH, V21, P183, DOI 10.1111/tmi.12633
   Regitz-Zagrosek V, 2008, CLIN RES CARDIOL, V97, P630, DOI 10.1007/s00392-008-0685-2
   Regitz-Zagrosek V, 2011, DTSCH ARZTEBL INT, V108, P267, DOI 10.3238/arztebl.2011.0267
   Rossi AC, 2012, ARCH GYNECOL OBSTET, V285, P1499, DOI 10.1007/s00404-012-2301-y
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza JP, 2013, REV BRAS GINECOL OBS, V35, P533, DOI 10.1590/S0100-72032013001200001
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization, 2015, BRAZ WHO STAT PROF
NR 23
TC 4
Z9 5
U1 1
U2 1
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAR
PY 2018
VL 40
IS 3
BP 106
EP 114
DI 10.1055/s-0038-1623511
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GB3HX
UT WOS:000428948500002
PM 29609192
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Neto, AFO
   Parpinelli, MA
   Costa, ML
   Souza, RT
   do Valle, CR
   Cecatti, JG
AF Oliveira Neto, Antonio Francisco
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Souza, Renato Teixeira
   do Valle, Carolina Ribeiro
   Cecatti, Jose Guilherme
TI Exploring Epidemiological Aspects, Distribution of WHO Maternal Near
   Miss Criteria, and Organ Dysfunction Defined by SOFA in Cases of Severe
   Maternal Outcome Admitted to Obstetric ICU: A Cross-Sectional Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID FAILURE ASSESSMENT SCORE; INTENSIVE-CARE
AB Objective. To explore the epidemiological aspects, to describe the frequency and distribution of WHO maternal near miss (MNM) criteria and the presence of organ dysfunction and failure measured by the maximum SOFA (Sequential Organ Failure Assessment) score (SOFA max) in cases of severe maternal outcome (SMO). Methods. In an observational cross-sectional study performed between January 2013 and December 2015, 279 pregnant or postpartum women were admitted to an obstetric ICU (intensive care unit) in Brazil. MNM, maternal death (grouped as SMO), and potentially life-threatening conditions (PLTC) were defined according to WHO criteria. For categorical variables, a descriptive analysis was carried out. Frequency and distribution of WHO criteria, organ dysfunction, or failure defined by SOFA max were performed. Results. WHO criteria identified 65 SMO and 214 PLTC. Management criteria were present in 58/65 (89.2%) while 61/65 (93.8%) of SMO cases had dysfunction or failure by SOFA. Conclusions. The systematic evaluation of the organic function by SOFA max score identified the presence of organic dysfunction or failure in almost all SMO cases. Management criteria were present in all MD cases. Our results indicate the need for new studies evaluating the parameterization of the WHO laboratory criteria for values compatible with the definition of organic dysfunction by the SOFA to identify MNM.
C1 [Oliveira Neto, Antonio Francisco; Parpinelli, Mary Angela; Costa, Maria Laura; Souza, Renato Teixeira; do Valle, Carolina Ribeiro; Cecatti, Jose Guilherme] Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; Cecatti, Jose Guilherme/M-5945-2013
OI Souza, Renato Teixeira/0000-0002-9075-9269; Cecatti, Jose
   Guilherme/0000-0003-1285-8445
FU FAPESP (Foundation for Research Support of the State of Sao Paulo),
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors acknowledge the Department of Obstetrics and Gynaecology of
   University of Campinas, the Womans' Hospital, CAISM, and the financial
   support provided by FAPESP (Foundation for Research Support of the State
   of Sao Paulo), Brazil.
CR Akrawi Vian Sabri, 2017, Oman Med J, V32, P386, DOI 10.5001/omj.2017.74
   American College of Surgeons, 2012, ADV TRAUM LIV SUPP A
   Breslow MJ, 2012, CHEST, V141, P245, DOI 10.1378/chest.11-0330
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Chantry AA, 2015, CRIT CARE MED, V43, P78, DOI 10.1097/CCM.0000000000000601
   Clark SL, 2012, OBSTET GYNECOL, V119, P360, DOI 10.1097/AOG.0b013e3182411907
   Fink MP, 2002, INTENS CARE MED, V28, P369, DOI 10.1007/s00134-001-1205-2
   Jain S, 2016, INT J GYNECOL OBSTET, V132, P332, DOI 10.1016/j.ijgo.2015.08.005
   Lee ACC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0724-8
   Mekango DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183886
   Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931
   Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856
   Nathan HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168535
   Oliveira Leonam Costa, 2015, Rev. bras. ter. intensiva, V27, P220, DOI 10.5935/0103-507X.20150033
   Pandharipande PP, 2006, CRIT CARE MED, V34, pA1, DOI 10.1097/00003246-200612002-00004
   Purandare CN, 2013, J OBSTET GYN INDIA, V63, P213, DOI 10.1007/s13224-013-0463-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   Vasquez DN, 2015, CRIT CARE MED, V43, P1887, DOI 10.1097/CCM.0000000000001139
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156
   Witteveen T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1370-0
   Witteveen T, 2016, ACTA OBSTET GYN SCAN, V95, P106, DOI 10.1111/aogs.12793
   World Health Organization, 2011, NEAR MISS APPR MAT H
NR 25
TC 2
Z9 2
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2018
VL 2018
AR 5714890
DI 10.1155/2018/5714890
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA HB6FI
UT WOS:000451161200001
PM 30539015
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Santana, DS
   Cecatti, JG
   Haddad, SM
   Parpinelli, MA
   Costa, ML
   Surita, FG
   Sousa, MH
AF Santana, Danielly S.
   Cecatti, Jose G.
   Haddad, Samira M.
   Parpinelli, Mary A.
   Costa, Maria L.
   Surita, Fernanda G.
   Sousa, Maria H.
CA Brazilian Network Surveillance Sev
TI Severe maternal morbidity and perinatal outcomes of multiple pregnancy
   in the Brazilian Network for the Surveillance of Severe Maternal
   Morbidity
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Maternal mortality; Maternal near miss; Multiple pregnancy; Perinatal
   outcomes; Severe maternal morbidity
ID TWIN; COMPLICATIONS; DELIVERY
AB Objective: To compare severe maternal complications (potentially life-threatening conditions [PLTCs], maternal near miss [MNM], and maternal death) and perinatal outcomes between multiple and singleton pregnancies. Methods: A secondary analysis was undertaken using data from the Brazilian Network for Surveillance of Severe Maternal Morbidity (prospective surveillance of morbidities in 27 Brazilian obstetric units between July 2009 and June 2010). Health indicators and criteria used for PLTCs and MNM were assessed. Adjusted prevalence ratios (PRadj) with 95% confidence intervals (CIs) were calculated for perinatal outcomes. Results: Among 267 multiple pregnancies, 235 (88.0%) were affected by PLTCs, 25 (9.4%) by MNM, and 7 (2.6%) by maternal death; these prevalences did not differ from singleton pregnancies (n=7986). Management criteria for MNM were used almost twice as much in multiple pregnancies (PRadj 1.85, 95% CI 1.41-2.42). Preterm birth (PRadj 1.62, 95% CI 1.41-1.86), low birthweight (PRadj 1.73, 95% CI 1.45-2.06 for the first-born vs singleton), any adverse perinatal outcome (PRadj 1.12, 95% CI 1.03-1.22 for the second-vs first-born), and neonatal near miss (PRadj 1.37, 95% CI 1.13-1.67 for the second-born vs singleton) were significantly associated with multiple pregnancy. Conclusion: Among cases of severe maternal morbidity, perinatal but not maternal outcomes were poorer for multiple pregnancies than for singletons. Differentiated care is needed during pregnancy and childbirth.
C1 [Santana, Danielly S.; Cecatti, Jose G.; Haddad, Samira M.; Parpinelli, Mary A.; Costa, Maria L.; Surita, Fernanda G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Sousa, Maria H.] Jundiai Med Sch, Unit Stat, Jundiai, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Cecatti, Jose
   Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234;
   Santana, Danielly/0000-0001-8912-2626
FU National Research CouncilConsiglio Nazionale delle Ricerche (CNR);
   Department of Science and Technology of the Brazilian Ministry of Health
FX The National Research Council and the Department of Science and
   Technology of the Brazilian Ministry of Health
CR Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001
   Avenant T, 2009, BEST PRACT RES CL OB, V23, P369, DOI 10.1016/j.bpobgyn.2008.12.005
   Bangal V. B., 2012, International Journal of Biomedical and Advance Research, V3, P758
   Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939
   Burgess JL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.03.003
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   da Fonseca Catia Regina Branco, 2012, BMC Res Notes, V5, P60, DOI 10.1186/1756-0500-5-60
   DATASUS, 2011, INF HLTH VIT STAT
   Gyamfi C, 2005, CLIN PERINATOL, V32, P431, DOI 10.1016/j.clp.2005.02.004
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, P1
   National Institute for Health and Care Excellence, 2011, MULT PREGN ANT CAR T
   Obiechina NJ, 2011, INT J WOMENS HEALTH, V3, P227, DOI 10.2147/IJWH.S22059
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Qazi G, 2011, JCPSP-J COLL PHYSICI, V21, P142, DOI 03.2011/JCPSP.142145
   Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007
   Rizwan Naushaba, 2010, J Ayub Med Coll Abbottabad, V22, P105
   Santana DS, 2016, OBSTET GYNECOL, V127, P631, DOI 10.1097/AOG.0000000000001338
   Santos JP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0758-y
   Santos JP, 2015, CLINICS, V70, P820, DOI 10.6061/clinics/2015(12)10
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549
   Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x
   Young BC, 2012, SEMIN PERINATOL, V36, P162, DOI 10.1053/j.semperi.2012.02.007
NR 25
TC 2
Z9 2
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD NOV
PY 2017
VL 139
IS 2
BP 230
EP 238
DI 10.1002/ijgo.12287
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO8XE
UT WOS:000417170700018
PM 28755514
DA 2020-12-08
ER

PT J
AU Dias, TZ
   Passini, R
   Tedesco, RP
   Lajos, GJ
   Rehder, PM
   Nomura, ML
   Costa, ML
   Oliveira, PF
   Sousa, MH
   Cecatti, JG
AF Dias, Tabata Z.
   Passini, Renato, Jr.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Rehder, Patricia M.
   Nomura, Marcelo L.
   Costa, Maria L.
   Oliveira, Paulo F.
   Sousa, Maria H.
   Cecatti, Jose G.
CA Brazilian Multictr Study Preterm B
TI Evaluation of prenatal corticosteroid use in spontaneous preterm labor
   in the Brazilian Multicenter Study on Preterm Birth (EMIP)
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Late preterm; Neonatal outcomes; Prenatal corticosteroid; Preterm
   delivery; Preterm labor
ID ANTENATAL CORTICOSTEROIDS
AB Objective: To evaluate prenatal corticosteroid use in women experiencing spontaneous preterm labor and preterm delivery.
   Methods: The present cross-sectional multicenter study analyzed interview data from patients attending 20 hospitals in Brazil owing to preterm delivery between April 1, 2011 and July 30, 2012. Patients were stratified based on preterm delivery occurring before 34 weeks or at 34-36(+6) weeks of pregnancy, and the frequency of prenatal corticosteroid use at admission was compared. Prenatal corticosteroid use, socio-demographic data, obstetric characteristics, and neonatal outcomes were examined.
   Results: There were 1455 preterm deliveries included in the present study; 527 (36.2%) occurred before 34 weeks of pregnancy and prenatal corticosteroids were used in 285 (54.1%) of these pregnancies. Among neonates delivered at 32-33(+6) weeks, prenatal corticosteroid use was associated with lower pneumonia (P=0.026) and mortality (P=0.029) rates. Among neonates delivered at 34-36(+6) weeks, prenatal corticosteroid use was associated with longer neonatal hospital admission (P<0.001), and an increased incidence of 5-minute Apgar scores below 7 (P=0.010), endotracheal intubation (P=0.042), surfactant use (P=0.006), neonatal morbidities (P=0.048), respiratory distress (P=0.048), and intraventricular hemorrhage (P=0.023).
   Conclusion: Preterm labor and late preterm delivery were associated with worse neonatal outcomes following prenatal corticosteroids. This could reflect a sub-optimal interval between administration and delivery.
C1 [Dias, Tabata Z.; Passini, Renato, Jr.; Lajos, Giuliane J.; Rehder, Patricia M.; Nomura, Marcelo L.; Costa, Maria L.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, Brazil.
   [Oliveira, Paulo F.] Univ Estadual Campinas, Sch Med Sci, Unit Stat, Campinas, SP, Brazil.
   [Sousa, Maria H.] Jundiai Med Sch, Unit Stat, Jundiai, Brazil.
RP Dias, TZ (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM tabatazumpano@gmail.com
RI BORGES, VERA T/B-7363-2014; Cecatti, Jose Guilherme/M-5945-2013; Amorim,
   Melania M/C-5807-2013; Nomura, Marcelo Luis/H-9534-2019; Costa, Maria
   Laura/I-4980-2019; Dias, T\\xc3\\x83\\xc2\\xa1bata/U-4512-2019
OI BORGES, VERA T/0000-0002-9347-9641; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Amorim, Melania M/0000-0003-1047-2514;
   Costa, Maria Laura/0000-0001-8280-3234; Santos,
   Mateus/0000-0003-2919-8551
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq); Foundation for Support to Research of
   the State of Sao Paulo
FX Brazilian National Research Council; Foundation for Support to Research
   of the State of Sao Paulo
CR ACOG Committee on Obstetric Practice, 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00
   Aleman A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-4
   American College of Obstetricians and Gynecologists' Committee on Obstetric Practice; Society for Maternal-Fetal Medicine, 2016, OBSTET GYNECOL, V128, pe187
   Bonanno C, 2012, OBSTET GYN CLIN N AM, V39, P47, DOI 10.1016/j.ogc.2011.12.006
   Brazil Ministry of Health, 2010, TECHN MAN HIGH RISK
   Crowther CA, 2016, NEW ENGL J MED, V374, P1376, DOI 10.1056/NEJMe1601867
   de Oliveira RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141852
   Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X
   Porto AMF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1696
   GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783
   Gyamfi-Bannerman C, 2012, OBSTET GYNECOL, V119, P555, DOI 10.1097/AOG.0b013e31824758f6
   Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226
   How HY, 2009, AM J PERINAT, V26, P1, DOI 10.1055/s-0028-1090586
   Kamath-Rayne BD, 2016, AM J OBSTET GYNECOL, V215, P423, DOI 10.1016/j.ajog.2016.06.023
   LIGGINS GC, 1972, PEDIATRICS, V50, P515
   Lotgering Frederik K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS17, DOI 10.1186/1471-2393-7-S1-S17
   NICE guideline, 2015, PRETERM LABOUR BIRTH
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Peaceman AM, 2005, AM J OBSTET GYNECOL, V193, P1165, DOI 10.1016/j.ajog.2005.06.050
   Ramadan M K, 2016, J Neonatal Perinatal Med, V9, P15, DOI 10.3233/NPM-16915086
   Ring AM, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.018
   Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3
   Royal College of Obstetricians, 2010, GREEN TOP GUID NO 7
   Society for Maternal-Fetal Medicine (SMFM) Publications Committee, 2016, IMPL US ANT CORT LAT
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
NR 27
TC 1
Z9 1
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD NOV
PY 2017
VL 139
IS 2
BP 222
EP 229
DI 10.1002/ijgo.12297
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FO8XE
UT WOS:000417170700017
PM 28803456
DA 2020-12-08
ER

PT J
AU Guida, JPD
   Surita, FG
   Parpinelli, MA
   Costa, ML
AF de Siqueira Guida, Jose Paulo
   Surita, Fernanda Garanhani
   Parpinelli, Mary Angela
   Costa, Maria Laura
TI Preterm Preeclampsia and Timing of Delivery: A Systematic Literature
   Review
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Review
DE preeclampsia; delivery; prematurity; preterm preeclampsia
ID ORGANIZATION MULTICOUNTRY SURVEY; HYPERTENSIVE DISORDERS;
   CARDIOVASCULAR-DISEASE; EXPECTANT MANAGEMENT; PERINATAL OUTCOMES;
   MAGNESIUM-SULFATE; PREGNANCY; WOMEN; RISK; HEALTH
AB Introduction Preeclampsia, a multifactorial disease with pathophysiology not yet fully understood, is a major cause of maternal and perinatal morbidity and mortality, especially when preterm. The diagnosis is performed when there is an association between arterial hypertension and proteinuria or evidence of severity. There are unanswered questions in the literature considering the timing of delivery once preterm preeclampsia has been diagnosed, given the risk of developingmaternal complications versus the risk of adverse perinatal outcomes associated with prematurity. The objective of this systematic review is to determine the best timing of delivery for women diagnosed with preeclampsia before 37 weeks of gestation.
   Methods Systematic literature review, performed in the PubMed database, using the terms preeclampsia, parturition and timing of delivery to look for studies conducted between 2014 and 2017. Studies that compared the maternal and perinatal outcomes of women who underwent immediate delivery or delayed delivery, in the absence of evidence of severe preeclampsia, were selected.
   Results A total of 629 studies were initially retrieved. After reading the titles, 78 were selected, and their abstracts, evaluated; 16 were then evaluated in full and, in the end, 6 studies (2 randomized clinical trials and 4 observational studies) met the inclusion criteria. The results were presented according to gestational age range (< 34 weeks and between 34 and 37 weeks) and by maternal and perinatal outcomes, according to the timing of delivery, considering immediate delivery or expectant management. Before 34 weeks, thematernal outcomeswere similar, but the perinatal outcomes were significantly worse when immediate delivery occurred. Between 34 and 37 weeks, the progression to severe maternal disease was slightly higher among women undergoing expectant management, however, with better perinatal outcomes.
   Conclusions When there is no evidence of severe preeclampsia or impaired fetal wellbeing, especially before 34 weeks, the pregnancy should be carefully surveilled, and the delivery, postponed, aiming at improving the perinatal outcomes. Between 34 and 37 weeks, the decision on the timing of delivery should be shared with the pregnant woman and her family, after providing information regarding the risks of adverse outcomes associated with preeclampsia and prematurity.
C1 [de Siqueira Guida, Jose Paulo; Surita, Fernanda Garanhani; Parpinelli, Mary Angela; Costa, Maria Laura] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM mlaura@unicamp.br
RI Guida, Jose Paulo Siqueira/H-2391-2012; Costa, Maria Laura/I-4980-2019;
   Surita, Fernanda Garanhani/H-9575-2012
OI Guida, Jose Paulo Siqueira/0000-0002-3648-6159; Costa, Maria
   Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
CR Acharya A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0491-3
   Anderson UD, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0584-7
   Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X
   BROSENS I, 1964, J OBSTET GYN BR COMM, V71, P222
   Browne JL, 2015, TROP MED INT HEALTH, V20, P1778, DOI 10.1111/tmi.12606
   Chappell LC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h191
   Charlton F, 2014, HEART LUNG CIRC, V23, P203, DOI 10.1016/j.hlc.2013.10.087
   Churchill D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003106.pub2
   Cluver C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009273.pub2
   Costa ML, 2015, J OBSTET GYNAECOL CA, V37, P887, DOI 10.1016/S1701-2163(16)30023-8
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Facca Thais Alquezar, 2012, J. Bras. Nefrol., V34, P87, DOI 10.1590/S0101-28002012000100015
   Giannubilo SR, 2014, OBSTET GYNECOL SURV, V69, P747, DOI 10.1097/OGX.0000000000000126
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Hagmann H, 2012, CLIN CHEM, V58, P837, DOI 10.1373/clinchem.2011.169094
   Helou A, 2016, AUST NZ J OBSTET GYN
   Jacquemyn Y, 2015, ARCH GYNECOL OBSTET, V291, P969, DOI 10.1007/s00404-014-3581-1
   Klein E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156013
   Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4
   Lee G, 2015, MIDWIFERY, V31, P1127, DOI 10.1016/j.midw.2015.09.005
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472
   Locatelli A, 2015, OBSTET GYN CLIN N AM, V42, P255, DOI 10.1016/j.ogc.2015.01.004
   Lotufo FA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1055-0
   Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x
   McDonald SD, 2012, INT J GYNECOL OBSTET, V118, P90, DOI 10.1016/j.ijgo.2012.01.028
   McKinney D, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.050
   Melamed N, 2012, J MATERN-FETAL NEO M, V25, P2248, DOI 10.3109/14767058.2012.684174
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Newman MG, 2003, AM J OBSTET GYNECOL, V188, P264, DOI 10.1067/mob.2003.84
   O'Sullivan D, 2013, STUD HEALTH TECHNOL, V192, P1057, DOI 10.3233/978-1-61499-289-9-1057
   Owens Michelle Y, 2014, J Miss State Med Assoc, V55, P208
   Pettit F, 2015, PREGNANCY HYPERTENS, V5, P198, DOI 10.1016/j.preghy.2015.02.002
   Phipps E, 2016, CLIN J AM SOC NEPHRO, V11, P1102, DOI 10.2215/CJN.12081115
   Pryde PG, 2011, J PERINAT MED, V39, P375, DOI [10.1515/JPM.2011.036, 10.1515/jpm.2011.036]
   Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009
   ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Seely EW, 2015, SEMIN PERINATOL, V39, P276, DOI 10.1053/j.semperi.2015.05.006
   Seely EW, 2014, CIRCULATION, V129, P1254, DOI 10.1161/CIRCULATIONAHA.113.003904
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.04.017, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.02.001]
   van der Graaf AM, 2012, NEPHROL DIAL TRANSPL, V27, P51, DOI 10.1093/ndt/gfs278
   van Oostwaard MF, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.009
   Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037
   Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   Wang YH, 2017, ARCH GYNECOL OBSTET, V295, P607, DOI 10.1007/s00404-016-4281-9
NR 52
TC 9
Z9 10
U1 0
U2 3
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD NOV
PY 2017
VL 39
IS 11
BP 622
EP 631
DI 10.1055/s-0037-1604103
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FQ0UJ
UT WOS:000418071900007
PM 28701023
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Robinette, ML
   Bugatti, M
   Longtine, MS
   Colvin, BN
   Lantelme, E
   Vermi, W
   Colonna, M
   Nelson, DM
   Cella, M
AF Costa, Maria Laura
   Robinette, Michelle L.
   Bugatti, Mattia
   Longtine, Mark S.
   Colvin, Bryanne N.
   Lantelme, Erica
   Vermi, William
   Colonna, Marco
   Nelson, D. Michael
   Cella, Marina
TI Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal-Interface
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE placenta; antigen-presenting cells; inflammation; tolerance; pregnancy
ID DENDRITIC CELLS; GLEMBATUMUMAB VEDOTIN; CANCER-IMMUNOTHERAPY;
   HUMAN-PREGNANCY; BREAST-CANCER; CUTTING EDGE; NK CELLS; B-CELLS; C-MAF;
   CYTOKINES
AB During pregnancy, immune cells infiltrate the placenta at different stages of fetal development. NK cells and macrophages are the most predominant cell types. These immune cells play pleiotropic roles, as they control spiral artery remodeling to ensure appropriate blood supply and maintain long-term tolerance to a true allograft; yet, they must be able to mount appropriate immune defenses to pathogens that may threaten the fetus. Whether the same cell type accomplishes all these tasks or if there are dedicated subsets remains controversial. Here, we identify and characterize two distinct subsets of myeloid cells that differ in their pro-inflammatory/regulatory capacity. While one subset predominantly produces the immune-modulating cytokine IL-10, the second subset has superior capacity to secrete pro-inflammatory mediators, such as IL-1 beta and IL-6. The putative regulatory myeloid cells also express high levels of inhibitory receptors and their ligands, including programmed cell death 1 (PD1) ligands. Importantly, a large fraction of CD8 and CD4 cells in normal term human placenta are PD1 positive, suggesting that the PD1/PD1 ligands axis might be critical to maintain tolerance during pregnancy.
C1 [Costa, Maria Laura; Longtine, Mark S.; Colvin, Bryanne N.; Nelson, D. Michael] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Costa, Maria Laura] Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Robinette, Michelle L.; Lantelme, Erica; Vermi, William; Colonna, Marco; Cella, Marina] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [Bugatti, Mattia; Vermi, William] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy.
   [Colvin, Bryanne N.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
RP Cella, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
EM mcella@wustl.edu
RI Cella, Marina/ABA-8564-2020
OI costa, maria laura/0000-0001-8280-3234; VERMI,
   WILLIAM/0000-0002-2291-2997; Longtine, Mark/0000-0002-3315-1732; Cella,
   Marina/0000-0003-1230-1313
FU Science Without Borders [200356/2014-3]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Sao Paulo Research
   FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP - 2014/01925-0]; Associazione Italiana per la Ricerca sul
   CancroAssociazione Italiana per la Ricerca sul Cancro (AIRC) [IG 15378];
   [RO1CA176695]; NATIONAL CANCER INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, R01CA176695, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, R01CA176695, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, R01CA176695, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   R01CA176695, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, R01CA176695,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842, P30CA091842, P30CA091842,
   P30CA091842, P30CA091842, P30CA091842] Funding Source: NIH RePORTER
FX This work was supported by Grant RO1CA176695 to MCe. MLC was supported
   by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Science Without Borders (200356/2014-3) and by Sao Paulo Research
   Foundation, (FAPESP - 2014/01925-0). WV is supported by Associazione
   Italiana per la Ricerca sul Cancro (grant IG 15378).
CR Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912
   Banchereau J, 2012, P NATL ACAD SCI USA, V109, P18885, DOI 10.1073/pnas.1205785109
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Cella M, 2000, CURR TOP MICROBIOL, V251, P161
   Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360
   Chen B, 2015, PLACENTA, V36, P847, DOI 10.1016/j.placenta.2015.05.009
   Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306
   Das UN, 2015, NUTRITION, V31, P1083, DOI 10.1016/j.nut.2015.03.013
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Faas MM, 2017, PLACENTA, V56, P44, DOI 10.1016/j.placenta.2017.03.001
   Ferreira LMR, 2017, TRENDS IMMUNOL, V38, P272, DOI 10.1016/j.it.2017.01.009
   Flood-Nichols SK, 2013, MOL CELL PROTEOMICS, V12, P55, DOI 10.1074/mcp.M112.018192
   Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179
   Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019
   Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5
   Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014
   Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278
   Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153
   Hsu P, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00125
   Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200
   Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104
   Kim JR, 2013, INFLAMM RES, V62, P765, DOI 10.1007/s00011-013-0632-1
   Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658
   Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014
   Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906
   Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001
   Naumovski L, 2010, CURR OPIN MOL THER, V12, P248
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239
   Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Realegeno S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005705
   Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722
   Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014
   Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Sawant DV, 2015, J INTERF CYTOK RES, V35, P499, DOI 10.1089/jir.2015.0015
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   Slade L, 2017, MOL CANCER RES, V15, P1637, DOI 10.1158/1541-7786.MCR-17-0320
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537
   Tedder TF, 2014, NAT REV RHEUMATOL, V10, DOI 10.1038/nrrheum.2014.95
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366
   Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573
   Yardley DA, 2015, J CLIN ONCOL, V33, P1609, DOI 10.1200/JCO.2014.56.2959
   Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134
   Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501
   Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085
   Zhang JH, 2016, CELL TISSUE RES, V363, P249, DOI 10.1007/s00441-015-2315-4
   Zhou LT, 2012, NEOPLASMA, V59, P1, DOI 10.4149/neo_2012_001
   Zhou LT, 2017, CELL IMMUNOL, V316, P53, DOI 10.1016/j.cellimm.2017.03.006
NR 56
TC 3
Z9 4
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 25
PY 2017
VL 8
AR 1357
DI 10.3389/fimmu.2017.01357
PG 12
WC Immunology
SC Immunology
GA FK8II
UT WOS:000413750800001
PM 29123519
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Kam, YW
   Leite, JA
   Lum, FM
   Tan, JJL
   Lee, B
   Judice, CC
   Teixeira, DAD
   Andreata-Santos, R
   Vinolo, MA
   Angerami, R
   Resende, MR
   Freitas, ARR
   Amaral, E
   Passini, R
   Costa, ML
   Guida, JP
   Arns, CW
   Ferreira, LCS
   Nia, LR
   Proenca-Modena, JL
   Lisa, FPN
   Costa, FTM
AF Kam, Yiu-Wing
   Leite, Juliana Almeida
   Lum, Fok-Moon
   Tan, Jeslin J. L.
   Lee, Bernett
   Judice, Carla C.
   de Toledo Teixeira, Daniel Augusto
   Andreata-Santos, Robert
   Vinolo, Marco A.
   Angerami, Rodrigo
   Resende, Mariangela Ribeiro
   Ribas Freitas, Andre Ricardo
   Amaral, Eliana
   Passini Junior, Renato
   Costa, Maria Laura
   Guida, Jose Paulo
   Arns, Clarice Weis
   Ferreira, Luis Carlos S.
   Nia, Laurent R.
   Proenca-Modena, Jose Luiz
   Ng, Lisa F. P.
   Costa, Fabio T. M.
CA Zika-Unicamp Network
TI Specific Biomarkers Associated With Neurological Complications and
   Congenital Central Nervous System Abnormalities From Zika Virus-Infected
   Patients in Brazil
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; congenital CNS deformities; cytokines and biomarkers
ID HEPATOCYTE GROWTH-FACTOR; NK CELLS; KINETICS; AMERICA; DENGUE; BRAIN;
   MICRONESIA; EPIDEMIC; OUTBREAK; DISEASE
AB Background. Zika virus (ZIKV) infections have been linked to different levels of clinical outcomes, ranging from mild rash and fever to severe neurological complications and congenital malformations.
   Methods. We investigated the clinical and immunological response, focusing on the immune mediators profile in 95 acute ZIKV-infected adult patients from Campinas, Brazil. These patients included 6 pregnant women who later delivered during the course of this study. Clinical observations were recorded during hospitalization. Levels of 45 immune mediators were quantified using multiplex microbead-based immunoassays.
   Results. Whereas 11.6% of patients had neurological complications, 88.4% displayed mild disease of rash and fever. Several immune mediators were specifically higher in ZIKV-infected patients, and levels of interleukin 10, interferon gamma-induced protein 10 (IP-10), and hepatocyte growth factor differentiated between patients with or without neurological complications. Interestingly, higher levels of interleukin 22, monocyte chemoattractant protein 1, TNF-alpha, and IP-10 were observed in ZIKV-infected pregnant women carrying fetuses with fetal growth-associated malformations. Notably, infants with congenital central nervous system deformities had significantly higher levels of interleukin 18 and IP-10 but lower levels of hepatocyte growth factor than those without such abnormalities born to ZIKV-infected mothers.
   Conclusions. This study identified several key markers for the control of ZIKV pathogenesis. This will allow a better understanding of the molecular mechanisms of ZIKV infection in patients.
C1 [Kam, Yiu-Wing; Lum, Fok-Moon; Tan, Jeslin J. L.; Lee, Bernett; Nia, Laurent R.; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Leite, Juliana Almeida; Judice, Carla C.; de Toledo Teixeira, Daniel Augusto; Vinolo, Marco A.; Arns, Clarice Weis; Proenca-Modena, Jose Luiz; Costa, Fabio T. M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil.
   [Andreata-Santos, Robert; Ferreira, Luis Carlos S.] Univ Sao Paulo, Dept Microbiol, Biomed Sci Inst, Sao Paulo, Brazil.
   [Angerami, Rodrigo] Univ Estadual Campinas, Epidemiol Surveillance Sect, Hosp Clin, Campinas, SP, Brazil.
   [Resende, Mariangela Ribeiro] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Obstet & Gynecol Dept, Sao Paulo, Brazil.
   [Amaral, Eliana; Passini Junior, Renato; Costa, Maria Laura; Guida, Jose Paulo] Campinas Dept Publ Hlth Surveillance, Campinas, SP, Brazil.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Lisa, FPN (corresponding author), ASTAR, Singapore Immunol Network, Lab Microbial Immun, Biopolis, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Freitas, Andre Ricardo Ribas/L-1969-2016; Costa, Maria
   Laura/I-4980-2019; Costa, Fabio/E-1181-2012; Arns, Clarice
   W/G-7525-2012; Amorim, Mariene/C-4102-2019; Proenca-Modena, Jose
   Luiz/AAU-7622-2020; Vinolo, Marco Aurelio R/K-3753-2012; amsalu,
   ribka/G-8780-2019; Modena, Jose Luiz Proenca/C-8231-2014; Angerami,
   Rodrigo Nogueira/A-8926-2013; Toledo-Teixeira, Daniel A./C-6940-2017;
   Judice, Carla/P-4738-2014; Cavalheiro Martini, Matheus/E-9416-2015
OI Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Costa, Maria
   Laura/0000-0001-8280-3234; Costa, Fabio/0000-0001-9969-7300; Arns,
   Clarice W/0000-0002-7308-460X; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Modena, Jose Luiz Proenca/0000-0002-4996-3153;
   Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Judice,
   Carla/0000-0003-1839-053X; Ng, Lisa/0000-0003-4071-5222;
   Toledo-Teixeira, Daniel A./0000-0002-4055-058X; Cavalheiro Martini,
   Matheus/0000-0003-0135-4364; Vinolo, Marco Aurelio/0000-0003-1335-760X
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund
   [15/1/82/27/001]; Agency for Science, Technology and Research (A*STAR),
   SingaporeAgency for Science Technology & Research (ASTAR); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/00194-8]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq)
FX This work was supported by the Biomedical Research Council (BMRC; core
   research grants provided to the Singapore Immunology Network); the BMRC
   A*STAR-led Zika Virus Consortium Fund (project 15/1/82/27/001); the
   Agency for Science, Technology and Research (A*STAR), Singapore,
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 2016/00194-8
   and fellowship to J.A.L.); and the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (including research fellowships to M.A.V.,
   E.A., L.C.F., and F.T.M.C.).
CR Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627
   Cheng YL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/274025
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funakoshi H, 2011, CURR SIGNAL TRANSD T, V6, P156, DOI 10.2174/157436211795659982
   Gaddi PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042850
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OEHLER E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   World Health Organization, 2016, WORLD MALARIA REPORT, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 38
TC 33
Z9 34
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2017
VL 216
IS 2
BP 172
EP 181
DI 10.1093/infdis/jix261
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC4SX
UT WOS:000406832000005
PM 28838147
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Colvin, BN
   Longtine, MS
   Chen, BS
   Costa, ML
   Nelson, DM
AF Colvin, Bryanne N.
   Longtine, Mark S.
   Chen, Baosheng
   Costa, Maria Laura
   Nelson, D. Michael
TI Oleate attenuates palmitate-induced endoplasmic reticulum stress and
   apoptosis in placental trophoblasts
SO REPRODUCTION
LA English
DT Article
ID PANCREATIC BETA-CELLS; FREE FATTY-ACIDS; UNFOLDED PROTEIN RESPONSE;
   BODY-MASS INDEX; ER STRESS; HUMAN SYNCYTIOTROPHOBLASTS; TRIGLYCERIDE
   ACCUMULATION; MITOCHONDRIAL DYSFUNCTION; INDUCED LIPOTOXICITY; CHEMICAL
   CHAPERONES
AB Pre-pregnancy obesity is increasingly common and predisposes pregnant women and offspring to gestational diabetes, pre-eclampsia, fetal growth abnormalities and stillbirth. Obese women exhibit elevated levels of the two most common dietary fatty acids, palmitate and oleate, and the maternal blood containing these nutrients bathes the surface of trophoblasts of placental villi in vivo. We test the hypothesis that the composition and concentration of free fatty acids modulate viability and function of primary human villous trophoblasts in culture. We found that palmitate increases syncytiotrophoblast death, specifically by caspase-mediated apoptosis, whereas oleate does not cause enhanced cell death. Importantly, exposure to both fatty acids in equimolar amounts yielded no increase in death or apoptosis, suggesting that oleate can protect syncytiotrophoblasts from palmitate-induced death. We further found that palmitate, but not oleate or oleate with palmitate, increases endoplasmic reticulum (ER) stress, signaling through the unfolded protein response, and yielding CHOP-mediated induction of apoptosis. Finally, we show that oleate or oleate plus palmitate both lead to increased lipid droplets in syncytiotrophoblasts, whereas palmitate does not. The data show palmitate is toxic to human syncytiotrophoblasts, through the induction of ER stress and apoptosis mediated by CHOP, whereas oleate is not toxic, abrogates palmitate toxicity and induces fat accumulation. We speculate that our in vitro results offer pathways by which the metabolic milieu of the obese pregnant woman can yield villous trophoblast dysfunction and sub-optimal placental function.
C1 [Colvin, Bryanne N.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
   [Longtine, Mark S.; Chen, Baosheng; Costa, Maria Laura; Nelson, D. Michael] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Costa, Maria Laura] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Colvin, BN (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
EM colvin_b@kids.wustl.edu
RI Costa, Maria Laura/I-4980-2019
OI Costa, Maria Laura/0000-0001-8280-3234; Longtine,
   Mark/0000-0002-3315-1732
FU BJH Foundation; Department of Obstetrics and Gynecology at Washington
   University School of Medicine, St Louis, MO; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) - Science Without
   Borders [200356/2014-3]; Sao Paulo Research Foundation (FAPESP)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/01925-0]
FX This work was supported by the BJH Foundation, the Department of
   Obstetrics and Gynecology at Washington University School of Medicine,
   St Louis, MO, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) - Science Without Borders (200356/2014-3 to M. L. C.)
   and by Sao Paulo Research Foundation - (FAPESP - 2014/01925-0 to M. L.
   C.).
CR Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003
   American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60
   Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269
   Brass E, 2013, PLACENTA, V34, P503, DOI 10.1016/j.placenta.2013.03.009
   Chen B, 2015, PLACENTA, V36, P847, DOI 10.1016/j.placenta.2015.05.009
   Chen BS, 2012, AM J PHYSIOL-ENDOC M, V302, pE1142, DOI 10.1152/ajpendo.00003.2012
   Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010
   Chen XH, 2010, DIABETES CARE, V33, P2049, DOI 10.2337/dc10-0693
   Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771
   Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062
   Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014
   Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004
   El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410
   Finnie JW, 2001, J COMP PATHOL, V125, P318, DOI 10.1053/jcpa.2001.0510
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Higgins L, 2013, J MATERN-FETAL NEO M, V26, P783, DOI 10.3109/14767058.2012.760539
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   Huang LS, 2014, PLACENTA, V35, P563, DOI 10.1016/j.placenta.2014.05.006
   Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494
   Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255
   Kovo M, 2015, REPROD SCI, V22, P1643, DOI 10.1177/1933719115592712
   Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004
   Lager S, 2014, AM J PHYSIOL-CELL PH, V307, pC738, DOI 10.1152/ajpcell.00196.2014
   Lager S, 2013, J LIPID RES, V54, P725, DOI 10.1194/jlr.M033050
   Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007
   Leamy AK, 2014, J LIPID RES, V55, P1478, DOI 10.1194/jlr.M050237
   Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004
   Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]
   Lu J, 2012, ENDOCRINOLOGY, V153, P5275, DOI 10.1210/en.2012-1418
   Mantzaris MD, 2011, FEBS J, V278, P519, DOI 10.1111/j.1742-4658.2010.07972.x
   Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288
   Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009
   Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4
   Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088
   Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007
   Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050
   Nemcova-Furstova V, 2011, CELL PHYSIOL BIOCHEM, V27, P525, DOI 10.1159/000329954
   Palomer X, 2014, INT J CARDIOL, V174, P110, DOI 10.1016/j.ijcard.2014.03.176
   Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369
   Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009
   Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195
   Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006
   Prause M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087067
   Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x
   Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023
   Schilling JD, 2013, J IMMUNOL, V190, P1285, DOI 10.4049/jimmunol.1202208
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130
   Soumura M, 2010, BIOCHEM BIOPH RES CO, V402, P265, DOI 10.1016/j.bbrc.2010.10.012
   Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184
   Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734
   Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024
   van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792
   Villa PM, 2009, PROSTAG LEUKOTR ESS, V81, P17, DOI 10.1016/j.plefa.2009.05.002
   Wang Y, 2016, REPRODUCTION, V151, P97, DOI 10.1530/REP-15-0287
   Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068
   Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082
   Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193
   Yung HW, 2016, DIABETOLOGIA, V59, P2240, DOI 10.1007/s00125-016-4040-2
   Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010
NR 66
TC 8
Z9 9
U1 0
U2 7
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 1470-1626
J9 REPRODUCTION
JI Reproduction
PD APR
PY 2017
VL 153
IS 4
BP 369
EP 380
DI 10.1530/REP-16-0576
PG 12
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA EN2HH
UT WOS:000395830100004
PM 28159805
OA Bronze
DA 2020-12-08
ER

PT J
AU Lotufo, FA
   Parpinelli, MA
   Osis, MJ
   Surita, FG
   Costa, ML
   Cecatti, JG
AF Lotufo, Fatima Aparecida
   Parpinelli, Mary Angela
   Osis, Maria Jose
   Surita, Fernanda Garanhani
   Costa, Maria Laura
   Cecatti, Jose Guilherme
TI Obstetrician's risk perception on the prescription of magnesium sulfate
   in severe preeclampsia and eclampsia: A qualitative study in Brazil
SO PLOS ONE
LA English
DT Article
ID HEALTH; AVAILABILITY; MANAGEMENT; REGIMENS; BARRIERS; CARE
AB Introduction Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizures in the management of severe preeclampsia/eclampsia. Several barriers have been iden-tified in the use of MgSO4, especially in low and middle-income settings.
   Objective To describe the obstetrician's perception on possible reasons for underutilizing magnesium sulfate to treat preeclampsia/eclampsia.
   Method A qualitative clinical study, based on phenomenological reference by semi-structured inter-views and open-ended discussions with obstetricians of the public healthcare system in pri-mary care units (PCU) and referral maternity hospitals (RMH), in a southeastern Brazilian city.
   Results Fear of drug toxicity was the major cause for not prescribing the medication in PCU. Fear was justified by insufficient technical, structural and organizational resources of healthcare facilities and by a shortage of physicians properly trained for adequate drug use.
   Conclusion Fear of toxicity of magnesium sulfate was the main barrier towards timely and proper drug use. Periodic skill development and training of obstetricians, along with integration of the medical team in the work environment may contribute to decrease fear, ensuring safety of drug prescription and thus possibly reducing adverse outcomes related to PE.
C1 [Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Osis, Maria Jose] Univ Estadual Campinas, Sch Med Sci, Postgrad Program Obstet & Gynecol, Campinas, SP, Brazil.
RP Parpinelli, MA (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM parpinelli@caism.unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Cecatti, Jose
   Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234
CR Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005
   Austin A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0493-4
   Bardin L., 1977, ANAL OF CONTENT, V70
   Bigdeli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059158
   Brasil. Brazilian Institute of Geography and Statistics, 2010 CENS
   Brazil. Ministry of Health. Department of Informatics. Health information, HLTH INF VIT STAT MO
   Bruyne P, 1982, DINAMICA PESQUISA CI
   Campinas. Municipal Department of Health (Campinas), STRUCT UN HLTH SYST
   Chaturvedi S, 2013, J HEALTH POPUL NUTR, V31, P86
   DULEY L, 1995, LANCET, V345, P1455
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Ekele B A, 2005, Afr J Reprod Health, V9, P128
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Global Health Observatory (GHO) data, GLOB HLTH OBS GHO DA
   Campos CJG, 2009, REV LAT-AM ENFERM, V17, P259, DOI 10.1590/S0104-11692009000200019
   Gordon R, 2014, J OBSTET GYNAECOL CA, V36, P154, DOI 10.1016/S1701-2163(15)30662-9
   Long Q, 2016, BJOG
   Lotufo FA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1055-0
   Merigue MA, 2003, ABORDAGENS TEORICOME, P1
   Minossi José Guilherme, 2013, Rev. Col. Bras. Cir., V40, P494, DOI 10.1590/S0100-69912013000600013
   Minossi José Guilherme, 2009, Rev. Col. Bras. Cir., V36, P90, DOI 10.1590/S0100-69912009000100016
   Municipal Department of Halth (Campinas), HLTH INF HLTH NUMB
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42
   Pratt JJ, 2016, ACTA OBSTET GYN SCAN, V95, P144, DOI 10.1111/aogs.12807
   PRITCHARD JA, 1955, SURG GYNECOL OBSTET, V100, P131
   Salinger DH, 2013, BJOG-INT J OBSTET GY, V120, P894, DOI 10.1111/1471-0528.12222
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Shamsuddin L, 2005, Bangladesh Med Res Counc Bull, V31, P75
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   TRAN DN, 2015, J GLOB HLTH, V5
   Turato E. R., 2011, TRATADO METODOLOGIA
   Turato ER, 2005, REV SAUDE PUBL, V39, P507, DOI 10.1590/S0034-89102005000300025
   WHO, PRIOR MED MOTN CHILD
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
   Zuspan F P, 1966, Clin Obstet Gynecol, V9, P954, DOI 10.1097/00003081-196612000-00010
NR 38
TC 3
Z9 3
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2017
VL 12
IS 3
AR e0172602
DI 10.1371/journal.pone.0172602
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9KE
UT WOS:000396318300017
PM 28301493
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Guida, JPS
   Pacagnella, RC
   Costa, ML
   Ferreira, EC
   Cecatti, JG
AF Guida, Jose P. S.
   Pacagnella, Rodolfo C.
   Costa, Maria L.
   Ferreira, Elton C.
   Cecatti, Jose G.
TI Evaluating vaginal-delivery rates after previous cesarean delivery using
   the Robson 10-group classification system at a tertiary center in Brazil
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
DE Cesarean delivery; Childbirth; Delivery classification; Labor
ID SECTION
C1 [Guida, Jose P. S.; Pacagnella, Rodolfo C.; Costa, Maria L.; Ferreira, Elton C.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Gynecol & Obstet, Campinas, SP, Brazil.
RP Guida, JPS (corresponding author), Univ Estadual Campinas, Campinas, SP, Brazil.
EM zepauloguida@gmail.com
RI Costa, Maria Laura/I-4980-2019; Cecatti, Jose Guilherme/M-5945-2013;
   Guida, Jose Paulo Siqueira/H-2391-2012; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019
OI Costa, Maria Laura/0000-0001-8280-3234; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Guida, Jose Paulo
   Siqueira/0000-0002-3648-6159; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009
CR Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526
   Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769
   Costa ML, 2009, ACTA OBSTET GYN SCAN, V88, P793, DOI 10.1080/00016340903002857
   Nakamura-Pereira M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0228-7
   Osis MJD, 2006, REV SAUDE PUBL, V40, P233, DOI 10.1590/S0034-89102006000200008
   Zhao YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155565
NR 6
TC 2
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAR
PY 2017
VL 136
IS 3
BP 354
EP 355
DI 10.1002/ijgo.12082
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FB3DA
UT WOS:000406021600020
PM 28099719
DA 2020-12-08
ER

PT J
AU Serruya, SJ
   de Mucio, B
   Martinez, G
   Mainero, L
   de Francisco, A
   Say, L
   Sousa, MH
   Souza, RT
   Costa, ML
   Mayrink, J
   Cecatti, JG
AF Serruya, Suzanne J.
   de Mucio, Bremen
   Martinez, Gerardo
   Mainero, Luis
   de Francisco, Andres
   Say, Lale
   Sousa, Maria H.
   Souza, Renato T.
   Costa, Maria L.
   Mayrink, Jussara
   Cecatti, Jose G.
TI Exploring the Concept of Degrees of Maternal Morbidity as a Tool for
   Surveillance of Maternal Health in Latin American and Caribbean Settings
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID ORGANIZATION MULTICOUNTRY SURVEY; MORTALITY; BIRTH; PREGNANCY; DELIVERY;
   OUTCOMES; MISSES
AB Objectives. To assess a birth registry to explore maternal mortality and morbidity and their association with other factors. Study Design. Exploratory multicentre cross-sectional analysis with over 700 thousand childbirths from twelve Latin American and Caribbean countries between 2009 and 2012. The WHO criteria for maternal morbidity were employed to split women, following a gradient of severity of conditions, into (1) maternal death (MD); (2) maternal near miss (MNM); (3) potentially life-threatening conditions (PLTC); (4) less severe maternal morbidity (LSMM); (5) any maternal morbidity; and (6) women with no maternal morbidity. Their prevalence and estimated risks of adverse maternal outcomes were assessed. Results. 712,081 childbirths had a prevalence of MD and MNM of 0.14% and 3.1%, respectively, while 38% of women had experienced morbidity. Previous maternal morbidity was associated with higher risk of adverse maternal outcomes and also the extremes of reproductive ages, nonwhite ethnicity, no stable partner, no prenatal care, smoking, drug and alcohol use, elective C-section, or induction of labour. Poorer perinatal outcomes were proportional to the severity of maternal outcomes. Conclusions. The findings corroborate WHO concept regarding continuum of maternal morbidity, reinforcing its importance in preventing adverse maternal outcomes and improving maternal healthcare in different settings.
C1 [Serruya, Suzanne J.; de Mucio, Bremen; Martinez, Gerardo; Mainero, Luis] PAHO, FGL, CLAP WR, Latin Amer Ctr Perinatol, Montevideo, Uruguay.
   [de Francisco, Andres] PAHO, FGL, Washington, DC USA.
   [Say, Lale] WHO, RHR, HRP, Geneva, Switzerland.
   [Sousa, Maria H.; Souza, Renato T.; Costa, Maria L.; Mayrink, Jussara; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; Cecatti, Jose Guilherme/M-5945-2013;
   Mayrink, Jussara/G-3495-2017
OI Souza, Renato Teixeira/0000-0002-9075-9269; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Mayrink, Jussara/0000-0001-5957-4365; De
   Mucio, Bremen/0000-0003-0662-9742
FU PAHO/CLAP [CL/CNT/1400059.001]
FX Currently, the analysis was possible under the PAHO/CLAP support
   (Service Agreement CL/CNT/1400059.001).
CR Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7
   Awasthi A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009885
   Bianchi AL, 2016, JOGNN-J OBST GYN NEO, V45, P601, DOI 10.1016/j.jogn.2016.02.013
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Chou D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0789-4
   CLAP-Latin American Center for Perinatology and PAHO, 2015, SIP SIST INF PER
   Dahlin S, 2016, BJOG-INT J OBSTET GY, V123, P1938, DOI 10.1111/1471-0528.14213
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   MacDorman MF, 2016, OBSTET GYNECOL, V128, P447, DOI 10.1097/AOG.0000000000001556
   Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X
   McCall SJ, 2017, BJOG-INT J OBSTET GY, V124, P1225, DOI 10.1111/1471-0528.14216
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Nair M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153370
   Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450
   PAHO/CLAP, 2016, CLAP NETW LAT AM CAR
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Say L, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0164-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shah MK, 2014, J PEDIATR ADOL GYNEC, V27, P14, DOI 10.1016/j.jpag.2013.08.002
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   World Health Organization, 2016, TRENDS MAT MORT 1990
   World Health Organization, 2011, WHO NEAR MISS APPR M
   Wright TE, 2016, AM J OBSTET GYNECOL, V215, P539, DOI 10.1016/j.ajog.2016.06.038
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 28
TC 5
Z9 5
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2017
VL 2017
AR 8271042
DI 10.1155/2017/8271042
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FK3ZQ
UT WOS:000413426200001
PM 29201915
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Baptista, LC
   Costa, ML
   Ferreira, R
   Albuquerque, DM
   Lanaro, C
   Fertrin, KY
   Surita, FG
   Parpinelli, MA
   Costa, FF
   de Melo, MB
AF Baptista, Leticia C.
   Costa, Maria Laura
   Ferreira, Regiane
   Albuquerque, Dulcineia M.
   Lanaro, Carolina
   Fertrin, Kleber Y.
   Surita, Fernanda G.
   Parpinelli, Mary A.
   Costa, Fernando F.
   de Melo, Monica Barbosa
TI Abnormal expression of inflammatory genes in placentas of women with
   sickle cell anemia and sickle hemoglobin C disease
SO ANNALS OF HEMATOLOGY
LA English
DT Article
DE Sickle cell disease; Placenta; Pregnancy; Inflammation; Gene expression
ID REAL-TIME PCR; PREGNANCY; BIOMARKERS; MANAGEMENT; BCL-6
AB Sickle cell disease (SCD) is a complex disease that is characterized by the polymerization of deoxyhemoglobin S, altered red blood cell membrane biology, endothelial activation, hemolysis, a procoagulant state, acute and chronic inflammation, and vaso-occlusion. Among the physiological changes that occur during pregnancy, oxygen is consumed by fetal growth, and pregnant women with SCD are more frequently exposed to low oxygen levels. This might lead to red blood cells sickling, and, consequently, to vaso-occlusion. The mechanisms by which SCD affects placental physiology are largely unknown, and chronic inflammation might be involved in this process. This study aimed to evaluate the gene expression profile of inflammatory response mediators in the placentas of pregnant women with sickle cell cell anemia (HbSS) and hemoglobinopathy SC (HbSC). Our results show differences in a number of these genes. For the HbSS group, when compared to the control group, the following genes showed differential expression: IL1RAP (2.76-fold), BCL6 (4.49-fold), CXCL10 (-2.12-fold), CXCR1 (-3.66-fold), and C3 (-2.0-fold). On the other hand, the HbSC group presented differential expressions of the following genes, when compared to the control group: IL1RAP (4.33-fold), CXCL1 (3.05-fold), BCL6 (4.13-fold), CXCL10 (-3.32-fold), C3 (-2.0-fold), and TLR3 (2.38-fold). Taken together, these data strongly suggest a differential expression of several inflammatory genes in both SCD (HbSS and HbSC), indicating that the placenta might become an environment with hypoxia, and increased inflammation, which could lead to improper placental development.
C1 [Baptista, Leticia C.; de Melo, Monica Barbosa] Univ Estadual Campinas, CBMEG, Campinas, SP, Brazil.
   [Costa, Maria Laura; Surita, Fernanda G.; Parpinelli, Mary A.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sch Med, Campinas, SP, Brazil.
   [Ferreira, Regiane; Albuquerque, Dulcineia M.; Lanaro, Carolina; Fertrin, Kleber Y.; Costa, Fernando F.] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.
   [de Melo, Monica Barbosa] Univ Estadual Campinas, CBMEG, Lab Human Genet, POB 6010, BR-13083875 Campinas, SP, Brazil.
RP de Melo, MB (corresponding author), Univ Estadual Campinas, CBMEG, Campinas, SP, Brazil.; de Melo, MB (corresponding author), Univ Estadual Campinas, CBMEG, Lab Human Genet, POB 6010, BR-13083875 Campinas, SP, Brazil.
EM melomb@uol.com.br
RI Surita, Fernanda Garanhani/H-9575-2012; Fertrin, Kleber/M-4175-2013;
   Costa, Fernando/D-1566-2012; Costa, Maria Laura/I-4980-2019; de
   Albuquerque, Dulcineia Martins/U-8601-2019
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Fertrin,
   Kleber/0000-0003-2637-3297; Costa, Fernando/0000-0002-4632-572X; Costa,
   Maria Laura/0000-0001-8280-3234; 
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2008/57441-0, 2014/00984-3, 2014/
   01925-0]; Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by Sao Paulo Research Foundation (FAPESP) grant
   2008/57441-0, grant 2014/00984-3 and grant 2014/ 01925-0 to MLC and by
   the Coordination for the Improvement of Higher Education Personnel
   (CAPES) and the National Council for Scientific and Technological
   Development (CNPq).
CR Andemariam B, 2013, CLIN LAB MED, V33, P293, DOI 10.1016/j.cll.2013.03.023
   Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010
   Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x
   Benites BD, 2016, TRANSFUSION, V56, P119, DOI 10.1111/trf.13280
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   de Montalembert M, 2015, BLOOD, V125, P3216, DOI 10.1182/blood-2015-04-638288
   Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589
   GONCALVES MS, 1994, HUM HERED, V44, P322, DOI 10.1159/000154238
   Goodman SR, 2016, EXP BIOL MED, V241, P772, DOI 10.1177/1535370216640150
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hassell K, 2005, HEMATOL ONCOL CLIN N, V19, P903, DOI 10.1016/j.hoc.2005.07.003
   Hoppe CC, 2014, HEMATOL ONCOL CLIN N, V28, P265, DOI 10.1016/j.hoc.2013.11.006
   Howard J, 2012, BEST PRACT RES CL OB, V26, P25, DOI 10.1016/j.bpobgyn.2011.10.001
   Kadyrov M, 1998, LANCET, V352, P1747, DOI 10.1016/S0140-6736(98)02069-8
   Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445
   Louwen F, 2014, HUM PATHOL, V45, P1234, DOI 10.1016/j.humpath.2014.02.002
   Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126
   Naik RP, 2012, HEMATOL-AM SOC HEMAT, P208, DOI 10.1182/asheducation-2012.1.208
   Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x
   Orsi Nicolas Michel, 2008, Hum Fertil (Camb), V11, P222, DOI 10.1080/14647270802206879
   Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317
   Pantanowitz L, 2000, ARCH PATHOL LAB MED, V124, P1565
   POWARS DR, 1986, OBSTET GYNECOL, V67, P217, DOI 10.1097/00006250-198602000-00012
   Qari MH, 2012, CLIN APPL THROMB-HEM, V18, P195, DOI 10.1177/1076029611420992
   Rogers DT, 2010, OBSTET GYN CLIN N AM, V37, P223, DOI 10.1016/j.ogc.2010.02.015
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silva-Pinto Ana Cristina, 2014, Rev. Bras. Hematol. Hemoter., V36, P329, DOI 10.1016/j.bjhh.2014.07.002
   Tjoa ML, 2004, HYPERTENS PREGNANCY, V23, P171, DOI 10.1081/PRG-120028292
   Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003
   Yu CKH, 2009, J OBSTET GYNAECOL, V29, P512, DOI 10.1080/01443610903003175
NR 30
TC 5
Z9 5
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0939-5555
EI 1432-0584
J9 ANN HEMATOL
JI Ann. Hematol.
PD NOV
PY 2016
VL 95
IS 11
BP 1859
EP 1867
DI 10.1007/s00277-016-2780-1
PG 9
WC Hematology
SC Hematology
GA EB4PD
UT WOS:000387353500014
PM 27546026
DA 2020-12-08
ER

PT J
AU Lotufo, FA
   Parpinelli, MA
   Osis, MJ
   Surita, FG
   Costa, ML
   Cecatti, JG
AF Lotufo, Fatima Aparecida
   Parpinelli, Mary Angela
   Osis, Maria Jose
   Surita, Fernanda Garanhani
   Costa, Maria Laura
   Cecatti, Jose Guilherme
TI Situational analysis of facilitators and barriers to availability and
   utilization of magnesium sulfate for eclampsia and severe preeclampsia
   in the public health system in Brazil
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Magnesium sulfate; Eclampsia; Severe preeclampsia; Quality of care;
   Cause-effect diagram
ID OUTCOMES; WOMEN; CARE; MANAGEMENT; MORBIDITY; TRIAL
AB Background: Eclampsia is the main cause of maternal death in Brazil. Magnesium sulfate is the drug of choice for seizure prevention and control in the management of severe preeclampsia and eclampsia. Despite scientific evidence demonstrating its effectiveness and safety, there have been delays in managing hypertensive disorders, including timely access to magnesium sulfate. To conduct a general situational analysis on availability and use of magnesium sulfate for severe preeclampsia and eclampsia in the public health system.
   Method: A situational analysis was conducted with two components: a documental analysis on information available at the official websites on the policy, regulation and availability of the medication, plus a cross sectional study with field analysis and interviews with local managers of public obstetric health services in Campinas, in the southeast of Brazil. We used the fishbone cause and effect diagram to organize study components. Interviews with managers were held during field observations using specific questionnaires.
   Results: There was no access to magnesium sulfate in primary care facilities, obstetric care was excluded from urgency services and clinical protocols for professional guidance on the adequate use of magnesium sulfate were lacking in the emergency mobile care service. Magnesium sulfate is currently only administered in referral maternity hospitals.
   Conclusion: The lack of processes that promote the integration between urgency/emergency care and specialized obstetric care possibly favors the untimely use of magnesium sulfate and contributes to the high maternal morbidity/mortality rates.
C1 [Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Osis, Maria Jose] Univ Estadual Campinas, Sch Med, Postgrad Program Obstet & Gynecol, Campinas, SP, Brazil.
RP Parpinelli, MA (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM parpinelli@caism.unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Surita, Fernanda
   Garanhani/H-9575-2012; Costa, Maria Laura/I-4980-2019
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Costa, Maria Laura/0000-0001-8280-3234
CR Abdi Z, 2017, INT J HEALTH PLAN M, V32, P147, DOI 10.1002/hpm.2335
   Bain ES, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-195
   Bigdeli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059158
   Brazilian Institute of Geography and Statistics, 2010 CENS
   Campinas. Municipal Department of Health (Campinas), STRUCT UN HLTH SYST
   Cavalcanti Pauline Cristine da Silva, 2013, Physis, V23, P1297, DOI 10.1590/S0103-73312013000400014
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593
   DULEY L, 1995, LANCET, V345, P1455
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Echoka Elizabeth, 2014, Pan Afr Med J, V17 Suppl 1, P4, DOI 10.11694/pamj.supp.2014.17.1.3042
   Elsa Rodriguez-Angulo, 2014, Ginecol Obstet Mex, V82, P647
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Giovanella L, 2006, CAD SAUDE PUBLICA, V22, P951
   Gondim R, 2011, QUALIFICATION SUS MA, P47
   Gordon R, 2014, J OBSTET GYNAECOL CA, V36, P154, DOI 10.1016/S1701-2163(15)30662-9
   Ishikawa K., 1976, GUIDE QUALITY CONTRO
   Ministry of Health, 2014, BAS LIF SUPP ADV LIF
   Ministry of Health. Department of Health, 2000, MAT URG EM GUID DIAG
   Ministry of Health. Department of Health Care. Department of Strategic Programmatic Actions, HIGH RISK PREGN TECH
   Ministry of Health. Department of Informatics. Health information, VIT STAT MORT LIV BI
   Ministry of Health. Department of Pharmaceutical Care, 2014, NAT DRUG LIST RENAME
   Ministry of Health. National Sanitary Surveillance Agency, MAGN SULF 10 50
   Mkoka DA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0076-5
   Municipal Department of Health (Campinas), 2007, EMCS MAN MED ROUT MH
   Municipal Department of Health (Campinas), 2016, MUN DRUG LIST REMUME
   Municipal Department of Health (Campinas), HLTH INF HLTH NUMB
   Municipal Department of Health (Campinas). Virtual Library, PROT MAN BOOKL URG E
   Oguntunde O, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0554-8
   Okusanya BO, 2016, BJOG-INT J OBSTET GY, V123, P356, DOI 10.1111/1471-0528.13753
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340
   Shamsuddin L, 2005, Bangladesh Med Res Counc Bull, V31, P75
   SIBAI BM, 1986, AM J OBSTET GYNECOL, V154, P581, DOI 10.1016/0002-9378(86)90605-8
   Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-34
   State Department of Health (Sao Paulo). Coordination of Health Planning. Technical Assistance for Women's Health, 2010, ATT PREGN POSTP WOM
   Tran DN, 2015, J GLOB HEALTH, V5, P100, DOI 10.7189/jogh.05.010406
   UN Women (United Nations Women), 2012, SIT AN
   van Dijk MG, 2013, INT J GYNECOL OBSTET, V121, P110, DOI 10.1016/j.ijgo.2012.11.015
   WHO Guidelines Approved by the Guidelines Review Committee, 2011, WHO REC PREV TREATM
   World Health Organization, GLOB HLTH OBS DAT MA
NR 43
TC 7
Z9 7
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 30
PY 2016
VL 16
AR 254
DI 10.1186/s12884-016-1055-0
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DU5OI
UT WOS:000382260700002
PM 27577571
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Cecatti, JG
   Souza, RT
   Sulek, K
   Costa, ML
   Kenny, LC
   McCowan, LM
   Pacagnella, RC
   Villas-Boas, SG
   Mayrink, J
   Passini, R
   Franchini, KG
   Baker, PN
AF Cecatti, Jose G.
   Souza, Renato T.
   Sulek, Karolina
   Costa, Maria L.
   Kenny, Louise C.
   McCowan, Lesley M.
   Pacagnella, Rodolfo C.
   Villas-Boas, Silas G.
   Mayrink, Jussara
   Passini, Renato, Jr.
   Franchini, Kleber G.
   Baker, Philip N.
CA Preterm SAMBA SCOPE Study Grp
TI Use of metabolomics for the identification and validation of clinical
   biomarkers for preterm birth: Preterm SAMBA
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Spontaneous preterm birth; Metabolomics; Prediction; Biological
   biomarker; Mass spectrometry
ID EARLY-PREGNANCY PREDICTION; ASYMPTOMATIC WOMEN; NULLIPAROUS WOMEN;
   INCREASED RISK; GLOBAL LEVELS; PREECLAMPSIA; MORTALITY; INFANTS; WEIGHT;
   MARKER
AB Background: Spontaneous preterm birth is a complex syndrome with multiple pathways interactions determining its occurrence, including genetic, immunological, physiologic, biochemical and environmental factors. Despite great worldwide efforts in preterm birth prevention, there are no recent effective therapeutic strategies able to decrease spontaneous preterm birth rates or their consequent neonatal morbidity/mortality. The Preterm SAMBA study will associate metabolomics technologies to identify clinical and metabolite predictors for preterm birth. These innovative and unbiased techniques might be a strategic key to advance spontaneous preterm birth prediction.
   Methods/design: Preterm SAMBA study consists of a discovery phase to identify biophysical and untargeted metabolomics from blood and hair samples associated with preterm birth, plus a validation phase to evaluate the performance of the predictive modelling. The first phase, a case-control study, will randomly select 100 women who had a spontaneous preterm birth (before 37 weeks) and 100 women who had term birth in the Cork Ireland and Auckland New Zealand cohorts within the SCOPE study, an international consortium aimed to identify potential metabolomic predictors using biophysical data and blood samples collected at 20 weeks of gestation. The validation phase will recruit 1150 Brazilian pregnant women from five participant centres and will collect blood and hair samples at 20 weeks of gestation to evaluate the performance of the algorithm model (sensitivity, specificity, predictive values and likelihood ratios) in predicting spontaneous preterm birth (before 34 weeks, with a secondary analysis of delivery before 37 weeks).
   Discussion: The Preterm SAMBA study intends to step forward on preterm birth prediction using metabolomics techniques, and accurate protocols for sample collection among multi-ethnic populations. The use of metabolomics in medical science research is innovative and promises to provide solutions for disorders with multiple complex underlying determinants such as spontaneous preterm birth.
C1 [Cecatti, Jose G.; Souza, Renato T.; Costa, Maria L.; Pacagnella, Rodolfo C.; Mayrink, Jussara; Passini, Renato, Jr.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sch Med Sci, UNICAMP, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
   [Sulek, Karolina; Baker, Philip N.] Univ Auckland, Liggins Inst, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand.
   [Kenny, Louise C.] Univ Coll Cork, Dept Obstet & Gynaecol, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland.
   [McCowan, Lesley M.] Univ Auckland, South Auckland Clin Sch, Fac Med & Hlth Sci, Auckland, New Zealand.
   [Villas-Boas, Silas G.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand.
   [Franchini, Kleber G.] Univ Estadual Campinas, UNICAMP, LNBio Brazilian Biosci Natl Lab, Campinas, SP, Brazil.
   [Franchini, Kleber G.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Sch Med Sci, UNICAMP, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Villas-Boas, Silas/AAR-6748-2020; Kenny,
   Louise/X-6329-2019; Villas-Boas, Silas/AAS-5888-2020; Souza, Renato
   Teixeira/G-4205-2017; Cecatti, Jose Guilherme/M-5945-2013; Passini
   Junior, Renato/O-6169-2016; Kenny, Louise C/G-1112-2011; de Carvalho
   Pacagnella, Rodolfo/H-9390-2019; Pacagnella, Rodolfo/H-6247-2012;
   Calderon, Iracema/C-8136-2012
OI Costa, Maria Laura/0000-0001-8280-3234; Kenny,
   Louise/0000-0002-9011-759X; Villas-Boas, Silas/0000-0003-0148-5882;
   Souza, Renato Teixeira/0000-0002-9075-9269; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Passini Junior,
   Renato/0000-0001-8247-4549; Kenny, Louise C/0000-0002-9011-759X; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Pacagnella,
   Rodolfo/0000-0002-5739-0009; Roberts, Claire/0000-0002-9250-2192;
   McCowan, Lesley/0000-0001-9915-7873; Calderon,
   Iracema/0000-0003-4761-4336; Myers, Jenny/0000-0003-0913-2096
FU Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
   [401636/2013-5]; Science Foundation Ireland Program Grant for
   INFANTScience Foundation Ireland [12/RC/2272]; New Enterprise Research
   Fund, Foundation for Research Science and Technology; Health Research
   Council [04/198]; Evelyn Bond Fund, Auckland District Health Board
   Charitable Trust; Health Research Board of Ireland [CSA/2007/2;];
   research call "Grand Challenges Brazil: Reducing the burden of preterm
   birth" [05/2013]
FX This was one of the two big studies selected for sponsoring from the
   research call "Grand Challenges Brazil: Reducing the burden of preterm
   birth" number 05/2013 jointly issued by the Brazilian National Research
   Council (CNPq) and the Bill and Melinda Gates Foundation (Award
   401636/2013-5). The funders played no role at all in the study design,
   writing the manuscript nor in the decision to submit the manuscript for
   publication. LC Kenny is supported by a Science Foundation Ireland
   Program Grant for INFANT (12/RC/2272). The SCOPE database is provided
   and maintained by MedSciNet AB (http://medscinet.com). The New Zealand
   SCOPE study was funded by the New Enterprise Research Fund, Foundation
   for Research Science and Technology; Health Research Council (04/198);
   Evelyn Bond Fund, Auckland District Health Board Charitable Trust. The
   Irish SCOPE study was funded by the Health Research Board of Ireland
   (CSA/2007/2; http://www.hrb.ie).
CR Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754
   American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005
   Barros FC, 2015, JAMA PEDIATR, V169, P220, DOI 10.1001/jamapediatrics.2014.3040
   Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554
   Betsou F, 2010, CANCER EPIDEM BIOMAR, V19, P1004, DOI 10.1158/1055-9965.EPI-09-1268
   Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Bond L, 2015, 2 ANN EUR C CLIN MAS
   Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165
   COPPER RL, 1993, AM J OBSTET GYNECOL, V168, P78, DOI 10.1016/S0002-9378(12)90889-3
   Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659
   Crane JMG, 2008, ULTRASOUND OBST GYN, V31, P579, DOI 10.1002/uog.5323
   da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41
   Dessi A, 2015, BEST PRACT RES CL OB, V29, P156, DOI 10.1016/j.bpobgyn.2014.04.023
   Dharuri H, 2014, BBA-MOL BASIS DIS, V1842, P1923, DOI 10.1016/j.bbadis.2014.05.030
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Fanos V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/720514
   Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015
   Goldenberg RL, 2001, AM J OBSTET GYNECOL, V185, P643, DOI 10.1067/mob.2001.116752
   Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0
   Hankins G, 2010, AMERICAN JOURNAL OF, V203, pe1
   He XL, 2016, ACTA DIABETOL, V53, P119, DOI 10.1007/s00592-015-0737-9
   Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430
   Horgan RP, 2009, BJOG-INT J OBSTET GY, V116, P173, DOI 10.1111/j.1471-0528.2008.01997.x
   Huynh J, 2014, DIABETOLOGIA, V57, P2453, DOI 10.1007/s00125-014-3371-0
   Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385
   Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578
   Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x
   Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140
   Newnham JP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00584
   North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x
   Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007
   Requejo JH, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-42
   Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x
   Romero R, 2013, BJOG-INT J OBSTET GY, V120, P1, DOI 10.1111/1471-0528.12019
   Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003
   Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sulek K, 2014, THERANOSTICS, V4, P953, DOI 10.7150/thno.9265
   Torbe A, 2004, INT J GYNECOL OBSTET, V87, P125, DOI 10.1016/j.ijgo.2004.07.021
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001
   Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407
NR 47
TC 17
Z9 17
U1 1
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 8
PY 2016
VL 16
AR 212
DI 10.1186/s12884-016-1006-9
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DT4UG
UT WOS:000381476000002
PM 27503110
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Chen, BS
   Longtine, MS
   Costa, ML
   Nelson, DM
AF Chen, Baosheng
   Longtine, Mark S.
   Costa, Maria Laura
   Nelson, D. Michael
TI Punicalagin promotes human villous trophoblast differentiation
SO PLACENTA
LA English
DT Article
DE Placenta; Polyphenol; Differentiation; Pomegranate
ID HUMAN PLACENTA; POMEGRANATE JUICE; APOPTOSIS; SYNCYTIOTROPHOBLASTS;
   EXPRESSION; SYNCYTIN; CURCUMIN; STRESS
AB Poor differentiation of trophoblasts is associated with placental dysfunction, predisposing women to multiple pregnancy disorders. Punicalagin, a prominent ellagitannin in pomegranate juice has been shown to exert anti-apoptosis and anti-oxidative effects in human trophoblasts. We hypothesized that punicalagin modulates trophoblast differentiation. We found that punicalagin-treated primary trophoblast showed reduced E-cadherin, higher Syncytin 1, more beta-hCG, and increased GCM1, an upstream regulator of beta-hCG. Punicalagin exposure of villous explants enhanced the number of cytotrophoblasts expressing the proliferation marker Ki67. We conclude that punicalagin enhances trophoblast differentiation and speculate that punicalagin might be used therapeutically in pregnancies at risk for placental dysfunction. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chen, Baosheng; Longtine, Mark S.; Costa, Maria Laura; Nelson, D. Michael] Washington Univ, Sch Med, Dept Obstet & Gynecol, 4566 Scott Ave, St Louis, MO 63110 USA.
   [Costa, Maria Laura] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Chen, BS (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 4566 Scott Ave, St Louis, MO 63110 USA.
EM chenb@wudosis.wustl.edu
RI Costa, Maria Laura/I-4980-2019
OI Costa, Maria Laura/0000-0001-8280-3234; Longtine,
   Mark/0000-0002-3315-1732
FU BJH Foundation; Department of Obstetrics and Gynecology at Washington
   University School of Medicine, St Louis, MO; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)-Science Without Borders
   [200356/2014-3]; Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/01925-0]
FX This work was supported by the BJH Foundation, the Department of
   Obstetrics and Gynecology at Washington University School of Medicine,
   St Louis, MO, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)-Science Without Borders (200356/2014-3 to MLC), and
   by Sao Paulo Research Foundation - (FAPESP - 2014/01925-0 to MLC). We
   thank Dr. Deborah J. Frank for critical reading of the manuscript.
CR Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1
   Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009
   Chen BS, 2013, AM J PHYSIOL-ENDOC M, V305, pE1274, DOI 10.1152/ajpendo.00218.2013
   Chen BS, 2012, AM J PHYSIOL-ENDOC M, V302, pE1142, DOI 10.1152/ajpendo.00003.2012
   COUTIFARIS C, 1991, DEVELOPMENT, V113, P767
   Cudmore MJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.11.010
   Holder BS, 2012, PLACENTA, V33, P460, DOI 10.1016/j.placenta.2012.02.012
   Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008
   Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015
   Lu XY, 2016, PLACENTA, V39, P45, DOI 10.1016/j.placenta.2016.01.008
   Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002
   Patzko A, 2012, BRAIN, V135, P3551, DOI 10.1093/brain/aws299
   Scifres CM, 2011, J CLIN ENDOCR METAB, V96, pE1083, DOI 10.1210/jc.2010-2084
   Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116
   Solano ME, 2016, PLACENTA, V39, P7, DOI 10.1016/j.placenta.2015.12.017
   Wang QA, 2003, NEUROSCI LETT, V351, P83, DOI 10.1016/j.neulet.2003.07.002
   Wang Y, 2016, REPRODUCTION, V151, P97, DOI 10.1530/REP-15-0287
   Zhong JX, 2015, BIOCHEM BIOPH RES CO, V467, P179, DOI 10.1016/j.bbrc.2015.10.024
NR 18
TC 2
Z9 3
U1 0
U2 14
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2016
VL 44
BP 80
EP 82
DI 10.1016/j.placenta.2016.06.007
PG 3
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DT7EW
UT WOS:000381650900011
PM 27452441
DA 2020-12-08
ER

PT J
AU Silveira, C
   Parpinelli, MA
   Pacagnella, RC
   Andreucci, CB
   Ferreira, EC
   Angelini, CR
   Bussadori, JC
   Santos, JP
   Zanardi, DM
   Cecchino, GN
   Souza, RT
   Costa, ML
   Camargo, RS
   Cecatti, JG
AF Silveira, Carla
   Parpinelli, Mary A.
   Pacagnella, Rodolfo C.
   Andreucci, Carla B.
   Ferreira, Elton C.
   Angelini, Carina R.
   Bussadori, Jamile C.
   Santos, Juliana P.
   Zanardi, Dulce M.
   Cecchino, Gustavo N.
   Souza, Renato T.
   Costa, Maria L.
   Camargo, Rodrigo S.
   Cecatti, Jose G.
TI A cohort study of functioning and disability among women after severe
   maternal morbidity
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Daily activities; Disability; Functioning; Postpartum period; Severe
   maternal morbidity
ID MISS OBSTETRIC COMPLICATIONS; ASSESSMENT SCHEDULE; BURKINA-FASO; HEALTH;
   POSTPARTUM; CONSEQUENCES; MORTALITY; STRESS; LIVES; CARE
AB Objective: To assess functioning and disability related to severe maternal morbidity (SMM) via the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0). Methods: In a retrospective cohort study, women with or without a history of SMM who delivered at a tertiary public hospital in Brazil between July 2008 and June 2012, completed the WHODAS 2.0 questionnaire by individual interview between August 2012 and November 2013. General WHODAS scores were evaluated by maternal and neonatal characteristics, and specific domain scores according to SMM event. Results: Overall, 638 women were enrolled (315 with SMM and 323 without SMM). The mean general WHODAS score was higher among women with SMM (19.04 +/- 16.18) than among women without SMM (15.77 +/- 14.46; P = 0.015). Domain scores were also higher in the SMM group for mobility (16.00 +/- 20.22 vs 11.63 +/- 17.51; P = 0.003), household activities (26.79 +/- 30.16 vs 20.09 +/- 26.08; P = 0.005), participation (23.55 +/- 21.72 vs 17.27 +/- 19.17; P < 0.001), and work/school activities for women currently studying or working (20.52 +/- 26.64 vs 11.66 +/- 19.67; P = 0.001). Excluding SMM, a parity of two or more was the only factor significantly associated with higher scores overall (P = 0.013) and for domain 4 (getting along with people; P = 0.017). Conclusion: By comparison with women without childbirth complications, SMM impaired self-reported functioning among women 1-5 years after delivery. (C) 2016 Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics.
C1 [Silveira, Carla; Parpinelli, Mary A.; Pacagnella, Rodolfo C.; Andreucci, Carla B.; Ferreira, Elton C.; Angelini, Carina R.; Santos, Juliana P.; Zanardi, Dulce M.; Cecchino, Gustavo N.; Souza, Renato T.; Costa, Maria L.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, UNICAMP, Campinas, SP, Brazil.
   [Andreucci, Carla B.; Bussadori, Jamile C.] Fed Univ Sao Carlos UFSCAR, Sch Med, Sao Carlos, SP, Brazil.
   [Camargo, Rodrigo S.] Med Sch Jundiai, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
RP Parpinelli, MA (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM parpinelli@caism.unicamp.br
RI Pacagnella, Rodolfo/H-6247-2012; Bussadori, Jamile/ABG-2450-2020;
   Cecatti, Jose Guilherme/M-5945-2013; Souza, Renato Teixeira/G-4205-2017;
   de Carvalho Pacagnella, Rodolfo/H-9390-2019; Costa, Maria
   Laura/I-4980-2019; Andreucci, Carla B/J-4845-2015; Polido, Carla Betina
   Andreucci/Y-9743-2019; Cecchino, Gustavo/M-2220-2019
OI Pacagnella, Rodolfo/0000-0002-5739-0009; Bussadori,
   Jamile/0000-0002-3048-5593; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Souza, Renato Teixeira/0000-0002-9075-9269; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Costa, Maria Laura/0000-0001-8280-3234;
   Andreucci, Carla B/0000-0002-5590-108X; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Cecchino, Gustavo/0000-0003-1226-3353;
   ANGELINI, CARINA R/0000-0002-6351-0628
FU Brazilian CNPq agencyNational Council for Scientific and Technological
   Development (CNPq) [471142/2011-5]
FX The study was sponsored by the Brazilian CNPq agency (grant
   471142/2011-5).
CR [Anonymous], 2010, MEASURING HLTH DISAB
   Cecatti JC, 2009, REPROD HLTH, V6, P1
   Chisolm Theresa H, 2005, Trends Amplif, V9, P111, DOI 10.1177/108471380500900303
   Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8
   Furuta M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-133
   Galea LAM, 2014, J NEUROENDOCRINOL, V26, P641, DOI 10.1111/jne.12177
   Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51
   Hinton L, 2014, BJOG-INT J OBSTET GY, V121, P20, DOI 10.1111/1471-0528.12800
   Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P270, DOI 10.1002/art.23343
   Iyengar K, 2012, J HEALTH POPUL NUTR, V30, P226
   Lindquist A, 2015, BJOG-INT J OBSTET GY, V122, P1601, DOI 10.1111/1471-0528.13058
   Lydon-Rochelle MT, 2001, PAEDIATR PERINAT EP, V15, P232, DOI 10.1046/j.1365-3016.2001.00345.x
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Seng JS, 2001, OBSTET GYNECOL, V97, P17, DOI 10.1016/S0029-7844(00)01097-8
   Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005
   Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011
   Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   Waterstone M, 2003, BJOG-INT J OBSTET GY, V110, P128, DOI 10.1016/S1470-0328(02)02951-8
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   World Health Organization, 2001, ICF INT CLASFUNCT
   World Health Organization, 2014, WORLD HLTH STAT 20 1
NR 25
TC 13
Z9 13
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUL
PY 2016
VL 134
IS 1
BP 87
EP 92
DI 10.1016/j.ijgo.2015.10.027
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DQ9VU
UT WOS:000379558200021
PM 27105968
DA 2020-12-08
ER

PT J
AU Pfitscher, LC
   Cecatti, JG
   Pacagnella, RC
   Haddad, SM
   Parpinelli, MA
   Souza, JP
   Quintana, SM
   Surita, FG
   Sousa, MH
   Costa, ML
AF Pfitscher, L. C.
   Cecatti, J. G.
   Pacagnella, R. C.
   Haddad, S. M.
   Parpinelli, M. A.
   Souza, J. P.
   Quintana, S. M.
   Surita, F. G.
   Sousa, M. H.
   Costa, M. L.
CA Brazilian Network Surveillance Sev
TI Severe maternal morbidity due to respiratory disease and impact of 2009
   H1N1 influenza A pandemic in Brazil: results from a national multicenter
   cross-sectional study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Maternal morbidity; Maternal mortality; Maternal near miss; H1N1;
   Respiratory disease
ID PULMONARY-EDEMA; RISK-FACTORS; VIRUS; INFECTION; ILLNESS; SURVEILLANCE;
   VACCINATION; PREGNANCY; OUTCOMES; NETWORK
AB Background: The aim of this study was to assess the burden of respiratory disease, considering the influenza A pandemic season (H1N1pdm09), within the Brazilian Network for Surveillance of Severe Maternal Morbidity, and factors associated with worse maternal outcome.
   Methods: A multicenter cross-sectional study, involving 27 referral maternity hospitals in five Brazilian regions. Cases were identified in a prospective surveillance by using the WHO standardized criteria for potentially life-threatening conditions (PLTC) and maternal near miss (MNM). Women with severe complications from respiratory disease identified as suspected or confirmed cases of H1N1 influenza or respiratory failure were compared to those with other causes of severe morbidity. A review of suspected H1N1 influenza cases classified women as non-tested, tested positive and tested negative, comparing their outcomes. Factors associated with severe maternal outcome (SMO = MNM + MD) were assessed in both groups, in comparison to PLTC, using PR and 95 % CI adjusted for design effect of cluster sampling.
   Results: Among 9555 cases of severe maternal morbidity, 485 (5 %) had respiratory disease. Respiratory disease occurred in one-quarter of MNM cases and two-thirds of MD. H1N1 virus was suspected in 206 cases with respiratory illness. Around 60 % of these women were tested, yielding 49 confirmed cases. Confirmed H1N1 influenza cases had worse adverse outcomes (MNM:MD ratio < 1 (0.9:1), compared to 12:1 in cases due to other causes), and a mortality index > 50 %, in comparison to 7.4 % in other causes of severe maternal morbidity. Delay in medical care was associated with SMO in all cases considered, with a two-fold increased risk among respiratory disease patients. Perinatal outcome was worse in cases complicated by respiratory disease, with increased prematurity, stillbirth, low birth weight and Apgar score < 7.
   Conclusions: Respiratory disease, especially considering the influenza season, is a very severe cause of maternal near miss and death. Increased awareness about this condition, preventive vaccination during pregnancy, early diagnosis and treatment are required to improve maternal health.
C1 [Pfitscher, L. C.; Cecatti, J. G.; Pacagnella, R. C.; Haddad, S. M.; Parpinelli, M. A.; Souza, J. P.; Surita, F. G.; Sousa, M. H.; Costa, M. L.] Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
   [Souza, J. P.; Quintana, S. M.] Univ Sao Paulo, Sch Med Ribeirao Preto USPRP, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM mlaura@unicamp.br
RI Souza, Joao Paulo/G-1982-2010; CORDIOLI, EDUARDO/AAR-6100-2020;
   Nakamura-Pereira, Marcos/X-1107-2019; Surita, Fernanda
   Garanhani/H-9575-2012; Amorim, Melania M/C-5807-2013; Costa, Maria
   Laura/I-4980-2019; Cecatti, Jose Guilherme/M-5945-2013; Moises,
   Elaine/A-5708-2015; Rudge, Marilza V C/C-8338-2012; Moises, Elaine
   Christine Dantas/N-9522-2019; Pacagnella, Rodolfo/H-6247-2012; de
   Carvalho Pacagnella, Rodolfo/H-9390-2019; Peracoli, Jose
   Carlos/G-4923-2012; Calderon, Iracema/C-8136-2012
OI Souza, Joao Paulo/0000-0002-2288-4244; CORDIOLI,
   EDUARDO/0000-0001-5405-9380; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Amorim, Melania M/0000-0003-1047-2514;
   Costa, Maria Laura/0000-0001-8280-3234; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Moises, Elaine/0000-0001-9099-4544;
   Rudge, Marilza V C/0000-0002-9227-832X; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Pacagnella, Rodolfo/0000-0002-5739-0009; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Peracoli, Jose
   Carlos/0000-0002-3273-3001; Calderon, Iracema/0000-0003-4761-4336;
   Santana, Danielly/0000-0001-8912-2626
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), grant number 402702/2008-5. The authors are solely responsible
   for the content, which does not necessarily represent the official views
   of CNPq, nor influence manuscript content.
CR Al-Tawfiq JA, 2014, LANCET INFECT DIS, V3099, P1
   [Anonymous], 2014, TARG STRAT END PREV
   Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449
   Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016
   da Silva AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088624
   Doyle TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079040
   Duarte AG, 2014, CLIN OBSTET GYNECOL, V57, P862, DOI 10.1097/GRF.0000000000000067
   Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X
   Gandhi S, 2014, J OBSTET GYNAECOL CA, V36, P1065, DOI 10.1016/S1701-2163(15)30383-2
   Guntupalli KK, 2015, CHEST, V148, P1333, DOI 10.1378/chest.14-2365
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Hon KLE, 2003, LANCET, V361, P1984, DOI 10.1016/S0140-6736(03)13556-8
   Megarbane B, 2013, CHEM-BIOL INTERACT, V206, P444, DOI 10.1016/j.cbi.2013.10.011
   Mehta N, 2015, BEST PRACT RES CL OB, V29, P598, DOI 10.1016/j.bpobgyn.2015.04.005
   Mendoza-Sassi RA, 2015, CAD SAUDE PUBLICA, V31, P1247, DOI 10.1590/0102-311X00084514
   Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210
   O'Sullivan G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b784
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Rasmussen SA, 2014, NEW ENGL J MED, V371, P1373, DOI 10.1056/NEJMp1403496
   Rasmussen SA, 2012, CLIN OBSTET GYNECOL, V55, P487, DOI 10.1097/GRF.0b013e31824df23e
   Ribeiro AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118772
   Rojas-Suarez J, 2014, J PERINAT MED, V42, P19, DOI 10.1515/jpm-2013-0140
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3
   Sheffield JS, 2012, OBSTET GYNECOL, V120, P532, DOI 10.1097/AOG.0b013e318263a278
   SIBAI BM, 1987, AM J OBSTET GYNECOL, V156, P1174, DOI 10.1016/0002-9378(87)90135-9
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   United Nations, 2008, MILL DEV GOALS REP 2
   VanWormer JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-231
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   Wilson Kevin C, 2004, J Intensive Care Med, V19, P183, DOI 10.1177/0885066604263918
   World Health Organization United Nations Children's Fund United Nations Population Fund World Bank United Nations Population Division, 2014, TRENDS MAT MORT 1990
   Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233
   Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144
NR 37
TC 8
Z9 11
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 21
PY 2016
VL 16
AR 220
DI 10.1186/s12879-016-1525-z
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA DM9YJ
UT WOS:000376721300003
PM 27207244
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Cecatti, JG
   Costa, ML
   Haddad, SM
   Parpinelli, MA
   Souza, JP
   Sousa, MH
   Surita, FG
   Silva, JLPE
   Pacagnella, RC
   Passini, R
AF Cecatti, J. G.
   Costa, M. L.
   Haddad, S. M.
   Parpinelli, M. A.
   Souza, J. P.
   Sousa, M. H.
   Surita, F. G.
   Pinto e Silva, J. L.
   Pacagnella, R. C.
   Passini, R., Jr.
CA Severe Maternal Morbidity Study Gr
TI Network for Surveillance of Severe Maternal Morbidity: a powerful
   national collaboration generating data on maternal health outcomes and
   care
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
DE Audit; Brazil; maternal near miss; obstetric care; potentially
   life-threatening complications of pregnancy; severe maternal morbidity
ID MULTICENTER; MORTALITY; MISSES; AUDIT
AB ObjectiveTo identify cases of severe maternal morbidity (SMM) during pregnancy and childbirth, their characteristics, and to test the feasibility of scaling up World Health Organization criteria for identifying women at risk of a worse outcome.
   DesignMulticentre cross-sectional study.
   SettingTwenty-seven referral maternity hospitals from all regions of Brazil.
   PopulationCases of SMM identified among 82 388 delivering women over a 1-year period.
   MethodsProspective surveillance using the World Health Organization's criteria for potentially life-threatening conditions (PLTC) and maternal near-miss (MNM) identified and assessed cases with severe morbidity or death.
   Main outcome measuresIndicators of maternal morbidity and mortality; sociodemographic, clinical and obstetric characteristics; gestational and perinatal outcomes; main causes of morbidity and delays in care.
   ResultsAmong 9555 cases of SMM, there were 140 deaths and 770 cases of MNM. The main determining cause of maternal complication was hypertensive disease. Criteria for MNM conditions were more frequent as the severity of the outcome increased, all combined in over 75% of maternal deaths.
   ConclusionsThis study identified around 9.5% of MNM or death among all cases developing any severe maternal complication. Multicentre studies on surveillance of SMM, with organised collaboration and adequate study protocols can be successfully implemented, even in low-income and middle-income settings, generating important information on maternal health and care to be used to implement appropriate health policies and interventions.
   Tweetable abstractSurveillance of severe maternal morbidity was proved to be possible in a hospital network in Brazil.
   Tweetable abstract Surveillance of severe maternal morbidity was proved to be possible in a hospital network in Brazil.
C1 [Cecatti, J. G.; Costa, M. L.; Haddad, S. M.; Parpinelli, M. A.; Souza, J. P.; Surita, F. G.; Pinto e Silva, J. L.; Pacagnella, R. C.; Passini, R., Jr.] Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynaecol, BR-13083881 Campinas, SP, Brazil.
   [Sousa, M. H.] Ctr Res Reprod Hlth Campinas Cemicamp, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynaecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Nakamura-Pereira,
   Marcos/X-1107-2019; Passini Junior, Renato/O-6169-2016; Moises,
   Elaine/A-5708-2015; Surita, Fernanda Garanhani/H-9575-2012; Amorim,
   Melania M/C-5807-2013; Moises, Elaine Christine Dantas/N-9522-2019;
   Souza, Joao Paulo/G-1982-2010; Pacagnella, Rodolfo/H-6247-2012; Costa,
   Maria Laura/I-4980-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Calderon, Iracema/C-8136-2012; Vieira Cunha Rudge, Marilza/C-8338-2012
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Passini Junior, Renato/0000-0001-8247-4549;
   Moises, Elaine/0000-0001-9099-4544; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Amorim, Melania M/0000-0003-1047-2514;
   Moises, Elaine Christine Dantas/0000-0001-9099-4544; Souza, Joao
   Paulo/0000-0002-2288-4244; Pacagnella, Rodolfo/0000-0002-5739-0009;
   Costa, Maria Laura/0000-0001-8280-3234; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Calderon, Iracema/0000-0003-4761-4336;
   Vieira Cunha Rudge, Marilza/0000-0002-9227-832X; Santana,
   Danielly/0000-0001-8912-2626
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), grant number 402702/2008-5. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of CNPq. It did not influence the content of the
   manuscript.
CR Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Haddad SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/989815
   *HLTH CAN, 2004, SPEC REP MAT MORT SE
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Katz L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-28
   Luz AG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-122
   Marr L, 2014, CURR OPIN ANESTHESIO, V27, P275, DOI 10.1097/ACO.0000000000000079
   Oladapo Olufemi T, 2009, Reprod Health, V6, P8, DOI 10.1186/1742-4755-6-8
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Pattinson RC, 2003, BJOG-INT J OBSTET GY, V110, P889, DOI 10.1111/j.1471-0528.2003.03044.x
   Say L, 2004, REPROD HLTH, V1, P3, DOI DOI 10.1186/1742-4755-1-3
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Tuncalp O, 2014, MATERN CHILD HLTH J, V18, P1648, DOI 10.1007/s10995-013-1405-8
   van Dillen J, 2010, BJOG-INT J OBSTET GY, V117, P416, DOI 10.1111/j.1471-0528.2009.02480.x
   Vandecruys HIB, 2002, EUR J OBSTET GYN R B, V102, P6, DOI 10.1016/S0301-2115(01)00558-9
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization UNICEF UNFPA World Bank, 2012, TRENDS MAT MORT 1990
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 30
TC 26
Z9 32
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAY
PY 2016
VL 123
IS 6
BP 946
EP 953
DI 10.1111/1471-0528.13614
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DK1WG
UT WOS:000374705100015
PM 26412586
OA Bronze
DA 2020-12-08
ER

PT J
AU Santana, DS
   Cecatti, JG
   Surita, FG
   Silveira, C
   Costa, ML
   Souza, JP
   Mazhar, SB
   Jayaratne, K
   Qureshi, Z
   Sousa, MH
   Vogel, JP
AF Santana, Danielly S.
   Cecatti, Jose G.
   Surita, Fernanda G.
   Silveira, Carla
   Costa, Maria L.
   Souza, Joao P.
   Mazhar, Syeda B.
   Jayaratne, Kapila
   Qureshi, Zahida
   Sousa, Maria H.
   Vogel, Joshua P.
CA WHO Multicountry Survey Maternal N
TI Twin Pregnancy and Severe Maternal Outcomes The World Health
   Organization Multicountry Survey on Maternal and Newborn Health
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID VAGINAL DELIVERY; SECONDARY ANALYSIS; EPIDEMIOLOGY; COUNTRIES; NIGERIA;
   MODE
AB OBJECTIVE:
   To evaluate maternal complications (potentially life-threatening conditions, maternal near miss, and maternal death) that are mutually exclusive and severe maternal outcomes (maternal near miss or maternal death) associated with twin pregnancies.
   METHODS:
   We performed a secondary analysis of a cross-sectional World Health Organization Multicountry Survey, which was implemented in 29 countries. Data from 4,756 twin deliveries were compared with 308,111 singleton deliveries. Factors associated with maternal morbidity and twin pregnancies were reported with adjusted prevalence ratio (95% confidence interval).
   RESULTS:
   Potentially life-threatening conditions, maternal near miss, severe maternal outcomes, and maternal deaths were 2.14 (1.99-2.30), 3.03 (2.39-3.85), 3.19 (2.58-3.94), and 3.97 (2.47-6.38) times higher, respectively, among twin pregnancies. Maternal age older than 20 years, having a partner, multiparity, and elective cesarean delivery were associated with twin pregnancies. Postpartum hemorrhage and chronic hypertension were more frequently associated with severe maternal outcomes among twin pregnancies. Conditions indicating organ dysfunction (maternal near miss) were twofold to fivefold higher for twins. Poisson multiple regression analysis identified several factors independently associated with a severe maternal outcome, but not twin pregnancies.
   CONCLUSION:
   Twin pregnancy is associated with greater severe maternal morbidity and a higher rate of maternal death than singleton pregnancy.
C1 [Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
   Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Sao Paulo, Brazil.
   Pakistan Inst Med Sci, Islamabad, Pakistan.
   Minist Hlth, Maternal & Child Morbid & Mortal Surveillance Uni, Family Hlth Bur, Colombo, Sri Lanka.
   Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya.
   WHO, Dept Reprod Hlth Res, CH-1211 Geneva, Switzerland.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Cecatti, Jose Guilherme/M-5945-2013;
   Souza, Joao Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019; Surita,
   Fernanda Garanhani/H-9575-2012; Jayaratne, Kapila/ABC-9841-2020
OI Costa, Maria Laura/0000-0001-8280-3234; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Souza, Joao Paulo/0000-0002-2288-4244;
   Vogel, Joshua/0000-0002-3214-7096; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Jayaratne, Kapila/0000-0001-9795-4342;
   Santana, Danielly/0000-0001-8912-2626
FU United Nations Development Programme/UNFPA/UNICEF/World Health
   Organization/World Bank Special Programme of Research, Development and
   Research Training in Human Reproduction; World Health OrganizationWorld
   Health Organization; U.S. Agency for International Development, Ministry
   of Health, Labour and Welfare of JapanUnited States Agency for
   International Development (USAID); Gynuity Health Projects; University
   of Campinas (Faepex) [11014]
FX Supported by the United Nations Development Programme/UNFPA/UNICEF/World
   Health Organization/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction, World Health
   Organization, U.S. Agency for International Development, the Ministry of
   Health, Labour and Welfare of Japan, and Gynuity Health Projects.
   Specifically for this analysis we received a grant from the University
   of Campinas (Faepex, grant 11014). They played no other role nor
   influenced data analysis, interpretation of results and writing the
   manuscript.
CR Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001
   Bangal V. B., 2012, International Journal of Biomedical and Advance Research, V3, P758
   Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939
   Bortolus R, 1999, HUM REPROD UPDATE, V5, P179, DOI 10.1093/humupd/5.2.179
   Buhling Kai J., 2003, Archives of Gynecology and Obstetrics, V269, P33, DOI 10.1007/s00404-003-0483-z
   Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P89, DOI 10.1111/1471-0528.12635
   Ibrahim I, 2012, INT J WOMENS HEALTH, V4, P245, DOI 10.2147/IJWH.S31350
   Liu AL, 2012, HONG KONG MED J, V18, P99
   LONG PA, 1987, AUST NZ J OBSTET GYN, V27, P1, DOI 10.1111/j.1479-828X.1987.tb00920.x
   Nwankwo TO, 2013, NIGER J CLIN PRACT, V16, P490, DOI 10.4103/1119-3077.116895
   Piccoli GB, 2013, CLIN J AM SOC NEPHRO, V8, P41, DOI 10.2215/CJN.02550312
   Qazi G, 2011, JCPSP-J COLL PHYSICI, V21, P142, DOI 03.2011/JCPSP.142145
   Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007
   Rizwan Naushaba, 2010, J Ayub Med Coll Abbottabad, V22, P105
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286
   Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634
   United Nations Development Programme (UNDP), 2013, RIS SOUTH HUM PROGR
   Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-55
   Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x
   Werder E, 2013, FERTIL STERIL, V100, P142, DOI 10.1016/j.fertnstert.2013.01.153
   Young BC, 2012, SEMIN PERINATOL, V36, P162, DOI 10.1053/j.semperi.2012.02.007
NR 27
TC 35
Z9 41
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2016
VL 127
IS 4
BP 631
EP 641
DI 10.1097/AOG.0000000000001338
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DH4YF
UT WOS:000372791000003
PM 26959199
DA 2020-12-08
ER

PT J
AU Souza, RT
   Cecatti, JG
   Passini, R
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Haddad, SM
   Pacagnella, RC
   Costa, ML
AF Souza, Renato T.
   Cecatti, Jose G.
   Passini, Renato, Jr.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Haddad, Samira M.
   Pacagnella, Rodolfo C.
   Costa, Maria L.
CA Brazilian Multictr Study Preterm
TI The Burden of Provider-Initiated Preterm Birth and Associated Factors:
   Evidence from the Brazilian Multicenter Study on Preterm Birth (EMIP)
SO PLOS ONE
LA English
DT Article
ID ORGANIZATION MULTICOUNTRY SURVEY; RISK-FACTORS; SECONDARY ANALYSIS;
   ANTENATAL CORTICOSTEROIDS; PERINATAL-MORTALITY; SYSTEMATIC ANALYSIS;
   UNITED-STATES; TIME TRENDS; COUNTRIES; OBESITY
AB Background
   About 15 million children are born under 37 weeks of gestation worldwide. Prematurity is the leading cause of neonatal deaths and short/long term morbidities, entailing consequences not only for the individual, but also their family, health agencies, facilities and all community. The provider-initiated preterm birth is currently one of the most important obstetric conditions related to preterm births, particularly in middle and high income countries, thus decreasing the need for therapeutic preterm birth is essential to reduce global prematurity. Therefore detailed knowledge on the factors associated with provider-initiated preterm birth is essential for the efforts to reduce preterm birth rates and its consequences. In this current analysis we aimed to assess the proportion of provider-initiated (pi-PTB) among preterm births in Brazil and identify associated factors.
   Methods and Findings
   This is an analysis of a multicenter cross-sectional study with a nested case-control component called Brazilian Multicenter Study on Preterm Birth (EMIP). EMIP was conducted in 20 referral obstetric hospitals located in the three most populated of the five Brazilian regions. We analysed data of women with pi-PTB, defined as childbirth occurring at less than 37 weeks, medically indicated for maternal/fetal compromise or both; and women with term birth, childbirth at or after 37 weeks. Maternal, sociodemographic, obstetric, prenatal care, delivery, and postnatal characteristics were assessed as possible factors associated with pi-PTB, compared to term births. The overall prevalence of preterm births was 12.3%. Of these, approximately one-third of cases were initiated by the provider. Hypertensive disorders, placental abruption, and diabetes were the main maternal conditions leading to pi-PTB. Caesarean section was the most common mode of delivery. Chronic hypertension (OR 7.47; 95% CI 4.02-13.88), preeclampsia/eclampsia/HELLP syndrome (OR 15.35; 6.57-35.88), multiple pregnancy (OR 12.49; 4.86-32.05), and chronic diabetes (OR 5.24; 2.68-10.25) were the most significant factors independently associated with pi-PTB.
   Conclusions
   pi-PTB is responsible for about one-third of all preterm births, requiring special attention. The decision-making process relative to the choice of provider-initiated birth is complex, and many factors should be elucidated to improve strategies for its prevention, including evidence-based guidelines on proper management of the corresponding clinical conditions.
C1 [Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Tedesco, Ricardo P.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Haddad, Samira M.; Pacagnella, Rodolfo C.; Costa, Maria L.] Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; Passini Junior, Renato/O-6169-2016;
   Cecatti, Jose Guilherme/M-5945-2013; Dias,
   T\\xc3\\x83\\xc2\\xa1bata/U-4512-2019; Amorim, Melania M/C-5807-2013;
   Pacagnella, Rodolfo/H-6247-2012; Costa, Maria Laura/I-4980-2019; Nomura,
   Marcelo Luis/H-9534-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019
OI Souza, Renato Teixeira/0000-0002-9075-9269; Passini Junior,
   Renato/0000-0001-8247-4549; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Amorim, Melania M/0000-0003-1047-2514; Pacagnella,
   Rodolfo/0000-0002-5739-0009; Costa, Maria Laura/0000-0001-8280-3234; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009
FU FAPESP (Foundation for Support to Research of the State of Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/53245-5, Fapesp 2009/53245-5]; CNPq (Brazilian National Research
   Council) Brazil; CNPq (Brazilian National Research Council)National
   Council for Scientific and Technological Development (CNPq)
FX This work was supported by Grant 2009/53245-5 from FAPESP (Foundation
   for Support to Research of the State of Sao Paulo), and by CNPq
   (Brazilian National Research Council) Brazil (JGC). The funders had no
   role in the study design, data collection and analysis, decision to
   publish or preparation of the manuscript.; The authors acknowledge CNPq
   (Brazilian National Research Council) and FAPESP (Foundation for Support
   to Research of the State of Sao Paulo) for financial sponsorship of the
   study, Process Fapesp 2009/53245-5 (Call AP.PPSUS-1). These
   organizations did not participate in the study proposal, implementation
   or interpretation of results.
CR Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629
   Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7
   Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3
   Baschat AA, 2015, ULTRASOUND OBST GYN, V45, P119, DOI 10.1002/uog.14770
   Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554
   Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Brazilian Ministry of Health, 2006, SINASC NAT INF SYST
   Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295
   de Jongh BE, 2014, MATERN CHILD HLTH J, V18, P511, DOI 10.1007/s10995-013-1296-8
   de Oliveira FC, 2013, CLINICS, V68, P922, DOI 10.6061/clinics/2013(07)06
   Dean SV, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S3
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Farrar D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007122.pub3
   Friedman AM, 2014, SEMIN PERINATOL, V38, P177, DOI 10.1053/j.semperi.2014.03.002
   Gigante DP, 2009, REV SAUDE PUBL, V43, P83, DOI 10.1590/s0034-89102009000900011
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865
   Gyamfi-Bannerman C, 2012, SEMIN FETAL NEONAT M, V17, P132, DOI 10.1016/j.siny.2012.01.014
   Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007
   Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7
   [IOM (Institute of Medicine) NRC (National Research Council)], 2009, WEIGHT GAIN PREGN RE
   Joseph KS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-117
   Kattah AG, 2013, ADV CHRONIC KIDNEY D, V20, P229, DOI 10.1053/j.ackd.2013.01.014
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Lajos GJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-54
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Machado LC, 2014, J PEDIAT-BRAZIL, V90, P221, DOI 10.1016/j.jped.2013.08.012
   Malloy MH, 2009, BIRTH-ISS PERINAT C, V36, P26, DOI 10.1111/j.1523-536X.2008.00292.x
   McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Nizard J, 2013, J GYNECOL OBST BIO R, V42, P1008, DOI 10.1016/j.jgyn.2013.09.022
   Parker MG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-153
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22
   Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2
   Roberts JM, 2014, SEMIN PERINATOL, V38, P139, DOI 10.1053/j.semperi.2014.03.005
   Santos IS, 2008, CAD SAUDE PUBLICA, V24, pS381, DOI 10.1590/S0102-311X2008001500003
   Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022
   Tandu-Umba B, 2014, INT J WOMENS HEALTH, V6, P1011, DOI 10.2147/IJWH.S69230
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   Tranquilli AL, 2013, J MATERN-FETAL NEO M, V26, P1425, DOI 10.3109/14767058.2013.784263
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   Vogel JP, 2014, LANCET, V384, P1869, DOI 10.1016/S0140-6736(14)60580-8
   Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-56
NR 49
TC 23
Z9 23
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2016
VL 11
IS 2
AR e0148244
DI 10.1371/journal.pone.0148244
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9PR
UT WOS:000369554000056
PM 26849228
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Pfitscher, LC
   Cecatti, JG
   Haddad, SM
   Parpinelli, MA
   Souza, JP
   Quintana, SM
   Surita, FG
   Costa, ML
AF Pfitscher, L. C.
   Cecatti, J. G.
   Haddad, S. M.
   Parpinelli, M. A.
   Souza, J. P.
   Quintana, S. M.
   Surita, F. G.
   Costa, M. L.
CA Brazilian Network Surveillance Sev
TI The role of infection and sepsis in the Brazilian Network for
   Surveillance of Severe Maternal Morbidity
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE severe acute maternal morbidity; maternal mortality; maternal near miss;
   sepsis; infection
ID PREGNANCY; INFLUENZA; DEATH; CARE
AB ObjectiveTo identify the burden of severe infection within the Brazilian Network for Surveillance of Severe Maternal Morbidity and factors associated with worse maternal outcomes.
   MethodsThis was a multicentre cross-sectional study involving 27 referral maternity hospitals in Brazil. WHOs standardised criteria for potentially life-threatening conditions and maternal near miss were used to identify cases through prospective surveillance and the main cause of morbidity was identified as infection or other causes (hypertension, haemorrhage or clinical/surgical). Complications due to infection were compared to complications due to the remaining causes of morbidity. Factors associated with a severe maternal outcome were assessed for the cases of infection.
   ResultsA total of 502 (5.3%) cases of maternal morbidity were associated with severe infection vs. 9053 cases (94.7%) with other causes. Considering increased severity of cases, infection was responsible for one-fourth of all maternal near miss (23.6%) and nearly half (46.4%) of maternal deaths, with a maternal near miss to maternal death ratio three times (2.8:1) that of cases without infection (7.8:1) and a high mortality index (26.3%). Within cases of infection, substandard care was present in over one half of the severe maternal outcome cases. Factors independently associated with worse maternal outcomes were HIV/AIDS, hysterectomy, prolonged hospitalisation, intensive care admission and delays in medical care.
   ConclusionsInfection is an alarming cause of maternal morbidity and mortality and timely diagnosis and adequate management are key to improving outcomes during pregnancy. Delays should be addressed, risk factors identified, and specific protocols of surveillance and care developed for use during pregnancy.
C1 [Pfitscher, L. C.; Cecatti, J. G.; Haddad, S. M.; Parpinelli, M. A.; Souza, J. P.; Surita, F. G.; Costa, M. L.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Souza, J. P.; Quintana, S. M.] Univ Sao Paulo Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM lauracosta.unicamp@gmail.com
RI Moises, Elaine/A-5708-2015; Amorim, Melania M/C-5807-2013; Cecatti, Jose
   Guilherme/M-5945-2013; Nakamura-Pereira, Marcos/X-1107-2019; CORDIOLI,
   EDUARDO/AAR-6100-2020; Souza, Joao Paulo/G-1982-2010; Moises, Elaine
   Christine Dantas/N-9522-2019; Costa, Maria Laura/I-4980-2019; Surita,
   Fernanda Garanhani/H-9575-2012; Peracoli, Jose Carlos/G-4923-2012;
   Vieira Cunha Rudge, Marilza/C-8338-2012; Calderon, Iracema/C-8136-2012
OI Moises, Elaine/0000-0001-9099-4544; Amorim, Melania
   M/0000-0003-1047-2514; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; CORDIOLI,
   EDUARDO/0000-0001-5405-9380; Souza, Joao Paulo/0000-0002-2288-4244;
   Moises, Elaine Christine Dantas/0000-0001-9099-4544; Costa, Maria
   Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Peracoli, Jose
   Carlos/0000-0002-3273-3001; Vieira Cunha Rudge,
   Marilza/0000-0002-9227-832X; Santana, Danielly/0000-0001-8912-2626;
   Calderon, Iracema/0000-0003-4761-4336
CR Acosta CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067175
   Albright CM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.010
   Arulkumaran N, 2013, BEST PRACT RES CL OB, V27, P893, DOI 10.1016/j.bpobgyn.2013.07.004
   Bauer ME, 2014, OBSTET GYNECOL, V124, P535, DOI 10.1097/AOG.0000000000000423
   Bauer ME, 2013, ANESTH ANALG, V117, P944, DOI 10.1213/ANE.0b013e3182a009c3
   Bone RC, 1992, CHEST, V136, pe28
   Calegari SS, 2010, REV BRAS GINECOL OBS, V34, P369, DOI 10.1590/S0100-72032012000800005
   Cecatti JG, 2015, BJOG
   da Silva AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088624
   Dellinger RP, 2014, CLEV CLIN J MED, V82, P237, DOI 10.3949/ccjm.82gr.15001
   Domingues CMAS, 2012, VACCINE, V30, P4744, DOI 10.1016/j.vaccine.2012.05.007
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hill JB, 2005, OBSTET GYNECOL, V105, P18, DOI 10.1097/01.AOG.0000149154.96285.a0
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1
   Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1
   Matuszkiewicz-Rowinska J, 2015, ARCH MED SCI, V11, P67, DOI 10.5114/aoms.2013.39202
   Mertz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089697
   Nicolle LE, 2015, LANCET INFECT DIS, V15, P1252, DOI 10.1016/S1473-3099(15)00145-0
   Oud L, 2014, INFECT DIS THER
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Pattinson RC, 2003, BJOG-INT J OBSTET GY, V110, P889, DOI 10.1111/j.1471-0528.2003.03044.x
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Rasmussen SA, 2014, NEW ENGL J MED, V371, P1373, DOI 10.1056/NEJMp1403496
   Santana DS, 2012, INT J GYNECOL OBSTET, V119, P44, DOI 10.1016/j.ijgo.2012.05.025
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Tricco AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039437
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   WILSON RF, 1985, SURG CLIN N AM, V65, P965
   Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233
   Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235
NR 38
TC 5
Z9 6
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD FEB
PY 2016
VL 21
IS 2
BP 183
EP 193
DI 10.1111/tmi.12633
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DD5FO
UT WOS:000369948300004
PM 26578103
OA Bronze
DA 2020-12-08
ER

PT J
AU Souza, JP
   Betran, AP
   Dumont, A
   de Mucio, B
   Pickens, CMG
   Deneux-Tharaux, C
   Ortiz-Panozo, E
   Sullivan, E
   Ota, E
   Togoobaatar, G
   Carroli, G
   Knight, H
   Zhang, J
   Cecatti, JG
   Vogel, JP
   Jayaratne, K
   Leal, MC
   Gissler, M
   Morisaki, N
   Lack, N
   Oladapo, OT
   Tuncalp, O
   Lumbiganon, P
   Mori, R
   Quintana, S
   Passos, ADC
   Marcolin, AC
   Zongo, A
   Blondel, B
   Hernandez, B
   Hogue, CJ
   Prunet, C
   Landman, C
   Ochir, C
   Cuesta, C
   Pileggi-Castro, C
   Walker, D
   Alves, D
   Abalos, E
   Moises, ECD
   Vieira, EM
   Duarte, G
   Perdona, G
   Gurol-Urganci, I
   Takahiko, K
   Moscovici, L
   Campodonico, L
   Oliveira-Ciabati, L
   Laopaiboon, M
   Danansuriya, M
   Nakamura-Pereira, M
   Costa, ML
   Torloni, MR
   Kramer, MR
   Borges, P
   Olkhanud, PB
   Perez-Cuevas, R
   Agampodi, SB
   Mittal, S
   Serruya, S
   Bataglia, V
   Li, Z
   Temmerman, M
   Gulmezoglu, AM
AF Souza, J. P.
   Betran, A. P.
   Dumont, A.
   de Mucio, B.
   Pickens, C. M. Gibbs
   Deneux-Tharaux, C.
   Ortiz-Panozo, E.
   Sullivan, E.
   Ota, E.
   Togoobaatar, G.
   Carroli, G.
   Knight, H.
   Zhang, J.
   Cecatti, J. G.
   Vogel, J. P.
   Jayaratne, K.
   Leal, M. C.
   Gissler, M.
   Morisaki, N.
   Lack, N.
   Oladapo, O. T.
   Tuncalp, O.
   Lumbiganon, P.
   Mori, R.
   Quintana, S.
   Passos, A. D. Costa
   Marcolin, A. C.
   Zongo, A.
   Blondel, B.
   Hernandez, B.
   Hogue, C. J.
   Prunet, C.
   Landman, C.
   Ochir, C.
   Cuesta, C.
   Pileggi-Castro, C.
   Walker, D.
   Alves, D.
   Abalos, E.
   Moises, E. C. D.
   Vieira, E. M.
   Duarte, G.
   Perdona, G.
   Gurol-Urganci, I.
   Takahiko, K.
   Moscovici, L.
   Campodonico, L.
   Oliveira-Ciabati, L.
   Laopaiboon, M.
   Danansuriya, M.
   Nakamura-Pereira, M.
   Costa, M. L.
   Torloni, M. R.
   Kramer, M. R.
   Borges, P.
   Olkhanud, P. B.
   Perez-Cuevas, R.
   Agampodi, S. B.
   Mittal, S.
   Serruya, S.
   Bataglia, V.
   Li, Z.
   Temmerman, M.
   Guelmezoglu, A. M.
TI A global reference for caesarean section rates (C-Model): a multicountry
   cross-sectional study
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
DE Benchmarking; caesarean delivery rates; caesarean section rates;
   logistic regression
AB ObjectiveTo generate a global reference for caesarean section (CS) rates at health facilities.
   DesignCross-sectional study.
   SettingHealth facilities from 43 countries.
   Population/SampleThirty eight thousand three hundred and twenty-four women giving birth from 22 countries for model building and 10045875 women giving birth from 43 countries for model testing.
   MethodsWe hypothesised that mathematical models could determine the relationship between clinical-obstetric characteristics and CS. These models generated probabilities of CS that could be compared with the observed CS rates. We devised a three-step approach to generate the global benchmark of CS rates at health facilities: creation of a multi-country reference population, building mathematical models, and testing these models.
   Main outcome measuresArea under the ROC curves, diagnostic odds ratio, expected CS rate, observed CS rate.
   ResultsAccording to the different versions of the model, areas under the ROC curves suggested a good discriminatory capacity of C-Model, with summary estimates ranging from 0.832 to 0.844. The C-Model was able to generate expected CS rates adjusted for the case-mix of the obstetric population. We have also prepared an e-calculator to facilitate use of C-Model ().
   ConclusionsThis article describes the development of a global reference for CS rates. Based on maternal characteristics, this tool was able to generate an individualised expected CS rate for health facilities or groups of health facilities. With C-Model, obstetric teams, health system managers, health facilities, health insurance companies, and governments can produce a customised reference CS rate for assessing use (and overuse) of CS.
   Tweetable abstractThe C-Model provides a customized benchmark for caesarean section rates in health facilities and systems.
   Tweetable abstract The C-Model provides a customized benchmark for caesarean section rates in health facilities and systems.
C1 [Souza, J. P.; Passos, A. D. Costa; Alves, D.; Vieira, E. M.; Perdona, G.; Moscovici, L.; Oliveira-Ciabati, L.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Av Bandeirantes, BR-3900 Ribeirao Preto, Brazil.
   [Betran, A. P.; Vogel, J. P.; Oladapo, O. T.; Tuncalp, O.; Temmerman, M.; Guelmezoglu, A. M.] WHO, World Bank Special Programme Res Dev & Res Traini, UNDP UNFPA UNICEF WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.
   [Dumont, A.; Zongo, A.] Univ Paris 05, Sorbonne Paris Cite, UMR 216, Inst Dev Res, Paris, France.
   [de Mucio, B.; Serruya, S.] WHO Reg Off Amer, Women & Reprod Hlth CLAP WR, Latin Amer Ctr Perinatol, Montevideo, Uruguay.
   [Pickens, C. M. Gibbs; Hogue, C. J.; Kramer, M. R.; Mittal, S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Deneux-Tharaux, C.; Blondel, B.; Prunet, C.; Bataglia, V.] Paris Descartes Univ, Ctr Epidemiol & Biostat, Obstetr Perinatal & Pediat Epidemiol Res Team, Inserm U1153, Paris, France.
   [Ortiz-Panozo, E.] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico.
   [Sullivan, E.; Li, Z.] Univ Technol, Fac Hlth, Sydney, NSW, Australia.
   [Ota, E.; Togoobaatar, G.; Morisaki, N.; Mori, R.; Takahiko, K.] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.
   [Carroli, G.; Cuesta, C.; Abalos, E.; Campodonico, L.] Ctr Rosarino Estudios Perinat, Rosario, Argentina.
   [Knight, H.; Gurol-Urganci, I.] Lindsay Stewart R&D Ctr, Off Res & Clin Audit, Royal Coll Obstetricians & Gynaecologists, London, England.
   [Knight, H.; Gurol-Urganci, I.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.
   [Zhang, J.] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environ Hlth,Minist Ed, Shanghai 200030, Peoples R China.
   [Cecatti, J. G.; Costa, M. L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Jayaratne, K.; Danansuriya, M.; Agampodi, S. B.] Family Hlth Bur, Minist Hlth, Colombo, Sri Lanka.
   [Leal, M. C.; Landman, C.; Nakamura-Pereira, M.; Borges, P.] Fiocruz MS, ENSP, BR-21045900 Rio De Janeiro, Brazil.
   [Gissler, M.] Natl Inst Hlth & Welf, Helsinki, Finland.
   [Morisaki, N.] Univ Tokyo, Grad Sch Med, Dept Paediat, Tokyo, Japan.
   [Lack, N.] Bayer Krankenhausgesellschaft, Bayer Arbeitsgemeinschaft Qualitatssicherun Stati, Munich, Germany.
   [Lumbiganon, P.] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Khon, Kaen, Thailand.
   [Quintana, S.; Marcolin, A. C.; Moises, E. C. D.; Duarte, G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynaecol, BR-14049 Ribeirao Preto, Brazil.
   [Zongo, A.] Minist Sante, Direct Sante Famille, Ouagadougou, Burkina Faso.
   [Hernandez, B.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Ochir, C.; Olkhanud, P. B.] Univ Mongolia, Hlth Sci, Sch Publ Hlth, Ulaanbaatar, Mongolia.
   [Pileggi-Castro, C.; Moscovici, L.; Oliveira-Ciabati, L.] GLIDE Tech Cooperat & Res, Ribeirao Preto, SP, Brazil.
   [Pileggi-Castro, C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Paediat, BR-14049 Ribeirao Preto, SP, Brazil.
   [Walker, D.] Univ Calif San Francisco, Dept Obstet & Gynaecol & Global Hlth Sci, San Francisco, CA 94143 USA.
   [Laopaiboon, M.] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen, Thailand.
   [Torloni, M. R.] Univ Fed Sao Paulo, Sch Med Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Perez-Cuevas, R.] Inter Amer Dev Bank, Social Protect & Hlth Div, Mexico City, DF, Mexico.
   [Mittal, S.] Fortis Mem Res Inst, Gurgaon, Haryana, India.
   [Bataglia, V.] Hosp Nacl Itaugua, Itaugua, Paraguay.
RP Souza, JP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Av Bandeirantes, BR-3900 Ribeirao Preto, Brazil.
EM jpsouza@fmrp.usp.br
RI Prado, Bernardo Hernandez/AAG-9292-2019; Vieira, Elisabeth
   M./H-6842-2012; Li, Zhuoyang/B-2842-2015; MARCOLIN, ALESSANDRA
   CRISTINA/F-7929-2017; Dumont, Alexandre/I-9429-2016; Ochir,
   Chimedsuren/AAW-7743-2020; Vogel, Joshua/K-7649-2019; Sullivan,
   Elizabeth/V-6742-2017; Oliveira-Ciabati, Livia/M-6412-2019; Cecatti,
   Jose Guilherme/M-5945-2013; Kramer, Michael R/A-3195-2013;
   Nakamura-Pereira, Marcos/X-1107-2019; Moises, Elaine/A-5708-2015;
   Blondel, Beatrice/G-5011-2017; Nakamura-Pereira, Marcos/O-4496-2014;
   Moises, Elaine Christine Dantas/N-9522-2019; Deneux-Tharaux,
   Catherine/R-1111-2016; Agampodi, Suneth Buddhika/G-3320-2012; Costa,
   Maria Laura/I-4980-2019; Li, Zhuoyang/P-7433-2019; Ortiz-Panozo,
   Eduardo/AAY-7743-2020; Souza, Joao Paulo/G-1982-2010; Jayaratne,
   Kapila/ABC-9841-2020; Alves, Domingos/K-6897-2015; Oliveira-Ciabati,
   Livia/H-7982-2018; Tuncalp, Ozge/Y-2724-2018
OI Prado, Bernardo Hernandez/0000-0002-5960-8841; Li,
   Zhuoyang/0000-0002-7622-150X; MARCOLIN, ALESSANDRA
   CRISTINA/0000-0003-2536-2553; Dumont, Alexandre/0000-0003-3826-0193;
   Ochir, Chimedsuren/0000-0002-7134-5255; Vogel,
   Joshua/0000-0002-3214-7096; Sullivan, Elizabeth/0000-0002-8718-2753;
   Oliveira-Ciabati, Livia/0000-0002-7163-9456; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Kramer, Michael R/0000-0002-6372-6170;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Moises,
   Elaine/0000-0001-9099-4544; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Deneux-Tharaux,
   Catherine/0000-0002-6561-3321; Agampodi, Suneth
   Buddhika/0000-0001-7810-1774; Costa, Maria Laura/0000-0001-8280-3234;
   Li, Zhuoyang/0000-0002-7622-150X; Souza, Joao Paulo/0000-0002-2288-4244;
   Jayaratne, Kapila/0000-0001-9795-4342; Alves,
   Domingos/0000-0002-0800-5872; Oliveira-Ciabati,
   Livia/0000-0002-7163-9456; Perez-Cuevas, Ricardo/0000-0002-5564-5821; De
   Mucio, Bremen/0000-0003-0662-9742; Ortiz-Panozo,
   Eduardo/0000-0002-3141-210X; Mori, Rintaro/0000-0001-7656-6156; Tuncalp,
   Ozge/0000-0002-5370-682X; Pickens, Cassandra/0000-0003-3154-2374; Ota,
   Erika/0000-0002-3945-7441; Gurol-Urganci, Ipek/0000-0002-6517-3485;
   Morisaki, Naho/0000-0001-6151-4513
FU EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD052460,
   T32HD052460, T32HD052460, T32HD052460] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD052460,
   T32HD052460, T32HD052460, T32HD052460, T32HD052460, T32HD052460] Funding
   Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32 HD052460] Funding Source: Medline; World Health
   OrganizationWorld Health Organization [001] Funding Source: Medline
CR Althabe F, 2006, LANCET, V368, P1472, DOI 10.1016/S0140-6736(06)69616-5
   Angeja ACE, 2006, BJOG-INT J OBSTET GY, V113, P1253, DOI 10.1111/j.1471-0528.2006.01069.x
   [Anonymous], 1985, LANCET, V2, P436
   Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x
   Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045
   Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x
   Colais P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-54
   Cyr RM, 2006, AM J OBSTET GYNECOL, V194, P932, DOI 10.1016/j.ajog.2005.10.199
   Gruebaum A, 2008, J PERINAT MED, V36, P110, DOI 10.1515/JPM.2008.026
   Gurol-Urganci I, 2013, HUM REPROD, V28, P1943, DOI 10.1093/humrep/det130
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012
   Hartmann K E, 2012, 1213EHC128EF AG HEAL
   Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520
   Lauer J. A., 2010, DETERMINANTS CAESARE
   Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3
   Litorp H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-107
   Maso G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062364
   Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004
   Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156
   Robson MS, 2001, FETAL MATERNAL MED R, V12, P23, DOI DOI 10.1017/S0965539501000122
   SHEARER EL, 1993, SOC SCI MED, V37, P1223, DOI 10.1016/0277-9536(93)90334-Z
   Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566
   Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104
   Zizza A, 2011, J Prev Med Hyg, V52, P161
NR 26
TC 44
Z9 49
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD FEB
PY 2016
VL 123
IS 3
BP 427
EP 436
DI 10.1111/1471-0528.13509
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DC1SV
UT WOS:000368998000022
PM 26259689
OA Green Published, Green Accepted, Other Gold
DA 2020-12-08
ER

PT J
AU Campanharo, FF
   Cecatti, JG
   Haddad, SM
   Parpinelli, MA
   Born, D
   Costa, ML
   Mattar, R
AF Campanharo, Felipe F.
   Cecatti, Jose G.
   Haddad, Samira M.
   Parpinelli, Mary A.
   Born, Daniel
   Costa, Maria L.
   Mattar, Rosiane
CA Brazilian Network Surveillance
TI The Impact of Cardiac Diseases during Pregnancy on Severe Maternal
   Morbidity and Mortality in Brazil
SO PLOS ONE
LA English
DT Article
ID NEAR-MISS; SURVEILLANCE; OUTCOMES; NETWORK; COHORT; HEALTH; DEATH;
   WOMEN; CARE
AB Background
   To evaluate maternal heart disease as a cause or complicating factor for severe morbidity in the setting of the Brazilian Network for Surveillance of Severe Maternal Morbidity.
   Methods and Findings
   Secondary data analysis of this multicenter cross-sectional study was implemented in 27 referral obstetric units in Brazil. From July 2009 to June 2010, a prospective surveillance was conducted among all delivery hospitalizations to identify cases of severe maternal morbidity (SMM), including Potentially Life-Threatening Conditions (PLTC) and Maternal Near Miss (MNM), using the new criteria established by the WHO. The variables studied included: sociodemographic characteristics, clinical and obstetric history of the women; perinatal outcome and the occurrence of maternal outcomes (PLTC, MNM, MD) between groups of cardiac and non-cardiac patients. Only heart conditions with hemodynamic impact characterizing severity of maternal morbidity were considered. 9555 women were included in the Network with severe pregnancy-related complications: 770 maternal near miss cases and 140 maternal death cases. A total of 293 (3.6%) cases were related to heart disease and the condition was known before pregnancy in 82.6% of cases. Maternal near miss occurred in 15% of cardiac disease patients (most due to clinical-surgical causes, p<0.001) and 7.7% of non-cardiac patients (hemorrhagic and hypertensive causes, p<0.001). Maternal death occurred in 4.8% of cardiac patients and in 1.2% of non-cardiac patients, respectively.
   Conclusions In this study, heart disease was significantly associated with a higher occurrence of severe maternal outcomes, including maternal death and maternal near miss, among women presenting with any severe maternal morbidity.
C1 [Campanharo, Felipe F.; Mattar, Rosiane] Fed Univ Sao Paulo UNIFESP, Dept Obstet, Sao Paulo, Brazil.
   [Cecatti, Jose G.; Haddad, Samira M.; Parpinelli, Mary A.; Costa, Maria L.] State Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, Brazil.
   [Born, Daniel] Fed Univ Sao Paulo UNIFESP, Discipline Cardiol, Sao Paulo, Brazil.
RP Campanharo, FF (corresponding author), Fed Univ Sao Paulo UNIFESP, Dept Obstet, Sao Paulo, Brazil.
EM favorette@hotmail.com
RI Moises, Elaine Christine Dantas/N-9522-2019; CORDIOLI,
   EDUARDO/AAR-6100-2020; Nakamura-Pereira, Marcos/X-1107-2019; Moises,
   Elaine/A-5708-2015; Cecatti, Jose Guilherme/M-5945-2013; Rudge, Marilza
   V C/C-8338-2012; Costa, Maria Laura/I-4980-2019; Amorim, Melania
   M/C-5807-2013; Peracoli, Jose Carlos/G-4923-2012
OI Moises, Elaine Christine Dantas/0000-0001-9099-4544; CORDIOLI,
   EDUARDO/0000-0001-5405-9380; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Moises, Elaine/0000-0001-9099-4544; Cecatti,
   Jose Guilherme/0000-0003-1285-8445; Rudge, Marilza V
   C/0000-0002-9227-832X; Costa, Maria Laura/0000-0001-8280-3234; Amorim,
   Melania M/0000-0003-1047-2514; Peracoli, Jose Carlos/0000-0002-3273-3001
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX The study was financially supported by CNPq/DECIT (The National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health), grant number 402702/2008-5. The author(s) received
   no specific funding for the publication of this article. The funders had
   no role in study, design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alonso-Gonzalez R, 2014, WOMENS HEALTH, V10, P79, DOI [10.2217/WHE.13.70, 10.2217/whe.13.70]
   Brazil Ministry of Health, 2011, HLTH BRAZIL 2011, P345
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Ganaba R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-22
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Huisman CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056494
   Josefsson A, 2011, ACTA OBSTET GYN SCAN, V90, P659, DOI 10.1111/j.1600-0412.2011.01100.x
   Kaye K, 2009, FOG ZONE MISPERCEPTI
   Kuklina EV, 2011, BJOG-INT J OBSTET GY, V118, P345, DOI 10.1111/j.1471-0528.2010.02743.x
   Le HH, 2014, INT J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Nanna M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000712
   Ngu K, 2014, INT J GYNECOL OBSTET, V126, P252, DOI 10.1016/j.ijgo.2014.03.032
   Ouyang DW, 2010, INT J CARDIOL, V144, P195, DOI 10.1016/j.ijcard.2009.04.006
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Regitz-Zagrosek V, 2011, DTSCH ARZTEBL INT, V108, P267, DOI 10.3238/arztebl.2011.0267
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Simpson LL, 2012, OBSTET GYNECOL, V119, P345, DOI 10.1097/AOG.0b013e318242e260
   Small MJ, 2012, OBSTET GYNECOL, V119, P250, DOI 10.1097/AOG.0b013e31824265c7
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Waksmonski CA, 2014, ACQUIRED HEART DIS P
   WHO, 2012, EV QUAL CAR SEV PREG
NR 27
TC 7
Z9 7
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 9
PY 2015
VL 10
IS 12
AR e0144385
DI 10.1371/journal.pone.0144385
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CZ1YX
UT WOS:000366903300046
PM 26650684
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Andreucci, CB
   Cecatti, JG
   Pacagnella, RC
   Silveira, C
   Parpinelli, MA
   Ferreira, EC
   Angelini, CR
   Santos, JP
   Zanardi, DM
   Bussadori, JC
   Cecchino, GN
   Souza, RT
   Sousa, MH
   Costa, ML
AF Andreucci, Carla B.
   Cecatti, Jose G.
   Pacagnella, Rodolfo C.
   Silveira, Carla
   Parpinelli, Mary A.
   Ferreira, Elton C.
   Angelini, Carina R.
   Santos, Juliana P.
   Zanardi, Dulce M.
   Bussadori, Jamile C.
   Cecchino, Gustavo N.
   Souza, Renato T.
   Sousa, Maria H.
   Costa, Maria L.
TI Does Severe Maternal Morbidity Affect Female Sexual Activity and
   Function? Evidence from a Brazilian Cohort Study
SO PLOS ONE
LA English
DT Article
ID INDEX FSFI; NEAR-MISS; DYSFUNCTION; CHILDBIRTH; LIFE; PREVALENCE;
   HEALTH; WOMEN
AB Objective
   to assess Female Sexual Function Index (FSFI) scores and delay to resume sexual activity associated with a previous severe maternal morbidity.
   Method
   This was a multidimensional retrospective cohort study. Women who gave birth at a Brazilian tertiary maternity between 2008 and 2012 were included, with data extraction from the hospital information system. Those with potentially life-threatening conditions and maternal near miss episodes (severe maternal morbidity) were considered the exposed group. The control group was a random sample of women who had had uncomplicated pregnancy. Female sexual function was evaluated through FSFI questionnaire, and general and reproductive aspects were addressed through specific questions. Statistical analyses were performed using Mann-Whitney and Pearson's Chi-square for bivariate analyses. Logistic regression was used to identify variables independently associated with lower FSFI scores.
   Results
   638 women were included (315 at exposed and 323 at not exposed groups). The majority of women were under 30 years-old in the control group and between 30 and 46 years-old in the exposed group (p = 0.003). Women who experienced severe maternal morbidity (SMM) had statistically significant differences regarding cesarean section (82.4% versus 47.1% among deliveries without complications, p< 0.001), and some previous pathological conditions. FSFI mean scores were similar among groups ranging from 24.39 to 24.42. It took longer for exposed women to resume sexual activity after index pregnancy (mean 84 days after SMM and 65 days for control group, p = 0.01). Multiple analyses showed no significant association of FSFI below cut-off value with any predictor.
   Conclusion
   FSFI scores were not different in both groups. However, they were lower than expected. SMM delayed resumption of sexual activity after delivery, beyond postpartum period. However, the proportion of women in both groups having sex at 3 months after delivery was similar. Altered sexual response may be evaluated as one of possible long-term consequences after SMM episodes. Further studies on the growing population of women surviving severe maternal conditions might be worth for improvement of care for women.
C1 [Andreucci, Carla B.; Cecatti, Jose G.; Pacagnella, Rodolfo C.; Silveira, Carla; Parpinelli, Mary A.; Ferreira, Elton C.; Angelini, Carina R.; Santos, Juliana P.; Zanardi, Dulce M.; Cecchino, Gustavo N.; Souza, Renato T.; Sousa, Maria H.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Andreucci, Carla B.; Bussadori, Jamile C.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Maria Laura/I-4980-2019; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019; Cecchino, Gustavo/M-2220-2019; Polido, Carla Betina
   Andreucci/Y-9743-2019; Bussadori, Jamile/ABG-2450-2020; Andreucci, Carla
   B/J-4845-2015; Pacagnella, Rodolfo/H-6247-2012; Souza, Renato
   Teixeira/G-4205-2017; Cecatti, Jose Guilherme/M-5945-2013
OI Costa, Maria Laura/0000-0001-8280-3234; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Cecchino, Gustavo/0000-0003-1226-3353;
   Polido, Carla Betina Andreucci/0000-0002-5590-108X; Bussadori,
   Jamile/0000-0002-3048-5593; Andreucci, Carla B/0000-0002-5590-108X;
   Pacagnella, Rodolfo/0000-0002-5739-0009; Souza, Renato
   Teixeira/0000-0002-9075-9269; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; ANGELINI, CARINA R/0000-0002-6351-0628
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [471142/2011-5]
FX This study was fully sponsored by the Brazilian National Research
   Council (CNPq, research grant 471142/2011-5), which however played no
   role whatsoever in planning, implementing, analyzing, discussing results
   or writing the current manuscript.
CR Abdo CHN, 2010, MENOPAUSE, V17, P1114, DOI 10.1097/gme.0b013e3181e19755
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Blumel JE, 2009, MENOPAUSE, V16, P1139, DOI 10.1097/gme.0b013e3181a4e317
   Burri AV, 2009, J SEX MED, V6, P646, DOI 10.1111/j.1743-6109.2008.01144.x
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2011, CAD SAUDE PUBLICA, V27, P1801, DOI 10.1590/S0102-311X2011000900013
   de Araujo DB, 2010, ACTA REUMATOL PORT, V35, P16
   De Souza A, 2015, BJOG-INT J OBSTET GY, V122, P1410, DOI 10.1111/1471-0528.13331
   Ferreira DQ, 2012, REV BRAS GINECOL OBS, V34, P409, DOI 10.1590/S0100-72032012000900004
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   FRANKENBURG WK, 1992, PEDIATRICS, V89, P91
   Ganaba R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-22
   Handa VL, 2006, SEMIN PERINATOL, V30, P253, DOI 10.1053/j.semperi.2006.07.004
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537
   Leeman LM, 2012, OBSTET GYNECOL, V119, P647, DOI 10.1097/AOG.0b013e3182479611
   Lewis RW, 2004, J SEX MED, V1, P35, DOI 10.1111/j.1743-6109.2004.10106.x
   Mitchell KR, 2013, LANCET, V382, P1817, DOI 10.1016/S0140-6736(13)62366-1
   Morotti M, 2014, J SEX MED, V11, P1495, DOI 10.1111/jsm.12506
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Pacagnella RD, 2008, CAD SAUDE PUBLICA, V24, P416, DOI 10.1590/S0102-311X2008000200021
   Ribeiro MC, 2012, J SEX MED, V9, P786, DOI 10.1111/j.1743-6109.2011.02577.x
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Waterstone M, 2003, BJOG-INT J OBSTET GY, V110, P128, DOI 10.1016/S1470-0328(02)02951-8
   West SL, 2004, ANN REV SEX RES, V15, P40
   WHO. Management of substance abuse, 2011, MAN SUBST AB ASSIST
   Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206
   World Health Organisation (WHO), 2010, MEAS HLTH DIS MAN WH
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   Yeniel AO, 2014, INT UROGYNECOL J, V25, P5, DOI 10.1007/s00192-013-2118-7
NR 32
TC 11
Z9 11
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2015
VL 10
IS 12
AR e0143581
DI 10.1371/journal.pone.0143581
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX8BI
UT WOS:000365926300064
PM 26629897
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
AF Costa, Maria Laura
TI Preeclampsia: Reflections on How to Counsel About Preventing Recurrence
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
LA English
DT Article
DE Preeclampsia; pregnancy; maternal morbidity; recurrence
ID CALCIUM SUPPLEMENTATION; HYPERTENSIVE DISORDERS; ANTIPHOSPHOLIPID
   ANTIBODIES; PREGNANT-WOMEN; LOW-INCOME; HIGH-RISK; HEALTH; WEIGHT;
   LUPUS; PREDICTION
AB Preeclampsia is one of the most challenging diseases of pregnancy, with unclear etiology, no specific marker for prediction, and no precise treatment besides delivery of the placenta. Many risk factors have been identified, and diagnostic and management tools have improved in recent years. However, this disease remains one of the leading causes of maternal morbidity and mortality worldwide, especially in under-resourced settings. A history of previous preeclampsia is a known risk factor for a new event in a future pregnancy, with recurrence rates varying from less than 10% to 65%, depending on the population or methodology considered. A recent review that performed an individual participant data meta-analysis on the recurrence of hypertensive disorders of pregnancy in over 99 000 women showed an overall recurrence rate of 20.7%; when specifically considering preeclampsia, it was 13.8%, with milder disease upon recurrence. Prevention of recurrent preeclampsia has been attempted by changes in lifestyle, dietary supplementation, antihypertensive drugs, antithrombotic agents, and others, with much uncertainty about benefit. It is always challenging to treat and counsel a woman with a previous history of preeclampsia; this review will be based on hypothetical clinical cases, using common scenarios in obstetrical practice to consider the available evidence on how to counsel each woman during pre-conception and prenatal consultations.
C1 [Costa, Maria Laura] Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
CR Ahmed R, 2014, J AM COLL CARDIOL, V63, P1815, DOI 10.1016/j.jacc.2014.02.529
   Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56
   BELIZAN JM, 1980, AM J CLIN NUTR, V33, P2202
   Berenson AB, 2014, OBSTET GYNECOL, V124, P579, DOI 10.1097/AOG.0000000000000416
   Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677
   Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6
   Campbell-Jackson L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0423-x
   Carson MP, 2015, SEMIN PERINATOL, V39, P284, DOI 10.1053/j.semperi.2015.05.007
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   COCKBURN J, 1982, LANCET, V1, P647
   Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202
   Crawford NM, 2015, OBSTET GYN CLIN N AM, V42, P15, DOI 10.1016/j.ogc.2014.09.005
   D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   El Hassan MA, 2015, CLIN CHEM, V61, P694, DOI 10.1373/clinchem.2014.230565
   Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002
   Grace T, 2014, PREGNANCY HYPERTENS, V4, P209, DOI 10.1016/j.preghy.2014.04.003
   Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026
   Hakim J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953150
   HAMLIN RHJ, 1952, LANCET, V262, P64
   Hofmeyr GJ, 2007, BJOG-INT J OBSTET GY, V114, P933, DOI 10.1111/j.1471-0528.2007.01389.x
   Hofmeyr GJ, 2014, BJOG-INT J OBSTET GY, V121, P951, DOI 10.1111/1471-0528.12613
   Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4
   Jarjou LMA, 2010, AM J CLIN NUTR, V92, P450, DOI 10.3945/ajcn.2010.29217
   Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002
   Levy RA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00205
   Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345
   Magee LA, 2015, BEST PRACT RES CL OB, V29, P643, DOI 10.1016/j.bpobgyn.2015.04.001
   Magee LA, 2015, NEW ENGL J MED, V372, P407, DOI 10.1056/NEJMoa1404595
   McGuire W, 2010, SEMIN FETAL NEONAT M, V15, P108, DOI 10.1016/j.siny.2009.09.005
   Myatt L, 2014, HYPERTENSION, V63, P1293, DOI 10.1161/HYPERTENSIONAHA.113.02664
   Olafsdottir AS, 2006, BJOG-INT J OBSTET GY, V113, P301, DOI 10.1111/j.1471-0528.2006.00826.x
   Oliveira FC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-77
   Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x
   Ostensen M, 2015, AUTOIMMUN REV, V14, P376, DOI 10.1016/j.autrev.2014.12.011
   Pauli JM, 2015, OBSTET GYN CLIN N AM, V42, P299, DOI 10.1016/j.ogc.2015.01.007
   Powrie RO, 2007, JAMA-J AM MED ASSOC, V298, P1548, DOI 10.1001/jama.298.13.1548
   Redman Cwg, 2014, Pregnancy Hypertens, V4, P241, DOI [10.1016/j.preghy.2014.04.008, 10.1016/j.preghy.2014.04.009]
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Ruiz-Irastorza G, 2011, EUR J CLIN INVEST, V41, P672, DOI 10.1111/j.1365-2362.2010.02443.x
   Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X
   Schoenaker DAJM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0157-7
   Sibai BM, 2015, NAT REV ENDOCRINOL, V11, P6, DOI 10.1038/nrendo.2014.199
   Soh MC, 2015, RHEUMATOLOGY, V54, P572, DOI 10.1093/rheumatology/keu394
   Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Stojan G, 2012, EXPERT REV CLIN IMMU, V8, P439, DOI [10.1586/eci.12.36, 10.1586/ECI.12.36]
   Van Oostwaard MF, 2014, PREGNANCY HYPERTENS, V4, P194, DOI 10.1016/j.preghy.2014.04.001
   Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x
   von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8
   von Dadelszen P, 2012, J OBSTET GYNAECOL CA, V34, P917, DOI 10.1016/S1701-2163(16)35405-6
   Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203
NR 55
TC 5
Z9 6
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1701-2163
J9 J OBSTET GYNAECOL CA
JI J. Obstet. Gynaecol. Can.
PD OCT
PY 2015
VL 37
IS 10
BP 887
EP 893
DI 10.1016/S1701-2163(16)30023-8
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA VF7LZ
UT WOS:000443508200006
PM 26606702
OA Bronze
DA 2020-12-08
ER

PT J
AU Leonardo, DP
   Albuquerque, DM
   Lanaro, C
   Baptista, LC
   Cecatti, JG
   Surita, FG
   Parpinelli, MA
   Costa, FF
   Franco-Penteado, CF
   Fertrin, KY
   Costa, ML
AF Leonardo, Daniela P.
   Albuquerque, Dulcinela M.
   Lanaro, Carolina
   Baptista, Leticia C.
   Cecatti, Jose G.
   Surita, Fernanda G.
   Parpinelli, Mary A.
   Costa, Fernando F.
   Franco-Penteado, Carla F.
   Fertrin, Kleber Y.
   Costa, Maria Laura
TI Association of Nitric Oxide Synthase and Matrix Metalloprotease Single
   Nucleotide Polymorphisms with Preeclampsia and Its Complications
SO PLOS ONE
LA English
DT Article
ID CORONARY-ARTERY-DISEASE; HYPERTENSIVE DISORDERS; CARDIOVASCULAR-DISEASE;
   (MMP)-2 POLYMORPHISMS; MATERNAL MORTALITY; MMP-2 LEVELS; GENE;
   PREGNANCY; RISK; VARIANT
AB Background
   Preeclampsia is one of the leading causes of maternal and neonatal morbidity and mortality in the world, but its appearance is still unpredictable and its pathophysiology has not been entirely elucidated. Genetic studies have associated single nucleotide polymorphisms in genes encoding nitric oxide synthase and matrix metalloproteases with preeclampsia, but the results are largely inconclusive across different populations.
   Objectives
   To investigate the association of single nucleotide polymorphisms (SNPs) in NOS3 (G894T, T-786C, and a variable number of tandem repetitions VNTR in intron 4), MMP2 (C-1306T), and MMP9 (C-1562T) genes with preeclampsia in patients from Southeastern Brazil.
   Methods
   This prospective case-control study enrolled 77 women with preeclampsia and 266 control pregnant women. Clinical data were collected to assess risk factors and the presence of severe complications, such as eclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.
   Results
   We found a significant association between the single nucleotide polymorphism NOS3 T-786C and preeclampsia, independently from age, height, weight, or the other SNPs studied, and no association was found with the other polymorphisms. Age and history of preeclampsia were also identified as risk factors. The presence of at least one polymorphic allele for NOS3 T-786C was also associated with the occurrence of eclampsia or HELLP syndrome among preeclamptic women.
   Conclusions
   Our data support that the NOS3 T-786C SNP is associated with preeclampsia and the severity of its complications.
C1 [Leonardo, Daniela P.; Albuquerque, Dulcinela M.; Lanaro, Carolina; Baptista, Leticia C.; Costa, Fernando F.; Franco-Penteado, Carla F.; Fertrin, Kleber Y.] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil.
   [Cecatti, Jose G.; Surita, Fernanda G.; Parpinelli, Mary A.; Costa, Maria Laura] Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynaecol, Sao Paulo, Brazil.
   [Fertrin, Kleber Y.] Univ Campinas UNICAMP, Sch Med, Dept Clin Pathol, Sao Paulo, Brazil.
RP Fertrin, KY (corresponding author), Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil.
EM fertrin@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Costa, Maria Laura/I-4980-2019;
   Cecatti, Jose Guilherme/M-5945-2013; Fertrin, Kleber/M-4175-2013; Costa,
   Fernando/D-1566-2012
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Costa, Maria
   Laura/0000-0001-8280-3234; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Fertrin, Kleber/0000-0003-2637-3297; Costa,
   Fernando/0000-0002-4632-572X; Leonardo, Daniela/0000-0002-7413-8606
FU FAEPEX - PRP/UNICAMP (Fundo de Apoio ao Ensino, Pesquisa e Extensao)
   [MLC 699/13]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FFC
   2014/00984-3, 2008/57441-0]
FX This study was financially supported by FAEPEX - PRP/UNICAMP (Fundo de
   Apoio ao Ensino, Pesquisa e Extensao, grant to MLC 699/13), FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants to FFC
   2014/00984-3 and 2008/57441-0). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahmed R, 2014, J AM COLL CARDIOL, V63, P1815, DOI 10.1016/j.jacc.2014.02.529
   Alpoim PN, 2014, NITRIC OXIDE-BIOL CH, V42, P19, DOI 10.1016/j.niox.2014.07.006
   [Anonymous], 2002, OBSTET GYNECOL, V99, P159
   Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12
   Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640
   Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302
   Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257
   Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617
   Dai BQ, 2013, GENE, V519, P187, DOI 10.1016/j.gene.2013.01.004
   Davis LG, 1986, BASIC METHOD MOL BIO
   De Moura RR, 2015, AM J HUM BIOL, V27, P674, DOI 10.1002/ajhb.22714
   El Hassan MA, 2015, CLIN CHEM, V61, P694, DOI 10.1373/clinchem.2014.230565
   Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670
   Fernandez-Patron C, 1999, CIRC RES, V85, P906
   Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151
   Fraser R, 2008, BJOG-INT J OBSTET GY, V115, P1052, DOI 10.1111/j.1471-0528.2008.01771.x
   Hakli T, 2003, J SOC GYNECOL INVEST, V10, P154, DOI 10.1016/S1071-5576(03)00003-0
   Haram K, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/910751
   Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515
   Hsu P, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00125
   Kobashi G, 2001, AM J MED GENET, V103, P241, DOI 10.1002/ajmg.1535
   Landau R, 2004, AM J HYPERTENS, V17, P391, DOI 10.1016/j.amjhyper.2004.01.006
   Luizon MR, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/914704
   MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127
   MARSDEN PA, 1993, J BIOL CHEM, V268, P17478
   Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629
   Morgan AR, 2003, J MOL MED-JMM, V81, P321, DOI 10.1007/s00109-003-0441-z
   Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836
   Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9
   Palei ACT, 2012, PHARMACOGENOMICS J, V12, P489, DOI 10.1038/tpj.2011.31
   Palei ACT, 2012, BASIC CLIN PHARMACOL, V111, P262, DOI 10.1111/j.1742-7843.2012.00905.x
   Palei ACT, 2012, EXP MOL PATHOL, V92, P217, DOI 10.1016/j.yexmp.2012.01.008
   Pollanen PJ, 2001, ARTERIOSCL THROM VAS, V21, P1446, DOI 10.1161/hq0901.095545
   Rahimi Z, 2014, GENE, V538, P176, DOI 10.1016/j.gene.2013.12.013
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Sandrim VC, 2010, MOL HUM REPROD, V16, P506, DOI 10.1093/molehr/gaq030
   Sandrini VC, 2008, PHARMACOGENOMICS, V9, P1467, DOI 10.2217/14622416.9.10.1467
   Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305
   Seremak-Mrozikiewicz A, 2011, J MATERN-FETAL NEO M, V24, P432, DOI 10.3109/14767058.2010.511329
   Serrano NC, 2004, HYPERTENSION, V44, P702, DOI 10.1161/01.HYP.0000143483.66701.ec
   Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8
   Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9
   Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41
   Yoshimura T, 2000, J SOC GYNECOL INVEST, V7, P238, DOI 10.1016/S1071-5576(00)00060-5
   Yu Christina K H, 2006, BMC Pregnancy Childbirth, V6, P7, DOI 10.1186/1471-2393-6-7
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
   Zhang JH, 1999, J CELL PHYSIOL, V181, P312, DOI 10.1002/(SICI)1097-4652(199911)181:2<312::AID-JCP13>3.0.CO;2-1
NR 50
TC 15
Z9 18
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2015
VL 10
IS 8
AR e0136693
DI 10.1371/journal.pone.0136693
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ0PO
UT WOS:000360299100123
PM 26317342
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, EC
   Pacagnella, RC
   Costa, ML
   Cecatti, JG
AF Ferreira, Elton C.
   Pacagnella, Rodolfo C.
   Costa, Maria L.
   Cecatti, Jose G.
TI The Robson ten-group classification system for appraising deliveries at
   a tertiary referral hospital in Brazil
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Cesarean delivery; Severe maternal morbidity; Cesarean classification;
   Birth
ID CESAREAN-SECTION; RATES; CANADA; HEALTH; BIRTH; LABOR
AB Objective: To evaluate the distribution of women according to the Robson 10-group classification system (RTGCS) and the occurrence of severe maternal morbidity (SMM) by mode of delivery at a tertiary referral hospital. Methods: A retrospective cross-sectional study was conducted of all women admitted to the Women's Hospital at the University of Campinas (Campinas, Brazil) for delivery between January 2009 and July 2013. Women were grouped according to RTGCS. Mode of delivery and SMM (defined as need for admission to the intensive care unit) were assessed. Results: Among 12 771 women, 5957 (46.6%) delivered by cesarean. Overall, 3594 (28.1%) women were in group 1 (nulliparous, single pregnancy, cephalic, term, spontaneous labor), 2328 (18.2%) in group 5 (>= 1 previous cesarean, single pregnancy, cephalic, term), and 2112 (16.5%) in group 3 (multiparous excluding previous cesarean, single pregnancy, cephalic, term, spontaneous labor). Group 5 contributed the most cesarean deliveries (1626 [27.3%]), followed by group 2 (nulliparous, single pregnancy, cephalic, term, induced labor or cesarean before labor; 1049 [17.6%]). SMM was more common among women undergoing cesarean delivery than among those delivering vaginally in groups 1-5. Conclusion: The RTGCS allowed the identification of groups with the highest frequency of cesarean delivery and an assessment of SMM. This should be considered in related health policies. (C) 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Ferreira, Elton C.; Pacagnella, Rodolfo C.; Costa, Maria L.; Cecatti, Jose G.] Univ Estadual Campinas, Dept Obstet & Gynecol, Sch Med Sci, BR-13083881 Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Pacagnella, Rodolfo/H-6247-2012;
   Costa, Maria Laura/I-4980-2019; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Pacagnella,
   Rodolfo/0000-0002-5739-0009; Costa, Maria Laura/0000-0001-8280-3234; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009
CR Abdel-Aleem H, 2013, INT J GYNECOL OBSTET, V123, P119, DOI 10.1016/j.ijgo.2013.05.011
   [Anonymous], 1985, LANCET, V2, P436
   [Anonymous], FERT RAT TOT BIRTHS
   Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397
   Belizan JM, 2007, EPIDEMIOLOGY, V18, P485, DOI 10.1097/EDE.0b013e318068646a
   Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x
   Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18
   Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x
   Colais P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-54
   Costa ML, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-13
   Delbaere I, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-3
   Farine D, 2012, J OBSTET GYNAECOL CA, V34, P976, DOI 10.1016/S1701-2163(16)35412-3
   Grant Darren, 2005, Health Care Manag Sci, V8, P5, DOI 10.1007/s10729-005-5212-7
   Kelly S, 2013, J OBSTET GYNAECOL CA, V35, P206, DOI 10.1016/S1701-2163(15)30992-0
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025
   Paleari Leonardo, 2012, Ginecol Obstet Mex, V80, P263
   Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156
   Robson MS, 2001, FETAL MATERNAL MED R, V12, P23, DOI DOI 10.1017/S0965539501000122
   Ross S, 2005, J OBSTET GYNAECOL CA, V27, P51, DOI 10.1016/S1701-2163(16)30172-4
   Rossi AC, 2008, AM J OBSTET GYNECOL, V199, P224, DOI 10.1016/j.ajog.2008.04.025
   Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566
   Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7
   Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104
NR 26
TC 10
Z9 13
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUN
PY 2015
VL 129
IS 3
BP 236
EP 239
DI 10.1016/j.ijgo.2014.11.026
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CJ7WD
UT WOS:000355710200011
PM 25704253
DA 2020-12-08
ER

PT J
AU Trigo, LAMC
   Surita, FG
   Parpinelli, MA
   Pereira, BG
   Fertrin, KY
   Costa, ML
AF Monteiro Castro Trigo, Lucas Augusto
   Surita, Fernanda Garanhani
   Parpinelli, Mary Angela
   Pereira, Belmiro Goncalves
   Fertrin, Kleber Yotsumoto
   Costa, Maria Laura
TI Beta thalassemia major and pregnancy during adolescence: report of two
   cases
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA Portuguese
DT Article
DE Beta-thalassemia; Pregnancy, high-risk; Fetal growth restriction; Blood
   transfusion; Case reports
AB Beta thalassemia major is a rare hereditary blood disease in which impaired synthesis of beta globin chains causes severe anemia. Medical treatment consists of chronic blood transfusions and iron chelation. We describe two cases of adolescents with beta thalassemia major with unplanned pregnancies and late onset of prenatal care. One had worsening of anemia with increased transfusional requirement, fetal growth restriction, and placental senescence. The other was also diagnosed with hypothyroidism and low maternal weight, and was admitted twice during pregnancy due to dengue shock syndrome and influenza H1N1-associated respiratory infection. She also developed fetal growth restriction and underwent vaginal delivery at term complicated by uterine hypotonia. Both patients required blood transfusions after birth and chose medroxyprogesterone as a contraceptive method afterwards. This report highlights the importance of medical advice on contraceptive methods for these women and the role of a specialized prenatal follow-up in association with a hematologist.
C1 [Monteiro Castro Trigo, Lucas Augusto; Surita, Fernanda Garanhani; Parpinelli, Mary Angela; Pereira, Belmiro Goncalves; Costa, Maria Laura] Univ Estadual Campinas, Univ Estadual Campinas, Fac Ciencias Med, Dept Tocoginecol, Campinas, SP, Brazil.
   [Fertrin, Kleber Yotsumoto] Univ Estadual Campinas, Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil.
RP Trigo, LAMC (corresponding author), Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
RI Costa, Maria Laura/I-4980-2019; Surita, Fernanda Garanhani/H-9575-2012;
   Fertrin, Kleber/M-4175-2013
OI Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Fertrin, Kleber/0000-0003-2637-3297
CR Aessopos A, 1999, AM J OBSTET GYNECOL, V180, P360, DOI 10.1016/S0002-9378(99)70214-0
   Afrakhteh M, 2014, REV BRAS GINECOL OBS, V36, P35, DOI 10.1590/S0100-72032014000100008
   Borgna-Pignatti C, 2011, EXPERT REV HEMATOL, V4, P353, DOI [10.1586/EHM.11.29, 10.1586/ehm.11.29]
   Tavares NMC, 2013, REV BRAS GINECOL OBS, V35, P33, DOI 10.1590/S0100-72032013000100007
   Danjou F, 2015, HAEMATOLOGICA, V100, P455, DOI 10.3324/haematol.2014.113886
   de Oliveira FC, 2013, CLINICS, V68, P922, DOI 10.6061/clinics/2013(07)06
   Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630
   Gulino FA, 2013, BRATISL MED J, V114, P523, DOI 10.4149/BLL_2013_109
   Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3
   Marsella M, 2014, HEMATOL ONCOL CLIN N, V28, P703, DOI 10.1016/j.hoc.2014.04.004
   Maulik D, 2010, CLIN OBSTET GYNECOL, V53, P869, DOI 10.1097/GRF.0b013e3181fbb5f5
   McCarthy FP, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5887
   Naik RP, 2012, HEMATOL-AM SOC HEMAT, P208, DOI 10.1182/asheducation-2012.1.208
   dos Santos GHN, 2008, REV BRAS GINECOL OBS, V30, P224, DOI 10.1590/S0100-72032008000500004
   Origa R, 2010, HAEMATOL-HEMATOL J, V95, P376, DOI 10.3324/haematol.2009.012393
   Ott MA, 2014, PEDIATRICS, V134, pE1244, DOI 10.1542/peds.2014-2299
   Owen P, 2003, BJOG-INT J OBSTET GY, V110, P411, DOI [10.1016/S1470-0328(03)02971-9, 10.1046/j.1471-0528.2003.02371.x]
   Rachmilewitz EA, 2011, BLOOD, V118, P3479, DOI 10.1182/blood-2010-08-300335
   Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814
   Silva Camila de Azevedo, 2015, Rev. paul. pediatr., V33, P19, DOI 10.1016/j.rpped.2014.08.001
   Singer ST, 1999, AM J HEMATOL, V60, P24, DOI 10.1002/(SICI)1096-8652(199901)60:1<24::AID-AJH5>3.0.CO;2-C
   Singer ST, 2011, BLOOD, V118, P2878, DOI 10.1182/blood-2011-06-360271
   Thompson AA, 2013, AM J HEMATOL, V88, P771, DOI 10.1002/ajh.23506
   Toumba M., 2008, Eastern Mediterranean Health Journal, V14, P628
   Toumba Meropi, 2007, Pediatr Endocrinol Rev, V5, P642
   Verissimo Monica Pinheiro de Almeida, 2013, Rev. Bras. Hematol. Hemoter., V35, P428, DOI 10.5581/1516-8484.20130106
   Waseem F, 2011, INDIAN J PATHOL MICR, V54, P761, DOI 10.4103/0377-4929.91489
   Weatherall DJ, 2011, BRIT J HAEMATOL, V154, P736, DOI 10.1111/j.1365-2141.2011.08742.x
   Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692
NR 29
TC 0
Z9 0
U1 0
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUN
PY 2015
VL 37
IS 6
BP 291
EP 296
DI 10.1590/SO100-720320150005169
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA VA8ZI
UT WOS:000410568300008
PM 26200828
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, EC
   Costa, ML
   Cecatti, JG
   Haddad, SM
   Parpinelli, MA
   Robson, MS
AF Ferreira, Elton Carlos
   Costa, Maria Laura
   Cecatti, Jose Guilherme
   Haddad, Samira M.
   Parpinelli, Mary Angela
   Robson, Michael S.
CA Brazilian Network Surveillance
TI Robson Ten Group Classification System Applied to Women with Severe
   Maternal Morbidity
SO BIRTH-ISSUES IN PERINATAL CARE
LA English
DT Article
DE cesarean delivery; classification of cesarean delivery; maternal near
   miss; severe maternal morbidity
ID CESAREAN-SECTIONS; TRENDS; EPIDEMIOLOGY; CANADA; BIRTHS; RATES
AB ObjectiveTo evaluate the distribution of women with severe maternal morbidity according to Robson Ten Group Classification System (RTGCS).
   MethodsSecondary analysis of a multicenter cross-sectional study in 27 obstetric units in Brazil, using RTGCS. Cases were classified into potentially life-threatening condition or a maternal near miss or death, according to severity. Certain groups were subdivided for further analysis. Cesarean delivery (CD) rates were reported.
   ResultsAmong 7,247 women with severe maternal morbidity, 73.2 percent underwent CD. Group 10 (single, cephalic, preterm) was the most prevalent (33.9%). Groups mostly associated with a severe maternal outcome were: 7 (multiparous, breech), 9 (all abnormal lies, single, term), 8 (all multiple), and 10. Groups 1 (nulliparous, single, cephalic, term, spontaneous) and 3 (multiparous, single, cephalic, term, spontaneous) were associated with better maternal outcome. Group 3 had one severe maternal morbidity to 29 cases of potentially life-threatening, but the ratio was 1:10 for women undergoing CD, indicating a worse outcome. Group 4a (multiparous, no previous CD, single, cephalic, term, induced labor) had a better maternal outcome than those delivered by CD before labor (group 4b). Hypertension was the most common condition of severity.
   ConclusionsThe RTGCS was useful to consider severe maternal morbidity, showing groups with higher CD rates and worse maternal outcomes.
C1 [Ferreira, Elton Carlos; Costa, Maria Laura; Haddad, Samira M.] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Cecatti, Jose Guilherme; Parpinelli, Mary Angela] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Obstet, BR-13083881 Campinas, SP, Brazil.
   [Robson, Michael S.] Natl Matern Hosp, Obstet, Dublin 2, Ireland.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Gynecol & Obstet, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
RI Moises, Elaine Christine Dantas/N-9522-2019; Moises, Elaine/A-5708-2015;
   Costa, Maria Laura/I-4980-2019; Nakamura-Pereira, Marcos/X-1107-2019;
   Cecatti, Jose Guilherme/M-5945-2013; CORDIOLI, EDUARDO/AAR-6100-2020;
   Rudge, Marilza V C/C-8338-2012; Amorim, Melania M/C-5807-2013; Calderon,
   Iracema/C-8136-2012
OI Moises, Elaine Christine Dantas/0000-0001-9099-4544; Moises,
   Elaine/0000-0001-9099-4544; Costa, Maria Laura/0000-0001-8280-3234;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; CORDIOLI, EDUARDO/0000-0001-5405-9380;
   Rudge, Marilza V C/0000-0002-9227-832X; Amorim, Melania
   M/0000-0003-1047-2514; Calderon, Iracema/0000-0003-4761-4336
FU CNPq/DECIT (The National Research Council); CNPq/DECIT (Department of
   Science and Technology of the Brazilian Ministry of Health); 
   [402702/2008-5]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), grant number 402702/2008-5 and
   also the involvement of its Steering Committee members and all other
   investigators and coordinators from all centers.
CR Almerie Y, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-65
   [Anonymous], 1985, LANCET, V2, P436
   Barros FC, 2010, AM J PUBLIC HEALTH, V100, P1877, DOI 10.2105/AJPH.2010.196816
   Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898
   Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18
   Brennan DJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.021
   Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x
   Ciriello E, 2012, J MATERN-FETAL NEO M, V25, P2717, DOI 10.3109/14767058.2012.712567
   Costa ML, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-13
   Delbaere I, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-3
   Farine D, 2012, J OBSTET GYNAECOL CA, V34, P976, DOI 10.1016/S1701-2163(16)35412-3
   Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099
   Gibbons L, 2010, GLOBAL NUMBERS COSTS
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Homer CSE, 2010, MIDWIFERY, V26, P532, DOI 10.1016/j.midw.2010.03.010
   Howell S, 2009, AUST NZ J OBSTET GYN, V49, P606, DOI 10.1111/j.1479-828X.2009.01100.x
   Karolinski A, 2013, BJOG-INT J OBSTET GY, V120, P1685, DOI 10.1111/1471-0528.12395
   Kelly S, 2013, J OBSTET GYNAECOL CA, V35, P206, DOI 10.1016/S1701-2163(15)30992-0
   Lee YY, 2013, MED J AUSTRALIA, V199, P348, DOI 10.5694/mja13.10279
   Luz AG, 2008, REV BRAS GINECOL OBS, V30, P281, DOI 10.1590/S0100-72032008000600003
   National Institutes of Health, 2010, Semin Perinatol, V34, P351, DOI 10.1053/j.semperi.2010.06.002
   Pacagnella RC, 2010, J OBSTET GYNAECOL CA, V32, P730, DOI 10.1016/S1701-2163(16)34612-6
   Roberts CL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001725
   Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156
   Robson MS, 2001, FETAL MATERNAL MED R, V12, P23, DOI DOI 10.1017/S0965539501000122
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566
   UN Department of Economic and Social Affairs, 2013, MILL DEV GOALS REP 2
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104
NR 31
TC 6
Z9 9
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-7659
EI 1523-536X
J9 BIRTH-ISS PERINAT C
JI Birth-Issue Perinat. Care
PD MAR
PY 2015
VL 42
IS 1
BP 38
EP 47
DI 10.1111/birt.12155
PG 10
WC Nursing; Obstetrics & Gynecology; Pediatrics
SC Nursing; Obstetrics & Gynecology; Pediatrics
GA CC1NQ
UT WOS:000350108200005
PM 25676792
DA 2020-12-08
ER

PT J
AU Rocha, EA
   Costa, ML
   Cecatti, JG
   Parpinelli, MA
   Haddad, SM
   Pacagnella, RC
   Sousa, MH
   Melo, EF
   Surita, FG
   Souza, JP
AF Rocha Filho, Edilberto A.
   Costa, Maria L.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Haddad, Samira M.
   Pacagnella, Rodolfo C.
   Sousa, Maria H.
   Melo, Elias F., Jr.
   Surita, Fernanda G.
   Souza, Joao P.
CA Brazilian Network Surveillance Sev
TI Severe maternal morbidity and near miss due to postpartum hemorrhage in
   a national multicenter surveillance study
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Maternal near miss; Postpartum hemorrhage; Retained placenta; Severe
   maternal morbidity; Tissue lacerations; Uterine atony
ID MULTICOUNTRY SURVEY; NEWBORN HEALTH; RISK-FACTORS; BLOOD-LOSS; DEATH;
   MORTALITY; NETWORK
AB Objective: To assess the occurrence of severe maternal complications owing to postpartum hemorrhage (PPH) and its associated factors. Methods: A secondary analysis of data from a multicenter cross-sectional prospective surveillance study included 9555 cases of severe maternal morbidity at 27 centers in Brazil between July 2009 and June 2010. Complications of PPH, conditions of severity management, and sociodemographic and obstetric characteristics were assessed. Factors independently associated with severe maternal outcome (SMO) were identified using multiple regression analysis. Results: Overall, 1192 (12.5%) of the 9555 women experienced complications owing to PPH (981 had potentially life-threatening conditions, 181 maternal near miss, and 30 had died). The SMO ratio was 2.6 per 1000 live births among women with PPH and 8.5 per 1000 live births among women with other complications. Women with PPH had a higher risk of blood transfusion and return to the operating theater than did those with complications from other causes. Maternal age, length of pregnancy, previous uterine scar, and cesarean delivery were the main factors associated with an increased risk of SMO secondary to PPH. Conclusion: PPH frequently leads to severe maternal morbidity. A surveillance system can identify the main causes of morbidity and could help to improve care, especially among women identified as being at high risk of PPH. (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Rocha Filho, Edilberto A.; Costa, Maria L.; Cecatti, Jose G.; Parpinelli, Mary A.; Haddad, Samira M.; Pacagnella, Rodolfo C.; Melo, Elias F., Jr.; Surita, Fernanda G.; Souza, Joao P.] Univ Estadual Campinas, Sch Med Sci, Dept Gynecol & Obstet, BR-13083881 Campinas, SP, Brazil.
   [Rocha Filho, Edilberto A.] Univ Fed Pernambuco, Sch Med, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.] Ctr Res Reprod Hlth Campinas, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Gynecol & Obstet, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Moises, Elaine/A-5708-2015; Nakamura-Pereira, Marcos/X-1107-2019;
   Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019;
   Surita, Fernanda Garanhani/H-9575-2012; Quintana, Silvana
   Maria/D-6953-2015; Amorim, Melania M/C-5807-2013; Moises, Elaine
   Christine Dantas/N-9522-2019; CORDIOLI, EDUARDO/AAR-6100-2020; Souza,
   Joao Paulo/G-1982-2010; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Rudge, Marilza V C/C-8338-2012; Calderon, Iracema/C-8136-2012; Peracoli,
   Jose Carlos/G-4923-2012
OI Moises, Elaine/0000-0001-9099-4544; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Quintana, Silvana
   Maria/0000-0002-9311-786X; Amorim, Melania M/0000-0003-1047-2514;
   Moises, Elaine Christine Dantas/0000-0001-9099-4544; CORDIOLI,
   EDUARDO/0000-0001-5405-9380; Souza, Joao Paulo/0000-0002-2288-4244; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Rudge, Marilza V
   C/0000-0002-9227-832X; Calderon, Iracema/0000-0003-4761-4336; Peracoli,
   Jose Carlos/0000-0002-3273-3001; Santana, Danielly/0000-0001-8912-2626;
   F Melo Jr, Elias/0000-0001-7897-8090
FU National Research CouncilConsiglio Nazionale delle Ricerche (CNR);
   Department of Science and Technology of the Brazilian Ministry of Health
   [402702/2008-5]
FX The authors acknowledge the financial support of the National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health (grant number 402702/2008-5).
CR Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59
   Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x
   Briley A, 2014, BJOG-INT J OBSTET GY, V121, P876, DOI 10.1111/1471-0528.12588
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591
   Glover Pauline, 2003, Aust J Midwifery, V16, P21, DOI 10.1016/S1031-170X(03)80005-3
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2
   Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d
   Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Prata N, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c555
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P254, DOI 10.1016/j.ijgo.2013.06.024
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   World Health Organization, 2012, WHO REC PREV TREATM
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
NR 23
TC 13
Z9 16
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD FEB
PY 2015
VL 128
IS 2
BP 131
EP 136
DI 10.1016/j.ijgo.2014.08.023
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CA9TQ
UT WOS:000349268100010
PM 25468058
DA 2020-12-08
ER

PT J
AU Rocha, EA
   Costa, ML
   Cecatti, JG
   Parpinelli, MA
   Haddad, SM
   Sousa, MH
   Melo, EF
   Surita, FG
   Souza, JP
AF Rocha Filho, Edilberto A.
   Costa, Maria L.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Haddad, Samira M.
   Sousa, Maria H.
   Melo, Elias F.
   Surita, Fernanda G.
   Souza, Joao P.
CA Brazilian Network Surveillance
TI Contribution of antepartum and intrapartum hemorrhage to the burden of
   maternal near miss and death in a national surveillance study
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE Maternal near miss; obstetric complication; maternal death; maternal
   morbidity; antepartum hemorrhage; intrapartum hemorrhage; obstetric
   hemorrhage
ID POSTPARTUM HEMORRHAGE; OBSTETRIC HEMORRHAGE; MORTALITY; TRANSFUSION;
   PREGNANCY; RISK
AB ObjectiveTo evaluate the occurrence of severe obstetric complications associated with antepartum and intrapartum hemorrhage among women from the Brazilian Network for Surveillance of Severe Maternal Morbidity.
   DesignMulticenter cross-sectional study.
   SettingTwenty-seven obstetric referral units in Brazil between July 2009 and June 2010.
   PopulationA total of 9555 women categorized as having obstetric complications.
   MethodsThe occurrence of potentially life-threatening conditions, maternal near miss and maternal deaths associated with antepartum and intrapartum hemorrhage was evaluated. Sociodemographic and obstetric characteristics and the use of criteria for management of severe bleeding were also assessed in these women.
   Main outcome measuresThe prevalence ratios with their respective 95% confidence intervals adjusted for the cluster effect of the design, and multiple logistic regression analysis were performed to identify factors independently associated with the occurrence of severe maternal outcome.
   ResultsAntepartum and intrapartum hemorrhage occurred in only 8% (767) of women experiencing any type of obstetric complication. However, it was responsible for 18.2% (140) of maternal near miss and 10% (14) of maternal death cases. On multivariate analysis, maternal age and previous cesarean section were shown to be independently associated with an increased risk of severe maternal outcome (near miss or death).
   ConclusionSevere maternal outcome due to antepartum and intrapartum hemorrhage was highly prevalent among Brazilian women. Certain risk factors, maternal age and previous cesarean delivery in particular, were associated with the occurrence of bleeding.
C1 [Rocha Filho, Edilberto A.; Costa, Maria L.; Cecatti, Jose G.; Parpinelli, Mary A.; Haddad, Samira M.; Sousa, Maria H.; Melo, Elias F.; Surita, Fernanda G.; Souza, Joao P.] State Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Cecatti, Jose G.] Ctr Studies Reprod Hlth Campinas Cemicamp, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Joao Paulo/G-1982-2010; Costa, Maria Laura/I-4980-2019; Cecatti,
   Jose Guilherme/M-5945-2013; Surita, Fernanda Garanhani/H-9575-2012
OI Souza, Joao Paulo/0000-0002-2288-4244; Costa, Maria
   Laura/0000-0001-8280-3234; Cecatti, Jose Guilherme/0000-0003-1285-8445;
   Surita, Fernanda Garanhani/0000-0003-4335-0337; F Melo Jr,
   Elias/0000-0001-7897-8090
FU CNPq/DECIT (The National Research Council) [402702/2008-5]; CNPq/DECIT
   (Department of Science and Technology of the Brazilian Ministry of
   Health) [402702/2008-5]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), grant number 402702/2008-5.
CR Alexander JM, 2013, OBSTET GYN CLIN N AM, V40, P15, DOI 10.1016/j.ogc.2012.12.003
   Allard S, 2014, BRIT J HAEMATOL, V164, P177, DOI 10.1111/bjh.12605
   Boisrame T, 2014, GYNECOL OBSTET FERTI, V42, P78, DOI 10.1016/j.gyobfe.2013.06.012
   Bonnet MP, 2011, TRANSFUS CLIN BIOL, V18, P129, DOI 10.1016/j.tracli.2011.02.011
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cheng HT, 2012, WORLD J SURG, V36, P2767, DOI 10.1007/s00268-012-1750-6
   Cook JR, 2013, BJOG-INT J OBSTET GY, V120, P1155, DOI 10.1111/1471-0528.12233
   Fitzpatrick KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052893
   Gasim T, 2013, J REPROD MED, V58, P312
   Giordano Rosalba, 2010, J Prenat Med, V4, P12
   Girard T, 2014, CURR OPIN ANESTHESIO, V27, P267, DOI 10.1097/ACO.0000000000000081
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Lawson GW, 2013, BIRTH-ISS PERINAT C, V40, P96, DOI 10.1111/birt.12041
   Marshall NE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.035
   Mercier Frederic J, 2008, Anesthesiol Clin, V26, P53, DOI 10.1016/j.anclin.2007.11.008
   Morikawa M, 2014, J OBSTET GYNAECOL RE, V40, P369, DOI 10.1111/jog.12175
   Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Su LL, 2012, BEST PRACT RES CL OB, V26, P77, DOI 10.1016/j.bpobgyn.2011.10.008
   Tikkanen M, 2013, ACTA OBSTET GYN SCAN, V92, P298, DOI 10.1111/aogs.12030
   Tikkanen M, 2011, ACTA OBSTET GYN SCAN, V90, P140, DOI 10.1111/j.1600-0412.2010.01030.x
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   World Health Organization, 2012, WHO REC PREV TREATM
   World Health Organization, 2013, MILL DEV GOALS REP
   World Health Organization UNICEF UNFPA World Bank, 2012, TRENDS MAT MORT 1990
   Yeung SW, 2012, AUST NZ J OBSTET GYN, V52, P167, DOI 10.1111/j.1479-828X.2011.01401.x
NR 30
TC 9
Z9 11
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD JAN
PY 2015
VL 94
IS 1
BP 50
EP 58
DI 10.1111/aogs.12529
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AX1JS
UT WOS:000346704100010
PM 25327163
DA 2020-12-08
ER

PT J
AU Suarez, MBB
   Costa, ML
   Parpinelli, MA
   Surita, FG
AF Bracco Suarez, Maria Beatriz
   Costa, Maria Laura
   Parpinelli, Mary Angela
   Surita, Fernanda Garanhani
TI Pregnancy in women undergoing hemodialysis: case series in a Southeast
   Brazilian reference center
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE Pregnancy; high risk; Hemodialysis; Polyhydramnios; Pregnancy outcomes
AB PURPOSE: To describe maternal and neonatal outcomes in pregnant women undergoing hemodialysis in a referral center in Brazilian Southeast side. METHODS: Retrospective and descriptive study, with chart review of all pregnancies undergoing hemodialysis that were followed-up at an outpatient clinic of high-risk prenatal care in Southeast Brazil. RESULTS: Among the 16 women identified, 2 were excluded due to follow-up loss. In 14 women described, hypertension was the most frequent cause of chronic renal failure (half of cases). The majority (71.4%) had performed hemodialysis treatment for more than one year and all of them underwent 5 to 6 hemodialysis sessions per week. Eleven participants had chronic hypertension, 1 of which was also diabetic, and 6 of them were smokers. Regarding pregnancy complications, 1 of the hypertensive women developed malignant hypertension (with fetal growth restriction and preterm delivery at 29 weeks), 2 had acute pulmonary edema and 2 had abruption placenta. The mode of delivery was cesarean section in 9 women (64.3%). All neonates had Apgar score at five minutes above 7. CONCLUSIONS: To improve perinatal and maternal outcomes of women undergoing hemodialysis, it is important to ensure multidisciplinary approach in referral center, strict control of serum urea, hemoglobin and maternal blood pressure, as well as close monitoring of fetal well-being and maternal morbidities. Another important strategy is suitable guidance for contraception in these women.
C1 Hosp da Mulher Prof Doutor Jose Aristodemo Pinott, UNICAMP, Obstet Div, Campinas, SP, Brazil.
   [Bracco Suarez, Maria Beatriz] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Tocogynecol Residence Program, Campinas, SP, Brazil.
   [Costa, Maria Laura; Parpinelli, Mary Angela; Surita, Fernanda Garanhani] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Tocogynecol, Campinas, SP, Brazil.
RP Surita, FG (corresponding author), Univ Estadual Campinas, Dept Tocoginecol, Fac Ciencias Med, Rue Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
RI Costa, Maria Laura/I-4980-2019; Surita, Fernanda Garanhani/H-9575-2012
OI Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
CR Bramham K, 2012, J NEPHROL, V25, P450, DOI 10.5301/jn.5000130
   Castellano G, 2011, KIDNEY BLOOD PRESS R, V34, P253, DOI 10.1159/000327904
   Chao AS, 2002, AM J OBSTET GYNECOL, V187, P152, DOI 10.1067/mob.2002.123200
   Espinoza F, 2013, REV MED CHILE, V141, P1003, DOI 10.4067/S0034-98872013000800006
   Furaz-Czerpak KR, 2012, NEFROLOGIA, V32, P287, DOI 10.3265/Nefrologia.pre2012.Jan.11319
   Hladunewich M, 2011, SEMIN DIALYSIS, V24, P634, DOI 10.1111/j.1525-139X.2011.00996.x
   Hladunewich MA, 2014, J AM SOC NEPHROL, V25, P1103, DOI 10.1681/ASN.2013080825
   Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9
   HOU SH, 1994, BAILLIERE CLIN OB GY, V8, P481, DOI 10.1016/S0950-3552(05)80332-3
   Piccoli GB, 2014, NEPHROL DIAL TRANSPL, V29, P1578, DOI 10.1093/ndt/gfu092
   Pipili C, 2011, HEMODIAL INT, V15, P306, DOI 10.1111/j.1542-4758.2011.00552.x
   Podymow T, 2010, OBSTET GYN CLIN N AM, V37, P195, DOI 10.1016/j.ogc.2010.02.012
   Reddy SS, 2007, ADV CHRONIC KIDNEY D, V14, P146, DOI 10.1053/j.ackd.2007.01.005
   Shahir AK, 2013, NEPHROLOGY, V18, P276, DOI 10.1111/nep.12044
   Shemin D, 2003, SEMIN DIALYSIS, V16, P379, DOI 10.1046/j.1525-139X.2003.16084_1.x
   Silva GB, 2009, ARCH GYNECOL OBSTET, V279, P131, DOI 10.1007/s00404-008-0682-8
   Siviero Pamila Cristina Lima, 2014, Cad. saúde colet., V22, P75, DOI 10.1590/1414-462X201400010012
NR 17
TC 1
Z9 2
U1 0
U2 7
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JAN
PY 2015
VL 37
IS 1
BP 5
EP 9
DI 10.1590/SO100-720320140005130
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA VA8YX
UT WOS:000410565700002
PM 25607123
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Baptista, LC
   Fertrin, KY
   Ferreira, R
   Lanaro, C
   Albuquerque, DM
   Costa, FF
   Costa, ML
   Melo, MB
AF Baptista, Leticia Carvalho
   Fertrin, Kleber Yotsumoto
   Ferreira, Regiane
   Lanaro, Carolina
   Albuquerque, Dulcineia Martins
   Costa, Fernando Ferreira
   Costa, Maria Laura
   Melo, Monica Barbosa
TI Hyperexpression of Inflammatory Genes in Placental Tissue in Patients
   with Hemoglobin SC Disease
SO BLOOD
LA English
DT Meeting Abstract
C1 [Baptista, Leticia Carvalho; Fertrin, Kleber Yotsumoto; Ferreira, Regiane; Lanaro, Carolina; Albuquerque, Dulcineia Martins; Costa, Fernando Ferreira; Costa, Maria Laura; Melo, Monica Barbosa] Univ Estadual Campinas, UNICAMP, Campinas, SP, Brazil.
RI de Albuquerque, Dulcineia Martins/U-8601-2019; Fertrin,
   Kleber/M-4175-2013
OI Fertrin, Kleber/0000-0003-2637-3297
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD DEC 6
PY 2014
VL 124
IS 21
PG 3
WC Hematology
SC Hematology
GA CA9KQ
UT WOS:000349242703059
DA 2020-12-08
ER

PT J
AU Passini, R
   Cecatti, JG
   Lajos, GJ
   Tedesco, RP
   Nomura, ML
   Dias, TZ
   Haddad, SM
   Rehder, PM
   Pacagnella, RC
   Costa, ML
   Sousa, MH
AF Passini, Renato, Jr.
   Cecatti, Jose G.
   Lajos, Giuliane J.
   Tedesco, Ricardo P.
   Nomura, Marcelo L.
   Dias, Tabata Z.
   Haddad, Samira M.
   Rehder, Patricia M.
   Pacagnella, Rodolfo C.
   Costa, Maria L.
   Sousa, Maria H.
CA Brazilian Multicentre Study Preter
TI Brazilian Multicentre Study on Preterm Birth (EMIP): Prevalence and
   Factors Associated with Spontaneous Preterm Birth
SO PLOS ONE
LA English
DT Article
ID MULTIPLE PREGNANCY; SHORT CERVIX; EPIDEMIOLOGY; METAANALYSIS; COUNTRIES;
   RISK
AB Background: Preterm birth rate is increasing and is currently a worldwide concern. The purpose of this study was to estimate the prevalence of preterm birth in a sample of health facilities in Brazil and to identify the main risk factors associated with spontaneous preterm births.
   Methods and Findings: This was a multicentre cross sectional study on preterm births in 20 referral obstetric hospitals with a case-control component to identify factors associated with spontaneous preterm birth. Surveillance was implemented at all centres to identify preterm births. For eligible consenting women, data were collected through a post-delivery questionnaire completed with information from all mother-newborn medical records until death or discharge or at a maximum of 60 days post-delivery, whichever came first. The risk of spontaneous preterm birth was estimated with OR and 95%CI for several predictors. A non-conditional logistic regression analysis was then performed to identify independently associated factors. The overall prevalence of preterm birth was 12.3%. Among them, 64.6% were spontaneous and 35.4% therapeutic. In the case-control component, 2,682 spontaneous preterm births were compared to a sample of 1,146 term births. Multivariate analyses identified the following as risk factors for spontaneous preterm birth among women with at least one previous birth: a previous preterm birth (ORadj = 3.19, 2.30-4.43), multiple pregnancy (ORadj = 29.06, 8.43-100.2), cervical insufficiency (ORadj = 2.93, 1.07-8.05), foetal malformation (ORadj = 2.63, 1.43-4.85), polyhydramnios (ORadj = 2.30, 1.17-4.54), vaginal bleeding (ORadj = 2.16, 1.50-3.11), and previous abortion (ORadj = 1.39, 1.08-1.78). High BMI (ORadj = 0.94, 0.91-0.97) and weight gain during gestation (ORadj = 0.92, 0.89-0.95) were found to be protective factors.
   Conclusions: The preterm birth rate in these health facilities in Brazil is high and spontaneous preterm births account for two thirds of them. A better understanding of the factors associated with spontaneous preterm birth is of utmost importance for planning effective measures to reduce the burden of its increasing rates.
C1 [Passini, Renato, Jr.; Cecatti, Jose G.; Lajos, Giuliane J.; Tedesco, Ricardo P.; Nomura, Marcelo L.; Dias, Tabata Z.; Haddad, Samira M.; Rehder, Patricia M.; Pacagnella, Rodolfo C.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.] Ctr Studies Reprod Hlth Campinas CEMICAMP, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.] Jundiai Sch Med, Jundiai, Brazil.
RP Passini, R (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
EM passini@caism.unicamp.br
RI de Carvalho Pacagnella, Rodolfo/H-9390-2019; Rehder,
   Patricia/N-6731-2015; Cecatti, Jose Guilherme/M-5945-2013; BORGES, VERA
   T/B-7363-2014; Quintana, Silvana Maria/D-6953-2015; Dias,
   T\\xc3\\x83\\xc2\\xa1bata/U-4512-2019; Nomura, Marcelo Luis/H-9534-2019;
   Passini Junior, Renato/O-6169-2016; Amorim, Melania M/C-5807-2013;
   Souza, Renato Teixeira/G-4205-2017
OI de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; BORGES, VERA T/0000-0002-9347-9641;
   Quintana, Silvana Maria/0000-0002-9311-786X; Passini Junior,
   Renato/0000-0001-8247-4549; Amorim, Melania M/0000-0003-1047-2514;
   Souza, Renato Teixeira/0000-0002-9075-9269; costa, maria
   laura/0000-0001-8280-3234
FU CNPq (Brazilian National Research Council)National Council for
   Scientific and Technological Development (CNPq); Fapesp (Foundation for
   Support to Research of the State of Sao Paulo) [Fapesp 2009/53245-5
   (Call AP.PPSUS-1)]
FX The authors thank the CNPq (Brazilian National Research Council) and
   Fapesp (Foundation for Support to Research of the State of Sao Paulo)
   for the financial sponsorship of this study, Process Fapesp 2009/53245-5
   (Call AP.PPSUS-1). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdel-Aleem H, 2013, COCHRANE DB SYST REV, V5
   Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P1557, DOI 10.1016/j.ajog.2006.05.021
   Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Blondel B, 2006, BJOG-INT J OBSTET GY, V113, P528, DOI 10.1111/j.1471-0528.2006.00923.x
   Brazil. United Nation Organisation, 2013, UNICEF SUPP STUD WAR
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   da Fonseca EB, 2009, SEMIN PERINATOL, V33, P334, DOI 10.1053/j.semperi.2009.06.006
   Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865
   Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2
   Hamilton BE, 2011, NATL VITAL STAT REP, V62, P1
   Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021
   Lajos GJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-54
   Lim K, 2011, J OBSTET GYNAECOL CA, V33, P486, DOI 10.1016/S1701-2163(16)34884-8
   McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428
   Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126
   Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308
   Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22
   Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181
   Polyzos NP, 2009, AM J OBSTET GYNECOL, V200, P225, DOI 10.1016/j.ajog.2008.09.020
   Reis Liane G., 2008, Rev. Bras. Saude Mater. Infant., V8, P217, DOI 10.1590/S1519-38292008000200009
   Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022
   Shiozaki A, 2014, J OBSTET GYNAECOL RE, V40, P53, DOI 10.1111/jog.12120
   Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x
   Tedesco RP, 2013, MATERN CHILD HLTH J, V17, P1638, DOI 10.1007/s10995-012-1177-6
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0
   WHO, 2012, BORN TOO SOON GLOB A
   Zhang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052780
NR 31
TC 43
Z9 43
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2014
VL 9
IS 10
AR e109069
DI 10.1371/journal.pone.0109069
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0AP
UT WOS:000343941200033
PM 25299699
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Giordano, JC
   Parpinelli, MA
   Cecatti, JG
   Haddad, SM
   Costa, ML
   Surita, FG
   Silva, JLPE
   Sousa, MH
AF Giordano, Juliana C.
   Parpinelli, Mary A.
   Cecatti, Jose G.
   Haddad, Samira M.
   Costa, Maria L.
   Surita, Fernanda G.
   Pinto e Silva, Joao L.
   Sousa, Maria H.
TI The Burden of Eclampsia: Results from a Multicenter Study on
   Surveillance of Severe Maternal Morbidity in Brazil
SO PLOS ONE
LA English
DT Article
ID NEAR-MISS; MORTALITY; PREECLAMPSIA; PREGNANCY; DEATH; INTERVENTIONS;
   NETWORK; HEALTH; UNIT; CARE
AB Objective: Maternal mortality (MM) is a core indicator of disparities in women's rights. The study of Near Miss strategic to identifying the breakdowns in obstetrical care. In absolute numbers, both MM and occurrence of eclampsia are rare events. We aim to assess the obstetric care indicators and main predictors for severe maternal outcome from eclampsia (SMO: maternal death plus maternal near miss).
   Methods: Secondary analysis of a multicenter, cross-sectional study, including 27 centers from all geographic regions of Brazil, from 2009 to 2010. 426 cases of eclampsia were identified and classified according to the outcomes: SMO and non-SMO. We classified facilities as coming from low-and high-income regions and calculated the WHO's obstetric health indicators. SPSS and Stata softwares were used to calculate the prevalence ratios (PR) and respective 95% confidence interval (CI) to assess maternal characteristics, clinical and obstetrical history, and access to health services as predictors for SMO, subsequently correlating them with the corresponding perinatal outcomes, also applying multiple regression analysis (adjusted for cluster effect).
   Results: Prevalence of and mortality indexes for eclampsia in higher and lower income regions were 0.2%/ 0.8% and 8.1%/22%, respectively. Difficulties in access to health care showed that ICU admission (adjPR 3.61; 95% CI 1.77-7.35) and inadequate monitoring (adjPR 2.31; 95% CI 1.48-3.59) were associated with SMO.
   Conclusions: Morbidity and mortality associated with eclampsia were high in Brazil, especially in lower income regions. Promoting quality maternal health care and improving the availability of obstetric emergency care are essential actions to relieve the burden of eclampsia.
C1 [Giordano, Juliana C.; Parpinelli, Mary A.; Cecatti, Jose G.; Haddad, Samira M.; Costa, Maria L.; Surita, Fernanda G.; Pinto e Silva, Joao L.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.] Ctr Studies Reprod Hlth Campinas CEMICAMP, Campinas, SP, Brazil.
RP Parpinelli, MA (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM parpinelli@caism.unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019;
   Surita, Fernanda Garanhani/H-9575-2012
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria
   Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX The study was financially supported by CNPq/DECIT (The National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health), grant number 402702/2008-5. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005
   Brazil, 2010, MILL DEV GOALS NAT R
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   DATASUS, INF HLTH VIT STAT
   DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000127.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002
   Fong A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.050
   Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Khosla AH, 2000, INT J GYNECOL OBSTET, V68, P163, DOI 10.1016/S0020-7292(99)00185-X
   Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846
   Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x
   Kullberg G, 2002, HYPERTENS PREGNANCY, V21, P13, DOI 10.1081/PRG-120002906
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   McDonald SD, 2012, INT J GYNECOL OBSTET, V118, P90, DOI 10.1016/j.ijgo.2012.01.028
   Morikawa M, 2012, INT J GYNECOL OBSTET, V117, P66, DOI 10.1016/j.ijgo.2011.11.009
   Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   PNUD Brazil, 2010, PROGR UN DEV
   Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Schutte JM, 2008, BJOG-INT J OBSTET GY, V115, P732, DOI 10.1111/j.1471-0528.2008.01702.x
   Sousa Maria H, 2008, Reprod Health, V5, P6, DOI 10.1186/1742-4755-5-6
   Souza JP, 2010, BJOG-INT J OBSTET GY, V117, P1586, DOI 10.1111/j.1471-0528.2010.02746.x
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   United Nations, 2013, MILL DEV GOALS
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 33
TC 20
Z9 20
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2014
VL 9
IS 5
AR e97401
DI 10.1371/journal.pone.0097401
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AH8EY
UT WOS:000336369200109
PM 24825164
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Pacagnella, RC
   Cecatti, JG
   Parpinelli, MA
   Sousa, MH
   Haddad, SM
   Costa, ML
   Souza, JP
   Pattinson, RC
AF Pacagnella, Rodolfo C.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Sousa, Maria H.
   Haddad, Samira M.
   Costa, Maria L.
   Souza, Joao P.
   Pattinson, Robert C.
CA Brazilian Network Surveillance Sev
TI Delays in receiving obstetric care and poor maternal outcomes: results
   from a national multicentre cross-sectional study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Severe maternal morbidity; Maternal mortality; Maternal near miss;
   Delays in obstetric care; Emergency obstetric care
ID NEAR-MISS MORBIDITY; MORTALITY; BRAZIL; HOSPITALS; QUALITY; HEALTH;
   WOMEN; SURVEILLANCE; COUNTRIES; ATTITUDES
AB Background: The vast majority of maternal deaths in low-and middle-income countries are preventable. Delay in obtaining access to appropriate health care is a fairly common problem which can be improved. The objective of this study was to explore the association between delay in providing obstetric health care and severe maternal morbidity/death.
   Methods: This was a multicentre cross-sectional study, involving 27 referral obstetric facilities in all Brazilian regions between 2009 and 2010. All women admitted to the hospital with a pregnancy related cause were screened, searching for potentially life-threatening conditions (PLTC), maternal death (MD) and maternal near-miss (MNM) cases, according to the WHO criteria. Data on delays were collected by medical chart review and interview with the medical staff. The prevalence of the three different types of delays was estimated according to the level of care and outcome of the complication. For factors associated with any delay, the PR and 95%CI controlled for cluster design were estimated.
   Results: A total of 82,144 live births were screened, with 9,555 PLTC, MNM or MD cases prospectively identified. Overall, any type of delay was observed in 53.8% of cases; delay related to user factors was observed in 10.2%, 34.6% of delays were related to health service accessibility and 25.7% were related to quality of medical care. The occurrence of any delay was associated with increasing severity of maternal outcome: 52% in PLTC, 68.4% in MNM and 84.1% in MD.
   Conclusions: Although this was not a population-based study and the results could not be generalized, there was a very clear and significant association between frequency of delay and severity of outcome, suggesting that timely and proper management are related to survival.
C1 [Pacagnella, Rodolfo C.; Cecatti, Jose G.; Parpinelli, Mary A.; Haddad, Samira M.; Costa, Maria L.; Souza, Joao P.; Pattinson, Robert C.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.] Ctr Studies Reprod Hlth Campinas Cemicamp, Campinas, SP, Brazil.
   [Pattinson, Robert C.] Univ Pretoria, MRC Maternal & Infant Hlth Care Strategies Res Un, Gauteng, South Africa.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Rudge, Marilza V C/C-8338-2012; Nakamura-Pereira, Marcos/X-1107-2019;
   Andreucci, Carla B/J-4845-2015; Amorim, Melania M/C-5807-2013; Surita,
   Fernanda Garanhani/H-9575-2012; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019; Souza, Joao Paulo/G-1982-2010; Cecatti, Jose
   Guilherme/M-5945-2013; Quintana, Silvana Maria/D-6953-2015; Costa, Maria
   Laura/I-4980-2019; Moises, Elaine Christine Dantas/N-9522-2019; Polido,
   Carla Betina Andreucci/Y-9743-2019; Moises, Elaine/A-5708-2015;
   CORDIOLI, EDUARDO/AAR-6100-2020
OI Rudge, Marilza V C/0000-0002-9227-832X; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Andreucci, Carla B/0000-0002-5590-108X;
   Amorim, Melania M/0000-0003-1047-2514; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Souza, Joao Paulo/0000-0002-2288-4244;
   Cecatti, Jose Guilherme/0000-0003-1285-8445; Quintana, Silvana
   Maria/0000-0002-9311-786X; Costa, Maria Laura/0000-0001-8280-3234;
   Moises, Elaine Christine Dantas/0000-0001-9099-4544; Polido, Carla
   Betina Andreucci/0000-0002-5590-108X; Moises,
   Elaine/0000-0001-9099-4544; CORDIOLI, EDUARDO/0000-0001-5405-9380
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5];
   FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/08454-3]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), grant number 402702/2008-5 and
   also the involvement of the members of its Steering Committee and all
   the other investigators and coordinators from all the centres involved
   in the National Network for the Surveillance of Severe Maternal
   Morbidity, in addition the medical staff who helped provide missing
   information from the women in their clinical records. The publication of
   the current manuscript was sponsored by Fapesp (Process 2014/08454-3).
CR Adisasmita Asri, 2008, BMC Pregnancy Childbirth, V8, P10, DOI 10.1186/1471-2393-8-10
   Amaral E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-9
   Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759
   Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1
   Broughton EI, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002554
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Cham M, 2005, REPROD HLTH, V2, P3, DOI DOI 10.1186/1742-4755-2-3
   Donabedian A, 2000, B WORLD HEALTH ORGAN, V78, P857
   Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1
   Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x
   Filippi V, 2009, BEST PRACT RES CL OB, V23, P389, DOI 10.1016/j.bpobgyn.2008.12.006
   Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001
   Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591
   Gohou V, 2004, TROP MED INT HEALTH, V9, P406, DOI 10.1111/j.1365-3156.2004.01204.x
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hartnell N, 2012, BMJ QUAL SAF, V21, P361, DOI 10.1136/bmjqs-2011-000299
   Hirose A, 2011, SOC SCI MED, V73, P1003, DOI 10.1016/j.socscimed.2011.07.011
   Jonkers M, 2011, REPROD HEALTH MATTER, V19, P144, DOI 10.1016/S0968-8080(11)37556-8
   Kaye DK, 2011, INT J GYNECOL OBSTET, V114, P84, DOI 10.1016/j.ijgo.2011.01.026
   Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403
   Kingston M, 2004, MED J AUSTRALIA, V181, P1
   Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846
   Lori JR, 2012, MIDWIFERY, V28, P67, DOI 10.1016/j.midw.2010.12.001
   LOUDON I, 1986, BMJ-BRIT MED J, V293, P606, DOI 10.1136/bmj.293.6547.606
   Maine D, 1991, SAFE MOTHERHOOD PROG
   Morse Márcia Lait, 2011, Rev. bras. epidemiol., V14, P310, DOI 10.1590/S1415-790X2011000200012
   Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025
   Okong P, 2006, ACTA OBSTET GYN SCAN, V85, P797, DOI 10.1080/00016340600593331
   Oladapo OT, 2007, INT J GYNECOL OBSTET, V98, P278, DOI 10.1016/j.ijgo.2007.05.018
   Oliveira-Neto A, 2012, SCI WORLD J, DOI 10.1100/2012/172145
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026
   Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120
   Pirkle CM, 2011, INT J QUAL HEALTH C, V23, P456, DOI 10.1093/intqhc/mzr033
   Roost M, 2009, BJOG-INT J OBSTET GY, V116, P1210, DOI 10.1111/j.1471-0528.2009.02209.x
   Roost Mattias, 2009, Reprod Health, V6, P13, DOI 10.1186/1742-4755-6-13
   Roost M, 2010, ACTA OBSTET GYN SCAN, V89, P335, DOI 10.3109/00016340903511050
   Rosa ML, 2002, CAD SAUDE PUBLICA, V16, P773
   Sanghera IS, 2007, ANAESTHESIA, V62, P53, DOI 10.1111/j.1365-2044.2006.04858.x
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x
   Souza João Paulo, 2006, Cad. Saúde Pública, V22, P255, DOI 10.1590/S0102-311X2006000200003
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Vettore M, 2012, PRENATAL CARE BRAZIL
   Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   World Health Organization, 1996, MOTH BAB PACK IMPL S
NR 51
TC 74
Z9 74
U1 0
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD MAY 5
PY 2014
VL 14
AR 159
DI 10.1186/1471-2393-14-159
PG 15
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AG7GP
UT WOS:000335586600001
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Oliveira, FC
   Surita, FG
   Silva, JLPE
   Cecatti, JG
   Parpinelli, MA
   Haddad, SM
   Costa, ML
   Pacagnella, RC
   Sousa, MH
   Souza, JP
AF Oliveira, Fernando Cesar, Jr.
   Surita, Fernanda Garanhani
   Pinto e Silva, Joao Luiz
   Cecatti, Jose Guilherme
   Parpinelli, Mary Angela
   Haddad, Samira M.
   Costa, Maria Laura
   Pacagnella, Rodolfo Carvalho
   Sousa, Maria Helena
   Souza, Joao Paulo
CA Brazilian Network Surveillance Sev
TI Severe maternal morbidity and maternal near miss in the extremes of
   reproductive age: results from a national cross- sectional multicenter
   study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Maternal near-miss; Obstetric complication; Maternal death; Maternal
   age; Extremes of reproductive age; Maternal morbidity
ID HEALTH; SURVEILLANCE; PREGNANCY; MORTALITY; NETWORK; BRAZIL; DEATH; RISK
AB Background: The aim of this study was to assess severe maternal morbidity (SMM) and near miss (NM) cases among adolescent girls and women over 35 years of age in the Brazilian Network for Surveillance of Severe Maternal Morbidity, using a set of standard criteria, compared to pregnant women aged 20 to 34 years.
   Methods: A cross-sectional multicenter study conducted in 27 referral obstetric units in Brazil. All pregnant women admitted to these centers during a one-year period of prospective surveillance were screened to identify cases of maternal death (MD), NM and other SMM. Indicators of maternal morbidity and mortality were evaluated for the three age groups. Sociodemographic, clinical and obstetric characteristics, gestational and perinatal outcomes, main causes of morbidity and delays in care were also compared. Two multiple analysis models were performed, to estimate the adjusted prevalence ratio for identified factors that were independently associated with the occurrence of severe maternal outcome (SMO = MNM + MD).
   Results: Among SMM and MD cases identified, the proportion of adolescent girls and older women were 17% each. The risk of MNM or death was 25% higher among older women. Maternal near miss ratio and maternal mortality ratios increased with age, but these ratios were also higher among adolescents aged 10 to 14, although the absolute numbers were low. On multivariate analysis, younger age was not identified as an independent risk factor for SMO, while this was true for older age (PR 1.25; 1.07-1.45).
   Conclusions: SMO was high among women below 14 years of age and increased with age in Brazilian pregnant women.
C1 [Oliveira, Fernando Cesar, Jr.; Surita, Fernanda Garanhani; Pinto e Silva, Joao Luiz; Cecatti, Jose Guilherme; Parpinelli, Mary Angela; Haddad, Samira M.; Costa, Maria Laura; Pacagnella, Rodolfo Carvalho] Univ Estadual Campinas, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Oliveira, Fernando Cesar, Jr.] Univ Fed Parana, Dept Gynecol & Obstet, BR-80060000 Curitiba, Parana, Brazil.
   [Sousa, Maria Helena; Souza, Joao Paulo] Cemicamp Ctr Res Reprod Hlth Campinas, Campinas, SP, Brazil.
RP Surita, FG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM surita@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Cecatti, Jose
   Guilherme/M-5945-2013; Souza, Joao Paulo/G-1982-2010; Moises, Elaine
   Christine Dantas/N-9522-2019; Amorim, Melania M/C-5807-2013; CORDIOLI,
   EDUARDO/AAR-6100-2020; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Nakamura-Pereira, Marcos/X-1107-2019; Rudge, Marilza V C/C-8338-2012;
   Moises, Elaine/A-5708-2015; Costa, Maria Laura/I-4980-2019; Peracoli,
   Jose Carlos/G-4923-2012; Calderon, Iracema/C-8136-2012
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Souza, Joao Paulo/0000-0002-2288-4244;
   Moises, Elaine Christine Dantas/0000-0001-9099-4544; Amorim, Melania
   M/0000-0003-1047-2514; CORDIOLI, EDUARDO/0000-0001-5405-9380; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Rudge, Marilza V C/0000-0002-9227-832X;
   Moises, Elaine/0000-0001-9099-4544; Costa, Maria
   Laura/0000-0001-8280-3234; Peracoli, Jose Carlos/0000-0002-3273-3001;
   Calderon, Iracema/0000-0003-4761-4336
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/03200-3]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), grant number 402702/2008-5. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of CNPq. It did not influence the content of the
   manuscript. This publication was supported by Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP), process number: 2014/03200-3.
CR Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x
   Brazil Ministry of Health, 2009, DATASUS SYST INF LIV
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Cleary-Goldman J, 2005, OBSTET GYNECOL
   Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593
   Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Ham P, 2012, AM FAM PHYSICIAN, V86, P1109
   Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be
   Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5
   Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47
   Lampinen Reeta, 2009, Open Nurs J, V3, P33, DOI 10.2174/1874434600903010033
   Lisonkova S, 2011, J OBSTET GYNAECOL CA, V33, P1020, DOI 10.1016/S1701-2163(16)35051-4
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2010, BJOG-INT J OBSTET GY, V117, P1586, DOI 10.1111/j.1471-0528.2010.02746.x
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   World Health Organization(WHO), 2008, WHOMPS0814
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 26
TC 23
Z9 25
U1 3
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD FEB 20
PY 2014
VL 14
AR 77
DI 10.1186/1471-2393-14-77
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AE0YF
UT WOS:000333691500001
PM 24555831
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zanette, E
   Parpinelli, MA
   Surita, FG
   Costa, ML
   Haddad, SM
   Sousa, MH
   Silva, JLPE
   Souza, JP
   Cecatti, JG
AF Zanette, Elvira
   Parpinelli, Mary Angela
   Surita, Fernanda Garanhani
   Costa, Maria Laura
   Haddad, Samira Maerrawi
   Sousa, Maria Helena
   Pinto e Silva, Joao Luiz
   Souza, Joao Paulo
   Cecatti, Jose Guilherme
CA Brazilian Network Surveillance Sev
TI Maternal near miss and death among women with severe hypertensive
   disorders: a Brazilian multicenter surveillance study
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Organ dysfunction; Organ failure; Severe preeclampsia; Eclampsia;
   Maternal mortality; Maternal morbidity
ID SEVERE OBSTETRIC MORBIDITY; NEAR-MISS; PREGNANCY; MORTALITY;
   PREECLAMPSIA; INTERVENTIONS; COMPLICATIONS; PREVALENCE; SURROGATE;
   NETWORK
AB Background: Hypertensive disorders represent the major cause of maternal morbidity in middle income countries. The main objective of this study was to identify the prevalence and factors associated with severe maternal outcomes in women with severe hypertensive disorders.
   Methods: This was a cross-sectional, multicenter study, including 6706 women with severe hypertensive disorder from 27 maternity hospitals in Brazil. A prospective surveillance of severe maternal morbidity with data collected from medical charts and entered into OpenClinica (R), an online system, over a one-year period (2009 to 2010). Women with severe preeclampsia, severe hypertension, eclampsia and HELLP syndrome were included in the study. They were grouped according to outcome in near miss, maternal death and potentially life-threatening condition. Prevalence ratios and 95% confidence intervals adjusted for cluster effect for maternal and perinatal variables and delays in receiving obstetric care were calculated as risk estimates of maternal complications having a severe maternal outcome (near miss or death). Poisson multiple regression analysis was also performed.
   Results: Severe hypertensive disorders were the main cause of severe maternal morbidity (6706/ 9555); the prevalence of near miss was 4.2 cases per 1000 live births, there were 8.3 cases of Near Miss to 1 Maternal Death and the mortality index was 10.7% (case fatality). Early onset of the disease and postpartum hemorrhage were independent variables associated with severe maternal outcomes, in addition to acute pulmonary edema, previous heart disease and delays in receiving secondary and tertiary care.
   Conclusions: In women with severe hypertensive disorders, the current study identified situations independently associated with a severe maternal outcome, which could be modified by interventions in obstetric care and in the healthcare system. Furthermore, the study showed the feasibility of a hospital system for surveillance of severe maternal morbidity.
C1 [Zanette, Elvira; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura; Haddad, Samira Maerrawi; Pinto e Silva, Joao Luiz; Souza, Joao Paulo; Cecatti, Jose Guilherme] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Sousa, Maria Helena] Ctr Res Reprod Hlth Campinas Cemicamp, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, 101,POB 6030, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Quintana, Silvana
   Maria/D-6953-2015; Souza, Joao Paulo/G-1982-2010; Surita, Fernanda
   Garanhani/H-9575-2012; Amorim, Melania M/C-5807-2013; Costa, Maria
   Laura/I-4980-2019; Moises, Elaine Christine Dantas/N-9522-2019;
   Nakamura-Pereira, Marcos/X-1107-2019; Calderon, Iracema/C-8136-2012
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Quintana, Silvana
   Maria/0000-0002-9311-786X; Souza, Joao Paulo/0000-0002-2288-4244;
   Surita, Fernanda Garanhani/0000-0003-4335-0337; Amorim, Melania
   M/0000-0003-1047-2514; Costa, Maria Laura/0000-0001-8280-3234; Moises,
   Elaine Christine Dantas/0000-0001-9099-4544; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Calderon, Iracema/0000-0003-4761-4336;
   Santana, Danielly/0000-0001-8912-2626; de Araujo Costa, Roberto
   Antonio/0000-0003-4074-252X
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX The study was financially supported by CNPq/DECIT (The National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health), grant number 402702/2008-5. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adisasmita Asri, 2008, BMC Pregnancy Childbirth, V8, P10, DOI 10.1186/1471-2393-8-10
   Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af
   Bauer ST, 2009, SEMIN PERINATOL, V33, P158, DOI 10.1053/j.semperi.2009.02.008
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6
   DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Goldenberg RL, 2011, INT J GYNECOL OBSTET, V113, P91, DOI 10.1016/j.ijgo.2011.01.002
   Haddad B, 2009, SEMIN PERINATOL, V33, P143, DOI 10.1053/j.semperi.2009.02.002
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x
   Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25
   Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102
   Leveno KJ, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P389, DOI 10.1016/B978-0-12-374213-1.00021-5
   Liu SL, 2007, MATERN CHILD HLTH J, V11, P181, DOI 10.1007/s10995-006-0154-3
   Lotufo FA, 2012, CLINICS, V67, P225, DOI 10.6061/clinics/2012(03)04
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d
   Oladapo Olufemi T, 2005, Reprod Health, V2, P9, DOI 10.1186/1742-4755-2-9
   Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025
   Oliveira-Neto A, 2012, SCI WORLD J, DOI 10.1100/2012/172145
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Pattinson RC, 2003, BJOG-INT J OBSTET GY, V110, P889, DOI 10.1111/j.1471-0528.2003.03044.x
   Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120
   Souza ASR, 2008, REV ASSOC MED BRAS, V54, P232, DOI 10.1590/S0104-42302008000300016
   Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3
   Sibai BM, 1999, NEW ENGL J MED, V340, P50, DOI 10.1056/NEJM199901073400110
   Sibai BM, 2005, CLIN OBSTET GYNECOL, V48, P478, DOI 10.1097/01.grf.0000160314.59736.d2
   Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Thornton C, 2011, BEST PRACT RES CL OB, V25, P509, DOI 10.1016/j.bpobgyn.2011.03.002
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   van Pampus MG, 1999, AM J OBSTET GYNECOL, V180, P1146, DOI 10.1016/S0002-9378(99)70608-3
   von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   WHO, 2011, REC PREV TREATM PREE
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066
   Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 50
TC 31
Z9 38
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JAN 16
PY 2014
VL 11
AR 4
DI 10.1186/1742-4755-11-4
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AB3MC
UT WOS:000331693900001
PM 24428879
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Rocha, EA
   Santana, DS
   Cecatti, JG
   Costa, ML
   Haddad, SM
   Parpinelli, MA
   Sousa, MH
   Camargo, RS
   Pacagnella, RC
   Surita, FG
   Silva, JLPE
AF Rocha Filho, Edilberto Alves
   Santana, Danielly Scaranello
   Cecatti, Jose Guilherme
   Costa, Maria Laura
   Haddad, Samira Maerrawe
   Parpinelli, Mary Angela
   Sousa, Maria Helena
   Camargo, Rodrigo Soares
   Pacagnella, Rodolfo Carvalho
   Surita, Fernanda Garanhani
   Pinto e Silva, Joao Luiz
TI Awareness about a Life-Threatening Condition: Ectopic Pregnancy in a
   Network for Surveillance of Severe Maternal Morbidity in Brazil
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MORTALITY; DEATH
AB Objective. To assess occurrence of severe maternal complications associated with ectopic pregnancy (EP). Method. A multicenter cross-sectional study was conducted, with prospective surveillance of potentially life-threatening conditions (PLTC), maternal near miss (MNM), and maternal death (MD). EP complications, patient sociodemographic/obstetric characteristics, and conditions of severity management were assessed, estimating prevalence ratios with respective 95% CI. Factors independently associated with greater severity were identified using multiple regression analysis. Results. Of the 9.555 severe maternal morbidity patients, 312 women (3.3%) had complications after EP: 286 (91.7%) PLTC, 25 (8.0%) MNM, and 1 (0.3%) MD. Severe maternal outcome ratio (SMOR) was 0.3/1000 LB among EP cases and 10.8/1000 LB among other causes. Complicated EP patients faced a higher risk of blood transfusion, laparotomy, and lower risk of ICU admission and prolonged hospitalization than women developing complications resulting from other causes. Substandard care was the most common in more severe maternal morbidity and EP cases (22.7% MNM and MD versus 15% PLTC), although not significant. Conclusion. Increased maternal morbidity due to EP raised awareness about the condition and its impact on female reproductive life. No important risk factors for greater severity were identified. Care providers should develop specific guidelines and interventions to prevent severe maternal morbidity.
C1 [Rocha Filho, Edilberto Alves; Santana, Danielly Scaranello; Cecatti, Jose Guilherme; Costa, Maria Laura; Haddad, Samira Maerrawe; Parpinelli, Mary Angela; Camargo, Rodrigo Soares; Pacagnella, Rodolfo Carvalho; Surita, Fernanda Garanhani; Pinto e Silva, Joao Luiz] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Cecatti, Jose Guilherme; Sousa, Maria Helena] Campinas Ctr Studies Reprod Hlth CEMICAMP, BR-13083888 Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019;
   Surita, Fernanda Garanhani/H-9575-2012; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019
OI Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria
   Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Santana, Danielly/0000-0001-8912-2626
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), Grant no. 402702/2008-5, and also
   the involvement of its Steering Committee members and all other
   investigators and coordinators from all the centers. The authors also
   acknowledge the participation of the members of the Brazilian Network
   for the Surveillance of Severe Maternal Morbidity Group: Joao P Souza,
   Marilza V Rudge, Iracema M Calderon, Maria V Bahamondes, Simone
   PGoncalves, Eliana M Amaral, Olimpio B Moraes Filho, Simone A Carvalho,
   Francisco E Feitosa, George N Chaves, Ione R Brum, Gloria C Saintynes,
   Carlos A Menezes, Patricia N Santos, Everardo M Guanabara, Elson J
   Almeida Jr, Joaquim L Moreira, Maria R Sousa, Frederico A Peret, Liv B
   Paula, Luiza E Schmaltz, Cleire Pessoni, Leila Katz, Adriana Bione,
   Antonio C Barbosa Lima, Edilberto A Rocha Filho, Melania M Amorim,
   Debora Leite, Ivelyne Radaci, Marilia G Martins, Frederico Barroso,
   Fernando C Oliveira Jr, Denis J Nascimento, Claudio S Paiva, Moises D
   Lima, Djacyr M Freire, Roger D Rohloff, Simone M Rodrigues, Sergio M
   Costa, Lucia C Pfitscher, Adriana G Luz, Daniela Guimaraes, Gustavo
   Lobato, Marcos Nakamura-Pereira, Eduardo Cordioli, Alessandra Peterossi,
   Cynthia D Perez, Jose C Peracoli, Roberto A Costa, Nelson L Maia Filho,
   Jacinta P Matias, Silvana M Quintana, Elaine C Moises, Fatima A Lotufo,
   Luiz E Carvalho, Elvira A Zanette, Carla B Andreucci, Marcia M Aquino,
   Maria H Ohnuma, Rosiane Mattar, and Felipe F Campanharo.
CR Abubakar P, 2012, ANN NIGERIAN MED, V6, P87
   Agdi M, 2009, BEST PRACT RES CL OB, V23, P519, DOI 10.1016/j.bpobgyn.2008.12.009
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lawani OL, 2013, INT J WOMENS HEALTH, V5, P515, DOI 10.2147/IJWH.S49672
   Mol F, 2010, EUR J OBSTET GYN R B, V151, P163, DOI 10.1016/j.ejogrb.2010.04.014
   Nama V, 2009, ARCH GYNECOL OBSTET, V279, P443, DOI 10.1007/s00404-008-0731-3
   Noell Dani, 2012, Morbidity and Mortality Weekly Report, V61, P106
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shaw JLV, 2012, CLIN CHEM, V58, P1278, DOI 10.1373/clinchem.2012.184168
   Sindos M, 2009, ARCH GYNECOL OBSTET, V279, P621, DOI 10.1007/s00404-008-0772-7
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Stucki David, 2008, J Med Life, V1, P40
   Stulberg DB, 2011, MATERN CHILD HLTH J, V15, P234, DOI 10.1007/s10995-010-0579-6
   UNDP/UNFPA/WHO/World Bank Special Programme of Research, 2005, PROGR REPR HLTH RES, V71, P5
   van Mello NM, 2012, FERTIL STERIL, V98, P1066, DOI 10.1016/j.fertnstert.2012.09.040
   van Mello NM, 2012, FERTIL STERIL, V97, P623, DOI 10.1016/j.fertnstert.2011.12.021
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 21
TC 3
Z9 5
U1 0
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 965724
DI 10.1155/2014/965724
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AE1NH
UT WOS:000333735600001
PM 24772441
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Haddad, SM
   Cecatti, JG
   Souza, JP
   Sousa, MH
   Parpinelli, MA
   Costa, ML
   Pacagnella, RC
   Brum, IR
   Moraes, OB
   Feitosa, FE
   Menezes, CA
   Guanabara, EM
   Moreira, JL
   Peret, FA
   Schmaltz, LE
   Katz, L
   Lima, ACB
   Amorim, MM
   Martins, MG
   Nascimento, DJ
   Paiva, CS
   Rohloff, RD
   Costa, SM
   Luz, AG
   Lobato, G
   Cordioli, E
   Peracoli, JC
   Maia, NL
   Quintana, SM
   Lotufo, FA
   Andreucci, CB
   Aquino, MM
   Mattar, R
AF Haddad, Samira Maerrawi
   Cecatti, Jose Guilherme
   Souza, Joao Paulo
   Sousa, Maria Helena
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Pacagnella, Rodolfo C.
   Brum, Ione R.
   Moraes Filho, Olimpio B.
   Feitosa, Francisco E.
   Menezes, Carlos A.
   Guanabara, Everardo M.
   Moreira, Joaquim L.
   Peret, Frederico A.
   Schmaltz, Luiza E.
   Katz, Leila
   Barbosa Lima, Antonio C.
   Amorim, Melania M.
   Martins, Marilia G.
   Nascimento, Denis J.
   Paiva, Claudio S.
   Rohloff, Roger D.
   Costa, Sergio M.
   Luz, Adriana G.
   Lobato, Gustavo
   Cordioli, Eduardo
   Peracoli, Jose C.
   Maia Filho, Nelson L.
   Quintana, Silvana M.
   Lotufo, Fatima A.
   Andreucci, Carla B.
   Aquino, Marcia M.
   Mattar, Rosiane
TI Applying the Maternal Near Miss Approach for the Evaluation of Quality
   of Obstetric Care: A Worked Example from a Multicenter Surveillance
   Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID NEWBORN HEALTH; MORBIDITY; MORTALITY
AB Objective. To assess quality of care of women with severe maternal morbidity and to identify associated factors. Method. This is a national multicenter cross-sectional study performing surveillance for severe maternal morbidity, using the World Health Organization criteria. The expected number of maternal deaths was calculated with the maternal severity index (MSI) based on the severity of complication, and the standardized mortality ratio (SMR) for each center was estimated. Analyses on the adequacy of care were performed. Results. 17 hospitals were classified as providing adequate and 10 as nonadequate care. Besides almost twofold increase in maternal mortality ratio, the main factors associated with nonadequate performance were geographic difficulty in accessing health services (P < 0.001), delays related to quality of medical care (P = 0.012), absence of blood derivatives (P = 0.013), difficulties of communication between health services (P = 0.004), and any delay during the whole process (P = 0.039). Conclusions. This is an example of how evaluation of the performance of health services is possible, using a benchmarking tool specific to Obstetrics. In this study the MSI was a useful tool for identifying differences in maternal mortality ratios and factors associated with nonadequate performance of care.
C1 [Haddad, Samira Maerrawi; Cecatti, Jose Guilherme; Souza, Joao Paulo; Parpinelli, Mary Angela; Costa, Maria Laura; Pacagnella, Rodolfo C.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, BR-13083881 Campinas, SP, Brazil.
   [Cecatti, Jose Guilherme; Sousa, Maria Helena] Ctr Res Reprod Hlth Campinas Cemicamp, BR-13083888 Campinas, SP, Brazil.
   [Brum, Ione R.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Moraes Filho, Olimpio B.] Sch Med Sci, CISAM, Recife, PE, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Menezes, Carlos A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Guanabara, Everardo M.] Hosp Geral Cesar Cals, Fortaleza, Ceara, Brazil.
   [Moreira, Joaquim L.] Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil.
   [Peret, Frederico A.] Maternidade Odete Valadares, Belo Horizonte, MG, Brazil.
   [Schmaltz, Luiza E.] Hosp Materno Infantil, Goiania, Go, Brazil.
   [Katz, Leila] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   [Barbosa Lima, Antonio C.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Amorim, Melania M.] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Martins, Marilia G.] Univ Fed Maranhao, Sao Luis, MA, Brazil.
   [Nascimento, Denis J.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   [Paiva, Claudio S.] Univ Fed Paraiba, BR-58059900 Joao Pessoa, Paraiba, Brazil.
   [Rohloff, Roger D.] Hosp Maternidade Fernando Magalhaes, Rio De Janeiro, RJ, Brazil.
   [Costa, Sergio M.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Luz, Adriana G.] Hosp Maternidade Celso Pierro, Campinas, SP, Brazil.
   [Lobato, Gustavo] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Cordioli, Eduardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Peracoli, Jose C.] Univ State Sao Paulo, Botucatu, SP, Brazil.
   [Maia Filho, Nelson L.] Jundiai Sch Med, Jundiai, SP, Brazil.
   [Quintana, Silvana M.] Univ Sao Paulo, BR-14049 Ribeirao Preto, SP, Brazil.
   [Lotufo, Fatima A.] Santa Casa Limeira, Limeira, SP, Brazil.
   [Andreucci, Carla B.] Santa Casa Sao Carlos, Sao Carlos, SP, Brazil.
   [Aquino, Marcia M.] Maternidade Leonor Mendes de Barros, Sao Paulo, Brazil.
   [Mattar, Rosiane] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, R Alexander Fleming 101,POB 6030, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI de Carvalho Pacagnella, Rodolfo/H-9390-2019; Cordioli,
   Eduardo/X-1934-2019; Amorim, Melania M/C-5807-2013; CORDIOLI,
   EDUARDO/AAR-6100-2020; Quintana, Silvana Maria/D-6953-2015; Katz,
   Leila/M-5291-2013; Polido, Carla Betina Andreucci/Y-9743-2019; Cecatti,
   Jose Guilherme/M-5945-2013; Souza, Joao Paulo/G-1982-2010; Costa, Maria
   Laura/I-4980-2019; Andreucci, Carla B/J-4845-2015; Peracoli, Jose
   Carlos/G-4923-2012
OI de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Amorim, Melania
   M/0000-0003-1047-2514; CORDIOLI, EDUARDO/0000-0001-5405-9380; Quintana,
   Silvana Maria/0000-0002-9311-786X; Katz, Leila/0000-0001-9854-7917;
   Polido, Carla Betina Andreucci/0000-0002-5590-108X; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Souza, Joao Paulo/0000-0002-2288-4244;
   Costa, Maria Laura/0000-0001-8280-3234; Andreucci, Carla
   B/0000-0002-5590-108X; Peracoli, Jose Carlos/0000-0002-3273-3001
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), Grant number 402702/2008-5. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of CNPq. It did not influence the content of the paper.
   Brazilian Network for the Surveillance of Severe Maternal Morbidity
   Group consisted of Joao L. Pinto e. Silva, Fernanda G. Surita, Rodolfo
   C. Pacagnella, Rodrigo S. Camargo, Vilma Zotareli, Lucio T. Gurgel, Lale
   Say, Robert C. Pattinson, Marilza V. Rudge, Iracema M. Calderon, Maria
   V. Bahamondes, Danielly S. Santana, Simone P. Goncalves, Olimpio B.
   Moraes Filho, Simone A. Carvalho, Francisco E. Feitosa, George N.
   Chaves, Ione R. Brum, Gloria C. Saint'Ynes, Carlos A. Menezes, Patricia
   N. Santos, Everardo M. Guanabara, Elson J. Almeida Jr, Joaquim L.
   Moreira, Maria R. Sousa, Frederico A. Peret, Liv B. Paula, Luiza E.
   Schmaltz, Cleire Pessoni, Leila Katz, Adriana Bione, Antonio C. Barbosa
   Lima, Edilberto A. Rocha Filho, Melania M. Amorim, Debora Leite, Ivelyne
   Radaci, Marilia G. Martins, Frederico Barroso, Fernando C. Oliveira Jr,
   Denis J. Nascimento, Claudio S. Paiva, Moises D. Lima, Djacyr M. Freire,
   Roger D. Rohloff, Simone M. Rodrigues, Sergio M. Costa, Lucia C.
   Pfitscher, Adriana G. Luz, Daniela Guimaraes, Gustavo Lobato, Marcos
   Nakamura-Pereira, Eduardo Cordioli, Alessandra Peterossi, Cynthia D.
   Perez, Jose C. Peracoli, Roberto A. Costa, Nelson L. Maia Filho, Jacinta
   P. Matias, Silvana M. Quintana, Elaine C. Moises, Fatima A. Lotufo, Luiz
   E. Carvalho, Carla B. Andreucci, Marcia M. Aquino, Maria H. Ohnuma,
   Rosiane Mattar, and Felipe F. Campanharo.
CR [Anonymous], 2010, TRENDS MAT MORT 1990
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cochet L, 2003, SAMJ S AFR MED J, V93, P700
   De Savigny D., 2009, SYSTEMS THINKING HLT
   Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2
   Donati S, 2012, ACTA OBSTET GYN SCAN, V91, P452, DOI 10.1111/j.1600-0412.2012.01352.x
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520
   Lapinsky SE, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.003
   Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d
   Raven J, 2011, INT J GYNECOL OBSTET, V114, P4, DOI 10.1016/j.ijgo.2011.02.007
   Say L, 2004, REPROD HLTH, V1, P3, DOI DOI 10.1186/1742-4755-1-3
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 22
TC 18
Z9 20
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 989815
DI 10.1155/2014/989815
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AM8XF
UT WOS:000340161700001
PM 25147830
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Silveira, C
   Parpinelli, MA
   Pacagnella, RC
   de Camargo, RS
   Costa, ML
   Zanardi, DM
   Ferreira, EC
   Santos, JP
   Hanson, L
   Cecatti, JG
   Andreucci, CB
AF Silveira, Carla
   Parpinelli, Mary Angela
   Pacagnella, Rodolfo Carvalho
   de Camargo, Rodrigo Soares
   Costa, Maria Laura
   Zanardi, Dulce Maria
   Ferreira, Elton Carlos
   Santos, Juliana Paula
   Hanson, Lesley
   Cecatti, Jose Guilherme
   Andreucci, Carla Betina
TI Cross-cultural adaptation of the World Health Organization Disability
   Assessment Schedule (WHODAS 2.0) into Portuguese
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE Disability and functioning; Cross-cultural adaptation; Pregnancy;
   Postpartum period
ID INTERNATIONAL CLASSIFICATION; EQUIVALENCE; WOMEN; TOOL
AB Objective: The World Health Organization Disability Assessment Schedule (WHODAS 2.0) was designed to assess the functioning level in six life domains (cognition, mobility, self-care, getting along, life activities, and participation in community activities). There are different versions, from the simplest to the most complete, various presentations (either interviews or self-administered), comprehending the domains of the International Classification of Functioning, Disability and Health (ICF). This study aimed to make a cross-cultural adaptation of the complete version into Portuguese.
   Methods: The proceeding was developed over six stages: translation, back-translation, semantic equivalence, evaluation of previous stages by experts, tool pretest, and final version.
   Results: After the pretest, an adjustment to a more colloquial Portuguese was made. The versions were shown to be similar regarding general and referential meaning.
   Conclusion: WHODAS 2.0 was shown to be easily applied and understood by women in the pregnancy-postpartum cycle. (c) 2013 Elsevier Editora Ltda. All rights reserved.
C1 [Silveira, Carla; Parpinelli, Mary Angela; Pacagnella, Rodolfo Carvalho; de Camargo, Rodrigo Soares; Costa, Maria Laura; Zanardi, Dulce Maria; Ferreira, Elton Carlos; Santos, Juliana Paula; Cecatti, Jose Guilherme; Andreucci, Carla Betina] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Tocoginecol, Campinas, SP, Brazil.
   [Silveira, Carla; de Camargo, Rodrigo Soares] Fac Med Jundiai, Dept Obstet & Ginecol, Jundiai, SP, Brazil.
   [Pacagnella, Rodolfo Carvalho; Andreucci, Carla Betina] Univ Fed Sao Carlos UFSCAR, Dept Med, Sao Carlos, SP, Brazil.
   [Hanson, Lesley] Univ Estadual Campinas, Fac Ciencias Med, Programa Posgrad Tocoginecol, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Dept Tocoginecol FCM UNICAMP, Av Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Andreucci, Carla B/J-4845-2015; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019; Polido, Carla Betina Andreucci/Y-9743-2019; Costa,
   Maria Laura/I-4980-2019; Pacagnella, Rodolfo/H-6247-2012
OI Andreucci, Carla B/0000-0002-5590-108X; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Costa, Maria Laura/0000-0001-8280-3234;
   Pacagnella, Rodolfo/0000-0002-5739-0009
CR BATTISTELLA LR, 2002, ACTA FISIATRICA, V9, P98
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Diniz D, 2007, CAD SAUDE PUBLICA, V23, P2507, DOI 10.1590/S0102-311X2007001000025
   Farias Norma, 2005, Rev. bras. epidemiol., V8, P187, DOI 10.1590/S1415-790X2005000200011
   Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8
   Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51
   Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616
   Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536
   Jomeen J., 2004, CLIN EFFECTIVENESS N, V8, P143, DOI DOI 10.1016/J.CEIN.2005.02.001
   JORGE MR, 1998, REV PSIQUIATR CLIN, V25, P233
   Nubila Heloisa B. V. Di, 2010, Rev. bras. saúde ocup., V35, P122, DOI 10.1590/S0303-76572010000100013
   Organizacao Mundial da Saude, 2007, CLASS INT FUNC INC S
   Reichenheim ME, 2000, REV SAUDE PUBL, V34, P610, DOI 10.1590/S0034-89102000000600008
   Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035
   Sampaio RF, 2009, CAD SAUDE PUBLICA, V25, P475, DOI 10.1590/S0102-311X2009000300002
   Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea
   Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x
   Stucki G, 2008, ACTA FISIATRICA, V15, P63
   Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231
   Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063
   World Health Organisation (WHO), 2010, MEAS HLTH DIS MAN WH
   World Health Organization, PROC TRANSL AD INSTR
   World Health Organization, 2001, INT CLASS FUNCT DIS
NR 25
TC 26
Z9 32
U1 0
U2 13
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAY-JUN
PY 2013
VL 59
IS 3
BP 234
EP 240
DI 10.1016/j.ramb.2012.11.005
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 182KX
UT WOS:000321742300007
PM 23684209
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Surita, FG
   Cintra, GF
   Nomura, ML
   Milanez, H
   Passini, R
AF Costa, M. L.
   Surita, F. G.
   Cintra, G. F.
   Nomura, M. L.
   Milanez, H.
   Passini Jr, R.
TI Selective embolization of uterine arteries in the prevention of maternal
   hemorrhage associated with placenta accreta
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Accreta; Uterine Artery Embolization; Placenta
C1 [Costa, M. L.; Surita, F. G.; Cintra, G. F.; Nomura, M. L.; Milanez, H.; Passini Jr, R.] Univ Estadual Campinas, Fac Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RI Passini Junior, Renato/O-6169-2016; Surita, Fernanda
   Garanhani/H-9575-2012; Nomura, Marcelo Luis/H-9534-2019
OI Passini Junior, Renato/0000-0001-8247-4549; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A20
EP A20
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100058
DA 2020-12-08
ER

PT J
AU de Oliveira, FC
   Costa, ML
   Cecatti, JG
   Silva, JLPE
   Surita, FG
AF de Oliveira, Fernando Cesar, Jr.
   Costa, Maria Laura
   Cecatti, Jose Guilherme
   Pinto e Silva, Joao Luiz
   Surita, Fernanda Garanhani
TI Maternal morbidity and near miss associated with maternal age: the
   innovative approach of the 2006 Brazilian demographic health survey
SO CLINICS
LA English
DT Article
DE Morbidity; Obstetric Complication; Pregnancy in Adolescence; Maternal
   Age
ID NEAR-MISS; WOMEN; RISK
AB OBJECTIVE: To study the prevalence of potentially life-threatening maternal conditions and near miss in Brazil according to maternal age.
   METHODS: A secondary analysis of the 2006 Brazilian demographic health survey database using a validated questionnaire to evaluate maternal morbidity with a focus on age extremes. The study included 5,025 women with at least 1 live birth in the 5-year reference period preceding their interviews. Three age range periods were used: 15-19 years (younger age), 20-34 years (control), and 35-49 years (advanced maternal age). According to a pragmatic definition, any woman reporting eclampsia, hysterectomy, blood transfusion, or admission to the intensive care unit during her pregnancy/childbirth was considered a near-miss case. The associations between age and severe maternal morbidity were further assessed.
   RESULTS: For the 6,833 reported pregnancies, 73.7% of the women were 20-34 years old, 17.9% were of advanced maternal age, and only 8.4% were of younger age. More than 22% of the women had at least one of the complications appraised, and blood transfusion, which was more prevalent among the controls, was the only variable with a significant difference among the age groups. The overall rate of maternal near miss was 21.1 per 1000 live births. There was a trend of higher maternal near miss with increasing age. The only significant risk factor identified for maternal near miss was a lower literacy level among older women.
   CONCLUSIONS: There is a trend towards worse results with increasing age. The investigation of the determinants of maternal near miss at the community level using an innovative approach through a demographic health survey is an example suggested for under-resourced settings.
C1 [de Oliveira, Fernando Cesar, Jr.; Costa, Maria Laura; Cecatti, Jose Guilherme; Pinto e Silva, Joao Luiz; Surita, Fernanda Garanhani] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP de Oliveira, FC (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM surita@unicamp.br
RI Surita, Fernanda Garanhani/H-9575-2012; Costa, Maria Laura/I-4980-2019
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Costa, Maria
   Laura/0000-0001-8280-3234
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/03889-9]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), process number: 2013/03889-9.
CR Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x
   Brazil. Ministry of Health, 2012, B EPIDEMIOLOGICO, V43, P1
   Brazilian Ministry of Health, 2008, BRAZ NAT RES DEM HLT
   Camargo RS, 2011, CLINICS, V66, P1367, DOI 10.1590/S1807-59322011000800010
   Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7
   Gibbs CM, 2012, PAEDIATR PERINAT EP, V26, P259, DOI 10.1111/j.1365-3016.2012.01290.x
   Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011
   Haerty A, 2005, MONATSSCHR KINDERH, V153, P114, DOI 10.1007/s00112-005-1084-7
   Hardee K, 2012, GLOB PUBLIC HEALTH, V7, P603, DOI 10.1080/17441692.2012.668919
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be
   Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47
   Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8
   Macro International, 2008, DEM HLTH SURV PROGR
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Souza JP, 2010, BJOG-INT J OBSTET GY, V117, P1586, DOI 10.1111/j.1471-0528.2010.02746.x
   Souza JP, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-16
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   Tough S, 2007, MATERN CHILD HLTH J, V11, P189, DOI 10.1007/s10995-006-0156-1
   World Health Organization, 2006, REPR HLTH RES REPR H
   World Health Organization, 2011, MAK PREGN SAF MAT NE
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 22
TC 11
Z9 13
U1 0
U2 3
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2013
VL 68
IS 7
BP 922
EP 927
DI 10.6061/clinics/2013(07)06
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 194AC
UT WOS:000322601600006
PM 23917654
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Santana, DS
   Cecatti, JG
   Parpinelli, MA
   Haddad, SM
   Costa, ML
   Sousa, MH
   Souza, JP
   Camargo, RS
   Pacagnella, RC
   Surita, FG
   Silva, JLPE
AF Santana, Danielly S.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Haddad, Samira M.
   Costa, Maria L.
   Sousa, Maria H.
   Souza, Joao P.
   Camargo, Rodrigo S.
   Pacagnella, Rodolfo C.
   Surita, Fernanda G.
   Pinto e Silva, Joao L.
CA Brazilian Network Surveillance
TI Severe maternal morbidity due to abortion prospectively identified in a
   surveillance network in Brazil
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Abortion; Maternal death; Maternal near miss; Severe maternal
ID UNSAFE ABORTION; MORTALITY; DEATH
AB Objective: To evaluate the occurrence of severe maternal complications associated with abortion in Brazil. Methods: In a cross-sectional multicenter study, prospective surveillance was done for cases of potentially life-threatening conditions (PLTC), maternal near miss (MNM), and maternal death (MD) among 9555 women with obstetric complications between June 2009 and May 2010. Abortion was evaluated as a cause, and sociodemographic and obstetric characteristics, safety conditions where the abortion was performed, and the medical procedures used were also assessed. Prevalence ratios adjusted for the cluster effect of the design were calculated with 95% confidence intervals. Multiple logistic regression analysis was performed to identify factors independently associated with greater severity. Results: For 237 women (2.5%), abortion resulted in severe complications including PLTC (81.9%), MNM (15.2%), and MD (3%). When abortion was unsafe, infectious causes were more common for PLTC, whereas management criteria were more important for MNM and MD. In multivariate analysis, the presence of previous matemal conditions (sickle cell disease, low weight, neoplasm), being transferred or referred, previous uterine scar, and delays were associated with greater severity. Conclusion: Abortion was responsible for only a small percentage of the complications associated with pregnancy; however, the risk of abortion-related complications progressing unfavorably was higher. (c) 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Santana, Danielly S.; Cecatti, Jose G.; Parpinelli, Mary A.; Haddad, Samira M.; Costa, Maria L.; Camargo, Rodrigo S.; Pacagnella, Rodolfo C.; Surita, Fernanda G.; Pinto e Silva, Joao L.] Univ Estadual Campinas, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.] Campinas Ctr Studies Reprod Hlth CEMICAMP, Campinas, SP, Brazil.
   [Souza, Joao P.] WHO, UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Joao Paulo/G-1982-2010; Pacagnella, Rodolfo/H-6247-2012; Costa,
   Maria Laura/I-4980-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Surita, Fernanda Garanhani/H-9575-2012
OI Souza, Joao Paulo/0000-0002-2288-4244; Pacagnella,
   Rodolfo/0000-0002-5739-0009; Costa, Maria Laura/0000-0001-8280-3234; de
   Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Santana, Danielly/0000-0001-8912-2626
FU CNPq/DECIT (The National Research Council); Department of Science and
   Technology of the Brazilian Ministry of Health [402702/2008-5]
FX Financial support was received from CNPq/DECIT (The National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health; grant number 402702/2008-5).
CR Camargo RS, 2011, INT J GYNECOL OBSTET, V112, P88, DOI 10.1016/j.ijgo.2010.08.013
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Diniz D, 2009, ABORTION PUBLICH HLT
   Fawcus SR, 2008, BEST PRACT RES CL OB, V22, P533, DOI 10.1016/j.bpobgyn.2007.10.006
   Geller SE, 2006, WOMEN HEALTH ISS, V16, P176, DOI 10.1016/j.whi.2006.06.003
   Grimes DA, 2003, BRIT MED BULL, V67, P99, DOI 10.1093/bmb/ldg002
   Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6
   Haas T, 1999, SHARING RESPONSIBILI
   Haddad Lisa B, 2009, Rev Obstet Gynecol, V2, P122
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Menezes G, 2009, CAD SAUDE PUBLICA, V25, pS193, DOI 10.1590/S0102-311X2009001400002
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120
   Royal College of Obstetricians and Gynecologists, 2006, GREEN TOP GUID
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   Van Look PFA, 2002, BEST PRACT RES CL OB, V16, P205, DOI 10.1053/beog.2002.0271
   World Health Organization, 1992, PREV MAN UNS AB
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 21
TC 21
Z9 24
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD OCT
PY 2012
VL 119
IS 1
BP 44
EP 48
DI 10.1016/j.ijgo.2012.05.025
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 012OU
UT WOS:000309247200012
PM 22819315
DA 2020-12-08
ER

PT J
AU Kasawara, KT
   Do Nascimento, SL
   Costa, ML
   Surita, FG
   Silva, JLPE
AF Kasawara, Karina Tamy
   Do Nascimento, Simony Lira
   Costa, Maria Laura
   Surita, Fernanda Garanhani
   Pinto E Silva, Joao Luiz
TI Exercise and physical activity in the prevention of pre-eclampsia:
   systematic review
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Review
DE Pregnancy; systematic review; physical activity; exercise; pre-eclampsia
ID OCCUPATIONAL RISK-FACTORS; PROSPECTIVE COHORT; PREGNANT-WOMEN; WORKING
   HOURS; REDUCE; HYPERTENSION; GUIDELINES; QUALITY
AB Exercise and physical activity have been studied and suggested as a way to reduce or minimize the effects of pre-eclampsia. Our aim was to evaluate the association between exercise and/or physical activity and occurrence of pre-eclampsia. We conducted electronic searches without year of publication and language limitations. This was a systematic review designed according to PRISMA. Different databases accessed were as follows: PubMed (R); Latin-American and Caribbean Literature in Health Sciences (LILACS); Scientific Electronic Library On-line (SciELO); Physiotherapy Evidence Database (PEDro); and ISI web of KnowledgeSM. The Medical Subject Headings (MeSH) were as follows: (exercise OR motor activity OR physical activity) AND (pre-eclampsia OR eclampsia OR hypertension, pregnancy-induced). Inclusion criteria were studies conducted in adults who were engaged in some physical activity. The selection and methodological evaluation were carried out by two independent reviewers. Risk assessment was made by the odds ratio (OR) and incidence of pre-eclampsia in the population who performed physical activity/exercise. A total of 231 articles were found, 214 of which were excluded based on title and full-text, so that 17 remained. Comparison of six casecontrol studies showed that physical activity had a protective effect on the development of pre-eclampsia [OR 0.77, 95% confidence interval (CI) 0.640.91, p < 0.01]. The 10 prospective cohort studies showed no significant difference (OR 0.99, 95% CI 0.931.05, p= 0.81). The only randomized clinical trial showed a protective effect on the development of pre-eclampsia in the stretching group (OR 6.34, 95% CI 0.7255.37, p= 0.09). This systematic review indicates a trend toward a protective effect of physical activity in the prevention of pre-eclampsia.
C1 [Kasawara, Karina Tamy; Do Nascimento, Simony Lira; Costa, Maria Laura; Surita, Fernanda Garanhani; Pinto E Silva, Joao Luiz] Univ Estadual Campinas, Dept Obstet & Gynecol, UNICAMP, BR-13084971 Campinas, SP, Brazil.
RP Silva, JLPE (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, UNICAMP, Alexander Fleming,1001,Cidade Univ, BR-13084971 Campinas, SP, Brazil.
EM psilva@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Surita, Fernanda Garanhani/H-9575-2012;
   Nascimento, Simony L/E-1842-2012; Kasawara, Karina T/M-1004-2017
OI Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Nascimento, Simony L/0000-0001-6248-5590;
   Kasawara, Karina T/0000-0003-1388-2615
CR [Anonymous], 2002, OBSTET GYNECOL, V99, P171
   Arena B, 2002, SPORTS MED ARTHROSC, V10, P10, DOI 10.1097/00132585-200210010-00003
   *BIOST INC, 2006, COMPR MET AN
   Bonzini M, 2007, OCCUP ENVIRON MED, V64, P228, DOI 10.1136/oem.2006.026872
   CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126
   Chang PJ, 2010, OCCUP MED-OXFORD, V60, P66, DOI 10.1093/occmed/kqp119
   Dempsey JC, 2005, EXERC SPORT SCI REV, V33, P141
   Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x
   Falcao S, 2010, J HYPERTENS, V28, P2446, DOI 10.1097/HJH.0b013e32833e97d0
   Fortner RT, 2011, MED SCI SPORT EXER, V43, P639, DOI 10.1249/MSS.0b013e3181f58d3e
   Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1
   Haelterman E, 2007, SCAND J WORK ENV HEA, V33, P304, DOI 10.5271/sjweh.1147
   Hegaard HK, 2010, J OBSTET GYNAECOL, V30, P21, DOI 10.3109/01443610903315686
   IRWIN DE, 1994, AM J IND MED, V25, P349, DOI 10.1002/ajim.4700250305
   Joles JA, 2010, J HYPERTENS, V28, P2384, DOI 10.1097/HJH.0b013e3283400653
   Juhl M, 2010, EPIDEMIOLOGY, V21, P253, DOI 10.1097/EDE.0b013e3181cb6267
   Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lavoie JL, 2011, J HYPERTENS, V29, P1465, DOI 10.1097/HJH.0b013e3283480e26
   Longo-Mbenza B, 2008, Niger J Med, V17, P45
   Longo-Mbenza B, 2008, Niger J Med, V17, P265
   Magnus P, 2008, AM J EPIDEMIOL, V168, P952, DOI 10.1093/aje/kwn189
   MARCOUX S, 1989, J EPIDEMIOL COMMUN H, V43, P147, DOI 10.1136/jech.43.2.147
   Martin CL, 2010, BIRTH-ISS PERINAT C, V37, P202, DOI 10.1111/j.1523-536X.2010.00407.x
   Osterdal ML, 2007, AM J EPIDEMIOL, V165, pS38
   Osterdal ML, 2009, BJOG-INT J OBSTET GY, V116, P98, DOI 10.1111/j.1471-0528.2008.02001.x
   Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x
   Rudra CB, 2007, AM J EPIDEMIOL, V165, pS38
   Rudra CB, 2008, MED SCI SPORT EXER, V40, P1581, DOI 10.1249/MSS.0b013e31817cab1
   Rudra CB, 2005, MED SCI SPORT EXER, V37, P1836, DOI 10.1249/01.mss.0000175862.41620.41
   Saftlas AF, 2004, AM J EPIDEMIOL, V160, P758, DOI 10.1093/aje/kwh277
   Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5
   Sorensen T, 2001, AM J OBSTET GYNECOL, V185, pS170, DOI 10.1016/S0002-9378(01)80354-9
   Sorensen TK, 2003, HYPERTENSION, V41, P1273, DOI 10.1161/01.HYP.0000072270.82815.91
   Souza Viviani Fink Fernandes de, 2010, Fisioter. mov., V23, P663, DOI 10.1590/S0103-51502010000400016
   SPINILLO A, 1995, AUST NZ J OBSTET GYN, V35, P380, DOI 10.1111/j.1479-828X.1995.tb02146.x
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Stutzman SS, 2010, BIOL RES NURS, V12, P137, DOI 10.1177/1099800410375979
   Tendais I, 2011, CAD SAUDE PUBLICA, V27, P219, DOI 10.1590/S0102-311X2011000200003
   Tyldum EV, 2010, ACTA OBSTET GYN SCAN, V89, P315, DOI 10.3109/00016340903370106
   Vollebregt KC, 2010, ACTA OBSTET GYN SCAN, V89, P261, DOI 10.3109/00016340903433982
   Weissgerber TL, 2004, MED SCI SPORT EXER, V36, P2024, DOI 10.1249/01.MSS.0000147627.35139.DC
   Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI 10.1139/h06-060
   Wolfe LA, 2003, CLIN OBSTET GYNECOL, V46, P488, DOI 10.1097/00003081-200306000-00027
   Yeo S, 2008, HYPERTENS PREGNANCY, V27, P113, DOI 10.1080/10641950701826778
   Yeo S, 2010, J NURS SCHOLARSHIP, V42, P113, DOI 10.1111/j.1547-5069.2010.01344.x
   Zavorsky GS, 2011, SPORTS MED, V41, P345, DOI 10.2165/11583930-000000000-00000
NR 47
TC 40
Z9 42
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD OCT
PY 2012
VL 91
IS 10
BP 1147
EP 1157
DI 10.1111/j.1600-0412.2012.01483.x
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 007KN
UT WOS:000308887300004
PM 22708966
DA 2020-12-08
ER

PT J
AU Haddad, SM
   Sousa, MH
   Cecatti, JG
   Parpinelli, MA
   Costa, ML
   Souza, JP
AF Haddad, Samira M.
   Sousa, Maria H.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Costa, Maria L.
   Souza, Joao P.
CA Brazilian Network Surveillance Sev
TI Intraclass correlation coefficients in the Brazilian network for
   surveillance of severe maternal morbidity study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Intraclass correlation coefficient; Maternal near miss; Severe maternal
   morbidity; Maternal and perinatal health
ID CLUSTER RANDOMIZED-TRIALS; DESIGN
AB Background: The purpose of the study was to evaluate intraclass correlation coefficients (ICC) of variables concerning personal characteristics, structure, outcome and process in the Brazilian Network for Surveillance of Severe Maternal Morbidity study conducted to identify severe maternal morbidity/near miss cases using the World Health Organization criteria.
   Method: It was a cross-sectional, multicenter study involving 27 hospitals providing care for pregnant women in Brazil. Cluster size and the mean size of the primary sampling unit were described. Estimated prevalence rates, ICC, their respective 95% confidence intervals, the design effect and the mean cluster size were presented for each variable.
   Results: Overall, 9,555 cases of severe maternal morbidity (woman admitted with potentially life-threatening conditions, near miss events or death) were included in the study. ICC ranged from < 0.001 to 0.508, with a median of 0.035. ICC was < 0.1 for approximately 75% of the variables. For process-related variables, median ICC was 0.09, with 0.021 for those related to outcome. These findings confirm data from previous studies. Homogeneity may be considered minor, thus increasing reliability of these findings.
   Conclusions: These results may be used to design new cluster trials in maternal and perinatal health and to help calculate sample sizes.
C1 [Haddad, Samira M.; Cecatti, Jose G.; Parpinelli, Mary A.; Costa, Maria L.] Univ Estadual Campinas, Dept Obstet & Gynecol, BR-13083881 Campinas, SP, Brazil.
   [Sousa, Maria H.; Cecatti, Jose G.] Campinas Ctr Studies Reprod Hlth CEMICAMP, Campinas, SP, Brazil.
   [Souza, Joao P.] UNDP UNFPA WHO World Bank Special Programme Res D, World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, R Alexander Fleming 101, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Joao Paulo/G-1982-2010; Moises, Elaine/A-5708-2015; Costa, Maria
   Laura/I-4980-2019; Amorim, Melania M/C-5807-2013; Nakamura-Pereira,
   Marcos/X-1107-2019; Surita, Fernanda Garanhani/H-9575-2012; Moises,
   Elaine Christine Dantas/N-9522-2019; Calderon, Iracema/C-8136-2012
OI Souza, Joao Paulo/0000-0002-2288-4244; Moises,
   Elaine/0000-0001-9099-4544; Costa, Maria Laura/0000-0001-8280-3234;
   Amorim, Melania M/0000-0003-1047-2514; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Calderon, Iracema/0000-0003-4761-4336;
   Santana, Danielly/0000-0001-8912-2626
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5];
   FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/18414-3]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), [grant number 402702/2008-5] and
   also the involvement of the members of its Steering Committee and all
   the other investigators and coordinators from the centers involved in
   the study. We also thank the financial support of Fapesp (Grant number
   2012/18414-3) for publishing this manuscript.
CR Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   Brazilian Ministry of Health, 2011, NAT REG HLTH FAC
   Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa
   Campbell MK, 2009, BMC MED RES METHODOL, V4, P9
   Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Kish L., 1965, SURVEY SAMPLING
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390
   Pagel C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-151
   Piaggio G, 2001, STAT MED, V20, P401, DOI 10.1002/1097-0258(20010215)20:3<401::AID-SIM801>3.0.CO;2-1
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shackman G, 2001, ALB CHAPT AM STAT AS
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   *SPSS INC, 2008, SPSS WIND REL 17 0
   StataCorp, 2015, STAT STAT SOFTW REL
   Taljaard M, 2005, PAEDIATR PERINAT EP, V2008, P117
   Thomson A, 2009, STAT MED, V28, P1739, DOI 10.1002/sim.3582
   Ukoumunne OC, 1999, HEALTH TECHNOL ASSES, V3, P5, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]
   US Census Bureau, 2002, 63RV US CENS BUR, P14
   van de Ven J, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-59
NR 22
TC 11
Z9 12
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD SEP 21
PY 2012
VL 12
AR 101
DI 10.1186/1471-2393-12-101
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 089CX
UT WOS:000314888000001
PM 22998520
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Souza, JP
   Cecatti, JG
   Haddad, SM
   Parpinelli, MA
   Costa, ML
   Katz, L
   Say, L
AF Souza, Joao Paulo
   Cecatti, Jose Guilherme
   Haddad, Samira M.
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Katz, Leila
   Say, Lale
CA Severe Maternal Morbidity Grp
TI The WHO Maternal Near-Miss Approach and the Maternal Severity Index
   Model (MSI): Tools for Assessing the Management of Severe Maternal
   Morbidity
SO PLOS ONE
LA English
DT Article
ID INTENSIVE-CARE-UNIT; MORTALITY; DEATH; ICU
AB Objectives: To validate the WHO maternal near-miss criteria and develop a benchmark tool for severe maternal morbidity assessments.
   Methods: In a multicenter cross-sectional study implemented in 27 referral maternity hospitals in Brazil, a one-year prospective surveillance on severe maternal morbidity and data collection was carried out. Diagnostic accuracy tests were used to assess the validity of the WHO maternal near-miss criteria. Binary logistic regression was used to model the death probability among women with severe maternal complications and benchmark the management of severe maternal morbidity.
   Results: Of the 82,388 women having deliveries in the participating health facilities, 9,555 women presented pregnancy-related complications, including 140 maternal deaths and 770 maternal near misses. The WHO maternal near-miss criteria were found to be accurate and highly associated with maternal deaths (Positive likelihood ratio 106.8 (95% CI 99.56-114.6)). The maternal severity index (MSI) model was developed and found to able to describe the relationship between life-threatening conditions and mortality (Area under the ROC curve: 0.951 (95% CI 0.909-0.993)).
   Conclusion: The identification of maternal near-miss cases using the WHO list of pregnancy-related life-threatening conditions was validated. The MSI model can be used as a tool for benchmarking the performance of health services managing women with severe maternal complications and provide case-mix adjustment.
C1 [Souza, Joao Paulo; Say, Lale] World Hlth Org, UNDP UNFPA WHO World Bank Special Programme Res, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Cecatti, Jose Guilherme; Haddad, Samira M.; Parpinelli, Mary Angela; Costa, Maria Laura] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Dept Obstet, Recife, PE, Brazil.
RP Souza, JP (corresponding author), World Hlth Org, UNDP UNFPA WHO World Bank Special Programme Res, Dept Reprod Hlth & Res, Geneva, Switzerland.
EM souzaj@who.int
RI Surita, Fernanda Garanhani/H-9575-2012; Andreucci, Carla B/J-4845-2015;
   Amorim, Melania M/C-5807-2013; Pacagnella, Rodolfo/H-6247-2012; Costa,
   Maria Laura/I-4980-2019; Katz, Leila/M-5291-2013; Moises,
   Elaine/A-5708-2015; Nakamura-Pereira, Marcos/X-1107-2019; Souza, Joao
   Paulo/G-1982-2010; CORDIOLI, EDUARDO/AAR-6100-2020; Rudge, Marilza V
   C/C-8338-2012; Polido, Carla Betina Andreucci/Y-9743-2019; Moises,
   Elaine Christine Dantas/N-9522-2019; de Carvalho Pacagnella,
   Rodolfo/H-9390-2019; Peracoli, Jose Carlos/G-4923-2012; Calderon,
   Iracema/C-8136-2012
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Andreucci, Carla
   B/0000-0002-5590-108X; Amorim, Melania M/0000-0003-1047-2514;
   Pacagnella, Rodolfo/0000-0002-5739-0009; Costa, Maria
   Laura/0000-0001-8280-3234; Katz, Leila/0000-0001-9854-7917; Moises,
   Elaine/0000-0001-9099-4544; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Souza, Joao Paulo/0000-0002-2288-4244;
   CORDIOLI, EDUARDO/0000-0001-5405-9380; Rudge, Marilza V
   C/0000-0002-9227-832X; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Santana, Danielly/0000-0001-8912-2626;
   Peracoli, Jose Carlos/0000-0002-3273-3001; Rocha Filho,
   Edilberto/0000-0002-6434-2654; Calderon, Iracema/0000-0003-4761-4336
FU CNPq/DECIT (The Brazilian National Research Council and the Department
   of Science and Technology of the Brazilian Ministry of Health)
   [402702/2008-5]
FX The Brazilian Network for Surveillance of Severe Maternal Morbidity was
   financially supported by CNPq/DECIT (The Brazilian National Research
   Council and the Department of Science and Technology of the Brazilian
   Ministry of Health), grant number 402702/2008-5. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045
   Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Haddad SM, 2011, INTRACLASS COR UNPUB
   Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520
   Knaus WA, 2002, ARCH SURG-CHICAGO, V137, P37, DOI 10.1001/archsurg.137.1.37
   Lapinsky SE, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.003
   Lewis G, 2007, CONF ENQ MAT CHILD H
   Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3
   Muench MV, 2008, J REPROD MED, V53, P914
   Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Pattinson R, 2009, BEST PRACT RES CL OB, V23, P285, DOI 10.1016/j.bpobgyn.2009.01.013
   Price LC, 2008, BEST PRACT RES CL OB, V22, P775, DOI 10.1016/j.bpobgyn.2008.06.001
   Say L, 2004, REPROD HLTH, V1, P3, DOI DOI 10.1186/1742-4755-1-3
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x
   Tempe Anjali, 2007, Indian J Med Sci, V61, P179
   Togal T, 2010, J CRIT CARE, V25, P628, DOI 10.1016/j.jcrc.2010.02.015
   United Nations, 2010, GLOB STRAT WOM CHILD, V2010
   Vasquez DN, 2007, CHEST, V131, P718, DOI 10.1378/chest.06-2388
   Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016
   WHO UNICEF UNFPA The World Bank, 2012, TRENDS MAT MORT 1990
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 30
TC 81
Z9 88
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2012
VL 7
IS 8
AR e44129
DI 10.1371/journal.pone.0044129
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 997ZC
UT WOS:000308206000086
PM 22952897
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Krupa, FG
   Rehder, PM
   Sousa, MH
   Costa-Paiva, L
   Cecatti, JG
AF Costa, M. L.
   Krupa, F. G.
   Rehder, P. M.
   Sousa, M. H.
   Costa-Paiva, L.
   Cecatti, J. G.
TI Forearm bone mineral density changes during postpartum and the effects
   of breastfeeding, amenorrhea, body mass index and contraceptive use
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE Amenorrhea; Bone density; Breastfeeding; Contraceptive method;
   Postpartum
ID PREGNANCY; WOMEN; LACTATION
AB Prospective cohort study performed to evaluate bone mineral density (BMD) changes up to 12 months postpartum of healthy women and its association with breastfeeding, contraceptive methods, amenorrhea, and body mass index (BMI). There is a trend in bone loss during the first 6 months with posterior recovery, with evidence of a protective effect of hormonal contraception.
   This study was conducted to evaluate bone mineral density (BMD) changes during postpartum period among healthy women and its association with breastfeeding, use of contraceptive methods, amenorrhea and body mass index (BMI).
   A prospective cohort study including 100 healthy women. Distal BMD was measured 7-10 days, 3, 6, and 12 months postpartum at the nondominant forearm using dual-energy X-ray absorptiometry. Data about breastfeeding duration, amenorrhea, contraceptive use and BMI were collected.
   Seventy-eight women had a complete set of BMD measurements. The mean duration of exclusive breastfeeding was 125.9 (+/- 66.6) days, with a median total lactation period of 263.5 days. The mean duration of amenorrhea was 164.2 (+/- 119.2) days. BMD measurements showed a significant decrease in the distal radius, however with no significance in the ultradistal radius. When considering only the nonhormonal contraceptive users, the difference at 12 months was significant. Multivariate analysis of variance showed that both BMI and contraceptive use were significantly correlated with BMD. Multiple linear regression analysis showed significant correlation of distal radius with baseline BMD at the same site, pregestational BMI, age, years of schooling and difference in BMI. For ultradistal radius, there was a significant direct correlation with its baseline BMD and pregestational BMI.
   There was a trend in bone loss during the first 6 months postpartum with posterior recovery. Also, hormonal contraceptive methods provided protection of bone loss. However, the long duration of breastfeeding and the follow-up were not sufficient to draw definitive conclusions on postweaning BMD conditions.
C1 [Cecatti, J. G.] Univ Estadual Campinas, Sch Med Sci, Dept Ob & Gyn, Campinas, SP, Brazil.
   [Costa, M. L.; Krupa, F. G.; Rehder, P. M.; Sousa, M. H.; Costa-Paiva, L.; Cecatti, J. G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Ob & Gyn, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Costa-Paiva, Lucia/A-6012-2015
OI Costa, Maria Laura/0000-0001-8280-3234; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/04555-3];
   FAEPEX/UNICAMP [421/2010]
FX Financial support was received from the Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) under the grant 2006/04555-3, and also from
   the FAEPEX/UNICAMP through the grant 421/2010.
CR Affinito P, 1996, J CLIN ENDOCR METAB, V81, P2314, DOI 10.1210/jc.81.6.2314
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   DRINKWATER BL, 1991, BONE MINER, V14, P153, DOI 10.1016/0169-6009(91)90092-E
   Eis Sergio Ragi, 2006, Arq Bras Endocrinol Metab, V50, P596, DOI 10.1590/S0004-27302006000400005
   Ensom MHH, 2002, OBSTET GYNECOL SURV, V57, P99, DOI 10.1097/00006254-200202000-00022
   Holmberg-Marttila D, 2000, OSTEOPOROSIS INT, V11, P570, DOI 10.1007/s001980070077
   IBGE-Instituto Brasileiro de Geografia e Estatistica, 2010, STUD FAM BUDG 2008 2
   International Society for Clinical Densitometry (ISCD), 2007, 2007 ISCD OFF POS
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5
   Karlsson MK, 2005, BJOG-INT J OBSTET GY, V112, P851, DOI 10.1111/j.1471-0528.2005.00571.x
   Kish L., 1965, SURVEY SAMPLING
   Laskey MA, 1997, LANCET, V349, P1518, DOI 10.1016/S0140-6736(05)62097-1
   Laskey MA, 1999, OBSTET GYNECOL, V94, P608, DOI 10.1016/S0029-7844(99)00369-5
   Lenora Janaka, 2009, BMC Womens Health, V9, P19, DOI 10.1186/1472-6874-9-19
   More C, 2001, OSTEOPOROSIS INT, V12, P732, DOI 10.1007/s001980170048
   Sena Maria Cristina Ferreira, 2007, Rev. bras. epidemiol., V10, P499, DOI 10.1590/S1415-790X2007000400008
   SOWERS M, 1993, JAMA-J AM MED ASSOC, V269, P3130, DOI 10.1001/jama.269.24.3130
   WHO-World Health Organization, 2000, WHO SCI GROUP REP SE
NR 18
TC 8
Z9 9
U1 0
U2 5
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD JUN
PY 2012
VL 23
IS 6
BP 1691
EP 1698
DI 10.1007/s00198-011-1767-y
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 943ZN
UT WOS:000304167300006
PM 21881967
DA 2020-12-08
ER

PT J
AU Costa, ML
   Cecatti, JG
   Krupa, FG
   Rehder, PM
   Sousa, MH
   Costa-Paiva, L
AF Costa, Maria Laura
   Cecatti, Jose Guilherme
   Krupa, Fabiana G.
   Rehder, Patricia Moretti
   Sousa, Maria Helena
   Costa-Paiva, Lucia
TI Progestin-only contraception prevents bone loss in postpartum
   breastfeeding women
SO CONTRACEPTION
LA English
DT Article
DE Bone mineral density; Progestin; Contraception; Breastfeeding
ID DEPOT-MEDROXYPROGESTERONE ACETATE; MINERAL DENSITY; PREMENOPAUSAL WOMEN;
   LACTATION; OSTEOPOROSIS; FOREARM; METAANALYSIS; PREGNANCY; HORMONE;
   USERS
AB Background: There are an increase in bone loss during the first 6 months postpartum and a complete recovery postweaning. A few studies of steroid contraceptive use during this period provide some evidence towards protection of bone loss with progestin-only contraceptive methods.
   Objective: The study was conducted to evaluate forearm bone mineral density (BMD) of breastfeeding postpartum women using nonhormonal and progestin-only contraceptive methods.
   Study Design: A prospective cohort study of postpartum women had an analysis performed at 6 months postpartum correlating BMD with contraceptive use. Forearm BMD was measured 7-10 days, 3 months and 6 months postpartum. Eighty-two women were analyzed, comparing nonhormonal (54) and progestin-only (28) contraceptive methods. Information about breastfeeding duration, amenorrhea and body mass index was collected.
   Results: Baseline characteristics of the study population showed no statistical differences between the groups. The median duration of breastfeeding for both groups was 183 days. A significant BMD decrease was observed for the nonhormonal group (p<.001); however, no statistical difference was detected for the progestin-only group. Body mass index, BMD at 7-10 days postpartum and total duration of breastfeeding were positively correlated with BMD at 6 months.
   Conclusions: Our findings suggest a preventive effect towards postpartum bone loss with progestin-only contraception in breastfeeding women. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Costa, Maria Laura; Cecatti, Jose Guilherme; Krupa, Fabiana G.; Rehder, Patricia Moretti; Sousa, Maria Helena; Costa-Paiva, Lucia] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, BR-13083881 Sao Paulo, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, POB 6030, BR-13083881 Sao Paulo, Brazil.
EM cecatti@unicamp.br
RI Costa-Paiva, Lucia/A-6012-2015; Rehder, Patricia/N-6731-2015; Costa,
   Maria Laura/I-4980-2019
OI Costa, Maria Laura/0000-0001-8280-3234
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FA PESP)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/04555-3];
   FAEPEX/UNICAMP [421/2010]
FX Financial support was received from the Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FA PESP) under grant number 2006/04555-3 and also
   from the FAEPEX/UNICAMP through grant 421/2010.
CR Bahamondes L, 1999, FERTIL STERIL, V71, P849, DOI 10.1016/S0015-0282(99)00084-9
   Beksinska ME, 2009, CONTRACEPTION, V79, P345, DOI 10.1016/j.contraception.2008.11.009
   CAIRD LE, 1994, CLIN ENDOCRINOL, V41, P739, DOI 10.1111/j.1365-2265.1994.tb02788.x
   Costa Paiva Lucia, 1998, Contraception, V58, P351, DOI 10.1016/S0010-7824(98)00125-5
   d'Arcangues C, 2006, CONTRACEPTION, V73, P443, DOI 10.1016/j.contraception.2006.01.002
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   Diaz S, 1999, HUM REPROD, V14, P2499, DOI 10.1093/humrep/14.10.2499
   Ensom MHH, 2002, OBSTET GYNECOL SURV, V57, P99, DOI 10.1097/00006254-200202000-00022
   Fraser IS, 1981, MED J AUST S, V1, P2
   Holmberg-Marttila D, 2000, OSTEOPOROSIS INT, V11, P570, DOI 10.1007/s001980070077
   International Planned Parenthood Federation, 1990, IPPF MED B, V24, P2
   Jarjou LMA, 2010, AM J CLIN NUTR, V92, P450, DOI 10.3945/ajcn.2010.29217
   Jones T, 1998, BRIT J RHEUMATOL, V37, P539
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5
   Karlsson MK, 2005, ACTA ORTHOP, V76, P2, DOI 10.1080/00016470510030274
   Kaunitz AM, 2008, CONTRACEPTION, V77, P67, DOI 10.1016/j.contraception.2007.10.005
   Kish L., 1965, SURVEY SAMPLING
   LAM SY, 1988, BRIT J OBSTET GYNAEC, V95, P963, DOI 10.1111/j.1471-0528.1988.tb06498.x
   Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254
   MEHTA S, 1993, ACTA OBSTET GYN SCAN, V72, P148, DOI 10.3109/00016349309013363
   NAESSEN T, 1995, CONTRACEPTION, V52, P35, DOI 10.1016/0010-7824(95)00121-P
   Perrotti M, 2001, FERTIL STERIL, V76, P469, DOI 10.1016/S0015-0282(01)01936-7
   Picard D, 2004, J CLIN DENSITOM, V7, P111, DOI 10.1385/JCD:7:1:111
   PRIOR JC, 1990, ENDOCR REV, V11, P386, DOI 10.1210/edrv-11-2-386
   Scholes D, 2002, EPIDEMIOLOGY, V13, P581, DOI 10.1097/00001648-200209000-00015
   SHAABAN M, 1994, CONTRACEPTION, V50, P35
   WHO World Health Organization, 2000, REP SER WHO
NR 27
TC 8
Z9 9
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
J9 CONTRACEPTION
JI Contraception
PD APR
PY 2012
VL 85
IS 4
BP 374
EP 380
DI 10.1016/j.contraception.2011.08.015
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 915BY
UT WOS:000301999100009
PM 22036473
DA 2020-12-08
ER

PT J
AU Costa, MLB
   Couto, E
   Furlan, E
   Zaccaria, R
   Andrade, K
   Barini, R
   Nomura, ML
AF Botelho Costa, Maria Laura
   Couto, Egle
   Furlan, Erica
   Zaccaria, Renata
   Andrade, Kleber
   Barini, Ricardo
   Nomura, Marcelo Luis
TI Body stalk anomaly: adverse maternal outcomes in a series of 21 cases
SO PRENATAL DIAGNOSIS
LA English
DT Article
DE body stalk; pregnancy; abdominal wall defect; limb body wall complex;
   prenatal diagnosis
ID ABDOMINAL-WALL DEFECTS; PRENATAL-DIAGNOSIS; MANAGEMENT
AB Objective To evaluate the demographic characteristics of cases with body stalk anomaly (BSA) and describe the obstetric outcome.
   Method Retrospective review of a case series of BSA diagnosed from 2000 to 2010.
   Results Among the 21 cases, mean gestational age at diagnosis was 22 weeks (range 11-35 weeks). Ten cases elected termination of pregnancy, which was performed at a median gestational age of 24 weeks. One termination of pregnancy at 33 weeks' gestation in a woman with late diagnosis of BSA and a previous uterine scar, required cesarean section during labor because of clinical signs of uterine rupture. Of the remaining 11 cases, four were lost to follow-up, three delivered vaginally, three underwent elective cesarean sections, and one underwent cesarean section because of obstructed labor. Six of seven cases were growth restricted and six of seven were small for gestational age. There were no abnormal karyotypes among the nine cases which underwent cytogenetic studies.
   Conclusion Continuation of pregnancy in the presence of BSA is associated with greater maternal risks, in the form of labor complications requiring cesarean section. This information should be discussed with couples at the time of diagnosis. (C) 2012 John Wiley & Sons, Ltd.
C1 [Botelho Costa, Maria Laura; Couto, Egle; Furlan, Erica; Zaccaria, Renata; Andrade, Kleber; Barini, Ricardo; Nomura, Marcelo Luis] Univ Estadual Campinas, Campinas, SP, Brazil.
RP Nomura, ML (corresponding author), Univ Estadual Campinas, Campinas, SP, Brazil.
EM mlnomura@unicamp.br
RI Nomura, Marcelo Luis/H-9534-2019; Barini, Ricardo/U-8446-2019; Costa,
   Maria Laura/I-4980-2019; BARINI, RICARDO/B-9920-2019
OI Costa, Maria Laura/0000-0001-8280-3234; BARINI,
   RICARDO/0000-0002-4138-6945
CR Chan Y, 2000, AM J MED GENET, V94, P284, DOI 10.1002/1096-8628(20001002)94:4<284::AID-AJMG4>3.0.CO;2-M
   Chen CP, 2011, TAIWAN J OBSTET GYNE, V50, P126, DOI 10.1016/j.tjog.2011.01.039
   Daskalakis G, 1997, ULTRASOUND OBST GYN, V10, P416, DOI 10.1046/j.1469-0705.1997.10060416.x
   GOLDSTEIN I, 1989, AM J PERINAT, V6, P84, DOI 10.1055/s-2007-999552
   MANN L, 1984, PRENATAL DIAG, V4, P427, DOI 10.1002/pd.1970040606
   MORROW RJ, 1993, PRENATAL DIAG, V13, P111, DOI 10.1002/pd.1970130205
   Negishi H, 1998, J REPROD MED, V43, P659
   PILU G, 1999, DIAGNOSIS FETAL ABNO
   Shavlev E, 1995, J ULTRAS MED, V14, P641
   Smrcek JM, 2003, ULTRASOUND OBST GYN, V21, P322, DOI 10.1002/uog.84
   Werler MM, 2003, BIRTH DEFECTS RES A, V67, P68, DOI 10.1002/bdra.10001
NR 11
TC 6
Z9 6
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0197-3851
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD MAR
PY 2012
VL 32
IS 3
BP 264
EP 267
DI 10.1002/pd.2947
PG 4
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA 910LT
UT WOS:000301639300010
PM 22430725
DA 2020-12-08
ER

PT J
AU Haddad, SM
   Cecatti, JG
   Parpinelli, MA
   Souza, JP
   Costa, ML
   Sousa, MH
   Surita, FG
   Silva, JLPE
   Pacagnella, RC
   Camargo, RS
   Bahamondes, MV
   Zotareli, V
   Gurgel, LT
   Say, L
   Pattinson, RC
AF Haddad, Samira M.
   Cecatti, Jose G.
   Parpinelli, Mary A.
   Souza, Joao P.
   Costa, Maria L.
   Sousa, Maria H.
   Surita, Fernanda G.
   Pinto e Silva, Joao L.
   Pacagnella, Rodolfo C.
   Camargo, Rodrigo S.
   Bahamondes, Maria V.
   Zotareli, Vilma
   Gurgel, Lucio T.
   Say, Lale
   Pattinson, Robert C.
CA Natl Network Surveillance Severe M
TI From planning to practice: building the national network for the
   surveillance of severe maternal morbidity
SO BMC PUBLIC HEALTH
LA English
DT Article
DE surveillance network severe maternal morbidity; near-miss; multicenter
   cross-sectional study
ID PREGNANCY; MISSES
AB Background: Improving maternal health is one of the Millennium Development Goals for 2015. Recently some progress has been achieved in reducing mortality. On the other hand, in developed regions, maternal death is a relatively rare event compared to the number of cases of morbidity; hence studying maternal morbidity has become more relevant. Electronic surveillance systems may improve research by facilitating complete data reporting and reducing the time required for data collection and analysis. Therefore the purpose of this study was to describe the methods used in elaborating and implementing the National Network for the Surveillance of Severe Maternal Morbidity in Brazil.
   Methods: The project consisted of a multicenter, cross-sectional study for the surveillance of severe maternal morbidity including near-miss, in Brazil.
   Results: Following the development of a conceptual framework, centers were selected for inclusion in the network, consensus meetings were held among the centers, an electronic data collection system was identified, specific software and hardware tools were developed, research material was prepared, and the implementation process was initiated and analyzed.
   Conclusion: The conceptual framework developed for this network was based on the experience acquired in various studies carried out in the area over recent years and encompasses maternal and perinatal health. It is innovative especially in the context of a developing country. The implementation of the project represents the first step towards this planned management. The system online elaborated for this surveillance network may be used in further studies in reproductive and perinatal health.
C1 [Haddad, Samira M.; Cecatti, Jose G.; Parpinelli, Mary A.; Costa, Maria L.; Surita, Fernanda G.; Pinto e Silva, Joao L.; Pacagnella, Rodolfo C.; Camargo, Rodrigo S.; Gurgel, Lucio T.; Natl Network Surveillance Severe M] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Cecatti, Jose G.; Sousa, Maria H.; Bahamondes, Maria V.; Zotareli, Vilma] Campinas Ctr Studies Reprod Hlth CEMICAMP, Campinas, SP, Brazil.
   [Souza, Joao P.; Say, Lale] WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva, Switzerland.
   [Pattinson, Robert C.] Univ Pretoria, MRC Maternal & Infant Hlth Care Strategies Res Un, Gauteng, South Africa.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Moises, Elaine/A-5708-2015; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Polido, Carla Betina Andreucci/Y-9743-2019; Moises, Elaine Christine
   Dantas/N-9522-2019; Pacagnella, Rodolfo/H-6247-2012; Nakamura-Pereira,
   Marcos/X-1107-2019; Souza, Joao Paulo/G-1982-2010; Surita, Fernanda
   Garanhani/H-9575-2012; Andreucci, Carla B/J-4845-2015; Quintana, Silvana
   Maria/D-6953-2015; Amorim, Melania M/C-5807-2013; Calderon,
   Iracema/C-8136-2012
OI Moises, Elaine/0000-0001-9099-4544; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Pacagnella, Rodolfo/0000-0002-5739-0009;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Souza, Joao
   Paulo/0000-0002-2288-4244; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Andreucci, Carla B/0000-0002-5590-108X;
   Quintana, Silvana Maria/0000-0002-9311-786X; Amorim, Melania
   M/0000-0003-1047-2514; Santana, Danielly/0000-0001-8912-2626; Calderon,
   Iracema/0000-0003-4761-4336; Rocha Filho, Edilberto/0000-0002-6434-2654
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX The authors acknowledge the financial support of CNPq/DECIT (The
   National Research Council and the Department of Science and Technology
   of the Brazilian Ministry of Health), grant number 402702/2008-5 and
   also the involvement of the members of its Steering Committee and all
   the other investigators and coordinators from all the centers involved
   in the National Network for the Surveillance of Severe Maternal
   Morbidity Group: A Metin Gulmezoglu, Marilza V Rudge, Iracema M
   Calderon, Danielly S Santana, Simone P Goncalves, Eliana M Amaral,
   Olimpio B Moraes Filho, Simone A Carvalho, Francisco E Feitosa, George N
   Chaves, Ione R Brum, Gloria C Saintynes, Carlos A Menezes, Patricia N
   Santos, Everardo M Guanabara, Elson J Almeida Jr, Joaquim L Moreira,
   Maria R Sousa, Frederico A Peret, Liv B Paula, Luiza E Schmaltz, Cleire
   Pessoni, Leila Katz, Adriana Bione, Antonio C Barbosa Lima, Edilberto A
   Rocha Filho, Melania M Amorim, Debora Leite, Ivelyne Radaci, Marilia G
   Martins, Frederico Barroso, Femando C Oliveira Jr, Denis J Nascimento,
   Claudio S Paiva, Moises D Lima, Djacyr M Freire, Roger D Rohloff, Simone
   M Rodrigues, Sergio M Costa, Lucia C Pfitscher, Adriana G Luz, Daniela
   Guimaraes, Gustavo Lobato, Marcos N Pereira, Eduardo Cordioli,
   Alessandra Peterossi, Cynthia D Perez, Jose C Peracoli, Roberto A Costa,
   Nelson L Maia Filho, Jacinta P Matias, Silvana M Quintana, Elaine C
   Moises, Fatima A Lotufo, Luiz E Carvalho, Elvira A Zanette, Carla B
   Andreucci, Marcia M Aquino, Maria H Ohnuma, Rosiane Mattar and Felipe F
   Campanharo.
CR *BRAZ MIN HLTH, 2011, HOSP SYST APPL
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9
   Dwyer L., 2009, Morbidity and Mortality Weekly Report, V58, P804
   Geller SE, 2004, J CLIN EPIDEMIOL, V57, P716, DOI 10.1016/j.jclinepi.2004.01.003
   Geller Stacie E, 2002, J Am Med Womens Assoc (1972), V57, P135
   *HLTH CAN, 2004, SPEC REP MAT MORT SE
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   Islam M, 2009, BJOG-INT J OBSTET GY, V116, P2, DOI 10.1111/j.1471-0528.2009.02335.x
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   *OPENCLINICA, 2010, OP SOURC CLIN RES
   *PAHO, 2000, EPIDEMIOLOGICAL B, V21
   Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007
   Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026
   Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4
   Rolfhamre P, 2006, Euro Surveill, V11, P103
   Ronsmans C, 2009, BJOG-INT J OBSTET GY, V116, P82, DOI 10.1111/j.1471-0528.2008.01913.x
   Say L, 2004, REPROD HLTH, V1, P3, DOI DOI 10.1186/1742-4755-1-3
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Shekelle Paul G, 2006, Evid Rep Technol Assess (Full Rep), P1
   Sousa Maria H, 2008, Reprod Health, V5, P6, DOI 10.1186/1742-4755-5-6
   Souza JP, 2008, J CLIN EPIDEMIOL, V61, P169, DOI 10.1016/j.jclinepi.2007.04.009
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   SOUZA JP, 2002, J AM MED WOMEN ASSOC, V57, P135
   United Nations, 2008, MILL DEV GOALS REP 2
   WHO, 2009, WORLD HLTH STAT 2009
   World Health Organization, 1997, WHOEMCDIS972
   ZHANG LQ, 2008, INT ARCH PHOTOGR REM, V37, P171
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 30
TC 31
Z9 33
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 8
PY 2011
VL 11
AR 283
DI 10.1186/1471-2458-11-283
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 769HS
UT WOS:000291004100001
PM 21549009
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, MLB
   Surita, FGC
   Passini, R
   Cecatti, JG
   Boin, IFSF
AF Costa, M. L. B.
   Surita, F. G. C.
   Passini, R., Jr.
   Cecatti, J. G.
   Boin, I. F. S. F.
TI Pregnancy Outcome in Female Liver Transplant Recipients
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
AB Transplantation has become an available and successful treatment option for numerous congenital and acquired hepatic disorders. Studies have shown that when the prepregnancy recipient graft function is stable and adequate, pregnancy is normally well tolerated with favorable neonatal outcomes. However, there are reports of increased incidences of hypertension and preeclampsia as well as lower birth weights and prematurity. Patients administered tacrolimus-based therapies seem to have lower incidences of these complications.
   Case Reports. The 5 reported patients, aged 23-37 years at the time of conception, were 2-11 years posttransplantation. A preterm delivery for fetal distress was the most clinically important complication among these patients. One episode of acute genital herpes infection, 1 liver hematoma in a patient who was anticoagulated owing to a history of deep vein thrombosis, and 1 case of wound infection postpartum were also observed. Despite these complications, all 5 pregnancies were successful. The mean gestational age at delivery was 35.2 weeks. No structural malformations or early complications were observed in the neonates. All cases showed stable liver parameters.
C1 [Costa, M. L. B.; Surita, F. G. C.; Passini, R., Jr.; Cecatti, J. G.] Univ Estadual Campinas, Dept Gynecol & Obstet, Campinas, SP, Brazil.
   [Boin, I. F. S. F.] Univ Estadual Campinas, Unit Liver Transplantat, Campinas, SP, Brazil.
RP Boin, IFSF (corresponding author), Rua Aldo Oliveira Barbosa 184, BR-13086030 Campinas, SP, Brazil.
EM ilkaboin@yahoo.com
RI Boin, Ilka/M-7184-2019; Surita, Fernanda Garanhani/H-9575-2012; Boin,
   Ilka FSF/C-7811-2009; Passini Junior, Renato/O-6169-2016
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Passini Junior,
   Renato/0000-0001-8247-4549
CR Armenti Vincent T, 2005, Clin Transpl, P69
   Armenti VT, 2000, LIVER TRANSPLANT, V6, P671, DOI 10.1053/jlts.2000.18703
   Armenti VT, 2002, DRUGS, V62, P2361, DOI 10.2165/00003495-200262160-00004
   Bermas BL, 1995, ARTHRITIS RHEUM-US, V38, P1722, DOI 10.1002/art.1780381203
   Clavien PA, 2008, J HEPATOL, V49, P505, DOI 10.1016/j.jhep.2008.07.010
   Czaja AJ, 2006, HEPATOLOGY, V43, P532, DOI 10.1002/hep.21074
   Kainz A, 2000, TRANSPLANTATION, V70, P1718, DOI 10.1097/00007890-200012270-00010
   Miller JC, 2000, AM J PERINAT, V17, P299, DOI 10.1055/s-2000-13435
   Nagy S, 2003, OBSTET GYNECOL, V102, P121, DOI 10.1016/S0029-7844(03)00369-7
   RIELY CA, 2001, LIVER TRANSPL S1, V7, P74
   ZIENIEWICZ ZJ, 2006, TRANSPL P, V38, P255
NR 11
TC 14
Z9 14
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD MAY
PY 2011
VL 43
IS 4
BP 1337
EP 1339
DI 10.1016/j.transproceed.2011.02.026
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 773EI
UT WOS:000291289400100
PM 21620123
DA 2020-12-08
ER

PT J
AU Discacciati, MG
   Simoes, JA
   Silva, MG
   Marconi, C
   Brolazo, E
   Costa, ML
   Cecatti, JG
AF Discacciati, Michelle G.
   Simoes, Jose A.
   Silva, Marcia G.
   Marconi, Camila
   Brolazo, Eliane
   Costa, Maria L.
   Cecatti, Jose G.
TI Microbiological characteristics and inflammatory cytokines associated
   with preterm labor
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Article
DE Preterm labor; Cytokines; Interleukins; Bacterial vaginosis
ID BACTERIAL VAGINOSIS; PREMATURE RUPTURE; CERVICAL SECRETIONS; FETAL
   FIBRONECTIN; BIRTH; MEMBRANES; RISK; INTERLEUKIN-6; WOMEN; FLUID
AB To evaluate vaginal microflora and interleukin-1 beta (IL-beta), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) concentrations in the cervicovaginal fluid of a group of pregnant women in preterm labor when compared with a group of full-term pregnant women not yet in labor.
   Case-control study performed in a University tertiary referral maternity in Campinas, Brazil with 45 pregnant women in preterm labor and 45 full-term pregnant women not in labor. All patients underwent speculum examination for the collection of cervicovaginal fluid. Bacterial vaginosis (BV) was diagnosed according to the criteria of Amsel and Nugent. Culture was performed for group B streptococcus (GBS) and lactobacilli, and hybrid capture assay for screening for chlamydial and gonococcal infection. Cytokine concentrations were measured using ELISA technique. Statistical analysis was performed using chi(2), Fisher's exact, and crude and adjusted odds ratios. Significance level was defined at 5%. The main outcome measures were cervicovaginal cytokines in preterm labor.
   IL-6 and IL-8 were significantly associated with preterm labor. The changes in vaginal microflora, as well as BV and GBS, were more frequent in women in preterm labor, although BV and GBS showed no statistical significance. The presence of Candida sp., absence of lactobacilli, positive screening for chlamydial and gonococcal infection and the presence of IL-1 beta and TNF-alpha were not associated with preterm labor.
   IL-6 and IL-8 and the presence of any type of vaginal infection were the factors that were significantly associated with preterm labor.
C1 [Discacciati, Michelle G.; Brolazo, Eliane; Costa, Maria L.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Silva, Marcia G.; Marconi, Camila] Univ Estadual Paulista Julio de Mesquita Filho UN, Dept Pathol, Botucatu, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Silva, Marcia G/C-2050-2012; Marconi, Camila/C-6936-2012; da Silva,
   Marcia Guimaraes/M-8080-2019; Discacciati, Michelle Garcia/B-4608-2014
OI Silva, Marcia G/0000-0002-4663-7926; Marconi,
   Camila/0000-0001-7742-1186; da Silva, Marcia
   Guimaraes/0000-0002-4663-7926; Discacciati, Michelle
   Garcia/0000-0003-3660-3826
FU Sao Paulo FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX The authors gratefully acknowledge the collaboration of Jossimara
   Polettini in performing the ELISA tests, Andreia Leal for her help in
   providing care for the patients included in the study and Sirlei Morais
   for collaborating in the statistical analysis. The financial support of
   the Sao Paulo Foundation for the Support of Research (FAPESP) is also
   gratefully acknowledged. Unfortunately, after the end of this study,
   Prof. J.A. Simoes died. All the authors would like to recognize his
   leadership in this topic.
CR AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9
   Basso Beatriz, 2005, Infect Dis Obstet Gynecol, V13, P207, DOI 10.1155/2005/358107
   BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57
   Coleman MAG, 2001, EUR J OBSTET GYN R B, V95, P154, DOI 10.1016/S0301-2115(00)00450-4
   Denison FC, 1999, AM J OBSTET GYNECOL, V180, P614, DOI 10.1016/S0002-9378(99)70263-2
   Doh Kunihiko, 2004, Infect Dis Obstet Gynecol, V12, P79, DOI 10.1080/10647440400003667
   Donders GGG, 2000, AM J OBSTET GYNECOL, V183, P431, DOI 10.1067/mob.2000.105738
   Dowd J, 2001, GYNECOL OBSTET INVES, V51, P165, DOI 10.1159/000052917
   Fortunato SJ, 1996, AM J OBSTET GYNECOL, V174, P1855, DOI 10.1016/S0002-9378(96)70221-1
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   GUASCHINO S, 2006, BJOG, V115, P46
   Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021
   Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7
   Hoyme UB, 2004, EUR J OBSTET GYN R B, V115, P148, DOI 10.1016/j.ejogrb.2004.02.038
   Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034
   Kalinka Jaroslaw, 2005, Ginekol Pol, V76, P704
   Kilpatrick SJ, 2006, AM J OBSTET GYNECOL, V194, P1168, DOI 10.1016/j.ajog.2005.12.017
   Kurkinen-Raty M, 2001, BRIT J OBSTET GYNAEC, V108, P875, DOI 10.1111/j.1471-0528.2001.00199.x
   Larsson P-G, 2007, BMC Womens Health, V7, P20, DOI 10.1186/1472-6874-7-20
   Mattsby-Baltzer I, 1998, ACTA OBSTET GYN SCAN, V77, P701, DOI 10.1034/j.1600-0412.1998.770701.x
   Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016
   *MIN HLTH, 2000, HIGH RISK PREGN TECH
   Nomura ML, 2005, INT J GYNECOL OBSTET, V91, P69, DOI 10.1016/j.ijgo.2005.06.023
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991
   Quesnel A, 1997, J IMMUNOL METHODS, V202, P153, DOI 10.1016/S0022-1759(97)00003-3
   Reedy NJ, 2007, J MIDWIFERY WOM HEAL, V52, P281, DOI 10.1016/j.jmwh.2007.02.022
   Rizzo G, 1996, AM J OBSTET GYNECOL, V175, P812, DOI 10.1016/S0002-9378(96)80004-4
   SCHULTZ R, 1991, BRIT MED J, V303, P1369, DOI 10.1136/bmj.303.6814.1369
   Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x
   Simoes J.A., 1996, REV BRAS GINECOL OBS, V18, P459
   Swadpanich U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006178.pub2
   Tanaka Y, 1998, AM J OBSTET GYNECOL, V179, P644, DOI 10.1016/S0002-9378(98)70058-4
   Varma R, 2006, EUR J OBSTET GYN R B, V127, P145, DOI 10.1016/j.ejogrb.2006.02.001
   WATCHARASERANEE N, 2006, J MED ASS THAI, V89, P18
NR 34
TC 8
Z9 11
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD MAR
PY 2011
VL 283
IS 3
BP 501
EP 508
DI 10.1007/s00404-010-1427-z
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 718RV
UT WOS:000287144700015
PM 20237933
DA 2020-12-08
ER

PT J
AU Barbieri, C
   Cecatti, JG
   Surita, FG
   Costa, ML
   Marussi, EF
   Costa, JV
AF Barbieri, Cristiane
   Cecatti, Jose G.
   Surita, Fernanda G.
   Costa, Maria L.
   Marussi, Emilio F.
   Costa, Jose V.
TI Area of Wharton's jelly as an estimate of the thickness of the umbilical
   cord and its relationship with estimated fetal weight
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE ultrasonography; pregnancy; umbilical cord; umbilical vessels; Wharton's
   jelly
ID CROSS-SECTIONAL AREA; SONOGRAPHIC MEASUREMENTS; GLYCOSAMINOGLYCANS;
   COLLAGEN
AB Background: To build a reference curve for the area of Wharton's jelly (WJ) in low-risk pregnancies from 13 to 40 weeks and to assess its relationship with estimated fetal weight (EFW).
   Methods: 2,189 low-risk pregnancies had the area of WJ estimated by ultrasound and the 10th, 50th and 90th percentiles calculated using a third-degree polynomial regression procedure. EFW by ultrasound was correlated with the measurement of the area of WJ.
   Results: The area of WJ increased according to gestational age (R-2 = 0.64), stabilizing from the 32nd week onwards. There was a significant linear correlation between area of WJ and EFW up to 26 weeks (R = 0.782) and after that 5t remained practically constant (R = 0.047).
   Conclusion: The area of WJ increases according to gestational age, with a trend to stabilize at around 32 weeks of gestation. It is also linearly correlated with EFW only up to 26 weeks of gestation.
C1 [Barbieri, Cristiane; Cecatti, Jose G.; Surita, Fernanda G.; Costa, Maria L.; Marussi, Emilio F.; Costa, Jose V.] Univ Estadual Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Jose Vilton/P-3505-2014; Surita, Fernanda Garanhani/H-9575-2012
OI Costa, Jose Vilton/0000-0002-4986-7356; Surita, Fernanda
   Garanhani/0000-0003-4335-0337
CR Bankowski E, 1996, EUR J OBSTET GYN R B, V66, P109, DOI 10.1016/0301-2115(96)02390-1
   Barbieri C, 2008, REPROD HLTH, V5, P10
   Barbieri C, 2008, ACTA OBSTET GYN SCAN, V87, P286, DOI 10.1080/00016340701876106
   de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010
   Ghezzi F, 2001, ULTRASOUND OBST GYN, V18, P121, DOI 10.1046/j.1469-0705.2001.00468.x
   GOODLIN RC, 1987, AM J OBSTET GYNECOL, V156, P1357, DOI 10.1016/0002-9378(87)90180-3
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   KLEIN J, 1983, BIOCHIM BIOPHYS ACTA, V755, P400, DOI 10.1016/0304-4165(83)90243-X
   Kurita M, 2009, FETAL DIAGN THER, V26, P85, DOI 10.1159/000238118
   LABARRERE C, 1985, PLACENTA, V6, P555, DOI 10.1016/S0143-4004(85)80010-2
   Milnerowicz-Nabzdyk E, 2010, NEUROENDOCRINOL LETT, V31, P842
   Nanaev AK, 1997, PLACENTA, V18, P53, DOI 10.1016/S0143-4004(97)90071-0
   PHELAN JP, 1987, J REPROD MED, V32, P540
   Raio L, 1999, EUR J OBSTET GYN R B, V83, P131, DOI 10.1016/S0301-2115(98)00314-5
   Skulstad SM, 2006, ULTRASOUND OBST GYN, V28, P692, DOI 10.1002/uog.3814
   Sobolewski K, 1997, BIOL NEONATE, V71, P11
   Togni FA, 2007, INT J GYNECOL OBSTET, V96, P156, DOI 10.1016/j.ijgo.2006.10.003
   Togni FA, 2007, J PERINAT MED, V35, P130, DOI 10.1515/JPM.2007.020
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   WEISSMAN A, 1994, J ULTRAS MED, V13, P11
   Weissman A, 1997, J ULTRAS MED, V16, P691
NR 21
TC 9
Z9 10
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PY 2011
VL 8
AR 32
DI 10.1186/1742-4755-8-32
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V27IX
UT WOS:000208608000032
PM 22054163
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Coutinho, PR
   Cecatti, JG
   Surita, FG
   Costa, ML
   Morais, SS
AF Coutinho, Pedro R.
   Cecatti, Jose G.
   Surita, Fernanda G.
   Costa, Maria L.
   Morais, Sirlei S.
TI Perinatal outcomes associated with low birth weight in a historical
   cohort
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE low birth weight perinatal outcomes; prenatal care; preterm
ID BREECH PRESENTATION; PRETERM BIRTH; INFANTS; TERM
AB Objective: To identify perinatal outcomes associated with low birth weight (LBW).
   Methods: A retrospective cohort study in a tertiary maternity hospital. Analysis of the database on 43,499 liveborn infants delivered between 1986 and 2004 with low (n = 6,477) and normal (n = 37,467) birth weight. Outcomes associated with LBW were identified through crude and adjusted risk ratio (RR) and 95% CI with bivariate and multivariate analysis. The main outcomes were: onset of labor, mode of delivery, indication for cesarean section; amniotic fluid, fetal heart rate pattern, Apgar score, somatic gestational age, gender and congenital malformation.
   Results: LBW infants showed more frequently signs of perinatal compromise such as abnormal amniotic fluid volume (especially olygohydramnios), nonreassuring patterns of fetal heart rate, malformation, lower Apgar scores and lower gestational age at birth. They were associated with a greater risk of labor induction and cesarean delivery, but lower risk of forceps.
   Conclusion: There was a clear association between LBW and unfavorable perinatal outcomes.
C1 [Coutinho, Pedro R.; Cecatti, Jose G.; Surita, Fernanda G.; Costa, Maria L.; Morais, Sirlei S.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Coutinho, PR (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM prcoutinho@terra.com.br
RI Surita, Fernanda Garanhani/H-9575-2012; Costa, Maria Laura/I-4980-2019
OI Surita, Fernanda Garanhani/0000-0003-4335-0337; Costa, Maria
   Laura/0000-0001-8280-3234
CR [Anonymous], 2005, WORLD HLTH REP 2005, P79
   Barber Chad A, 2007, J Ark Med Soc, V104, P63
   Barg Ewa, 2003, Ginekol Pol, V74, P1585
   Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009
   Barros FC, 2011, REV SAUDE PUBLICA
   Barros FC, 2006, OBSTET GYNECOL, V107, P1035, DOI 10.1097/01.AOG.0000215984.36989.5e
   Coutinho PR, 2009, REV ASSOC MED BRAS, V55, P692, DOI 10.1590/S0104-42302009000600013
   Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0
   Dolan SM, 2007, OBSTET GYNECOL, V110, P318, DOI 10.1097/01.AOG.0000275264.78506.63
   ENKIN M, 2000, GUIDE EFFECTIVE CARE, P221
   Goldenberg RL, 2007, AM J CLIN NUTR, V85, p584S
   Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3
   Henry JA, 2006, J PERINATOL, V26, P125, DOI 10.1038/sj.jp.7211435
   Ingemarsson I, 2003, BJOG-INT J OBSTET GY, V110, P34, DOI 10.1016/S1470-0328(03)00022-3
   Joseph K S, 2007, BMC Pregnancy Childbirth, V7, P4, DOI 10.1186/1471-2393-7-4
   Kolatat Thrathip, 2000, Journal of the Medical Association of Thailand, V83, P1039
   Munz W, 2005, Z Geburtshilfe Neonatol, V209, P29, DOI 10.1055/s-2005-837797
   Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192
   Peters KL, 2009, PEDIATRICS, V124, P1009, DOI 10.1542/peds.2008-3808
   Robilio PA, 2007, J REPROD MED, V52, P473
   Sweha A, 1999, AM FAM PHYSICIAN, V59, P2487
   Teles EPB, 1992, REV BRAS GINECOL OBS, V14, P161
   Tharmaratnam S, 2000, BEST PRACT RES CL OB, V14, P155, DOI 10.1053/beog.1999.0069
   VEGA J, 1993, REV MED CHILE, V121, P1210
   Velez MP, 2009, REV PANAM SALUD PUBL, V26, P112, DOI 10.1590/S1020-49892009000800003
   WHO, 2005, CONTR NEGL ZOON DIS
NR 27
TC 16
Z9 17
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PY 2011
VL 8
AR 18
DI 10.1186/1742-4755-8-18
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V27IX
UT WOS:000208608000018
PM 21635757
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Cecatti, JG
   Souza, JP
   Milanez, HM
   Gulmezoglu, MA
AF Costa, Maria L.
   Cecatti, Jose G.
   Souza, Joao P.
   Milanez, Helaine M.
   Guelmezoglu, Metin A.
TI Using a Caesarean Section Classification System based on characteristics
   of the population as a way of monitoring obstetric practice
SO REPRODUCTIVE HEALTH
LA English
DT Article
ID RATES; AUDIT; DELIVERY; OUTCOMES; HEALTH; CARE
AB Objective: to compare the distribution of caesarean rates in the Robson's 10 groups classification in order to see if any change occurred after the implementation of an audit and feedback intervention. Design: cross sectional, before and after an audit and feedback study. Setting: a university hospital in Brazil.
   Methods: clinical records of all births during two three months-periods were evaluated. Each case of CS was classified into one of ten mutually exclusive categories according to obstetric characteristics. The proportion of CS in each group was compared in both periods.
   Results: total number of deliveries and the high rate of CS were similar in both periods. Group 3 (multiparous excluding previous CS, single, cephalic, >= 37 weeks, spontaneous labour) accounted for the largest proportion of deliveries, 28.5 and 26.8% in both periods. Group 1 (nulliparous, single, cephalic, >= 37 weeks, spontaneous labour) was the second largest one, while Group 5 (previous caesarean section, single, cephalic, and >= 37 weeks) was the third but the largest contributor to CS, accounting for 16.6 and 14.9% among all deliveries in both periods. Groups 2 (nulliparous, single, cephalic, >= 37 weeks, induction or CS before labour) and 4 (multiparous excluding previous CS, single, cephalic, >= 37 weeks, induction or CS before labour) were less prevalent, however had higher rates of CS. Only in Group 10 (All single, cephalic, <= 36 weeks, including previous CS), there was a significant decrease of CS rate from 70.5 to 42.6% between periods.
   Conclusion: Robson's classification did not identify any significant change in the pattern of CS rates with the audit and feedback process, but showed to be useful for comparing trends among similar obstetric populations.
C1 [Costa, Maria L.; Cecatti, Jose G.; Milanez, Helaine M.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Souza, Joao P.; Guelmezoglu, Metin A.] WHO, Special Programme Res Dev & Res Training Human Re, HRP, UNDP,UNFPA,World Bank, CH-1211 Geneva, Switzerland.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Joao Paulo/G-1982-2010
OI Souza, Joao Paulo/0000-0002-2288-4244
FU FAPESP (Foundation of Support to Research from the State of Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2007/01397-0]
FX We thank FAPESP (Foundation of Support to Research from the State of Sao
   Paulo) for financial sponsorship (Grant 2007/01397-0). It played no
   other rule in the development and report of this study.
CR Alfirevic Z, 2007, COCHRANE DATABASE SY
   [Anonymous], 1985, LANCET, V2, P436
   BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J
   Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x
   Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18
   Canadian Institute for Health Information, 2004, GIVING BIRTH IN CANA
   Chaillet N, 2007, B WORLD HEALTH ORGAN, V85, P791, DOI 10.2471/BLT.06.039289
   Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x
   Costa ML, 2009, ACTA OBSTET GYN SCAN, V88, P793, DOI 10.1080/00016340903002857
   Denk CE, 2006, BIRTH-ISS PERINAT C, V33, P203, DOI 10.1111/j.1523-536X.2006.00105.x
   FAUNDES A, 1993, HEALTH POLICY PLANN, V8, P33, DOI 10.1093/heapol/8.1.33
   Florica M, 2006, INT J GYNECOL OBSTET, V92, P181, DOI 10.1016/j.ijgo.2005.10.016
   GULMEZOGLU AM, 2007, COCHRANE DATABASE SY
   Harper LM, 2008, OBSTET GYNECOL SURV, V63, P538, DOI 10.1097/OGX.0b013e31817f1505
   Hodnett ED, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub2
   Kongnyuy EJ, 2009, ACTA OBSTET GYN SCAN, V88, P873, DOI 10.1080/00016340903093542
   Main E K, 1999, Pediatrics, V103, P374
   McCarthy FP, 2007, AUST NZ J OBSTET GYN, V47, P316, DOI 10.1111/j.1479-828X.2007.00753.x
   O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2
   Robson MS, 1996, AM J OBSTET GYNECOL, V174, P199, DOI 10.1016/S0002-9378(96)70394-0
   Robson MS, 2001, FETAL MATERNAL MED R, V12, P23, DOI DOI 10.1017/S0965539501000122
   Rossi AC, 2008, AM J OBSTET GYNECOL, V199, P224, DOI 10.1016/j.ajog.2008.04.025
   Vera P.G Claudio, 2004, Rev. chil. obstet. ginecol., V69, P219, DOI 10.4067/S0717-75262004000300007
   Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7
NR 24
TC 24
Z9 28
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JUN 26
PY 2010
VL 7
AR 13
DI 10.1186/1742-4755-7-13
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V27IN
UT WOS:000208607000001
PM 20579388
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, MLB
   de Souza, JPD
   Neto, AFD
   Silva, JLPE
AF Botelho Costa, Maria Laura
   Dias de Souza, Joao Paulo
   de Oliveira Neto, Antonio Francisco
   Pinto E Silva, Joao Luiz
TI CRYPTOCOCCAL MENINGITIS IN HIV NEGATIVE PREGNANT WOMEN: CASE REPORT AND
   REVIEW OF LITERATURE
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Review
DE Cryptococcal meningitis; Cryptococcosis; Pregnancy; Antifungal therapy
ID AMPHOTERICIN-B; FLUCYTOSINE; NEOFORMANS; THERAPY; MOTHER
AB Introduction: Cryptococcosis has become an important entity due to the epidemic of AIDS and therefore it is a significant opportunistic infection. However, there are case reports of cryptococcal meningitis in immune competent pregnant women. Since pregnancy is considered a period of relative immunosuppression, which likely prevents fetal rejection, this could explain the occurrence of opportunistic infections. Objective: To report a case of cryptococcosis, and review all cases involving pregnancy and neurocryptococcal infection in immune competent pregnant patients. Methods: Case report and systematic review of the literature using the MEDLINE and SciELO databases. Discussion: A total of 27 patients were analyzed from 19 studies. The mean age at diagnosis was 26.4 years. There were six patients in their first trimester of pregnancy, 10 in the second, eight in the third and three post-partum. The most prevalent symptoms were headache (85.2%), altered vision (44.4%), altered mental status (44.4%), nausea (40.7%) and fever (33.3%). There were nine deaths (33.3%). Most of the patients received intravenous amphotericin B as treatment (77.8%). The majority (66.6%) of the patients accomplished a term delivery with healthy infants. Conclusion: Cryptococcal meningitis should be considered during pregnancy in cases of unexplained headache, altered vision, altered mental status, nausea and fever. Patients with a confirmed diagnosis should be admitted and treated with amphotericin B.
C1 [Botelho Costa, Maria Laura; Dias de Souza, Joao Paulo; de Oliveira Neto, Antonio Francisco; Pinto E Silva, Joao Luiz] Univ Estadual Campinas, Dept Gynecol & Obstet, Campinas, SP, Brazil.
RP Costa, MLB (corresponding author), Adhelar Matthes 113,Casa 30, BR-13085015 Campinas, SP, Brazil.
EM mlaura@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Souza, Joao Paulo/G-1982-2010
OI Costa, Maria Laura/0000-0001-8280-3234; Souza, Joao
   Paulo/0000-0002-2288-4244
CR AITKEN GWE, 1962, J OBSTET GYN BR COMM, V69, P677
   BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303
   Castro G, 2006, REV SOC BRAS MED TRO, V39, P501, DOI 10.1590/S0037-86822006000500016
   Catanzaro A, 1984, Chest, V86, p14S, DOI 10.1378/chest.86.3.14S
   Chen CP, 1996, AM J PERINAT, V13, P35, DOI 10.1055/s-2007-994199
   CHOTMONGKOL V, 1991, Journal of the Medical Association of Thailand, V74, P421
   CROTTY J M, 1965, Med J Aust, V1, P184
   CUROLE DN, 1981, J REPROD MED, V26, P317
   DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602
   Ely EW, 1998, MEDICINE, V77, P153, DOI 10.1097/00005792-199805000-00001
   FELDMAN R, 1959, South Med J, V52, P1415, DOI 10.1097/00007611-195911000-00018
   GANTZ JA, 1958, ARCH INTERN MED, V102, P795, DOI 10.1001/archinte.1958.00260220111011
   IWATANI Y, 1988, AM J REPROD IMMUNOL, V18, P52
   JONES JM, 1983, SOUTHERN MED J, V76, P1567, DOI 10.1097/00007611-198312000-00029
   Kon AS, 2008, REV SOC BRAS MED TRO, V41, P524
   KUO D, 1962, MED J AUSTRALIA, V1, P558, DOI 10.5694/j.1326-5377.1962.tb26119.x
   Kwon-Chung KJ, 2000, MED MYCOL, V38, P205, DOI 10.1080/mmy.38.s1.205.213
   LITTMAN ML, 1959, AM J MED, V27, P976, DOI 10.1016/0002-9343(59)90181-0
   Lopes J O, 1997, Rev Soc Bras Med Trop, V30, P369, DOI 10.1590/S0037-86821997000500003
   MASATOSHI K, 1989, HUM PATHOL, V20, P920
   MOLNARNADASDY G, 1994, ARCH PATHOL LAB MED, V118, P757
   Nucci A, 1999, ARQ NEURO-PSIQUIAT, V57, P678, DOI 10.1590/S0004-282X1999000400023
   Pappalardo Mara C.S.M., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P299, DOI 10.1590/S0036-46652003000600001
   Pereira Carlos Alberto Pires, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P367, DOI 10.1590/S0036-46651993000400011
   ROSS C, 1972, MED J AUSTRALIA, V2, P1005, DOI 10.5694/j.1326-5377.1972.tb103682.x
   Sanfelice F, 1894, ANN IGIEN, V4, P463
   SILBERFARB PM, 1972, AM J OBSTET GYNECOL, V112, P714, DOI 10.1016/0002-9378(72)90800-9
   STAFFORD CR, 1983, OBSTET GYNECOL, V62, pS35
   Timerman HJ, 1935, FATAL CASE YEAST MEN
   Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
   WAGER H E, 1954, Trans Am Acad Ophthalmol Otolaryngol, V58, P61
NR 31
TC 16
Z9 16
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD SEP-OCT
PY 2009
VL 51
IS 5
BP 289
EP 294
DI 10.1590/S0036-46652009000500010
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 528PN
UT WOS:000272458800011
PM 19893983
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Costa, ML
   Cecatti, JG
   Milanez, HM
   Souza, JP
   Gulmezoglu, M
AF Costa, Maria L.
   Cecatti, Jose G.
   Milanez, Helaine M.
   Souza, Joao P.
   Guelmezoglu, Metin
TI Audit and feedback: Effects on professional obstetrical practice and
   healthcare outcomes in a university hospital
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE Audit and feedback; labor; obstetrics; RHL
ID GUIDELINES GUIDE PRACTICE; STRATEGIES
AB Objective. To assess the effects of audit and feedback on the practice of professionals in obstetrics. Design. Before-after intervention study. Setting. Obstetric unit of a university hospital in Brazil. Methods. Before the intervention the prevalence rates of six evidence-based interventions were assessed. Seminars and workshops were administered, with the baseline results and also the main contents from systematic reviews on the topics studied, followed by detailed discussion of each topic, based on the Reproductive Health Library. After four months, the same practices were measured again and compared with the pre-intervention period. Main outcome measures. Selective episiotomy; continuous electronic fetal monitoring (EFM) during labor of low-risk pregnant women; antibiotic prophylaxis in cesarean section; active management of third stage of labor; routine induction of labor at 41 weeks for uncomplicated pregnancies; and continuous support for women during childbirth. Results. Both periods showed a similar number and mode of deliveries. There was a significant reduction in episiotomies (RR = 0.84; 0.73-0.97) and an increase in continuous support for women during childbirth by a companion (RR = 1.42; 1.24-1.63). Although there was not a significant change in the use of oxytocin during the third stage of labor, there was a shift to the internationally recommended dosage of 10 IU (p0.0001). There was no significant change in the use of antibiotic prophylaxis for cesarean section, continuous EFM, or routine induction of labor at 41 weeks for uncomplicated pregnancies. Conclusion. Audit and feedback can be used as a tool to improve obstetrical practice, at least for some interventions and when the medical staff is open and receptive to change.
C1 [Costa, Maria L.; Cecatti, Jose G.; Milanez, Helaine M.; Souza, Joao P.] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Souza, Joao P.; Guelmezoglu, Metin] WHO, Special Programme Res Dev & Res Training Human Re, Dept Reprod Hlth & Res, UNDP,UNFPA,World Bank, CH-1211 Geneva, Switzerland.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Costa, Maria Laura/I-4980-2019; Souza, Joao Paulo/G-1982-2010
OI Costa, Maria Laura/0000-0001-8280-3234; Souza, Joao
   Paulo/0000-0002-2288-4244
FU FAPESP (Foundation of Support to Research from the State of Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2007/01397-0]
FX FAPESP (Foundation of Support to Research from the State of Sao Paulo)
   is thanked for financial sponsorship (Grant 2007/01397-0).
CR ABALOS E, 2007, ACTIVE MANAGEMENT TH
   ALFIREVIC Z, 2007, COCHRANE DB SYST REV, P3
   [Anonymous], 2004, Obstet Gynecol, V104, P213
   Belizan M, 2007, HEALTH EDUC RES, V22, P839, DOI 10.1093/her/cym012
   Bruggemann Odalea M, 2007, Reprod Health, V4, P5, DOI 10.1186/1742-4755-4-5
   Carrizo G, 2009, CPU-REV INVESTIG EDU, P2
   CECATTI JG, 2005, ANTIBIOTIC PROPHYLAX
   Chaillet N, 2006, OBSTET GYNECOL, V108, P1234, DOI 10.1097/01.AOG.0000236434.74160.8b
   Cochrane AL, 1972, EFFECTIVENESS EFFICI
   COTTER A, 2007, COCHRANE DB SYST REV, P4
   CROMBIE IK, 1997, AUDIT HDB IMPROVING
   CUERVO LG, 2006, INDUCTION LABOUR IMP
   Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298
   Grimshaw J. M., 2001, MED CARE S2, V39, pII, DOI DOI 10.1097/00005650-200108002-00002
   GULMEZOGLU AM, 2007, COCHRANE DB SYST REV, P4
   HODNETT ED, 2007, COCHRANE DB SYST REV, P4
   JAMTVEDT G, 2006, COCHRANE DB SYST REV, P2
   LANGER A, 2007, CONTINUOUS SUPPORT W
   Liljestrand J., 2003, EPISIOTOMY VAGINAL B
   LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906
   Mousa HA, 2000, ACTA OBSTET GYN SCAN, V79, P1086, DOI 10.1034/j.1600-0412.2000.0790121086.x
   Nardin J. M., 2007, CONTINUOUS CARDIOTOC
   Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446
   Penney G, 2007, BEST PRACT RES CL OB, V21, P657, DOI 10.1016/j.bpobgyn.2007.01.014
   PRENDIVILLE WJ, 2007, COCHRANE DB SYST REV, P4
   SMAILL F, 2007, COCHRANE DB SYST REV, P3
   Taylor G M, 2000, Health Bull (Edinb), V58, P38
   Waters E, 2006, J EPIDEMIOL COMMUN H, V60, P285, DOI 10.1136/jech.2003.015354
   *WHO, 2004, WHO M GEN WHO
   Young P, 2001, J ROY SOC MED, V94, P226
NR 30
TC 13
Z9 13
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PY 2009
VL 88
IS 7
BP 793
EP 800
AR PII 911264608
DI 10.1080/00016340903002857
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 460QN
UT WOS:000267202300008
PM 19452325
DA 2020-12-08
ER

EF